Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:antiviral drug
go back to main search page
Accession:CHEBI:36044 term browser browse the term
Definition:A substance used in the prophylaxis or therapy of virus diseases.
Synonyms:related_synonym: anti-viral drug;   anti-virus drug;   antiviral drugs



show annotations for term's descendants           Sort by:
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions
EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]
CTD PMID:31029725 NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
EXP Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA; 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein
CTD PMID:31029725 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein] CTD PMID:31029725 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA] CTD PMID:31029725 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein] CTD PMID:31029725 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein] CTD PMID:31029725 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation
multiple interactions
EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased phosphorylation of MAPK8 protein
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]
CTD PMID:31029725 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions
affects localization
EXP NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein] CTD PMID:31029725 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of and affects the stability of NFKBIA protein] CTD PMID:31029725 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions
increases expression
EXP NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA] CTD PMID:31029725 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions
increases expression
EXP Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA] CTD PMID:31029725 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA] CTD PMID:31029725 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
5-iodo-2'-deoxyuridine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Mbd4 methyl-CpG binding domain protein 4 affects response to substance EXP MBD4 protein affects the susceptibility to Idoxuridine CTD PMID:16885370 NCBI chr 6:115,817,658...115,830,361
Ensembl chr 6:115,817,658...115,830,332
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Idoxuridine results in increased activity of NR1I2 protein CTD PMID:25455453 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Slc28a1 solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 multiple interactions ISO Idoxuridine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine] CTD PMID:8713072 NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
JBrowse link
G Tyms thymidylate synthase affects uptake EXP TYMS protein affects the uptake of Idoxuridine CTD PMID:15001691 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
abacavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions
increases export
decreases export
ISO
EXP
[Estradiol results in decreased activity of ABCG2 protein] which results in increased uptake of abacavir; [isopropyl 5,12-hydroxypentadeca-8,10-dien-6,14-diynoate results in decreased activity of ABCG2 protein] which results in increased uptake of abacavir
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of abacavir]; Elacridar inhibits the reaction [ABCG2 protein results in decreased export of abacavir]; Elacridar inhibits the reaction [ABCG2 protein results in increased export of abacavir]; Nelfinavir inhibits the reaction [ABCG2 protein results in increased export of abacavir]; pluronic block copolymer p85 inhibits the reaction [ABCG2 protein results in increased export of abacavir]
CTD PMID:17437964 PMID:19056916 PMID:25844889 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Alb albumin affects binding
multiple interactions
ISO abacavir binds to ALB protein
abacavir inhibits the reaction [Heme binds to ALB protein]; Heme inhibits the reaction [abacavir binds to ALB protein]
CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 decreases expression ISO abacavir results in decreased expression of ALDH1A2 mRNA CTD PMID:31711903 NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
JBrowse link
G Crp C-reactive protein, pentraxin-related increases expression ISO abacavir results in increased expression of CRP protein CTD PMID:19891054 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity ISO abacavir results in decreased activity of CYP1A1 protein CTD PMID:33814510 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO abacavir results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Eya1 EYA transcriptional coactivator and phosphatase 1 decreases expression ISO abacavir results in decreased expression of EYA1 mRNA CTD PMID:31711903 NCBI chr 1:14,239,177...14,381,259
Ensembl chr 1:14,239,178...14,380,459
JBrowse link
G Fgf8 fibroblast growth factor 8 increases expression ISO abacavir results in increased expression of FGF8 mRNA CTD PMID:31711903 NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354
JBrowse link
G Foxc2 forkhead box C2 decreases expression ISO abacavir results in decreased expression of FOXC2 mRNA CTD PMID:31711903 NCBI chr 8:121,842,910...121,845,634
Ensembl chr 8:121,842,910...121,845,634
JBrowse link
G Gfap glial fibrillary acidic protein increases expression ISO abacavir results in increased expression of GFAP protein CTD PMID:19358275 NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 affects response to substance
multiple interactions
increases response to substance
ISO
EXP
HLA-B protein affects the susceptibility to abacavir
HLA-B gene polymorphism results in increased susceptibility to [CPG-oligonucleotide co-treated with abacavir]
[HLA-B protein alternative form results in increased susceptibility to abacavir] which results in increased expression of PDCD1; [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of IFNG protein; [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of IL13 protein; [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of TNF protein
HLA-B gene polymorphism results in increased susceptibility to abacavir; HLA-B protein alternative form results in increased susceptibility to abacavir; HLA-B protein polymorphism results in increased susceptibility to abacavir
CTD PMID:11943262 PMID:15024131 PMID:23541086 PMID:29319822 PMID:34606953 NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G Hoxb7 homeobox B7 increases expression ISO abacavir results in increased expression of HOXB7 mRNA CTD PMID:31711903 NCBI chr11:96,176,431...96,180,989
Ensembl chr11:96,177,449...96,180,988
JBrowse link
G Hoxb9 homeobox B9 increases expression ISO abacavir results in increased expression of HOXB9 mRNA CTD PMID:31711903 NCBI chr11:96,162,156...96,167,421
Ensembl chr11:96,162,283...96,167,421
JBrowse link
G Ifng interferon gamma multiple interactions ISO [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of IFNG protein CTD PMID:23541086 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il13 interleukin 13 multiple interactions ISO [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of IL13 protein CTD PMID:23541086 NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
JBrowse link
G Il4 interleukin 4 affects response to substance ISO IL4 protein affects the susceptibility to abacavir CTD PMID:15867870 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Meox1 mesenchyme homeobox 1 decreases expression ISO abacavir results in decreased expression of MEOX1 mRNA CTD PMID:31711903 NCBI chr11:101,768,336...101,785,309
Ensembl chr11:101,768,336...101,785,200
JBrowse link
G Mesp2 mesoderm posterior 2 decreases expression ISO abacavir results in decreased expression of MESP2 mRNA CTD PMID:31711903 NCBI chr 7:79,460,475...79,463,179
Ensembl chr 7:79,460,475...79,463,187
JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression ISO abacavir results in increased expression of MMP9 protein CTD PMID:19891054 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mpo myeloperoxidase increases expression ISO abacavir results in increased expression of MPO protein CTD PMID:19891054 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Neurog2 neurogenin 2 increases expression ISO abacavir results in increased expression of NEUROG2 mRNA CTD PMID:31711903 NCBI chr 3:127,426,382...127,429,285
Ensembl chr 3:127,426,784...127,429,280
JBrowse link
G Olig3 oligodendrocyte transcription factor 3 increases expression ISO abacavir results in increased expression of OLIG3 mRNA CTD PMID:31711903 NCBI chr10:19,232,287...19,234,352
Ensembl chr10:19,232,281...19,234,352
JBrowse link
G Pax3 paired box 3 decreases expression ISO abacavir results in decreased expression of PAX3 mRNA CTD PMID:31711903 NCBI chr 1:78,077,904...78,173,773
Ensembl chr 1:78,077,904...78,173,771
JBrowse link
G Pax6 paired box 6 increases expression ISO abacavir results in increased expression of PAX6 mRNA CTD PMID:31711903 NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
JBrowse link
G Pdcd1 programmed cell death 1 multiple interactions ISO [HLA-B protein alternative form results in increased susceptibility to abacavir] which results in increased expression of PDCD1 CTD PMID:34606953 NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
JBrowse link
G Slc22a1 solute carrier family 22 (organic cation transporter), member 1 multiple interactions ISO [Quinine results in decreased activity of SLC22A1] which results in decreased uptake of abacavir CTD PMID:25844889 NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
JBrowse link
G Syp synaptophysin increases expression ISO abacavir results in increased expression of SYP protein CTD PMID:19358275 NCBI chr  X:7,504,819...7,519,495
Ensembl chr  X:7,504,710...7,519,495
JBrowse link
G Tcf15 transcription factor 15 decreases expression ISO abacavir results in decreased expression of TCF15 mRNA CTD PMID:31711903 NCBI chr 2:151,984,973...151,991,017
Ensembl chr 2:151,985,481...151,991,017
JBrowse link
G Tert telomerase reverse transcriptase decreases activity ISO abacavir results in decreased activity of TERT protein CTD PMID:19358275 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [HLA-B protein polymorphism results in increased susceptibility to abacavir] which results in increased secretion of TNF protein CTD PMID:23541086 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Ucp1 uncoupling protein 1 (mitochondrial, proton carrier) increases expression ISO abacavir results in increased expression of UCP1 mRNA CTD PMID:14518702 NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
JBrowse link
G Uncx UNC homeobox decreases expression ISO abacavir results in decreased expression of UNCX mRNA CTD PMID:31711903 NCBI chr 5:139,529,620...139,533,934
Ensembl chr 5:139,529,249...139,533,934
JBrowse link
acyclovir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) affects transport
multiple interactions
EXP
ISO
ABCG2 protein affects the transport of Acyclovir
tryptoquivaline inhibits the reaction [ABCG2 protein affects the transport of Acyclovir]
CTD PMID:21859328 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Aqp2 aquaporin 2 decreases expression ISO Acyclovir results in decreased expression of AQP2 protein CTD PMID:14675048 NCBI chr15:99,476,937...99,482,426
Ensembl chr15:99,476,936...99,482,428
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO Acyclovir inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] CTD PMID:36416909 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO Acyclovir inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] CTD PMID:36416909 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 increases expression
multiple interactions
ISO Acyclovir results in increased expression of CXCL8 mRNA
Acyclovir inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]
CTD PMID:32816093 PMID:36416909 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase decreases activity ISO Acyclovir results in decreased activity of HAAO protein CTD PMID:17174341 NCBI chr17:84,138,777...84,157,589
Ensembl chr17:84,138,585...84,155,392
JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 decreases activity ISO Acyclovir results in decreased activity of IDO1 protein CTD PMID:17174341 NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
JBrowse link
G Il12b interleukin 12b multiple interactions ISO Acyclovir inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] CTD PMID:36416909 NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Acyclovir results in increased expression of IL1A mRNA CTD PMID:32816093 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Acyclovir results in increased expression of IL1B mRNA CTD PMID:32816093 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il24 interleukin 24 increases expression ISO Acyclovir results in increased expression of IL24 mRNA CTD PMID:32816093 NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
JBrowse link
G Mr1 major histocompatibility complex, class I-related affects expression ISO Acyclovir affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr 1:155,003,620...155,022,560
Ensembl chr 1:155,003,023...155,022,560
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression ISO Acyclovir results in increased expression of PTGS2 mRNA CTD PMID:32816093 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Slc12a1 solute carrier family 12, member 1 decreases expression ISO Acyclovir results in decreased expression of SLC12A1 mRNA; Acyclovir results in decreased expression of SLC12A1 protein CTD PMID:14675048 NCBI chr 2:124,994,430...125,071,922
Ensembl chr 2:124,994,425...125,071,922
JBrowse link
G Slc17a1 solute carrier family 17 (sodium phosphate), member 1 decreases expression ISO Acyclovir results in decreased expression of SLC17A1 mRNA; Acyclovir results in decreased expression of SLC17A1 protein CTD PMID:14675048 NCBI chr13:24,051,607...24,079,713
Ensembl chr13:24,051,733...24,079,713
JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 increases expression ISO Acyclovir results in increased expression of SLC7A11 mRNA CTD PMID:32816093 NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO Acyclovir results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase decreases activity ISO Acyclovir results in decreased activity of TDO2 protein CTD PMID:18665439 NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Acyclovir inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] CTD PMID:36416909 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
adefovir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb4 ATP-binding cassette, sub-family B member 4 multiple interactions
affects transport
ISO Calcitriol promotes the reaction [ABCB4 protein affects the transport of adefovir] CTD PMID:21240898 PMID:21341280 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
G Abcc4 ATP-binding cassette, sub-family C member 4 affects abundance
decreases expression
multiple interactions
increases export
ISO ABCC4 protein affects the abundance of adefovir
adefovir results in decreased expression of ABCC4 protein
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of ABCC4 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] affects the expression of ABCC4 protein; [adefovir co-treated with Probenecid] results in decreased expression of ABCC4 protein
ABCC4 protein results in increased export of adefovir
CTD PMID:18364470 PMID:35114312 NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
JBrowse link
G Acta2 actin alpha 2, smooth muscle, aorta increases expression
multiple interactions
ISO adefovir results in increased expression of ACTA2 protein
[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]
CTD PMID:35114312 NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
JBrowse link
G Agt angiotensinogen multiple interactions ISO [Probenecid co-treated with adefovir] results in increased expression of AGT protein; [Probenecid co-treated with Valsartan co-treated with adefovir] results in increased expression of AGT protein; Cromolyn Sodium inhibits the reaction [[Probenecid co-treated with adefovir] results in increased expression of AGT protein] CTD PMID:35114312 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G B2m beta-2 microglobulin increases secretion ISO adefovir results in increased secretion of B2M protein CTD PMID:27742868 NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
JBrowse link
G Calb1 calbindin 1 increases secretion ISO adefovir results in increased secretion of CALB1 protein CTD PMID:27742868 NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064
JBrowse link
G Cma1 chymase 1, mast cell increases secretion ISO adefovir results in increased secretion of CMA1 protein CTD PMID:35114312 NCBI chr14:56,178,908...56,182,132
Ensembl chr14:56,178,908...56,182,132
JBrowse link
G Cst3 cystatin C multiple interactions
increases expression
ISO [adefovir co-treated with Probenecid] results in increased expression of CST3 protein; [Probenecid co-treated with Valsartan co-treated with adefovir] results in increased expression of CST3 protein; [Probenecid co-treated with Valsartan] inhibits the reaction [adefovir results in increased expression of CST3 protein]; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of CST3 protein] CTD PMID:35114312 NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 decreases activity ISO adefovir results in decreased activity of CYP2C9 protein CTD PMID:17162464 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases secretion ISO adefovir results in increased secretion of HAVCR1 protein CTD PMID:27742868 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Lcn2 lipocalin 2 increases secretion ISO adefovir results in increased secretion of LCN2 protein CTD PMID:27742868 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
JBrowse link
G Mmut methylmalonyl-Coenzyme A mutase affects expression
increases expression
ISO adefovir affects the expression of MMUT mRNA mutant form; adefovir affects the expression of MMUT protein mutant form
adefovir results in increased expression of MMUT mRNA; adefovir results in increased expression of MMUT protein
CTD PMID:19199343 PMID:19427250 NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
JBrowse link
G Slc22a6 solute carrier family 22 (organic anion transporter), member 6 increases uptake
decreases expression
multiple interactions
affects response to substance
increases response to substance
ISO SLC22A6 protein results in increased uptake of adefovir
adefovir results in decreased expression of SLC22A6 protein
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of SLC22A6 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] affects the expression of SLC22A6 protein; [adefovir co-treated with Probenecid] results in decreased expression of SLC22A6 protein; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A6 protein]
SLC22A6 protein affects the susceptibility to adefovir
adefovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]; Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to adefovir]; quercetin 3'-sulfate inhibits the reaction [SLC22A6 protein affects the susceptibility to adefovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to adefovir
CTD PMID:16857889 PMID:21244849 PMID:23856525 PMID:25448811 PMID:35114312 NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 increases response to substance
decreases expression
multiple interactions
ISO SLC22A8 protein results in increased susceptibility to adefovir
adefovir results in decreased expression of SLC22A8 protein
[adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] results in increased expression of SLC22A8 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] results in increased expression of SLC22A8 protein; [adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein]
CTD PMID:25448811 PMID:35114312 NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Spp1 secreted phosphoprotein 1 increases secretion ISO adefovir results in increased secretion of SPP1 protein CTD PMID:27742868 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
ISO [adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein]; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein]
adefovir results in increased expression of TGFB1 protein
CTD PMID:35114312 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
adefovir pivoxil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl-hydrocarbon receptor affects activity ISO adefovir dipivoxil affects the activity of AHR protein CTD PMID:25596134 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Ak4 adenylate kinase 4 increases expression ISO adefovir dipivoxil results in increased expression of AK4 mRNA CTD PMID:25596134 NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
JBrowse link
G Akr1c21 aldo-keto reductase family 1, member C21 decreases expression ISO adefovir dipivoxil results in decreased expression of AKR1C2 mRNA CTD PMID:25596134 NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 decreases expression ISO adefovir dipivoxil results in decreased expression of ALDH18A1 mRNA CTD PMID:25596134 NCBI chr19:40,538,701...40,576,907
Ensembl chr19:40,538,701...40,576,907
JBrowse link
G Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 increases expression ISO adefovir dipivoxil results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
JBrowse link
G Als2cl ALS2 C-terminal like increases expression ISO adefovir dipivoxil results in increased expression of ALS2CL mRNA CTD PMID:25596134 NCBI chr 9:110,709,203...110,729,598
Ensembl chr 9:110,708,938...110,729,598
JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO adefovir dipivoxil results in increased expression of ANGPTL4 mRNA CTD PMID:25596134 NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
JBrowse link
G Asns asparagine synthetase decreases expression ISO adefovir dipivoxil results in decreased expression of ASNS mRNA CTD PMID:25596134 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO adefovir dipivoxil results in increased expression of ATAD2 mRNA CTD PMID:25596134 NCBI chr15:57,957,440...57,998,516
Ensembl chr15:57,957,440...57,998,478
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO adefovir dipivoxil results in increased expression of ATF3 mRNA CTD PMID:25596134 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Aurkb aurora kinase B increases expression ISO adefovir dipivoxil results in increased expression of AURKB mRNA CTD PMID:25596134 NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
JBrowse link
G Axl AXL receptor tyrosine kinase increases expression ISO adefovir dipivoxil results in increased expression of AXL mRNA CTD PMID:25596134 NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
JBrowse link
G Bax BCL2-associated X protein increases expression ISO adefovir dipivoxil results in increased expression of BAX mRNA CTD PMID:25596134 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bcar3 breast cancer anti-estrogen resistance 3 increases expression ISO adefovir dipivoxil results in increased expression of BCAR3 mRNA CTD PMID:25596134 NCBI chr 3:122,213,406...122,323,840
Ensembl chr 3:122,087,785...122,323,840
JBrowse link
G Bend5 BEN domain containing 5 decreases expression ISO adefovir dipivoxil results in decreased expression of BEND5 mRNA CTD PMID:25596134 NCBI chr 4:111,271,993...111,317,495
Ensembl chr 4:111,272,203...111,317,495
JBrowse link
G Bmf BCL2 modifying factor decreases expression ISO adefovir dipivoxil results in decreased expression of BMF mRNA CTD PMID:25596134 NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO adefovir dipivoxil results in increased expression of BTG2 mRNA CTD PMID:25596134 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
JBrowse link
G Ccne2 cyclin E2 increases expression ISO adefovir dipivoxil results in increased expression of CCNE2 mRNA CTD PMID:25596134 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Cdk6 cyclin dependent kinase 6 increases expression ISO adefovir dipivoxil results in increased expression of CDK6 mRNA CTD PMID:25596134 NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A increases expression ISO adefovir dipivoxil results in increased expression of CDKN1A mRNA CTD PMID:25596134 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cmbl carboxymethylenebutenolidase homolog increases expression ISO adefovir dipivoxil results in increased expression of CMBL mRNA CTD PMID:25596134 NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265
JBrowse link
G Coch cochlin increases expression ISO adefovir dipivoxil results in increased expression of COCH mRNA CTD PMID:25596134 NCBI chr12:51,640,156...51,652,558
Ensembl chr12:51,640,124...51,652,554
JBrowse link
G Col4a1 collagen, type IV, alpha 1 decreases expression ISO adefovir dipivoxil results in decreased expression of COL4A1 mRNA CTD PMID:25596134 NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
JBrowse link
G Cth cystathionine gamma lyase decreases expression ISO adefovir dipivoxil results in decreased expression of CTH mRNA CTD PMID:25596134 NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714
JBrowse link
G Ctsc cathepsin C decreases expression ISO adefovir dipivoxil results in decreased expression of CTSC mRNA CTD PMID:25596134 NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO adefovir dipivoxil results in increased expression of CYP1B1 mRNA CTD PMID:25596134 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 decreases activity ISO adefovir dipivoxil results in decreased activity of CYP2C9 protein CTD PMID:17162464 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Ddb2 damage specific DNA binding protein 2 increases expression ISO adefovir dipivoxil results in increased expression of DDB2 mRNA CTD PMID:25596134 NCBI chr 2:91,041,924...91,067,465
Ensembl chr 2:91,041,917...91,067,327
JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression ISO adefovir dipivoxil results in increased expression of DGKA mRNA CTD PMID:25596134 NCBI chr10:128,556,000...128,581,002
Ensembl chr10:128,556,003...128,580,724
JBrowse link
G Dlgap5 DLG associated protein 5 increases expression ISO adefovir dipivoxil results in increased expression of DLGAP5 mRNA CTD PMID:25596134 NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
JBrowse link
G Dlx1 distal-less homeobox 1 decreases expression ISO adefovir dipivoxil results in decreased expression of DLX1 mRNA CTD PMID:25596134 NCBI chr 2:71,358,457...71,364,325
Ensembl chr 2:71,358,457...71,364,325
JBrowse link
G Dnai3 dynein axonemal intermediate chain 3 increases expression ISO adefovir dipivoxil results in increased expression of DNAI3 mRNA CTD PMID:25596134 NCBI chr 3:145,746,281...145,813,855
Ensembl chr 3:145,746,281...145,813,885
JBrowse link
G Dpysl3 dihydropyrimidinase-like 3 increases expression ISO adefovir dipivoxil results in increased expression of DPYSL3 mRNA CTD PMID:25596134 NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351
JBrowse link
G Efna1 ephrin A1 decreases expression ISO adefovir dipivoxil results in decreased expression of EFNA1 mRNA CTD PMID:25596134 NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO adefovir dipivoxil results in increased expression of ERO1A mRNA CTD PMID:25596134 NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
JBrowse link
G Fas Fas cell surface death receptor increases expression ISO adefovir dipivoxil results in increased expression of FAS mRNA CTD PMID:25596134 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fbxo22 F-box protein 22 increases expression ISO adefovir dipivoxil results in increased expression of FBXO22 mRNA CTD PMID:25596134 NCBI chr 9:55,116,219...55,131,717
Ensembl chr 9:55,116,209...55,131,717
JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 decreases expression ISO adefovir dipivoxil results in decreased expression of GABARAPL1 mRNA CTD PMID:25596134 NCBI chr 6:129,510,155...129,519,294
Ensembl chr 6:129,510,123...129,519,309
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha increases expression ISO adefovir dipivoxil results in increased expression of GADD45A mRNA CTD PMID:25596134 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 decreases expression ISO adefovir dipivoxil results in decreased expression of GALNT16 mRNA CTD PMID:25596134 NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression ISO adefovir dipivoxil results in increased expression of GCNT3 mRNA CTD PMID:25596134 NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO adefovir dipivoxil results in increased expression of GDF15 mRNA CTD PMID:25596134 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble decreases expression ISO adefovir dipivoxil results in decreased expression of GOT1 mRNA CTD PMID:25596134 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gpr87 G protein-coupled receptor 87 increases expression ISO adefovir dipivoxil results in increased expression of GPR87 mRNA CTD PMID:25596134 NCBI chr 3:59,086,325...59,102,583
Ensembl chr 3:59,086,344...59,102,525
JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO adefovir dipivoxil results in increased expression of H1-2 mRNA CTD PMID:25596134 NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
JBrowse link
G Hmox1 heme oxygenase 1 decreases expression ISO adefovir dipivoxil results in decreased expression of HMOX1 mRNA CTD PMID:25596134 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hspa1b heat shock protein 1B decreases expression ISO adefovir dipivoxil results in decreased expression of HSPA1B mRNA CTD PMID:25596134 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
JBrowse link
G Ifng interferon gamma multiple interactions EXP adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] CTD PMID:9354585 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il19 interleukin 19 increases secretion ISO adefovir dipivoxil results in increased secretion of IL19 protein CTD PMID:24714768 NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
JBrowse link
G Kat6b K(lysine) acetyltransferase 6B decreases expression ISO adefovir dipivoxil results in decreased expression of KAT6B mRNA CTD PMID:25596134 NCBI chr14:21,549,284...21,722,546
Ensembl chr14:21,531,502...21,722,546
JBrowse link
G Kdm3a lysine (K)-specific demethylase 3A decreases expression ISO adefovir dipivoxil results in decreased expression of KDM3A mRNA CTD PMID:25596134 NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974
JBrowse link
G Krt15 keratin 15 increases expression ISO adefovir dipivoxil results in increased expression of KRT15 mRNA CTD PMID:25596134 NCBI chr11:100,022,585...100,026,775
Ensembl chr11:100,022,584...100,026,754
JBrowse link
G Lama3 laminin, alpha 3 increases expression ISO adefovir dipivoxil results in increased expression of LAMA3 mRNA CTD PMID:25596134 NCBI chr18:12,466,806...12,716,070
Ensembl chr18:12,466,876...12,716,070
JBrowse link
G Lcn2 lipocalin 2 increases secretion ISO adefovir dipivoxil results in increased secretion of LCN2 protein CTD PMID:24714768 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 increases expression ISO adefovir dipivoxil results in increased expression of MAP3K8 mRNA CTD PMID:25596134 NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 increases expression ISO adefovir dipivoxil results in increased expression of MDM2 mRNA CTD PMID:25596134 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
JBrowse link
G Mxi1 MAX interactor 1, dimerization protein decreases expression ISO adefovir dipivoxil results in decreased expression of MXI1 mRNA CTD PMID:25596134 NCBI chr19:53,298,509...53,361,724
Ensembl chr19:53,298,949...53,364,241
JBrowse link
G Ncapd2 non-SMC condensin I complex, subunit D2 increases expression ISO adefovir dipivoxil results in increased expression of NCAPD2 mRNA CTD PMID:25596134 NCBI chr 6:125,144,970...125,169,062
Ensembl chr 6:125,144,970...125,168,664
JBrowse link
G Ninj1 ninjurin 1 increases expression ISO adefovir dipivoxil results in increased expression of NINJ1 mRNA CTD PMID:25596134 NCBI chr13:49,341,005...49,349,727
Ensembl chr13:49,340,961...49,349,720
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions EXP adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] CTD PMID:9354585 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 decreases expression ISO adefovir dipivoxil results in decreased expression of NQO1 mRNA CTD PMID:25596134 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nrep neuronal regeneration related protein decreases expression ISO adefovir dipivoxil results in decreased expression of NREP mRNA CTD PMID:25596134 NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
JBrowse link
G Ntpcr nucleoside-triphosphatase, cancer-related increases expression ISO adefovir dipivoxil results in increased expression of NTPCR mRNA CTD PMID:25596134 NCBI chr 8:126,456,724...126,474,974
Ensembl chr 8:126,456,702...126,474,974
JBrowse link
G P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide decreases expression ISO adefovir dipivoxil results in decreased expression of P4HA1 mRNA CTD PMID:25596134 NCBI chr10:59,159,019...59,209,126
Ensembl chr10:59,159,118...59,209,126
JBrowse link
G Pank1 pantothenate kinase 1 decreases expression ISO adefovir dipivoxil results in decreased expression of PANK1 mRNA CTD PMID:25596134 NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855
JBrowse link
G Pdia5 protein disulfide isomerase associated 5 increases expression ISO adefovir dipivoxil results in increased expression of PDIA5 mRNA CTD PMID:25596134 NCBI chr16:35,217,678...35,311,289
Ensembl chr16:35,217,682...35,311,243
JBrowse link
G Pdlim1 PDZ and LIM domain 1 (elfin) increases expression ISO adefovir dipivoxil results in increased expression of PDLIM1 mRNA CTD PMID:25596134 NCBI chr19:40,210,683...40,260,060
Ensembl chr19:40,209,617...40,260,286
JBrowse link
G Pgr progesterone receptor multiple interactions ISO adefovir dipivoxil binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Phlda3 pleckstrin homology like domain, family A, member 3 increases expression ISO adefovir dipivoxil results in increased expression of PHLDA3 mRNA CTD PMID:25596134 NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874
JBrowse link
G Pidd1 p53 induced death domain protein 1 increases expression ISO adefovir dipivoxil results in increased expression of PIDD1 mRNA CTD PMID:25596134 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
JBrowse link
G Pir pirin increases expression ISO adefovir dipivoxil results in increased expression of PIR mRNA CTD PMID:25596134 NCBI chr  X:163,052,427...163,156,009
Ensembl chr  X:163,052,367...163,156,007
JBrowse link
G Plec plectin increases expression ISO adefovir dipivoxil results in increased expression of PLEC mRNA CTD PMID:25596134 NCBI chr15:76,055,174...76,115,578
Ensembl chr15:76,055,174...76,116,774
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO adefovir dipivoxil results in increased expression of PMAIP1 mRNA CTD PMID:25596134 NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma affects activity ISO adefovir dipivoxil affects the activity of PPARG protein CTD PMID:25596134 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppm1d protein phosphatase 1D magnesium-dependent, delta isoform increases expression ISO adefovir dipivoxil results in increased expression of PPM1D mRNA CTD PMID:25596134 NCBI chr11:85,202,080...85,237,897
Ensembl chr11:85,202,070...85,237,892
JBrowse link
G Prc1 protein regulator of cytokinesis 1 increases expression ISO adefovir dipivoxil results in increased expression of PRC1 mRNA CTD PMID:25596134 NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007
JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain increases expression ISO adefovir dipivoxil results in increased expression of PRDM1 mRNA CTD PMID:25596134 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
JBrowse link
G Prkab2 protein kinase, AMP-activated, beta 2 non-catalytic subunit decreases expression ISO adefovir dipivoxil results in decreased expression of PRKAB2 mRNA CTD PMID:25596134 NCBI chr 3:97,565,527...97,581,128
Ensembl chr 3:97,565,509...97,581,128
JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO adefovir dipivoxil results in decreased expression of PSAT1 mRNA CTD PMID:25596134 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Rara retinoic acid receptor, alpha decreases expression ISO adefovir dipivoxil results in decreased expression of RARA mRNA CTD PMID:25596134 NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
JBrowse link
G Rps27l ribosomal protein S27-like increases expression ISO adefovir dipivoxil results in increased expression of RPS27L mRNA CTD PMID:25596134 NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798
JBrowse link
G Rrm2b ribonucleotide reductase M2 B (TP53 inducible) increases expression ISO adefovir dipivoxil results in increased expression of RRM2B mRNA CTD PMID:25596134 NCBI chr15:37,924,196...37,961,562
Ensembl chr15:37,924,196...37,961,562
JBrowse link
G Serpinb5 serine (or cysteine) peptidase inhibitor, clade B, member 5 increases expression ISO adefovir dipivoxil results in increased expression of SERPINB5 mRNA CTD PMID:25596134 NCBI chr 1:106,788,905...106,811,078
Ensembl chr 1:106,788,903...106,811,078
JBrowse link
G Sesn1 sestrin 1 increases expression ISO adefovir dipivoxil results in increased expression of SESN1 mRNA CTD PMID:25596134 NCBI chr10:41,686,570...41,784,432
Ensembl chr10:41,685,931...41,784,420
JBrowse link
G Sfn stratifin increases expression ISO adefovir dipivoxil results in increased expression of SFN mRNA CTD PMID:25596134 NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
JBrowse link
G Sh3tc1 SH3 domain and tetratricopeptide repeats 1 decreases expression ISO adefovir dipivoxil results in decreased expression of SH3TC1 mRNA CTD PMID:25596134 NCBI chr 5:35,854,524...35,897,331
Ensembl chr 5:35,854,524...35,897,331
JBrowse link
G Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 decreases expression ISO adefovir dipivoxil results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
JBrowse link
G Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 decreases expression ISO adefovir dipivoxil results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 NCBI chr 4:117,692,240...117,726,502
Ensembl chr 4:117,691,703...117,732,395
JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 increases expression ISO adefovir dipivoxil results in increased expression of SLCO2B1 mRNA CTD PMID:25596134 NCBI chr 7:99,307,011...99,360,547
Ensembl chr 7:99,307,011...99,360,547
JBrowse link
G Smap1 small ArfGAP 1 decreases expression ISO adefovir dipivoxil results in decreased expression of SMAP1 mRNA CTD PMID:25596134 NCBI chr 1:23,883,925...23,961,462
Ensembl chr 1:23,883,927...23,961,398
JBrowse link
G Sulf2 sulfatase 2 increases expression ISO adefovir dipivoxil results in increased expression of SULF2 mRNA CTD PMID:25596134 NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583
JBrowse link
G Thra thyroid hormone receptor alpha multiple interactions ISO adefovir dipivoxil binds to and results in decreased activity of THRA protein CTD PMID:25752796 NCBI chr11:98,631,539...98,659,832
Ensembl chr11:98,631,464...98,659,832
JBrowse link
G Tigar Trp53 induced glycolysis regulatory phosphatase increases expression ISO adefovir dipivoxil results in increased expression of TIGAR mRNA CTD PMID:25596134 NCBI chr 6:127,062,079...127,086,564
Ensembl chr 6:127,062,079...127,086,520
JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression ISO adefovir dipivoxil results in increased expression of TIPARP mRNA CTD PMID:25596134 NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939
JBrowse link
G Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9 increases expression ISO adefovir dipivoxil results in increased expression of TNFSF9 mRNA CTD PMID:25596134 NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
JBrowse link
G Trafd1 TRAF type zinc finger domain containing 1 decreases expression ISO adefovir dipivoxil results in decreased expression of TRAFD1 mRNA CTD PMID:25596134 NCBI chr 5:121,509,788...121,524,543
Ensembl chr 5:121,509,788...121,523,695
JBrowse link
G Triap1 TP53 regulated inhibitor of apoptosis 1 increases expression ISO adefovir dipivoxil results in increased expression of TRIAP1 mRNA CTD PMID:25596134 NCBI chr 5:115,479,290...115,481,612
Ensembl chr 5:115,479,284...115,481,628
JBrowse link
G Trp53 transformation related protein 53 affects activity ISO adefovir dipivoxil affects the activity of TP53 protein CTD PMID:25596134 PMID:35435491 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trp53inp1 transformation related protein 53 inducible nuclear protein 1 increases expression ISO adefovir dipivoxil results in increased expression of TP53INP1 mRNA CTD PMID:25596134 NCBI chr 4:11,156,441...11,174,379
Ensembl chr 4:11,156,431...11,174,379
JBrowse link
G Ube2o ubiquitin-conjugating enzyme E2O decreases expression ISO adefovir dipivoxil results in decreased expression of UBE2O mRNA CTD PMID:25596134 NCBI chr11:116,428,500...116,472,281
Ensembl chr11:116,428,566...116,472,273
JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 decreases expression ISO adefovir dipivoxil results in decreased expression of YARS1 mRNA CTD PMID:25596134 NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400
JBrowse link
G Zmat3 zinc finger matrin type 3 increases expression ISO adefovir dipivoxil results in increased expression of ZMAT3 mRNA CTD PMID:25596134 NCBI chr 3:32,388,941...32,419,814
Ensembl chr 3:32,388,941...32,420,163
JBrowse link
amantadine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bdnf brain derived neurotrophic factor multiple interactions ISO [Fluoxetine co-treated with Amantadine] results in increased expression of BDNF mRNA CTD PMID:19211973 NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 increases expression ISO Amantadine results in increased expression of IFI27 mRNA CTD PMID:16756086 NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
JBrowse link
G Ifnar1 interferon (alpha and beta) receptor 1 affects expression ISO Amantadine affects the expression of IFNAR1 mRNA CTD PMID:16756086 NCBI chr16:91,281,016...91,307,411
Ensembl chr16:91,282,126...91,304,329
JBrowse link
G Jak1 Janus kinase 1 increases expression ISO Amantadine results in increased expression of JAK1 protein CTD PMID:16756086 NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
JBrowse link
G Kcnh2 potassium voltage-gated channel, subfamily H (eag-related), member 2 decreases activity ISO Amantadine results in decreased activity of KCNH2 protein CTD PMID:21158687 NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
JBrowse link
G Map2 microtubule-associated protein 2 decreases expression ISO Amantadine results in decreased expression of MAP2 mRNA CTD PMID:34748853 NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
JBrowse link
G Oas2 2'-5' oligoadenylate synthetase 2 increases expression ISO Amantadine results in increased expression of OAS2 mRNA CTD PMID:16756086 NCBI chr 5:120,868,398...120,887,949
Ensembl chr 5:120,868,398...120,887,918
JBrowse link
G Slc47a1 solute carrier family 47, member 1 multiple interactions ISO Amantadine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
JBrowse link
G Slc47a2 solute carrier family 47, member 2 multiple interactions ISO Amantadine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr11:61,192,453...61,233,686
Ensembl chr11:61,192,457...61,233,686
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO [Amantadine co-treated with Ursodeoxycholic Acid co-treated with 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester] results in increased activity of STAT1 CTD PMID:15918519 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
JBrowse link
G Tdp1 tyrosyl-DNA phosphodiesterase 1 decreases activity ISO Amantadine analog results in decreased activity of TDP1 protein CTD PMID:29248742 NCBI chr12:99,850,767...99,921,482
Ensembl chr12:99,850,776...99,921,478
JBrowse link
amprenavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases activity ISO amprenavir results in decreased activity of ABCB11 protein CTD PMID:20829430 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A increases transport
multiple interactions
affects binding
ISO ABCB1 protein results in increased transport of amprenavir
[Elacridar binds to and results in decreased activity of ABCB1 protein] which results in decreased export of amprenavir
amprenavir binds to ABCB1 protein
CTD PMID:23976943 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO amprenavir results in increased expression of CCL2 protein CTD PMID:17668557 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO amprenavir results in increased expression of CCL3 protein CTD PMID:17668557 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of amprenavir] CTD PMID:18799805 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
aphidicolin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atm ataxia telangiectasia mutated multiple interactions EXP [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRIM28 protein]; [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein] CTD PMID:22003191 NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
JBrowse link
G Atr ataxia telangiectasia and Rad3 related multiple interactions EXP [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein] CTD PMID:22003191 NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin multiple interactions
increases expression
EXP [7-hydroxystaurosporine results in decreased activity of [CHEK1 protein co-treated with BSCL2 protein]] inhibits the reaction [Aphidicolin results in increased expression of CHEK2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA] CTD PMID:22003191 NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047
JBrowse link
G Ccna2 cyclin A2 increases expression ISO Aphidicolin results in increased expression of CCNA2 mRNA CTD PMID:14738865 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions EXP [7-hydroxystaurosporine results in decreased activity of [CHEK1 protein co-treated with BSCL2 protein]] inhibits the reaction [Aphidicolin results in increased expression of CHEK2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein] CTD PMID:22003191 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO
EXP
Caffeine promotes the reaction [Aphidicolin promotes the reaction [PRKDC protein results in increased phosphorylation of and results in increased activity of CHEK2 protein]]
[7-hydroxystaurosporine results in decreased activity of [CHEK1 protein co-treated with BSCL2 protein]] inhibits the reaction [Aphidicolin results in increased expression of CHEK2 mRNA]
CTD PMID:18158334 PMID:22003191 NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 increases expression EXP Aphidicolin results in increased expression of CYP26A1 mRNA CTD PMID:29990529 NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984
JBrowse link
G Fgf8 fibroblast growth factor 8 increases expression EXP Aphidicolin results in increased expression of FGF8 mRNA CTD PMID:29990529 NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354
JBrowse link
G H2ax H2A.X variant histone multiple interactions ISO Aphidicolin inhibits the reaction [Docetaxel results in increased expression of H2AX protein] CTD PMID:20878124 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G Hoxb9 homeobox B9 decreases expression EXP Aphidicolin results in decreased expression of HOXB9 mRNA CTD PMID:29990529 NCBI chr11:96,162,156...96,167,421
Ensembl chr11:96,162,283...96,167,421
JBrowse link
G Hoxc6 homeobox C6 decreases expression EXP Aphidicolin results in decreased expression of HOXC6 mRNA CTD PMID:29990529 NCBI chr15:102,906,658...102,920,314
Ensembl chr15:102,906,689...102,920,313
JBrowse link
G Pola1 polymerase (DNA directed), alpha 1 decreases activity ISO Aphidicolin results in decreased activity of POLA1 protein CTD PMID:224865 NCBI chr  X:92,348,372...92,675,993
Ensembl chr  X:92,348,373...92,675,761
JBrowse link
G Prkdc protein kinase, DNA activated, catalytic polypeptide multiple interactions ISO Caffeine promotes the reaction [Aphidicolin promotes the reaction [PRKDC protein results in increased phosphorylation of and results in increased activity of CHEK2 protein]] CTD PMID:18158334 NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099
JBrowse link
G Rxra retinoid X receptor alpha increases expression ISO Aphidicolin results in increased expression of RXRA mRNA CTD PMID:14738865 NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
JBrowse link
G Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) increases expression EXP Aphidicolin results in increased expression of SRXN1 mRNA CTD PMID:22003191 NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
JBrowse link
G Tbx6 T-box 6 decreases expression EXP Aphidicolin results in decreased expression of TBX6 mRNA CTD PMID:29990529 NCBI chr 7:126,380,655...126,384,720
Ensembl chr 7:126,380,655...126,384,732
JBrowse link
G Tnfrsf8 tumor necrosis factor receptor superfamily, member 8 increases expression ISO Aphidicolin results in increased expression of TNFRSF8 protein CTD PMID:12441127 NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
JBrowse link
G Trim28 tripartite motif-containing 28 multiple interactions EXP [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRIM28 protein] CTD PMID:22003191 NCBI chr 7:12,758,079...12,764,959
Ensembl chr 7:12,733,041...12,764,962
JBrowse link
G Trp53 transformation related protein 53 multiple interactions EXP [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein] CTD PMID:22003191 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Wnt3a wingless-type MMTV integration site family, member 3A decreases expression EXP Aphidicolin results in decreased expression of WNT3A mRNA CTD PMID:29990529 NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578
JBrowse link
G Xrcc4 X-ray repair complementing defective repair in Chinese hamster cells 4 decreases response to substance ISO XRCC4 results in decreased susceptibility to Aphidicolin CTD PMID:21785230 NCBI chr13:89,997,033...90,237,727
Ensembl chr13:89,922,146...90,237,727
JBrowse link
atazanavir sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases activity
multiple interactions
ISO Atazanavir Sulfate results in decreased activity of ABCB11 protein
Atazanavir Sulfate inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:24014644 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A increases transport
multiple interactions
ISO ABCB1 protein results in increased transport of Atazanavir Sulfate
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ABCB1 mRNA
CTD PMID:29859254 PMID:33819548 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb4 ATP-binding cassette, sub-family B member 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ABCB4 mRNA CTD PMID:33819548 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 decreases expression ISO Atazanavir Sulfate results in decreased expression of ABCC2 mRNA CTD PMID:32152650 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 decreases expression ISO Atazanavir Sulfate results in decreased expression of ABCC3 mRNA CTD PMID:32152650 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of ABCG2 mRNA CTD PMID:33819548 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ABCG8 mRNA CTD PMID:33819548 NCBI chr17:84,983,730...85,007,761
Ensembl chr17:84,983,730...85,007,761
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ACSL1 mRNA CTD PMID:33819548 NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
JBrowse link
G Adgrg1 adhesion G protein-coupled receptor G1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of ADGRG1 mRNA CTD PMID:33819548 NCBI chr 8:95,701,321...95,740,836
Ensembl chr 8:95,701,379...95,740,845
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH1C mRNA CTD PMID:33819548 NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH4 mRNA CTD PMID:33819548 NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
JBrowse link
G Adh6b alcohol dehydrogenase 6B (class V) multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA CTD PMID:33819548 NCBI chr 3:138,047,176...138,064,621
Ensembl chr 3:138,047,536...138,064,622
JBrowse link
G Akp3 alkaline phosphatase 3, intestine, not Mn requiring multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA CTD PMID:33819548 NCBI chr 1:87,052,676...87,056,450
Ensembl chr 1:87,052,695...87,055,634
JBrowse link
G Akr1c6 aldo-keto reductase family 1, member C6 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of AKR1C4 mRNA CTD PMID:33819548 NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876
JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 NCBI chr 6:37,506,913...37,551,856
Ensembl chr 6:37,507,108...37,545,750
JBrowse link
G Alb albumin affects binding
multiple interactions
ISO Atazanavir Sulfate binds to ALB protein
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALB mRNA
CTD PMID:15814459 PMID:16336266 PMID:33819548 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of AMPD3 mRNA CTD PMID:33819548 NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612
JBrowse link
G Apoa1 apolipoprotein A-I multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of APOA1 mRNA CTD PMID:33819548 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
JBrowse link
G Atf4 activating transcription factor 4 increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of ATF4 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF4 mRNA
CTD PMID:32152650 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of ATF6 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA
CTD PMID:32152650 NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
JBrowse link
G Atg7 autophagy related 7 multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA
Atazanavir Sulfate results in increased expression of ATG7 mRNA
CTD PMID:32152650 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
JBrowse link
G Atp8b1 ATPase, class I, type 8B, member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ATP8B1 mRNA CTD PMID:33819548 NCBI chr18:64,662,050...64,794,342
Ensembl chr18:64,662,038...64,794,338
JBrowse link
G Baat bile acid-Coenzyme A: amino acid N-acyltransferase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of BAAT mRNA CTD PMID:33819548 NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
JBrowse link
G Bcl2l1 BCL2-like 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Cat catalase multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CAT mRNA
Atazanavir Sulfate results in decreased expression of CAT mRNA
CTD PMID:32152650 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Atazanavir Sulfate results in increased expression of CCL2 protein CTD PMID:17668557 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Atazanavir Sulfate results in increased expression of CCL3 protein CTD PMID:17668557 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Chi3l1 chitinase 3 like 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CHI3L1 mRNA CTD PMID:33819548 NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of CSF1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CSF1 mRNA
CTD PMID:32152650 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CTNNB1 mRNA CTD PMID:33819548 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Cttn cortactin multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of CTTN mRNA CTD PMID:33819548 NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of CXCL8 mRNA CTD PMID:33819548 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cyld CYLD lysine 63 deubiquitinase increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of CYLD mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of CYLD mRNA
CTD PMID:32152650 NCBI chr 8:89,423,506...89,478,574
Ensembl chr 8:89,423,675...89,478,573
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP1A2 mRNA CTD PMID:33819548 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP27A1 mRNA CTD PMID:33819548 NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
JBrowse link
G Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP2A6 mRNA CTD PMID:33819548 NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of CYP2B6 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA
CTD PMID:32152650 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP2C19 mRNA CTD PMID:33819548 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c52-ps cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP2C18 mRNA CTD PMID:33819548 NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP2C9 mRNA CTD PMID:33819548 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of CYP7A1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA
CTD PMID:32152650 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
JBrowse link
G Cyp7b1 cytochrome P450, family 7, subfamily b, polypeptide 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502
JBrowse link
G Cyp8b1 cytochrome P450, family 8, subfamily b, polypeptide 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP8B1 mRNA CTD PMID:33819548 NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DDIT3 mRNA
Atazanavir Sulfate results in increased expression of DDIT3 mRNA
CTD PMID:32152650 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of DNAJB9 mRNA CTD PMID:33819548 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJC10 mRNA
Atazanavir Sulfate results in increased expression of DNAJC10 mRNA
CTD PMID:32152650 NCBI chr 2:80,145,790...80,184,399
Ensembl chr 2:80,145,810...80,184,387
JBrowse link
G Dnajc12 DnaJ heat shock protein family (Hsp40) member C12 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of DNAJC12 mRNA CTD PMID:33819548 NCBI chr10:63,218,222...63,244,619
Ensembl chr10:63,218,222...63,246,355
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression ISO Atazanavir Sulfate results in increased expression of DNAJC9 mRNA CTD PMID:32152650 NCBI chr14:20,434,706...20,438,978
Ensembl chr14:20,434,706...20,438,978
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of EPHX1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of EPHX1 mRNA
CTD PMID:32152650 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G Fkbp5 FK506 binding protein 5 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA
Atazanavir Sulfate results in decreased expression of FKBP5 mRNA
CTD PMID:32152650 NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
JBrowse link
G Fmo1 flavin containing monooxygenase 1 decreases expression ISO Atazanavir Sulfate results in decreased expression of FMO1 mRNA CTD PMID:32152650 NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
JBrowse link
G Fosl1 fos-like antigen 1 multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of FOSL1 mRNA
Atazanavir Sulfate results in increased expression of FOSL1 mRNA
CTD PMID:32152650 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of GGT1 mRNA CTD PMID:33819548 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of GJB1 mRNA CTD PMID:33819548 NCBI chr  X:100,419,982...100,429,235
Ensembl chr  X:100,419,984...100,429,235
JBrowse link
G Gk glycerol kinase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of GK mRNA CTD PMID:33819548 NCBI chr  X:84,745,543...84,820,425
Ensembl chr  X:84,745,543...84,820,425
JBrowse link
G Gprc5b G protein-coupled receptor, family C, group 5, member B multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of GPRC5B mRNA CTD PMID:33819548 NCBI chr 7:118,571,263...118,594,434
Ensembl chr 7:118,571,270...118,594,434
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of GPX2 mRNA
Atazanavir Sulfate results in decreased expression of GPX2 mRNA
CTD PMID:32152650 PMID:33819548 NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
JBrowse link
G Gsta3 glutathione S-transferase, alpha 3 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTA3 mRNA
Atazanavir Sulfate results in decreased expression of GSTA3 mRNA
CTD PMID:32152650 NCBI chr 1:21,310,837...21,335,885
Ensembl chr 1:21,310,813...21,335,885
JBrowse link
G Gstm4 glutathione S-transferase, mu 4 multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM4 mRNA CTD PMID:32152650 NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of HACL1 mRNA CTD PMID:33819548 NCBI chr14:31,329,183...31,364,201
Ensembl chr14:31,320,687...31,363,243
JBrowse link
G Hgf hepatocyte growth factor multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of HGF mRNA CTD PMID:33819548 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO Atazanavir Sulfate promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Atazanavir Sulfate results in increased expression of HMOX1 mRNA]
Atazanavir Sulfate results in increased expression of HMOX1 mRNA; Atazanavir Sulfate results in increased expression of HMOX1 protein
CTD PMID:26968795 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hpx hemopexin multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of HPX mRNA CTD PMID:33819548 NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
JBrowse link
G Hspa5 heat shock protein 5 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of HSPA5 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of HSPA5 mRNA
CTD PMID:32152650 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO Atazanavir Sulfate results in increased expression of ICAM1 protein CTD PMID:26968795 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IER3 mRNA CTD PMID:33819548 NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
JBrowse link
G Ifi204 interferon activated gene 204 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IFI16 mRNA CTD PMID:33819548 NCBI chr 1:173,574,859...173,594,606
Ensembl chr 1:173,574,859...173,594,509
JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IFI27 mRNA CTD PMID:33819548 NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of IGFBP1 mRNA CTD PMID:33819548 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of IL6 mRNA CTD PMID:33819548 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Jun jun proto-oncogene multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of JUN mRNA CTD PMID:32152650 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Jund jun D proto-oncogene multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of JUND mRNA CTD PMID:32152650 NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
JBrowse link
G Kynu kynureninase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of KYNU mRNA CTD PMID:33819548 NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
JBrowse link
G Lbp lipopolysaccharide binding protein multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of LBP mRNA CTD PMID:33819548 NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LDLR mRNA CTD PMID:33819548 NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
JBrowse link
G Lipc lipase, hepatic multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of LIPC mRNA CTD PMID:33819548 NCBI chr 9:70,705,410...70,859,503
Ensembl chr 9:70,705,410...70,859,508
JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA CTD PMID:33819548 NCBI chr 1:16,758,680...16,779,829
Ensembl chr 1:16,758,275...16,779,835
JBrowse link
G Maff v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of MAFF mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA
CTD PMID:32152650 NCBI chr15:79,230,813...79,243,278
Ensembl chr15:79,230,821...79,243,276
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA
Atazanavir Sulfate results in increased expression of MAP1LC3B mRNA
CTD PMID:32152650 NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of MAP2K6 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA
CTD PMID:32152650 NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348
JBrowse link
G Mapkapk3 mitogen-activated protein kinase-activated protein kinase 3 multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA
Atazanavir Sulfate results in increased expression of MAPKAPK3 mRNA
CTD PMID:32152650 NCBI chr 9:107,132,125...107,167,082
Ensembl chr 9:107,132,126...107,167,076
JBrowse link
G Mlkl mixed lineage kinase domain-like multiple interactions
increases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of MLKL mRNA
Atazanavir Sulfate results in increased expression of MLKL mRNA
CTD PMID:32152650 PMID:33819548 NCBI chr 8:112,037,879...112,065,081
Ensembl chr 8:112,038,429...112,064,809
JBrowse link
G Mmut methylmalonyl-Coenzyme A mutase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of MMUT mRNA CTD PMID:33819548 NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
JBrowse link
G Mttp microsomal triglyceride transfer protein multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of MTTP mRNA CTD PMID:33819548 NCBI chr 3:137,795,616...137,849,179
Ensembl chr 3:137,795,615...137,850,729
JBrowse link
G Nfxl1 nuclear transcription factor, X-box binding-like 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA CTD PMID:33819548 NCBI chr 5:72,670,647...72,717,078
Ensembl chr 5:72,670,644...72,717,027
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of NR1H3 mRNA CTD PMID:33819548 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of NR1H4 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of NR1H4 mRNA
CTD PMID:32152650 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of NR1I2 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of NR1I2 mRNA
CTD PMID:32152650 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of NR1I3 mRNA
Atazanavir Sulfate results in decreased expression of NR1I3 mRNA
CTD PMID:32152650 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Pah phenylalanine hydroxylase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of PAH mRNA CTD PMID:33819548 NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998
JBrowse link
G Pik3c2g phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma decreases expression
multiple interactions
ISO Atazanavir Sulfate results in decreased expression of PIK3C2G mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2G mRNA
CTD PMID:32152650 NCBI chr 6:139,591,070...139,915,010
Ensembl chr 6:139,564,219...139,915,010
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3R1 mRNA
Atazanavir Sulfate results in decreased expression of PIK3R1 mRNA
CTD PMID:32152650 NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
JBrowse link
G Pon1 paraoxonase 1 decreases activity ISO Atazanavir Sulfate results in decreased activity of PON1 protein CTD PMID:27378623 NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of PPARA mRNA CTD PMID:33819548 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 NCBI chr19:36,709,131...36,714,004
Ensembl chr19:36,709,131...36,714,053
JBrowse link
G Rala v-ral simian leukemia viral oncogene A (ras related) multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA CTD PMID:32152650 NCBI chr13:18,055,160...18,118,802
Ensembl chr13:18,055,156...18,118,824
JBrowse link
G Reep5 receptor accessory protein 5 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA CTD PMID:33819548 NCBI chr18:34,477,938...34,508,044
Ensembl chr18:34,477,938...34,507,123
JBrowse link
G Ripk1 receptor (TNFRSF)-interacting serine-threonine kinase 1 multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA CTD PMID:32152650 NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
JBrowse link
G Scp2 sterol carrier protein 2, liver multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SCP2 mRNA CTD PMID:33819548 NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
JBrowse link
G Sdc2 syndecan 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SDC2 mRNA CTD PMID:33819548 NCBI chr15:32,920,869...33,034,867
Ensembl chr15:32,920,869...33,035,081
JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of SERPINE1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SERPINE1 mRNA
CTD PMID:32152650 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
JBrowse link
G Sh3glb1 SH3-domain GRB2-like B1 (endophilin) increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of SH3GLB1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA
CTD PMID:32152650 NCBI chr 3:144,389,426...144,426,186
Ensembl chr 3:144,389,439...144,426,096
JBrowse link
G Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SLC10A1 mRNA
Atazanavir Sulfate results in decreased expression of SLC10A1 mRNA
CTD PMID:32152650 NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
JBrowse link
G Slc17a1 solute carrier family 17 (sodium phosphate), member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SLC17A1 mRNA CTD PMID:33819548 NCBI chr13:24,051,607...24,079,713
Ensembl chr13:24,051,733...24,079,713
JBrowse link
G Slc22a1 solute carrier family 22 (organic cation transporter), member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SLC22A1 mRNA CTD PMID:33819548 NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
JBrowse link
G Slc51a solute carrier family 51, alpha subunit multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA CTD PMID:32152650 NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
JBrowse link
G Slc51b solute carrier family 51, beta subunit multiple interactions ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:32152650 NCBI chr 9:65,320,035...65,330,055
Ensembl chr 9:65,319,996...65,330,237
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of SOD2 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SOD2 mRNA
CTD PMID:32152650 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Sorl1 sortilin-related receptor, LDLR class A repeats-containing multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SORL1 mRNA CTD PMID:33819548 NCBI chr 9:41,876,005...42,035,593
Ensembl chr 9:41,876,016...42,035,593
JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions
ISO Atazanavir Sulfate results in increased expression of SQSTM1 mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SQSTM1 mRNA
CTD PMID:32152650 NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of SREBF1 mRNA CTD PMID:33819548 NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
JBrowse link
G Srp72 signal recognition particle 72 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA CTD PMID:33819548 NCBI chr 5:77,122,548...77,147,782
Ensembl chr 5:77,122,530...77,147,784
JBrowse link
G Sult2a1 sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 multiple interactions
decreases expression
ISO [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of SULT2A1 mRNA
Atazanavir Sulfate results in decreased expression of SULT2A1 mRNA
CTD PMID:32152650 NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334
JBrowse link
G Tfpi tissue factor pathway inhibitor multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of TFPI mRNA CTD PMID:33819548 NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of TLR4 mRNA CTD PMID:33819548 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
JBrowse link
G Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of TNFRSF10A mRNA CTD PMID:33819548 NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tnfsf11 tumor necrosis factor (ligand) superfamily, member 11 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of TNFSF11 mRNA CTD PMID:33819548 NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
JBrowse link
cidofovir anhydrous term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1810037I17Rik RIKEN cDNA 1810037I17 gene decreases expression ISO Cidofovir results in decreased expression of C4ORF3 mRNA CTD PMID:25596134 NCBI chr 3:122,718,046...122,719,843
Ensembl chr 3:122,717,852...122,719,833
JBrowse link
G Aars1 alanyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of AARS1 mRNA CTD PMID:25596134 NCBI chr 8:111,759,781...111,784,237
Ensembl chr 8:111,759,776...111,784,296
JBrowse link
G Abcb6 ATP-binding cassette, sub-family B member 6 increases expression ISO Cidofovir results in increased expression of ABCB6 mRNA CTD PMID:25596134 NCBI chr 1:75,148,284...75,157,066
Ensembl chr 1:75,148,361...75,157,036
JBrowse link
G Abcb9 ATP-binding cassette, sub-family B member 9 increases expression ISO Cidofovir results in increased expression of ABCB9 mRNA CTD PMID:25596134 NCBI chr 5:124,199,920...124,234,009
Ensembl chr 5:124,199,593...124,233,861
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO Cidofovir results in decreased expression of ABCG1 mRNA CTD PMID:25596134 NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
JBrowse link
G Abhd4 abhydrolase domain containing 4 increases expression ISO Cidofovir results in increased expression of ABHD4 mRNA CTD PMID:25596134 NCBI chr14:54,491,586...54,506,626
Ensembl chr14:54,491,645...54,508,094
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO Cidofovir results in decreased expression of ACSL1 mRNA CTD PMID:25596134 NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
JBrowse link
G Agrn agrin increases expression ISO Cidofovir results in increased expression of AGRN mRNA CTD PMID:25596134 NCBI chr 4:156,249,747...156,281,997
Ensembl chr 4:156,249,747...156,281,945
JBrowse link
G Ahr aryl-hydrocarbon receptor affects activity ISO Cidofovir affects the activity of AHR protein CTD PMID:25596134 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Ak3 adenylate kinase 3 increases expression ISO Cidofovir results in increased expression of AK3 mRNA CTD PMID:25596134 NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
JBrowse link
G Ak4 adenylate kinase 4 increases expression ISO Cidofovir results in increased expression of AK4 mRNA CTD PMID:25596134 NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
JBrowse link
G Akr1c21 aldo-keto reductase family 1, member C21 affects expression ISO Cidofovir affects the expression of AKR1C2 mRNA CTD PMID:25596134 NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 affects expression ISO Cidofovir affects the expression of ALDH18A1 mRNA CTD PMID:25596134 NCBI chr19:40,538,701...40,576,907
Ensembl chr19:40,538,701...40,576,907
JBrowse link
G Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 increases expression ISO Cidofovir results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
JBrowse link
G Als2cl ALS2 C-terminal like affects expression ISO Cidofovir affects the expression of ALS2CL mRNA CTD PMID:25596134 NCBI chr 9:110,709,203...110,729,598
Ensembl chr 9:110,708,938...110,729,598
JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO Cidofovir results in increased expression of ANGPTL4 mRNA CTD PMID:25596134 NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
JBrowse link
G Ankra2 ankyrin repeat family A member 2 decreases expression ISO Cidofovir results in decreased expression of ANKRA2 mRNA CTD PMID:25596134 NCBI chr13:98,399,584...98,411,262
Ensembl chr13:98,399,582...98,411,262
JBrowse link
G Arhgef10 Rho guanine nucleotide exchange factor 10 decreases expression ISO Cidofovir results in decreased expression of ARHGEF10 mRNA CTD PMID:25596134 NCBI chr 8:14,956,405...15,051,085
Ensembl chr 8:14,961,663...15,051,085
JBrowse link
G Asns asparagine synthetase increases expression ISO Cidofovir results in increased expression of ASNS mRNA CTD PMID:25596134 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO Cidofovir results in increased expression of ATAD2 mRNA CTD PMID:25596134 NCBI chr15:57,957,440...57,998,516
Ensembl chr15:57,957,440...57,998,478
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Cidofovir results in increased expression of ATF3 mRNA CTD PMID:25596134 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Atf4 activating transcription factor 4 affects activity ISO Cidofovir affects the activity of ATF4 protein CTD PMID:25596134 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
JBrowse link
G Atosa atos homolog A decreases expression ISO Cidofovir results in decreased expression of ATOSA mRNA CTD PMID:25596134 NCBI chr 9:74,860,162...74,939,750
Ensembl chr 9:74,860,166...74,939,750
JBrowse link
G Atxn1 ataxin 1 decreases expression ISO Cidofovir results in decreased expression of ATXN1 mRNA CTD PMID:25596134 NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484
JBrowse link
G Aurkb aurora kinase B increases expression ISO Cidofovir results in increased expression of AURKB mRNA CTD PMID:25596134 NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
JBrowse link
G Axl AXL receptor tyrosine kinase increases expression ISO Cidofovir results in increased expression of AXL mRNA CTD PMID:25596134 NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
JBrowse link
G Bax BCL2-associated X protein increases expression ISO Cidofovir results in increased expression of BAX; Cidofovir results in increased expression of BAX mRNA CTD PMID:12700662 PMID:25596134 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bbc3 BCL2 binding component 3 increases expression ISO Cidofovir results in increased expression of BBC3 mRNA CTD PMID:25596134 NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
JBrowse link
G Bcat2 branched chain aminotransferase 2, mitochondrial increases expression ISO Cidofovir results in increased expression of BCAT2 mRNA CTD PMID:25596134 NCBI chr 7:45,219,773...45,239,134
Ensembl chr 7:45,219,577...45,239,135
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression ISO Cidofovir results in decreased expression of BCL2 CTD PMID:12700662 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bend5 BEN domain containing 5 affects expression ISO Cidofovir affects the expression of BEND5 mRNA CTD PMID:25596134 NCBI chr 4:111,271,993...111,317,495
Ensembl chr 4:111,272,203...111,317,495
JBrowse link
G Bmf BCL2 modifying factor increases expression ISO Cidofovir results in increased expression of BMF mRNA CTD PMID:25596134 NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
JBrowse link
G Brd2 bromodomain containing 2 decreases expression ISO Cidofovir results in decreased expression of BRD2 mRNA CTD PMID:25596134 NCBI chr17:34,330,993...34,341,581
Ensembl chr17:34,330,997...34,341,608
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO Cidofovir results in increased expression of BTG2 mRNA CTD PMID:25596134 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
JBrowse link
G Camkk2 calcium/calmodulin-dependent protein kinase kinase 2, beta increases expression ISO Cidofovir results in increased expression of CAMKK2 mRNA CTD PMID:25596134 NCBI chr 5:122,856,064...122,918,295
Ensembl chr 5:122,869,233...122,917,472
JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of CARS1 mRNA CTD PMID:25596134 NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827
JBrowse link
G Casp3 caspase 3 decreases activity ISO Cidofovir results in decreased activity of CASP3 protein CTD PMID:11697818 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Ccdc90b coiled-coil domain containing 90B decreases expression ISO Cidofovir results in decreased expression of CCDC90B mRNA CTD PMID:25596134 NCBI chr 7:92,210,350...92,231,502
Ensembl chr 7:92,210,357...92,231,502
JBrowse link
G Ccne2 cyclin E2 increases expression ISO Cidofovir results in increased expression of CCNE2 mRNA CTD PMID:25596134 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Ccng2 cyclin G2 decreases expression ISO Cidofovir results in decreased expression of CCNG2 mRNA CTD PMID:25596134 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A increases expression ISO Cidofovir results in increased expression of CDKN1A mRNA; Cidofovir results in increased expression of CDKN1A protein CTD PMID:11697818 PMID:25596134 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cers5 ceramide synthase 5 increases expression ISO Cidofovir results in increased expression of CERS5 mRNA CTD PMID:25596134 NCBI chr15:99,633,473...99,670,396
Ensembl chr15:99,632,762...99,670,766
JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 decreases expression ISO Cidofovir results in decreased expression of CLIP4 mRNA CTD PMID:25596134 NCBI chr17:72,076,674...72,171,205
Ensembl chr17:72,075,468...72,171,268
JBrowse link
G Cmbl carboxymethylenebutenolidase homolog increases expression ISO Cidofovir results in increased expression of CMBL mRNA CTD PMID:25596134 NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265
JBrowse link
G Cmpk1 cytidine/uridine monophosphate kinase 1 increases phosphorylation ISO CMPK1 protein results in increased phosphorylation of Cidofovir CTD PMID:21128666 NCBI chr 4:114,817,810...114,844,425
Ensembl chr 4:114,816,533...114,844,438
JBrowse link
G Coch cochlin increases expression ISO Cidofovir results in increased expression of COCH mRNA CTD PMID:25596134 NCBI chr12:51,640,156...51,652,558
Ensembl chr12:51,640,124...51,652,554
JBrowse link
G Col4a1 collagen, type IV, alpha 1 affects expression ISO Cidofovir affects the expression of COL4A1 mRNA CTD PMID:25596134 NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
JBrowse link
G Cp ceruloplasmin increases expression ISO Cidofovir results in increased expression of CP mRNA CTD PMID:25596134 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G Ctdp1 CTD phosphatase subunit 1 decreases expression ISO Cidofovir results in decreased expression of CTDP1 mRNA CTD PMID:25596134 NCBI chr18:80,451,174...80,522,959
Ensembl chr18:80,451,174...80,512,910
JBrowse link
G Ctsc cathepsin C increases expression ISO Cidofovir results in increased expression of CTSC mRNA CTD PMID:25596134 NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096
JBrowse link
G Cttn cortactin increases expression ISO Cidofovir results in increased expression of CTTN mRNA CTD PMID:25596134 NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases expression ISO Cidofovir results in decreased expression of CYP1A1 mRNA CTD PMID:25596134 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO Cidofovir results in increased expression of CYP1B1 mRNA CTD PMID:25596134 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Ddb2 damage specific DNA binding protein 2 increases expression ISO Cidofovir results in increased expression of DDB2 mRNA CTD PMID:25596134 NCBI chr 2:91,041,924...91,067,465
Ensembl chr 2:91,041,917...91,067,327
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression ISO Cidofovir results in decreased expression of DDIT3 mRNA CTD PMID:25596134 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 affects expression ISO Cidofovir affects the expression of DDIT4 mRNA CTD PMID:25596134 NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
JBrowse link
G Ddx17 DEAD box helicase 17 decreases expression ISO Cidofovir results in decreased expression of DDX17 mRNA CTD PMID:25596134 NCBI chr15:79,411,897...79,430,976
Ensembl chr15:79,411,937...79,430,942
JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression ISO Cidofovir results in increased expression of DGKA mRNA CTD PMID:25596134 NCBI chr10:128,556,000...128,581,002
Ensembl chr10:128,556,003...128,580,724
JBrowse link
G Dhx37 DEAH-box helicase 37 decreases expression ISO Cidofovir results in decreased expression of DHX37 mRNA CTD PMID:25596134 NCBI chr 5:125,490,811...125,511,203
Ensembl chr 5:125,490,922...125,511,185
JBrowse link
G Dlgap5 DLG associated protein 5 increases expression ISO Cidofovir results in increased expression of DLGAP5 mRNA CTD PMID:25596134 NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO Cidofovir results in increased expression of DNAJB9 mRNA CTD PMID:25596134 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
JBrowse link
G Dpm3 dolichyl-phosphate mannosyltransferase polypeptide 3 increases expression ISO Cidofovir results in increased expression of DPM3 mRNA CTD PMID:25596134 NCBI chr 3:89,166,567...89,174,386
Ensembl chr 3:89,166,665...89,174,386
JBrowse link
G Dpysl3 dihydropyrimidinase-like 3 increases expression ISO Cidofovir results in increased expression of DPYSL3 mRNA CTD PMID:25596134 NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351
JBrowse link
G Dusp22 dual specificity phosphatase 22 increases expression ISO Cidofovir results in increased expression of DUSP22 mRNA CTD PMID:25596134 NCBI chr13:30,844,042...30,895,215
Ensembl chr13:30,843,982...30,895,214
JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression ISO Cidofovir results in increased expression of DUSP5 mRNA CTD PMID:25596134 NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
JBrowse link
G Efna1 ephrin A1 decreases expression ISO Cidofovir results in decreased expression of EFNA1 mRNA CTD PMID:25596134 NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
JBrowse link
G Eif3c eukaryotic translation initiation factor 3, subunit C decreases expression ISO Cidofovir results in decreased expression of EIF3C mRNA CTD PMID:25596134 NCBI chr 7:126,146,083...126,165,538
Ensembl chr 7:126,145,627...126,165,583
JBrowse link
G Elk4 ELK4, member of ETS oncogene family decreases expression ISO Cidofovir results in decreased expression of ELK4 mRNA CTD PMID:25596134 NCBI chr 1:131,935,129...131,954,186
Ensembl chr 1:131,935,345...131,960,350
JBrowse link
G Eno2 enolase 2, gamma neuronal increases expression ISO Cidofovir results in increased expression of ENO2 mRNA CTD PMID:25596134 NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
JBrowse link
G Entpd7 ectonucleoside triphosphate diphosphohydrolase 7 increases expression ISO Cidofovir results in increased expression of ENTPD7 mRNA CTD PMID:25596134 NCBI chr19:43,678,128...43,722,292
Ensembl chr19:43,678,111...43,722,136
JBrowse link
G Ep400 E1A binding protein p400 decreases expression ISO Cidofovir results in decreased expression of EP400 mRNA CTD PMID:25596134 NCBI chr 5:110,812,239...110,918,583
Ensembl chr 5:110,812,239...110,918,583
JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of EPRS1 mRNA CTD PMID:25596134 NCBI chr 1:185,093,614...185,160,557
Ensembl chr 1:185,095,241...185,160,557
JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO Cidofovir results in increased expression of ERO1A mRNA CTD PMID:25596134 NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
JBrowse link
G Fam162a family with sequence similarity 162, member A decreases expression ISO Cidofovir results in decreased expression of FAM162A mRNA CTD PMID:25596134 NCBI chr16:35,864,214...35,891,931
Ensembl chr16:35,864,131...35,891,964
JBrowse link
G Fam210a family with sequence similarity 210, member A increases expression ISO Cidofovir results in increased expression of FAM210A mRNA CTD PMID:25596134 NCBI chr18:68,393,248...68,433,404
Ensembl chr18:68,393,258...68,433,404
JBrowse link
G Fam210b family with sequence similarity 210, member B increases expression ISO Cidofovir results in increased expression of FAM210B mRNA CTD PMID:25596134 NCBI chr 2:172,187,444...172,197,669
Ensembl chr 2:172,187,485...172,197,669
JBrowse link
G Fam89a family with sequence similarity 89, member A increases expression ISO Cidofovir results in increased expression of FAM89A mRNA CTD PMID:25596134 NCBI chr 8:125,466,996...125,478,605
Ensembl chr 8:125,466,996...125,478,571
JBrowse link
G Fas Fas cell surface death receptor affects expression ISO Cidofovir affects the expression of FAS mRNA CTD PMID:25596134 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fbxo22 F-box protein 22 increases expression ISO Cidofovir results in increased expression of FBXO22 mRNA CTD PMID:25596134 NCBI chr 9:55,116,219...55,131,717
Ensembl chr 9:55,116,209...55,131,717
JBrowse link
G Fbxo30 F-box protein 30 decreases expression ISO Cidofovir results in decreased expression of FBXO30 mRNA CTD PMID:25596134 NCBI chr10:11,157,009...11,181,494
Ensembl chr10:11,157,074...11,173,796
JBrowse link
G Fech ferrochelatase decreases expression ISO Cidofovir results in decreased expression of FECH mRNA CTD PMID:25596134 NCBI chr18:64,589,613...64,622,169
Ensembl chr18:64,585,985...64,623,322
JBrowse link
G Flvcr2 feline leukemia virus subgroup C cellular receptor 2 affects expression ISO Cidofovir affects the expression of FLVCR2 mRNA CTD PMID:25596134 NCBI chr12:85,793,313...85,860,359
Ensembl chr12:85,793,313...85,860,359
JBrowse link
G Fosl1 fos-like antigen 1 increases expression ISO Cidofovir results in increased expression of FOSL1 mRNA CTD PMID:25596134 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
JBrowse link
G Fosl2 fos-like antigen 2 decreases expression ISO Cidofovir results in decreased expression of FOSL2 mRNA CTD PMID:25596134 NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
JBrowse link
G Frem2 Fras1 related extracellular matrix protein 2 decreases expression ISO Cidofovir results in decreased expression of FREM2 mRNA CTD PMID:25596134 NCBI chr 3:53,421,359...53,566,014
Ensembl chr 3:53,421,359...53,564,776
JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 decreases expression ISO Cidofovir results in decreased expression of GABARAPL1 mRNA CTD PMID:25596134 NCBI chr 6:129,510,155...129,519,294
Ensembl chr 6:129,510,123...129,519,309
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha affects expression ISO Cidofovir affects the expression of GADD45A mRNA CTD PMID:25596134 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
JBrowse link
G Gars1 glycyl-tRNA synthetase 1 increases expression ISO Cidofovir results in increased expression of GARS1 mRNA CTD PMID:25596134 NCBI chr 6:55,014,986...55,056,489
Ensembl chr 6:55,014,992...55,056,485
JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 increases expression ISO Cidofovir results in increased expression of GBE1 mRNA CTD PMID:25596134 NCBI chr16:70,110,837...70,366,608
Ensembl chr16:70,110,837...70,366,604
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression ISO Cidofovir results in decreased expression of GCLC mRNA CTD PMID:25596134 NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit increases expression ISO Cidofovir results in increased expression of GCLM mRNA CTD PMID:25596134 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression ISO Cidofovir results in increased expression of GCNT3 mRNA CTD PMID:25596134 NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO Cidofovir results in increased expression of GDF15 mRNA CTD PMID:25596134 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
JBrowse link
G Gm20348 predicted gene, 20348 increases expression ISO Cidofovir results in increased expression of TP53I3 mRNA CTD PMID:25596134 NCBI chr12:4,860,475...4,867,155
Ensembl chr12:4,860,494...4,867,142
JBrowse link
G Golim4 golgi integral membrane protein 4 decreases expression ISO Cidofovir results in decreased expression of GOLIM4 mRNA CTD PMID:25596134 NCBI chr 3:75,783,490...75,864,256
Ensembl chr 3:75,782,391...75,864,256
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble increases expression ISO Cidofovir results in increased expression of GOT1 mRNA CTD PMID:25596134 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gpa33 glycoprotein A33 transmembrane increases expression ISO Cidofovir results in increased expression of GPA33 mRNA CTD PMID:25596134 NCBI chr 1:165,957,790...165,994,079
Ensembl chr 1:165,957,807...165,994,079
JBrowse link
G Gpat3 glycerol-3-phosphate acyltransferase 3 increases expression ISO Cidofovir results in increased expression of GPAT3 mRNA CTD PMID:25596134 NCBI chr 5:100,994,095...101,046,968
Ensembl chr 5:100,993,579...101,046,968
JBrowse link
G Gpnmb glycoprotein (transmembrane) nmb decreases expression ISO Cidofovir results in decreased expression of GPNMB mRNA CTD PMID:25596134 NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
JBrowse link
G Gpr87 G protein-coupled receptor 87 decreases expression ISO Cidofovir results in decreased expression of GPR87 mRNA CTD PMID:25596134 NCBI chr 3:59,086,325...59,102,583
Ensembl chr 3:59,086,344...59,102,525
JBrowse link
G Gsr glutathione reductase increases expression ISO Cidofovir results in increased expression of GSR mRNA CTD PMID:25596134 NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO Cidofovir results in increased expression of H1-2 mRNA CTD PMID:25596134 NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions
increases secretion
ISO Probenecid inhibits the reaction [Cidofovir results in increased secretion of HAVCR1 protein]; Tenofovir inhibits the reaction [Cidofovir results in increased secretion of HAVCR1 protein] CTD PMID:29738843 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Herc3 hect domain and RLD 3 decreases expression ISO Cidofovir results in decreased expression of HERC3 mRNA CTD PMID:25596134 NCBI chr 6:58,808,440...58,897,383
Ensembl chr 6:58,808,450...58,897,383
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit affects activity ISO Cidofovir affects the activity of HIF1A protein CTD PMID:25596134 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Cidofovir results in increased expression of HMOX1 mRNA CTD PMID:25596134 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hspa1b heat shock protein 1B decreases expression ISO Cidofovir results in decreased expression of HSPA1B mRNA CTD PMID:25596134 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
JBrowse link
G Hspa5 heat shock protein 5 decreases expression ISO Cidofovir results in decreased expression of HSPA5 mRNA CTD PMID:25596134 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 affects expression ISO Cidofovir affects the expression of HTATIP2 mRNA CTD PMID:25596134 NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723
JBrowse link
G Iars1 isoleucyl-tRNA synthetase 1 increases expression ISO Cidofovir results in increased expression of IARS1 mRNA CTD PMID:25596134 NCBI chr13:49,835,606...49,887,743
Ensembl chr13:49,835,576...49,887,743
JBrowse link
G Ids iduronate 2-sulfatase decreases expression ISO Cidofovir results in decreased expression of IDS mRNA CTD PMID:25596134 NCBI chr  X:69,386,675...69,429,437
Ensembl chr  X:69,386,675...69,408,690
JBrowse link
G Igf2r insulin-like growth factor 2 receptor affects expression ISO Cidofovir affects the expression of IGF2R mRNA CTD PMID:25596134 NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
JBrowse link
G Il19 interleukin 19 increases secretion ISO Cidofovir results in increased secretion of IL19 protein CTD PMID:24714768 NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
JBrowse link
G Inka2 inka box actin regulator 2 increases expression ISO Cidofovir results in increased expression of INKA2 mRNA CTD PMID:25596134 NCBI chr 3:105,611,915...105,628,158
Ensembl chr 3:105,611,915...105,628,158
JBrowse link
G Insig1 insulin induced gene 1 increases expression ISO Cidofovir results in increased expression of INSIG1 mRNA CTD PMID:25596134 NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
JBrowse link
G Iscu iron-sulfur cluster assembly enzyme increases expression ISO Cidofovir results in increased expression of ISCU mRNA CTD PMID:25596134 NCBI chr 5:113,910,479...113,916,349
Ensembl chr 5:113,910,809...113,916,349
JBrowse link
G Itfg2 integrin alpha FG-GAP repeat containing 2 affects expression ISO Cidofovir affects the expression of ITFG2 mRNA CTD PMID:25596134 NCBI chr 6:128,386,407...128,401,873
Ensembl chr 6:128,386,407...128,401,894
JBrowse link
G Itgb1 integrin beta 1 (fibronectin receptor beta) affects expression ISO Cidofovir affects the expression of ITGB1 mRNA CTD PMID:25596134 NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
JBrowse link
G Kat6b K(lysine) acetyltransferase 6B decreases expression ISO Cidofovir results in decreased expression of KAT6B mRNA CTD PMID:25596134 NCBI chr14:21,549,284...21,722,546
Ensembl chr14:21,531,502...21,722,546
JBrowse link
G Kdm3a lysine (K)-specific demethylase 3A decreases expression ISO Cidofovir results in decreased expression of KDM3A mRNA CTD PMID:25596134 NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974
JBrowse link
G Keap1 kelch-like ECH-associated protein 1 increases expression ISO Cidofovir results in increased expression of KEAP1 mRNA CTD PMID:25596134 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
JBrowse link
G Krt15 keratin 15 increases expression ISO Cidofovir results in increased expression of KRT15 mRNA CTD PMID:25596134 NCBI chr11:100,022,585...100,026,775
Ensembl chr11:100,022,584...100,026,754
JBrowse link
G Krt19 keratin 19 increases expression ISO Cidofovir results in increased expression of KRT19 mRNA CTD PMID:25596134 NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
JBrowse link
G Lama3 laminin, alpha 3 affects expression ISO Cidofovir affects the expression of LAMA3 mRNA CTD PMID:25596134 NCBI chr18:12,466,806...12,716,070
Ensembl chr18:12,466,876...12,716,070
JBrowse link
G Lars1 leucyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of LARS1 mRNA CTD PMID:25596134 NCBI chr18:42,335,363...42,395,302
Ensembl chr18:42,335,363...42,395,259
JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 increases expression ISO Cidofovir results in increased expression of LMCD1 mRNA CTD PMID:25596134 NCBI chr 6:112,250,747...112,307,384
Ensembl chr 6:112,250,719...112,307,386
JBrowse link
G Lratd2 LRAT domain containing 1 increases expression ISO Cidofovir results in increased expression of LRATD2 mRNA CTD PMID:25596134 NCBI chr15:60,690,845...60,697,954
Ensembl chr15:60,690,843...60,725,627
JBrowse link
G Ltn1 listerin E3 ubiquitin protein ligase 1 decreases expression ISO Cidofovir results in decreased expression of LTN1 mRNA CTD PMID:25596134 NCBI chr16:87,173,539...87,229,504
Ensembl chr16:87,173,539...87,229,500
JBrowse link
G Man1a2 mannosidase, alpha, class 1A, member 2 decreases expression ISO Cidofovir results in decreased expression of MAN1A2 mRNA CTD PMID:25596134 NCBI chr 3:100,469,519...100,592,789
Ensembl chr 3:100,469,524...100,592,819
JBrowse link
G Mapre2 microtubule-associated protein, RP/EB family, member 2 increases expression ISO Cidofovir results in increased expression of MAPRE2 mRNA CTD PMID:25596134 NCBI chr18:23,885,390...24,026,918
Ensembl chr18:23,885,390...24,026,918
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 affects expression ISO Cidofovir affects the expression of MDM2 mRNA CTD PMID:25596134 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
JBrowse link
G Mt2 metallothionein 2 increases expression ISO Cidofovir results in increased expression of MT2A mRNA CTD PMID:25596134 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
JBrowse link
G Mtdh metadherin decreases expression ISO Cidofovir results in decreased expression of MTDH mRNA CTD PMID:25596134 NCBI chr15:34,082,613...34,143,683
Ensembl chr15:34,082,840...34,145,770
JBrowse link
G Mtfp1 mitochondrial fission process 1 increases expression ISO Cidofovir results in increased expression of MTFP1 mRNA CTD PMID:25596134 NCBI chr11:4,041,481...4,045,431
Ensembl chr11:4,041,480...4,045,445
JBrowse link
G Mxi1 MAX interactor 1, dimerization protein decreases expression ISO Cidofovir results in decreased expression of MXI1 mRNA CTD PMID:25596134 NCBI chr19:53,298,509...53,361,724
Ensembl chr19:53,298,949...53,364,241
JBrowse link
G Nampt nicotinamide phosphoribosyltransferase increases expression ISO Cidofovir results in increased expression of NAMPT mRNA CTD PMID:25596134 NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348
JBrowse link
G Nars1 asparaginyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of NARS1 mRNA CTD PMID:25596134 NCBI chr18:64,632,726...64,649,586
Ensembl chr18:64,632,718...64,649,723
JBrowse link
G Ncapd2 non-SMC condensin I complex, subunit D2 affects expression ISO Cidofovir affects the expression of NCAPD2 mRNA CTD PMID:25596134 NCBI chr 6:125,144,970...125,169,062
Ensembl chr 6:125,144,970...125,168,664
JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 decreases expression ISO Cidofovir results in decreased expression of NEDD9 mRNA CTD PMID:25596134 NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 affects activity
affects expression
ISO Cidofovir affects the activity of NFE2L2 protein
Cidofovir affects the expression of NFE2L2 mRNA
CTD PMID:25596134 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nin ninein decreases expression ISO Cidofovir results in decreased expression of NIN mRNA CTD PMID:25596134 NCBI chr12:70,058,209...70,160,575
Ensembl chr12:70,058,209...70,160,491
JBrowse link
G Ninj1 ninjurin 1 increases expression ISO Cidofovir results in increased expression of NINJ1 mRNA CTD PMID:25596134 NCBI chr13:49,341,005...49,349,727
Ensembl chr13:49,340,961...49,349,720
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 decreases expression ISO Cidofovir results in decreased expression of NQO1 mRNA CTD PMID:25596134 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 decreases expression ISO Cidofovir results in decreased expression of NR3C1 mRNA CTD PMID:25596134 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
JBrowse link
G Nrep neuronal regeneration related protein increases expression ISO Cidofovir results in increased expression of NREP mRNA CTD PMID:25596134 NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
JBrowse link
G Ntpcr nucleoside-triphosphatase, cancer-related increases expression ISO Cidofovir results in increased expression of NTPCR mRNA CTD PMID:25596134 NCBI chr 8:126,456,724...126,474,974
Ensembl chr 8:126,456,702...126,474,974
JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 affects expression ISO Cidofovir affects the expression of OSGIN1 mRNA CTD PMID:25596134 NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
JBrowse link
G Oxsm 3-oxoacyl-ACP synthase, mitochondrial increases expression ISO Cidofovir results in increased expression of OXSM mRNA CTD PMID:25596134 NCBI chr14:6,219,955...6,231,111
Ensembl chr14:6,219,955...6,231,111
JBrowse link
G P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide decreases expression ISO Cidofovir results in decreased expression of P4HA1 mRNA CTD PMID:25596134 NCBI chr10:59,159,019...59,209,126
Ensembl chr10:59,159,118...59,209,126
JBrowse link
G Pank1 pantothenate kinase 1 decreases expression ISO Cidofovir results in decreased expression of PANK1 mRNA CTD PMID:25596134 NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855
JBrowse link
G Pde8a phosphodiesterase 8A decreases expression ISO Cidofovir results in decreased expression of PDE8A mRNA CTD PMID:25596134 NCBI chr 7:80,863,013...80,984,283
Ensembl chr 7:80,863,344...80,984,281
JBrowse link
G Pdia5 protein disulfide isomerase associated 5 increases expression ISO Cidofovir results in increased expression of PDIA5 mRNA CTD PMID:25596134 NCBI chr16:35,217,678...35,311,289
Ensembl chr16:35,217,682...35,311,243
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 increases expression ISO Cidofovir results in increased expression of PDK4 mRNA CTD PMID:25596134 NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
JBrowse link
G Pdlim1 PDZ and LIM domain 1 (elfin) increases expression ISO Cidofovir results in increased expression of PDLIM1 mRNA CTD PMID:25596134 NCBI chr19:40,210,683...40,260,060
Ensembl chr19:40,209,617...40,260,286
JBrowse link
G Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 affects expression ISO Cidofovir affects the expression of PFKFB4 mRNA CTD PMID:25596134 NCBI chr 9:108,817,336...108,861,302
Ensembl chr 9:108,820,846...108,861,296
JBrowse link
G Phgdh 3-phosphoglycerate dehydrogenase affects expression ISO Cidofovir affects the expression of PHGDH mRNA CTD PMID:25596134 NCBI chr 3:98,220,487...98,247,285
Ensembl chr 3:98,220,486...98,247,306
JBrowse link
G Phlda3 pleckstrin homology like domain, family A, member 3 increases expression ISO Cidofovir results in increased expression of PHLDA3 mRNA CTD PMID:25596134 NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874
JBrowse link
G Pidd1 p53 induced death domain protein 1 affects expression ISO Cidofovir affects the expression of PIDD1 mRNA CTD PMID:25596134 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
JBrowse link
G Pir pirin increases expression ISO Cidofovir results in increased expression of PIR mRNA CTD PMID:25596134 NCBI chr  X:163,052,427...163,156,009
Ensembl chr  X:163,052,367...163,156,007
JBrowse link
G Plec plectin decreases expression ISO Cidofovir results in decreased expression of PLEC mRNA CTD PMID:25596134 NCBI chr15:76,055,174...76,115,578
Ensembl chr15:76,055,174...76,116,774
JBrowse link
G Plk3 polo like kinase 3 increases expression ISO Cidofovir results in increased expression of PLK3 mRNA CTD PMID:25596134 NCBI chr 4:116,985,852...116,991,244
Ensembl chr 4:116,985,852...116,991,160
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 affects expression ISO Cidofovir affects the expression of PMAIP1 mRNA CTD PMID:25596134 NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
JBrowse link
G Pmepa1 prostate transmembrane protein, androgen induced 1 increases expression ISO Cidofovir results in increased expression of PMEPA1 mRNA CTD PMID:25596134 NCBI chr 2:173,066,251...173,118,329
Ensembl chr 2:173,066,251...173,118,326
JBrowse link
G Pnpla6 patatin-like phospholipase domain containing 6 increases expression ISO Cidofovir results in increased expression of PNPLA6 mRNA CTD PMID:25596134 NCBI chr 8:3,565,341...3,594,267
Ensembl chr 8:3,565,384...3,594,267
JBrowse link
G Podxl podocalyxin-like decreases expression ISO Cidofovir results in decreased expression of PODXL mRNA CTD PMID:25596134 NCBI chr 6:31,496,428...31,540,872
Ensembl chr 6:31,496,423...31,540,916
JBrowse link
G Polr3f polymerase (RNA) III (DNA directed) polypeptide F decreases expression ISO Cidofovir results in decreased expression of POLR3F mRNA CTD PMID:25596134 NCBI chr 2:144,369,665...144,383,699
Ensembl chr 2:144,369,638...144,383,915
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma affects activity ISO Cidofovir affects the activity of PPARG protein CTD PMID:25596134 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppfibp1 PTPRF interacting protein, binding protein 1 (liprin beta 1) increases expression ISO Cidofovir results in increased expression of PPFIBP1 mRNA CTD PMID:25596134 NCBI chr 6:146,788,107...146,933,523
Ensembl chr 6:146,789,985...146,933,523
JBrowse link
G Ppig peptidyl-prolyl isomerase G (cyclophilin G) decreases expression ISO Cidofovir results in decreased expression of PPIG mRNA CTD PMID:25596134 NCBI chr 2:69,553,152...69,584,356
Ensembl chr 2:69,552,889...69,584,356
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression ISO Cidofovir results in increased expression of PPP1R15A mRNA CTD PMID:25596134 NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
JBrowse link
G Ppp4r2 protein phosphatase 4, regulatory subunit 2 decreases expression ISO Cidofovir results in decreased expression of PPP4R2 mRNA CTD PMID:25596134 NCBI chr 6:100,810,596...100,846,891
Ensembl chr 6:100,810,583...100,846,895
JBrowse link
G Prc1 protein regulator of cytokinesis 1 increases expression ISO Cidofovir results in increased expression of PRC1 mRNA CTD PMID:25596134 NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007
JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain decreases expression ISO Cidofovir results in decreased expression of PRDM1 mRNA CTD PMID:25596134 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
JBrowse link
G Prkab2 protein kinase, AMP-activated, beta 2 non-catalytic subunit decreases expression ISO Cidofovir results in decreased expression of PRKAB2 mRNA CTD PMID:25596134 NCBI chr 3:97,565,527...97,581,128
Ensembl chr 3:97,565,509...97,581,128
JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 increases expression ISO Cidofovir results in increased expression of PRPS1 mRNA CTD PMID:25596134 NCBI chr  X:139,357,352...139,376,889
Ensembl chr  X:139,357,362...139,376,889
JBrowse link
G Psat1 phosphoserine aminotransferase 1 increases expression ISO Cidofovir results in increased expression of PSAT1 mRNA CTD PMID:25596134 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Pspc1 paraspeckle protein 1 decreases expression ISO Cidofovir results in decreased expression of PSPC1 mRNA CTD PMID:25596134 NCBI chr14:56,959,898...57,015,775
Ensembl chr14:56,958,167...57,015,773
JBrowse link
G Pycr1 pyrroline-5-carboxylate reductase 1 increases expression ISO Cidofovir results in increased expression of PYCR1 mRNA CTD PMID:25596134 NCBI chr11:120,527,591...120,534,602
Ensembl chr11:120,526,538...120,534,595
JBrowse link
G Rab26 RAB26, member RAS oncogene family increases expression ISO Cidofovir results in increased expression of RAB26 mRNA CTD PMID:25596134 NCBI chr17:24,748,038...24,752,696
Ensembl chr17:24,746,215...24,753,184
JBrowse link
G Rab31 RAB31, member RAS oncogene family increases expression ISO Cidofovir results in increased expression of RAB31 mRNA CTD PMID:25596134 NCBI chr17:65,958,721...66,079,747
Ensembl chr17:65,958,724...66,079,747
JBrowse link
G Rara retinoic acid receptor, alpha increases expression ISO Cidofovir results in increased expression of RARA mRNA CTD PMID:25596134 NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
JBrowse link
G Rffl ring finger and FYVE like domain containing protein increases expression ISO Cidofovir results in increased expression of RFFL mRNA CTD PMID:25596134 NCBI chr11:82,694,645...82,762,065
Ensembl chr11:82,693,275...82,762,036
JBrowse link
G Rit1 Ras-like without CAAX 1 increases expression ISO Cidofovir results in increased expression of RIT1 mRNA CTD PMID:25596134 NCBI chr 3:88,624,154...88,638,354
Ensembl chr 3:88,624,145...88,638,356
JBrowse link
G Rlf rearranged L-myc fusion sequence decreases expression ISO Cidofovir results in decreased expression of RLF mRNA CTD PMID:25596134 NCBI chr 4:121,003,080...121,072,318
Ensembl chr 4:121,002,570...121,072,281
JBrowse link
G Rnd1 Rho family GTPase 1 increases expression ISO Cidofovir results in increased expression of RND1 mRNA CTD PMID:25596134 NCBI chr15:98,567,086...98,575,342
Ensembl chr15:98,561,302...98,575,342
JBrowse link
G Rnd3 Rho family GTPase 3 affects expression ISO Cidofovir affects the expression of RND3 mRNA CTD PMID:25596134 NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
JBrowse link
G Rnf121 ring finger protein 121 decreases expression ISO Cidofovir results in decreased expression of RNF121 mRNA CTD PMID:25596134 NCBI chr 7:101,668,344...101,721,712
Ensembl chr 7:101,668,344...101,714,676
JBrowse link
G Ro60 Ro60, Y RNA binding protein decreases expression ISO Cidofovir results in decreased expression of RO60 mRNA CTD PMID:25596134 NCBI chr 1:143,626,528...143,652,794
Ensembl chr 1:143,626,528...143,652,806
JBrowse link
G Rps27l ribosomal protein S27-like increases expression ISO Cidofovir results in increased expression of RPS27L mRNA CTD PMID:25596134 NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798
JBrowse link
G Rrm2b ribonucleotide reductase M2 B (TP53 inducible) decreases expression ISO Cidofovir results in decreased expression of RRM2B mRNA CTD PMID:25596134 NCBI chr15:37,924,196...37,961,562
Ensembl chr15:37,924,196...37,961,562
JBrowse link
G Rsl1d1 ribosomal L1 domain containing 1 affects expression ISO Cidofovir affects the expression of RSL1D1 mRNA CTD PMID:25596134 NCBI chr16:11,010,901...11,021,156
Ensembl chr16:11,010,834...11,021,195
JBrowse link
G Rsrc2 arginine/serine-rich coiled-coil 2 decreases expression ISO Cidofovir results in decreased expression of RSRC2 mRNA CTD PMID:25596134 NCBI chr 5:123,866,489...123,887,522
Ensembl chr 5:123,866,489...123,887,477
JBrowse link
G Runx1 runt related transcription factor 1 increases expression ISO Cidofovir results in increased expression of RUNX1 mRNA CTD PMID:25596134 NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
JBrowse link
G Runx2 runt related transcription factor 2 increases expression ISO Cidofovir results in increased expression of RUNX2 mRNA CTD PMID:25596134 NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
JBrowse link
G Sars1 seryl-tRNA synthetase 1 increases expression ISO Cidofovir results in increased expression of SARS1 mRNA CTD PMID:25596134 NCBI chr 3:108,332,180...108,352,575
Ensembl chr 3:108,332,181...108,352,525
JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 increases expression ISO Cidofovir results in increased expression of SDF2L1 mRNA CTD PMID:25596134 NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247
JBrowse link
G Serpinb5 serine (or cysteine) peptidase inhibitor, clade B, member 5 increases expression ISO Cidofovir results in increased expression of SERPINB5 mRNA CTD PMID:25596134 NCBI chr 1:106,788,905...106,811,078
Ensembl chr 1:106,788,903...106,811,078
JBrowse link
G Sertad1 SERTA domain containing 1 increases expression ISO Cidofovir results in increased expression of SERTAD1 mRNA CTD PMID:25596134 NCBI chr 7:27,186,378...27,189,741
Ensembl chr 7:27,186,335...27,189,741
JBrowse link
G Sesn1 sestrin 1 increases expression ISO Cidofovir results in increased expression of SESN1 mRNA CTD PMID:25596134 NCBI chr10:41,686,570...41,784,432
Ensembl chr10:41,685,931...41,784,420
JBrowse link
G Setx senataxin decreases expression ISO Cidofovir results in decreased expression of SETX mRNA CTD PMID:25596134 NCBI chr 2:29,013,600...29,072,483
Ensembl chr 2:29,014,193...29,072,483
JBrowse link
G Sfn stratifin increases expression ISO Cidofovir results in increased expression of SFN mRNA CTD PMID:25596134 NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
JBrowse link
G Sh3tc1 SH3 domain and tetratricopeptide repeats 1 decreases expression ISO Cidofovir results in decreased expression of SH3TC1 mRNA CTD PMID:25596134 NCBI chr 5:35,854,524...35,897,331
Ensembl chr 5:35,854,524...35,897,331
JBrowse link
G Shank3 SH3 and multiple ankyrin repeat domains 3 affects expression ISO Cidofovir affects the expression of SHANK3 mRNA CTD PMID:25596134 NCBI chr15:89,376,929...89,444,464
Ensembl chr15:89,383,826...89,444,464
JBrowse link
G Siah2 siah E3 ubiquitin protein ligase 2 affects expression ISO Cidofovir affects the expression of SIAH2 mRNA CTD PMID:25596134 NCBI chr 3:58,582,370...58,599,857
Ensembl chr 3:58,582,359...58,599,821
JBrowse link
G Sik1 salt inducible kinase 1 affects expression ISO Cidofovir affects the expression of SIK1 mRNA CTD PMID:25596134 NCBI chr17:32,063,222...32,074,808
Ensembl chr17:32,063,224...32,074,778
JBrowse link
G Sipa1l2 signal-induced proliferation-associated 1 like 2 decreases expression ISO Cidofovir results in decreased expression of SIPA1L2 mRNA CTD PMID:25596134 NCBI chr 8:126,144,807...126,296,602
Ensembl chr 8:126,144,802...126,296,547
JBrowse link
G Siva1 SIVA1, apoptosis-inducing factor increases expression ISO Cidofovir results in increased expression of SIVA1 mRNA CTD PMID:25596134 NCBI chr12:112,611,262...112,615,586
Ensembl chr12:112,611,113...112,615,583
JBrowse link
G Slc12a8 solute carrier family 12 (potassium/chloride transporters), member 8 affects expression ISO Cidofovir affects the expression of SLC12A8 mRNA CTD PMID:25596134 NCBI chr16:33,337,440...33,484,508
Ensembl chr16:33,337,698...33,484,505
JBrowse link
G Slc1a4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 increases expression ISO Cidofovir results in increased expression of SLC1A4 mRNA CTD PMID:25596134 NCBI chr11:20,252,180...20,282,713
Ensembl chr11:20,252,180...20,282,713
JBrowse link
G Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 5 increases expression ISO Cidofovir results in increased expression of SLC1A5 mRNA CTD PMID:25596134 NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
JBrowse link
G Slc22a6 solute carrier family 22 (organic anion transporter), member 6 multiple interactions
increases response to substance
increases import
ISO SLC22A6 protein results in increased uptake of and results in increased susceptibility to Cidofovir
SLC22A6 protein results in increased susceptibility to Cidofovir
SLC22A6 protein results in increased import of Cidofovir
CTD PMID:23856525 PMID:25448811 PMID:29738843 NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 increases response to substance ISO SLC22A8 protein results in increased susceptibility to Cidofovir CTD PMID:25448811 NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Slc25a20 solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 increases expression ISO Cidofovir results in increased expression of SLC25A20 mRNA CTD PMID:25596134 NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
JBrowse link
G Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 decreases expression ISO Cidofovir results in decreased expression of SLC27A2 mRNA CTD PMID:25596134 NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
JBrowse link
G Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 increases expression ISO Cidofovir results in increased expression of SLC2A1 mRNA CTD PMID:25596134 NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
JBrowse link
G Slc3a2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 increases expression ISO Cidofovir results in increased expression of SLC3A2 mRNA CTD PMID:25596134 NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
JBrowse link
G Slc6a6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 affects expression ISO Cidofovir affects the expression of SLC6A6 mRNA CTD PMID:25596134 NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
JBrowse link
G Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 decreases expression ISO Cidofovir results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 NCBI chr 4:117,692,240...117,726,502
Ensembl chr 4:117,691,703...117,732,395
JBrowse link
G Slc7a1 solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 increases expression ISO Cidofovir results in increased expression of SLC7A1 mRNA CTD PMID:25596134 NCBI chr 5:148,264,220...148,336,714
Ensembl chr 5:148,264,220...148,336,714
JBrowse link
G Slc7a5 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 increases expression ISO Cidofovir results in increased expression of SLC7A5 mRNA CTD PMID:25596134 NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 increases expression ISO Cidofovir results in increased expression of SLCO2B1 mRNA CTD PMID:25596134 NCBI chr 7:99,307,011...99,360,547
Ensembl chr 7:99,307,011...99,360,547
JBrowse link
G Smap1 small ArfGAP 1 decreases expression ISO Cidofovir results in decreased expression of SMAP1 mRNA CTD PMID:25596134 NCBI chr 1:23,883,925...23,961,462
Ensembl chr 1:23,883,927...23,961,398
JBrowse link
G Son Son DNA binding protein decreases expression ISO Cidofovir results in decreased expression of SON mRNA CTD PMID:25596134 NCBI chr16:91,444,712...91,476,080
Ensembl chr16:91,444,394...91,476,109
JBrowse link
G Sorl1 sortilin-related receptor, LDLR class A repeats-containing decreases expression ISO Cidofovir results in decreased expression of SORL1 mRNA CTD PMID:25596134 NCBI chr 9:41,876,005...42,035,593
Ensembl chr 9:41,876,016...42,035,593
JBrowse link
G Spry1 sprouty RTK signaling antagonist 1 affects expression ISO Cidofovir affects the expression of SPRY1 mRNA CTD PMID:25596134 NCBI chr 3:37,694,096...37,698,748
Ensembl chr 3:37,694,096...37,698,747
JBrowse link
G Srd5a3 steroid 5 alpha-reductase 3 decreases expression ISO Cidofovir results in decreased expression of SRD5A3 mRNA CTD PMID:25596134 NCBI chr 5:76,285,296...76,303,350
Ensembl chr 5:76,288,118...76,303,351
JBrowse link
G Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) increases expression ISO Cidofovir results in increased expression of SRXN1 mRNA CTD PMID:25596134 NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
JBrowse link
G Strbp spermatid perinuclear RNA binding protein decreases expression ISO Cidofovir results in decreased expression of STRBP mRNA CTD PMID:25596134 NCBI chr 2:37,459,880...37,593,890
Ensembl chr 2:37,373,240...37,593,871
JBrowse link
G Sulf2 sulfatase 2 decreases expression ISO Cidofovir results in decreased expression of SULF2 mRNA CTD PMID:25596134 NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583
JBrowse link
G Taldo1 transaldolase 1 increases expression ISO Cidofovir results in increased expression of TALDO1 mRNA CTD PMID:25596134 NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881
JBrowse link
G Taok1 TAO kinase 1 decreases expression ISO Cidofovir results in decreased expression of TAOK1 mRNA CTD PMID:25596134 NCBI chr11:77,419,988...77,516,185
Ensembl chr11:77,419,988...77,498,641
JBrowse link
G Tars1 threonyl-tRNA synthetase 1 decreases expression ISO Cidofovir results in decreased expression of TARS1 mRNA CTD PMID:25596134 NCBI chr15:11,383,749...11,399,744
Ensembl chr15:11,382,387...11,399,751
JBrowse link
G Tbxas1 thromboxane A synthase 1, platelet increases expression ISO Cidofovir results in increased expression of TBXAS1 mRNA CTD PMID:25596134 NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
JBrowse link
G Tfap2a transcription factor AP-2, alpha decreases expression ISO Cidofovir results in decreased expression of TFAP2A mRNA CTD PMID:25596134 NCBI chr13:40,867,278...40,891,715
Ensembl chr13:40,868,778...40,891,852
JBrowse link
G Tigar Trp53 induced glycolysis regulatory phosphatase increases expression ISO Cidofovir results in increased expression of TIGAR mRNA CTD PMID:25596134 NCBI chr 6:127,062,079...127,086,564
Ensembl chr 6:127,062,079...127,086,520
JBrowse link
G Timm17b translocase of inner mitochondrial membrane 17b affects expression ISO Cidofovir affects the expression of TIMM17B mRNA CTD PMID:25596134 NCBI chr  X:7,765,575...7,773,891
Ensembl chr  X:7,765,596...7,776,168
JBrowse link
G Tinag tubulointerstitial nephritis antigen decreases expression ISO Cidofovir results in decreased expression of TINAG mRNA CTD PMID:25596134 NCBI chr 9:76,858,980...76,953,084
Ensembl chr 9:76,858,975...76,953,076
JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression ISO Cidofovir results in increased expression of TIPARP mRNA CTD PMID:25596134 NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939
JBrowse link
G Tmem45b transmembrane protein 45b decreases expression ISO Cidofovir results in decreased expression of TMEM45B mRNA CTD PMID:25596134 NCBI chr 9:31,336,445...31,375,534
Ensembl chr 9:31,337,492...31,375,758
JBrowse link
G Tmem94 transmembrane protein 94 decreases expression ISO Cidofovir results in decreased expression of TMEM94 mRNA CTD PMID:25596134 NCBI chr11:115,656,245...115,689,859
Ensembl chr11:115,656,259...115,690,192
JBrowse link
G Tmtc2 transmembrane and tetratricopeptide repeat containing 2 decreases expression ISO Cidofovir results in decreased expression of TMTC2 mRNA CTD PMID:25596134 NCBI chr10:105,023,524...105,410,340
Ensembl chr10:105,023,524...105,410,312
JBrowse link
G Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9 increases expression ISO Cidofovir results in increased expression of TNFSF9 mRNA CTD PMID:25596134 NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
JBrowse link
G Top1 topoisomerase (DNA) I affects expression ISO Cidofovir affects the expression of TOP1 mRNA CTD PMID:25596134 NCBI chr 2:160,487,901...160,564,684
Ensembl chr 2:160,487,808...160,564,684
JBrowse link
G Tpcn1 two pore channel 1 increases expression ISO Cidofovir results in increased expression of TPCN1 mRNA CTD PMID:25596134 NCBI chr 5:120,672,222...120,726,731
Ensembl chr 5:120,672,218...120,726,738
JBrowse link
G Tpd52l1 tumor protein D52-like 1 affects expression ISO Cidofovir affects the expression of TPD52L1 mRNA CTD PMID:25596134 NCBI chr10:31,208,369...31,321,989
Ensembl chr10:31,208,372...31,321,954
JBrowse link
G Trafd1 TRAF type zinc finger domain containing 1 increases expression ISO Cidofovir results in increased expression of TRAFD1 mRNA CTD PMID:25596134 NCBI chr 5:121,509,788...121,524,543
Ensembl chr 5:121,509,788...121,523,695
JBrowse link
G Triap1 TP53 regulated inhibitor of apoptosis 1 increases expression ISO Cidofovir results in increased expression of TRIAP1 mRNA CTD PMID:25596134 NCBI chr 5:115,479,290...115,481,612
Ensembl chr 5:115,479,284...115,481,628
JBrowse link
G Trp53 transformation related protein 53 affects activity
increases expression
ISO Cidofovir affects the activity of TP53 protein
Cidofovir results in increased expression of TP53 protein
CTD PMID:11697818 PMID:25596134 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trp53inp1 transformation related protein 53 inducible nuclear protein 1 affects expression ISO Cidofovir affects the expression of TP53INP1 mRNA CTD PMID:25596134 NCBI chr 4:11,156,441...11,174,379
Ensembl chr 4:11,156,431...11,174,379
JBrowse link
G Tspan12 tetraspanin 12 decreases expression ISO Cidofovir results in decreased expression of TSPAN12 mRNA CTD PMID:25596134 NCBI chr 6:21,771,390...21,879,557
Ensembl chr 6:21,771,394...21,852,514
JBrowse link
G Txn1 thioredoxin 1 increases expression ISO Cidofovir results in increased expression of TXN mRNA CTD PMID:25596134 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO Cidofovir results in increased expression of TXNRD1 mRNA CTD PMID:25596134 NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
JBrowse link
G Ube2g2 ubiquitin-conjugating enzyme E2G 2 increases expression ISO Cidofovir results in increased expression of UBE2G2 mRNA CTD PMID:25596134 NCBI chr10:77,458,155...77,481,824
Ensembl chr10:77,458,109...77,481,827
JBrowse link
G Ube2o ubiquitin-conjugating enzyme E2O affects expression ISO Cidofovir affects the expression of UBE2O mRNA CTD PMID:25596134 NCBI chr11:116,428,500...116,472,281
Ensembl chr11:116,428,566...116,472,273
JBrowse link
G Unkl unkempt family like zinc finger affects expression ISO Cidofovir affects the expression of UNKL mRNA CTD PMID:25596134 NCBI chr17:25,407,336...25,453,417
Ensembl chr17:25,407,371...25,453,417
JBrowse link
G Usp3 ubiquitin specific peptidase 3 affects expression ISO Cidofovir affects the expression of USP3 mRNA CTD PMID:25596134 NCBI chr 9:66,421,573...66,501,996
Ensembl chr 9:66,421,919...66,500,424
JBrowse link
G Vegfb vascular endothelial growth factor B increases expression ISO Cidofovir results in increased expression of VEGFB mRNA CTD PMID:25596134 NCBI chr19:6,959,840...6,965,019
Ensembl chr19:6,959,841...6,965,019
JBrowse link
G Vipr1 vasoactive intestinal peptide receptor 1 increases expression ISO Cidofovir results in increased expression of VIPR1 mRNA CTD PMID:25596134 NCBI chr 9:121,471,782...121,502,020
Ensembl chr 9:121,471,782...121,502,020
JBrowse link
G Vtcn1 V-set domain containing T cell activation inhibitor 1 increases expression ISO Cidofovir results in increased expression of VTCN1 mRNA CTD PMID:25596134 NCBI chr 3:100,732,775...100,805,555
Ensembl chr 3:100,732,775...100,804,238
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase1 increases expression ISO Cidofovir results in increased expression of WARS1 mRNA CTD PMID:25596134 NCBI chr12:108,825,956...108,860,095
Ensembl chr12:108,825,956...108,860,100
JBrowse link
G Wwc2 WW, C2 and coiled-coil domain containing 2 decreases expression ISO Cidofovir results in decreased expression of WWC2 mRNA CTD PMID:25596134 NCBI chr 8:48,279,117...48,443,579
Ensembl chr 8:48,276,994...48,443,959
JBrowse link
G Xbp1 X-box binding protein 1 increases expression
affects activity
ISO Cidofovir results in increased expression of XBP1 mRNA
Cidofovir affects the activity of XBP1 protein
CTD PMID:25596134 NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
JBrowse link
G Xpc xeroderma pigmentosum, complementation group C increases expression ISO Cidofovir results in increased expression of XPC mRNA CTD PMID:25596134 NCBI chr 6:91,466,287...91,492,870
Ensembl chr 6:91,466,287...91,492,870
JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 affects expression ISO Cidofovir affects the expression of YARS1 mRNA CTD PMID:25596134 NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400
JBrowse link
G Yeats2 YEATS domain containing 2 affects expression ISO Cidofovir affects the expression of YEATS2 mRNA CTD PMID:25596134 NCBI chr16:19,959,803...20,051,323
Ensembl chr16:19,959,813...20,051,323
JBrowse link
G Ythdc2 YTH domain containing 2 decreases expression ISO Cidofovir results in decreased expression of YTHDC2 mRNA CTD PMID:25596134 NCBI chr18:44,961,521...45,022,782
Ensembl chr18:44,960,813...45,022,791
JBrowse link
G Zmat3 zinc finger matrin type 3 increases expression ISO Cidofovir results in increased expression of ZMAT3 mRNA CTD PMID:25596134 NCBI chr 3:32,388,941...32,419,814
Ensembl chr 3:32,388,941...32,420,163
JBrowse link
CMP-N-acetyl-beta-neuraminic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cmas cytidine monophospho-N-acetylneuraminic acid synthetase affects abundance ISO CMAS protein affects the abundance of Cytidine Monophosphate N-Acetylneuraminic Acid CTD PMID:27380425 NCBI chr 6:142,702,468...142,721,440
Ensembl chr 6:142,702,412...142,721,440
JBrowse link
costunolide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cat catalase increases activity ISO costunolide results in increased activity of CAT protein CTD PMID:20709041 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Il10 interleukin 10 multiple interactions EXP costunolide inhibits the reaction [Ethanol results in decreased expression of IL10 protein] CTD PMID:26970604 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Ins1 insulin I multiple interactions ISO costunolide inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein] CTD PMID:19007766 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions EXP costunolide inhibits the reaction [Ethanol results in increased expression of NOS2 protein] CTD PMID:26970604 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP costunolide inhibits the reaction [Ethanol results in decreased expression of PCNA protein] CTD PMID:26970604 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP costunolide inhibits the reaction [Ethanol results in increased expression of PTGS2 protein] CTD PMID:26970604 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP costunolide inhibits the reaction [Ethanol results in increased expression of TNF protein] CTD PMID:26970604 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
delavirdine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 decreases activity ISO Delavirdine results in decreased activity of CYP2C19 protein CTD PMID:11225565 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 decreases activity ISO Delavirdine results in decreased activity of CYP2C9 protein CTD PMID:11225565 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
didanosine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alb albumin affects binding ISO Didanosine binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Hfe homeostatic iron regulator multiple interactions ISO HFE gene SNP affects the susceptibility to [Didanosine co-treated with Stavudine] CTD PMID:16847405 NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
JBrowse link
G Il24 interleukin 24 decreases expression ISO Didanosine results in decreased expression of IL24 mRNA CTD PMID:32816093 NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial decreases expression
multiple interactions
ISO Didanosine results in decreased expression of COX2 mRNA
tenofovir promotes the reaction [Didanosine results in decreased expression of COX2 mRNA]
CTD PMID:16940060 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G Slc29a3 solute carrier family 29 (nucleoside transporters), member 3 affects transport ISO SLC29A3 protein affects the transport of Didanosine CTD PMID:19164483 NCBI chr10:60,547,851...60,588,624
Ensembl chr10:60,547,851...60,588,573
JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO Didanosine results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
JBrowse link
efavirenz term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 multiple interactions
decreases activity
ISO efavirenz inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
efavirenz results in decreased activity of ABCB11 protein
CTD PMID:24014644 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
decreases secretion
ISO efavirenz results in decreased expression of ADIPOQ mRNA
efavirenz results in decreased secretion of ADIPOQ protein
CTD PMID:21619898 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Alb albumin affects binding ISO efavirenz binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Bcl2l11 BCL2 like 11 increases response to substance
increases expression
ISO BCL2L11 protein results in increased susceptibility to efavirenz metabolite
efavirenz metabolite results in increased expression of BCL2L11 mRNA; efavirenz metabolite results in increased expression of BCL2L11 protein; efavirenz results in increased expression of BCL2L11 mRNA; efavirenz results in increased expression of BCL2L11 protein
CTD PMID:21958719 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
JBrowse link
G Canx calnexin affects localization ISO efavirenz affects the localization of CANX protein CTD PMID:28940366 NCBI chr11:50,184,784...50,216,500
Ensembl chr11:50,184,788...50,216,500
JBrowse link
G Casp3 caspase 3 multiple interactions ISO efavirenz metabolite results in increased cleavage of and results in increased activity of CASP3 protein; efavirenz results in increased cleavage of and results in increased activity of CASP3 protein
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein]
CTD PMID:21958719 PMID:36309141 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Cat catalase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein CTD PMID:34118364 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases secretion ISO efavirenz results in increased secretion of CCL2 protein CTD PMID:21619898 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression ISO efavirenz results in decreased expression of CEBPA mRNA CTD PMID:21619898 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 increases secretion ISO efavirenz results in increased secretion of CXCL8 protein CTD PMID:21619898 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 affects metabolic processing
decreases activity
multiple interactions
increases metabolic processing
ISO CYP2B6 gene polymorphism affects the metabolism of efavirenz; CYP2B6 protein affects the metabolism of efavirenz
efavirenz results in decreased activity of CYP2B6 protein
[efavirenz results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion; [efavirenz results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [efavirenz results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA
CYP2B6 protein results in increased metabolism of efavirenz
CTD PMID:15622315 PMID:15769884 PMID:17041008 PMID:17559344 PMID:26599973 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 decreases activity ISO efavirenz results in decreased activity of CYP2C19 protein CTD PMID:11225565 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 decreases activity ISO efavirenz results in decreased activity of CYP2C9 protein CTD PMID:11225565 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO efavirenz results in increased expression of DDIT3 protein CTD PMID:28940366 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Dnm1l dynamin 1-like affects localization ISO efavirenz affects the localization of DNM1L protein modified form CTD PMID:28940366 NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression ISO efavirenz results in increased expression of EIF2AK3 protein modified form CTD PMID:28940366 NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
JBrowse link
G Fis1 fission, mitochondrial 1 increases expression ISO efavirenz results in increased expression of FIS1 mRNA CTD PMID:28940366 NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
JBrowse link
G Hgf hepatocyte growth factor increases secretion ISO efavirenz results in increased secretion of HGF protein CTD PMID:21619898 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hspa9 heat shock protein 9 multiple interactions ISO efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein] CTD PMID:36309141 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 increases secretion ISO efavirenz results in increased secretion of IL6 protein CTD PMID:21619898 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Jun jun proto-oncogene increases phosphorylation ISO efavirenz metabolite results in increased phosphorylation of JUN protein; efavirenz results in increased phosphorylation of JUN protein CTD PMID:21958719 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Lep leptin decreases expression ISO efavirenz results in decreased expression of LEP mRNA CTD PMID:21619898 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions
increases expression
increases response to substance
ISO efavirenz results in increased expression of and affects the localization of LONP1 protein; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [efavirenz results in increased expression of LONP1 mRNA]
LONP1 protein results in increased susceptibility to efavirenz
CTD PMID:28940366 NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887
JBrowse link
G Lpl lipoprotein lipase decreases expression ISO efavirenz results in decreased expression of LPL mRNA CTD PMID:21619898 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 increases phosphorylation ISO efavirenz metabolite results in increased phosphorylation of MAP3K5 protein; efavirenz results in increased phosphorylation of MAP3K5 protein CTD PMID:21958719 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
ISO Acetylcysteine inhibits the reaction [efavirenz metabolite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz results in increased phosphorylation of MAPK8 protein]
efavirenz metabolite results in increased phosphorylation of MAPK8 protein; efavirenz results in increased phosphorylation of MAPK8 protein
CTD PMID:21958719 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Mfn2 mitofusin 2 increases expression ISO efavirenz results in increased expression of MFN2 mRNA CTD PMID:28940366 NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein CTD PMID:34118364 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO efavirenz results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions
increases activity
ISO [efavirenz results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [efavirenz results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 PMID:27732639 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase increases expression ISO efavirenz results in increased expression of OPA1 mRNA CTD PMID:28940366 NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma decreases expression ISO efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Rmdn3 regulator of microtubule dynamics 3 increases expression ISO efavirenz results in increased expression of RMDN3 protein CTD PMID:28940366 NCBI chr 2:118,967,479...118,987,515
Ensembl chr 2:118,967,482...118,987,515
JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 increases secretion ISO efavirenz results in increased secretion of SERPINE1 protein CTD PMID:21619898 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
JBrowse link
G Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5 multiple interactions ISO [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 protein CTD PMID:16030158 NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 decreases expression ISO efavirenz results in decreased expression of SREBF1 mRNA CTD PMID:21619898 NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
JBrowse link
G Tg thyroglobulin increases expression ISO efavirenz results in increased expression of TG mRNA; efavirenz results in increased expression of TG protein CTD PMID:16030158 NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein] CTD PMID:36309141 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tpo thyroid peroxidase increases expression ISO efavirenz results in increased expression of TPO mRNA; efavirenz results in increased expression of TPO protein CTD PMID:16030158 NCBI chr12:30,104,658...30,182,983
Ensembl chr12:30,104,658...30,182,623
JBrowse link
G Tshb thyroid stimulating hormone, beta subunit multiple interactions ISO [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 protein; efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]] CTD PMID:16030158 NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
JBrowse link
G Tshr thyroid stimulating hormone receptor increases expression ISO efavirenz results in increased expression of TSHR mRNA CTD PMID:16030158 NCBI chr12:91,367,767...91,507,283
Ensembl chr12:91,351,337...91,516,582
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions ISO efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
JBrowse link
emtricitabine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alb albumin affects binding ISO Emtricitabine binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions ISO [Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein CTD PMID:31545371 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Dck deoxycytidine kinase multiple interactions
affects binding
ISO DCK protein results in increased phosphorylation of and results in increased activity of Emtricitabine
Emtricitabine binds to DCK protein
CTD PMID:17530837 NCBI chr 5:88,912,872...88,931,136
Ensembl chr 5:88,912,855...88,931,140
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase decreases expression
multiple interactions
ISO Emtricitabine results in decreased expression of PRKN protein
[Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein
CTD PMID:31545371 NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
JBrowse link
G Trp53 transformation related protein 53 multiple interactions ISO [Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein CTD PMID:31545371 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
enfuvirtide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 affects activity ISO enfuvirtide affects the activity of CYP1A2 protein CTD PMID:15656696 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 affects activity ISO enfuvirtide affects the activity of CYP2C19 protein CTD PMID:15656696 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects activity ISO enfuvirtide affects the activity of CYP2E1 protein CTD PMID:15656696 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
favipiravir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Polg polymerase (DNA directed), gamma affects binding ISO favipiravir binds to POLG1 protein CTD PMID:36152797 NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
JBrowse link
floxuridine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Apex1 apurinic/apyrimidinic endonuclease 1 increases response to substance
decreases response to substance
ISO APEX1 protein mutant form results in increased susceptibility to Floxuridine
APEX1 protein results in decreased susceptibility to Floxuridine
CTD PMID:19470598 PMID:22194930 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
JBrowse link
G Atr ataxia telangiectasia and Rad3 related decreases response to substance ISO ATR protein results in decreased susceptibility to Floxuridine CTD PMID:21613406 PMID:22194930 NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
JBrowse link
G C1qbp complement component 1, q subcomponent binding protein decreases response to substance ISO C1QBP protein results in decreased susceptibility to Floxuridine CTD PMID:25354864 NCBI chr11:70,868,672...70,873,852
Ensembl chr11:70,868,662...70,873,852
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO Floxuridine results in increased phosphorylation of and results in increased activity of CHEK1 protein CTD PMID:21613406 PMID:22194930 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions
increases activity
ISO Floxuridine results in increased phosphorylation of and results in increased activity of CHEK2 protein
Floxuridine results in increased activity of CHEK2 protein
CTD PMID:21613406 PMID:22194930 NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
JBrowse link
G Mlh1 mutL homolog 1 multiple interactions
decreases response to substance
ISO olaparib inhibits the reaction [MLH1 protein results in decreased susceptibility to Floxuridine] CTD PMID:22194930 NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859
JBrowse link
G Msh2 mutS homolog 2 multiple interactions
decreases response to substance
ISO olaparib inhibits the reaction [MSH2 protein results in decreased susceptibility to Floxuridine] CTD PMID:22194930 NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141
JBrowse link
G Mthfr methylenetetrahydrofolate reductase affects response to substance ISO MTHFR protein affects the susceptibility to Floxuridine CTD PMID:18202788 NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 decreases response to substance ISO PARP1 protein results in decreased susceptibility to Floxuridine CTD PMID:21613406 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Timp3 tissue inhibitor of metalloproteinase 3 affects response to substance
decreases response to substance
ISO TIMP3 protein affects the susceptibility to Floxuridine
TIMP3 gene modified form results in decreased susceptibility to Floxuridine
CTD PMID:18202788 NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
JBrowse link
G Tk1 thymidine kinase 1 increases expression ISO Floxuridine results in increased expression of TK1 protein CTD PMID:16951200 NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
JBrowse link
G Trp53 transformation related protein 53 increases expression
affects activity
ISO Floxuridine results in increased expression of TP53 protein
Floxuridine affects the activity of TP53 protein
CTD PMID:19015155 PMID:35435491 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Tyms thymidylate synthase decreases response to substance
increases response to substance
affects response to substance
ISO TYMS protein results in decreased susceptibility to Floxuridine
TYMS results in increased susceptibility to Floxuridine
TYMS protein affects the susceptibility to Floxuridine
CTD PMID:2537495 PMID:10482907 PMID:15040806 PMID:17018589 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Ung uracil DNA glycosylase affects expression
increases response to substance
affects stability
ISO Floxuridine affects the expression of UNG mRNA; Floxuridine affects the expression of UNG protein
UNG protein results in increased susceptibility to Floxuridine
Floxuridine affects the stability of UNG protein alternative form
CTD PMID:16951200 NCBI chr 5:114,268,427...114,277,382
Ensembl chr 5:114,268,447...114,277,384
JBrowse link
G Xrcc1 X-ray repair complementing defective repair in Chinese hamster cells 1 decreases response to substance ISO XRCC1 protein results in decreased susceptibility to Floxuridine CTD PMID:21613406 PMID:22194930 NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
JBrowse link
G Xrcc4 X-ray repair complementing defective repair in Chinese hamster cells 4 decreases response to substance ISO XRCC4 results in decreased susceptibility to Floxuridine CTD PMID:21785230 NCBI chr13:89,997,033...90,237,727
Ensembl chr13:89,922,146...90,237,727
JBrowse link
ganciclovir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bcl2 B cell leukemia/lymphoma 2 decreases expression ISO Ganciclovir results in decreased expression of BCL2 protein CTD PMID:15592511 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 increases expression ISO Ganciclovir results in increased expression of MDM2 protein CTD PMID:15592511 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
JBrowse link
G Tnf tumor necrosis factor increases secretion
multiple interactions
ISO Ganciclovir results in increased secretion of TNF protein
Sulfasalazine promotes the reaction [Ganciclovir results in increased secretion of TNF protein]
CTD PMID:17143539 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 increases expression ISO Ganciclovir results in increased expression of TP53 protein CTD PMID:15592511 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
gemcitabine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin increases expression ISO Gemcitabine results in increased expression of A2M protein CTD PMID:20531411 NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A decreases expression ISO Gemcitabine results in decreased expression of ABCB1 mRNA; Gemcitabine results in decreased expression of ABCB1 protein CTD PMID:35063459 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Acp3 acid phosphatase 3 decreases expression ISO Gemcitabine results in decreased expression of ACP3 protein CTD PMID:20531411 NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947
JBrowse link
G Adam17 a disintegrin and metallopeptidase domain 17 multiple interactions ISO ADAM17 protein promotes the reaction [Gemcitabine results in increased cleavage of AREG protein] CTD PMID:20726858 NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression ISO Gemcitabine results in increased expression of ADIPOQ protein CTD PMID:20531411 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Afp alpha fetoprotein decreases expression ISO Gemcitabine results in decreased expression of AFP protein CTD PMID:20531411 NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
JBrowse link
G Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 decreases expression ISO Gemcitabine results in decreased expression of AGPAT2 mRNA CTD PMID:17039268 NCBI chr 2:26,483,069...26,494,429
Ensembl chr 2:26,483,069...26,494,429
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions
affects response to substance
ISO [Gemcitabine co-treated with licoricidin] results in decreased phosphorylation of AKT1 protein; [licoricidin co-treated with Gemcitabine] results in decreased phosphorylation of AKT1 protein
AKT1 protein affects the susceptibility to Gemcitabine
CTD PMID:15867245 PMID:29782821 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 multiple interactions
decreases expression
ISO sulforaphane promotes the reaction [Gemcitabine results in decreased expression of ALDH1A1 protein] CTD PMID:20940707 NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
JBrowse link
G Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 increases expression ISO Gemcitabine results in increased expression of ALDH1A3 mRNA CTD PMID:17039268 NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
JBrowse link
G Aldh6a1 aldehyde dehydrogenase family 6, subfamily A1 increases expression ISO Gemcitabine results in increased expression of ALDH6A1 mRNA CTD PMID:17039268 NCBI chr12:84,477,491...84,497,798
Ensembl chr12:84,477,491...84,497,778
JBrowse link
G Anapc1 anaphase promoting complex subunit 1 increases expression ISO Gemcitabine results in increased expression of ANAPC1 mRNA CTD PMID:17039268 NCBI chr 2:128,452,003...128,529,558
Ensembl chr 2:128,452,024...128,529,311
JBrowse link
G Ank3 ankyrin 3, epithelial increases expression ISO Gemcitabine results in increased expression of ANK3 mRNA CTD PMID:17039268 NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
JBrowse link
G Ankrd1 ankyrin repeat domain 1 increases expression ISO Gemcitabine results in increased expression of ANKRD1 mRNA CTD PMID:17039268 NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499
JBrowse link
G Antxr1 anthrax toxin receptor 1 affects expression ISO Gemcitabine affects the expression of ANTXR1 mRNA CTD PMID:17039268 NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
JBrowse link
G Apcs amyloid P component, serum decreases expression ISO Gemcitabine results in decreased expression of APCS protein CTD PMID:20531411 NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608
JBrowse link
G Apoh apolipoprotein H increases expression ISO Gemcitabine results in increased expression of APOH protein CTD PMID:20531411 NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
JBrowse link
G Ar androgen receptor multiple interactions ISO Gemcitabine binds to and results in decreased activity of AR protein CTD PMID:25752796 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Areg amphiregulin increases cleavage
decreases response to substance
increases expression
multiple interactions
ISO Gemcitabine results in increased cleavage of AREG protein
AREG protein results in decreased susceptibility to Gemcitabine
Gemcitabine results in increased expression of AREG protein
ADAM17 protein promotes the reaction [Gemcitabine results in increased cleavage of AREG protein]
CTD PMID:20726858 NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
JBrowse link
G Arf1 ADP-ribosylation factor 1 decreases expression ISO Gemcitabine results in decreased expression of ARF1 mRNA CTD PMID:17039268 NCBI chr11:59,102,237...59,119,042
Ensembl chr11:59,102,238...59,119,096
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator increases expression ISO Gemcitabine results in increased expression of ARNT mRNA CTD PMID:20103597 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Gemcitabine results in increased expression of ATF3 mRNA CTD PMID:17039268 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Axin2 axin 2 affects expression ISO Gemcitabine affects the expression of AXIN2 mRNA CTD PMID:20103597 NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609
JBrowse link
G Axl AXL receptor tyrosine kinase multiple interactions ISO AXL protein promotes the reaction [Warfarin results in increased susceptibility to Gemcitabine] CTD PMID:26206560 NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
JBrowse link
G Bax BCL2-associated X protein multiple interactions ISO [alvocidib co-treated with Gemcitabine] results in increased expression of BAX protein; [ICI 118551 co-treated with Gemcitabine] results in increased expression of BAX protein; [Mastic Resin co-treated with Gemcitabine] results in increased expression of BAX protein; [TNFSF10 co-treated with Gemcitabine] affects the localization of BAX protein CTD PMID:15770523 PMID:17671697 PMID:20523344 PMID:21570961 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression
multiple interactions
ISO
EXP
Gemcitabine results in decreased expression of BCL2 protein
[alvocidib co-treated with Gemcitabine] results in decreased expression of BCL2 protein; [Aminophylline co-treated with Gemcitabine] results in decreased expression of BCL2 protein; [ICI 118551 co-treated with Gemcitabine] results in decreased expression of BCL2 protein; [Mastic Resin co-treated with Gemcitabine] results in decreased expression of BCL2 protein; [Theophylline co-treated with Gemcitabine] results in decreased expression of BCL2 protein; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [Gemcitabine results in decreased expression of BCL2 protein]
[Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2 protein
CTD PMID:15476743 PMID:15645133 PMID:15770523 PMID:16929163 PMID:17440100 More... NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 multiple interactions
decreases expression
ISO
EXP
Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 protein]
Gemcitabine results in decreased expression of BCL2L1 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2L1 protein
CTD PMID:15476743 PMID:16929163 PMID:17440100 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Bcl2l11 BCL2 like 11 increases expression ISO Gemcitabine results in increased expression of BCL2L11 mRNA CTD PMID:17039268 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
JBrowse link
G Bcl6 B cell leukemia/lymphoma 6 increases expression ISO Gemcitabine results in increased expression of BCL6 mRNA CTD PMID:17039268 NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
JBrowse link
G Bdnf brain derived neurotrophic factor decreases expression ISO Gemcitabine results in decreased expression of BDNF protein CTD PMID:20531411 NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
JBrowse link
G Bid BH3 interacting domain death agonist increases cleavage ISO Gemcitabine results in increased cleavage of BID protein CTD PMID:14750167 NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression ISO Gemcitabine results in increased expression of BIRC2 mRNA CTD PMID:17039268 NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 affects expression
multiple interactions
ISO
EXP
Gemcitabine affects the expression of BIRC3 mRNA
[Curcumin co-treated with Gemcitabine] results in decreased expression of BIRC3 protein
CTD PMID:17039268 PMID:17440100 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
decreases expression
ISO
EXP
Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA]; Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein]
Gemcitabine results in decreased expression of BIRC5 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of BIRC5 protein
CTD PMID:16929163 PMID:17440100 PMID:38000456 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like increases expression ISO Gemcitabine results in increased expression of BNIP3L mRNA CTD PMID:17039268 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326
JBrowse link
G Braf Braf transforming gene decreases expression ISO Gemcitabine results in decreased expression of BRAF mRNA CTD PMID:20103597 NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
JBrowse link
G Brca1 breast cancer 1, early onset decreases response to substance
increases expression
EXP
ISO
BRCA1 results in decreased susceptibility to Gemcitabine
Gemcitabine results in increased expression of BRCA1 mRNA
CTD PMID:20103597 PMID:21771338 NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
increases expression
increases activity
ISO
EXP
[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Gemcitabine] affects the activity of CASP3 protein; [3-(4-methylphenylsulfonyl)-2-propenenitrile co-treated with Gemcitabine] affects the activity of CASP3 protein; [alvocidib co-treated with Gemcitabine] results in increased cleavage of CASP3 protein; [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP3 protein; [Gemcitabine co-treated with TNFRSF10B] affects the activity of CASP3 protein; [Vorinostat co-treated with Gemcitabine] results in increased activity of CASP3 protein; Gemcitabine results in increased activity of and results in increased cleavage of CASP3 protein; Gemcitabine results in increased expression of and results in increased activity of CASP3 protein; licoricidin promotes the reaction [Gemcitabine results in increased activity of CASP3 protein]; licoricidin promotes the reaction [Gemcitabine results in increased expression of and results in increased activity of CASP3 protein]; PIF1 protein affects the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP3 protein]; Quercetin promotes the reaction [Gemcitabine results in increased activity of CASP3 protein]; SMG1 protein inhibits the reaction [Gemcitabine results in increased activity of CASP3 protein]
Gemcitabine results in increased cleavage of CASP3 protein
[10-propargyl-10-deazaaminopterin co-treated with Gemcitabine] results in increased activity of CASP3 protein; [Curcumin co-treated with Gemcitabine] results in decreased expression of CASP3 protein
Gemcitabine results in increased expression of CASP3 protein modified form
CTD PMID:12479703 PMID:15476743 PMID:15726400 PMID:15770523 PMID:16153448 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp6 caspase 6 multiple interactions ISO [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP6 protein CTD PMID:20699664 NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
JBrowse link
G Casp8 caspase 8 increases activity
multiple interactions
increases cleavage
ISO Gemcitabine results in increased activity of CASP8 protein
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP8 protein; [Gemcitabine co-treated with TNFRSF10B] affects the activity of CASP8 protein; [TNFSF10 co-treated with Gemcitabine] results in increased activity of CASP8 protein; Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein; SFN protein inhibits the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; YAP1 protein affects the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]
Gemcitabine results in increased cleavage of CASP8 protein
CTD PMID:12479703 PMID:14750167 PMID:17159604 PMID:17671697 PMID:18089714 More... NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Casp9 caspase 9 increases cleavage
multiple interactions
increases activity
ISO
EXP
Gemcitabine results in increased cleavage of CASP9 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of CASP9 protein
Gemcitabine results in increased activity of CASP9 protein
[Calcitriol co-treated with Gemcitabine] results in increased expression of CASP9 protein; Quercetin promotes the reaction [Gemcitabine results in increased activity of CASP9 protein]; SMG1 protein inhibits the reaction [Gemcitabine results in increased activity of CASP9 protein]
CTD PMID:12479703 PMID:15476743 PMID:15726400 PMID:17159604 PMID:17440100 More... NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Gemcitabine results in decreased expression of CCL2 protein CTD PMID:20531411 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression ISO Gemcitabine results in increased expression of CCL20 mRNA CTD PMID:17039268 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Gemcitabine results in increased expression of CCL3 protein CTD PMID:20531411 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Ccnb1 cyclin B1 decreases expression
increases expression
ISO Gemcitabine results in decreased expression of CCNB1 mRNA
Gemcitabine results in increased expression of CCNB1 protein
CTD PMID:11504793 PMID:20103597 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions
ISO
EXP
Gemcitabine results in decreased expression of CCND1 mRNA; Gemcitabine results in decreased expression of CCND1 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of CCND1 protein
Celecoxib promotes the reaction [Gemcitabine results in decreased expression of CCND1 protein]
CTD PMID:16060994 PMID:17039268 PMID:17440100 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccng2 cyclin G2 increases expression ISO Gemcitabine results in increased expression of CCNG2 mRNA CTD PMID:17039268 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
JBrowse link
G Cd274 CD274 antigen multiple interactions ISO [Oleanolic Acid co-treated with Gemcitabine] inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]; [Oleanolic Acid co-treated with Gemcitabine] inhibits the reaction [IL1B protein results in increased expression of CD274 protein]; Gemcitabine inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]; Gemcitabine inhibits the reaction [IL1B protein results in increased expression of CD274 protein] CTD PMID:32894642 NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
JBrowse link
G Cd40 CD40 antigen decreases expression ISO Gemcitabine results in decreased expression of CD40 mRNA; Gemcitabine results in decreased expression of CD40 protein CTD PMID:17039268 PMID:20531411 NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
JBrowse link
G Cd40lg CD40 ligand decreases expression ISO Gemcitabine results in decreased expression of CD40LG protein CTD PMID:20531411 NCBI chr  X:56,257,448...56,269,402
Ensembl chr  X:56,257,503...56,269,402
JBrowse link
G Cd44 CD44 antigen affects expression ISO Gemcitabine affects the expression of CD44 mRNA CTD PMID:35063459 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G Cda cytidine deaminase multiple interactions
affects response to substance
ISO [Crizotinib results in decreased expression of CDA protein] which results in increased susceptibility to Gemcitabine; CDA protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]; CDA protein affects the susceptibility to [Gemcitabine co-treated with Oxaliplatin]
CDA protein affects the susceptibility to Gemcitabine
CTD PMID:18728667 PMID:22973962 NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [Gemcitabine co-treated with ON 01910] results in decreased expression of CDC25C protein CTD PMID:20103597 NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
JBrowse link
G Cdh1 cadherin 1 increases expression ISO Gemcitabine results in increased expression of CDH1 mRNA CTD PMID:17039268 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
increases expression
ISO [alvocidib co-treated with Gemcitabine] results in increased expression of CDKN1A protein; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of CDKN1A protein; Nicotine inhibits the reaction [Gemcitabine results in increased expression of CDKN1A protein]
Gemcitabine results in increased expression of CDKN1A mRNA; Gemcitabine results in increased expression of CDKN1A protein
CTD PMID:15476743 PMID:15770523 PMID:16601104 PMID:17039268 PMID:25189999 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B decreases response to substance ISO CDKN1B results in decreased susceptibility to Gemcitabine CTD PMID:21652059 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression ISO Gemcitabine results in increased expression of CEBPB mRNA CTD PMID:17039268 NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of CHRDL2 protein CTD PMID:24979617 NCBI chr 7:99,655,611...99,683,935
Ensembl chr 7:99,655,379...99,683,935
JBrowse link
G Ckb creatine kinase, brain decreases expression ISO Gemcitabine results in decreased expression of CKB mRNA CTD PMID:17039268 NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
JBrowse link
G Clic4 chloride intracellular channel 4 increases expression ISO Gemcitabine results in increased expression of CLIC4 mRNA CTD PMID:17039268 NCBI chr 4:134,941,280...135,000,071
Ensembl chr 4:134,941,280...135,000,125
JBrowse link
G Clu clusterin increases expression
affects response to substance
ISO Gemcitabine results in increased expression of CLU protein
CLU protein affects the susceptibility to Gemcitabine
CTD PMID:19007378 NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G Cnr1 cannabinoid receptor 1 multiple interactions
increases expression
ISO BAY 11-7085 inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA]; Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Gemcitabine results in increased expression of CNR1 mRNA] CTD PMID:21525939 NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
JBrowse link
G Cnr2 cannabinoid receptor 2 increases expression
multiple interactions
ISO Gemcitabine results in increased expression of CNR2 mRNA
BAY 11-7085 inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA]; Dactinomycin inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Gemcitabine results in increased expression of CNR2 mRNA]
CTD PMID:21525939 NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
JBrowse link
G Col1a1 collagen, type I, alpha 1 decreases expression
multiple interactions
ISO Gemcitabine results in decreased expression of COL1A1 protein
Gemcitabine inhibits the reaction [Niclosamide results in decreased expression of COL1A1 protein]; Niclosamide inhibits the reaction [Gemcitabine results in decreased expression of COL1A1 protein]
CTD PMID:35115509 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) decreases expression ISO Gemcitabine results in decreased expression of CSF2 protein CTD PMID:20531411 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) decreases expression ISO Gemcitabine results in decreased expression of CSF3 protein CTD PMID:20531411 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 increases expression ISO Gemcitabine results in increased expression of CSRP2 mRNA CTD PMID:17039268 NCBI chr10:110,756,037...110,775,375
Ensembl chr10:110,755,650...110,775,483
JBrowse link
G Cthrc1 collagen triple helix repeat containing 1 increases expression ISO Gemcitabine results in increased expression of CTHRC1 mRNA CTD PMID:17039268 NCBI chr15:38,940,327...38,950,516
Ensembl chr15:38,940,327...38,950,516
JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases expression
ISO Gemcitabine results in increased expression of CTNNB1 mRNA
Gemcitabine results in decreased expression of CTNNB1 protein
CTD PMID:25605917 PMID:38000456 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression ISO Gemcitabine results in increased expression of CXCL1 mRNA CTD PMID:17039268 NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
JBrowse link
G Cxcl11 chemokine (C-X-C motif) ligand 11 multiple interactions ISO [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of CXCL11 protein CTD PMID:24979617 NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 decreases expression
increases secretion
ISO Gemcitabine results in decreased expression of CXCL8 protein
Gemcitabine results in increased secretion of CXCL8 protein
CTD PMID:20531411 PMID:28007550 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO Gemcitabine results in increased expression of CXCL2 mRNA CTD PMID:17039268 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO Gemcitabine results in increased expression of CXCL1 mRNA CTD PMID:17039268 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 affects expression ISO Gemcitabine affects the expression of CXCR4 mRNA CTD PMID:20103597 NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 decreases expression ISO Gemcitabine results in decreased expression of CYP24A1 mRNA CTD PMID:17039268 NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 affects expression ISO Gemcitabine affects the expression of DDIT4 mRNA CTD PMID:17039268 NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression ISO Gemcitabine results in decreased expression of DHX9 mRNA CTD PMID:17039268 NCBI chr 1:153,331,506...153,363,464
Ensembl chr 1:153,331,504...153,363,406
JBrowse link
G Dlg2 discs large MAGUK scaffold protein 2 increases expression ISO Gemcitabine results in increased expression of DLG2 mRNA CTD PMID:17039268 NCBI chr 7:90,125,399...92,098,454
Ensembl chr 7:90,125,880...92,098,455
JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions ISO [DNMT1 protein binds to SFN promoter] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; [Gemcitabine results in decreased susceptibility to Gemcitabine] inhibits the reaction [DNMT1 protein binds to SFN promoter]; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of DNMT1 protein; [UHRF1 protein promotes the reaction [DNMT1 protein binds to SFN promoter]] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; DNMT1 protein inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine] CTD PMID:25189999 NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
JBrowse link
G Dnmt3b DNA methyltransferase 3B multiple interactions ISO [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of DNMT3B protein CTD PMID:25189999 NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [TYMP protein co-treated with DPYD protein] affects the susceptibility to Gemcitabine CTD PMID:18728667 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 decreases expression ISO Gemcitabine results in decreased expression of DYNC1H1 mRNA CTD PMID:17039268 NCBI chr12:110,567,829...110,633,378
Ensembl chr12:110,567,886...110,633,379
JBrowse link
G Edn1 endothelin 1 decreases expression ISO Gemcitabine results in decreased expression of EDN1 protein CTD PMID:20531411 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Edn2 endothelin 2 decreases expression ISO Gemcitabine results in decreased expression of EDN2 mRNA CTD PMID:17039268 NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557
JBrowse link
G Egf epidermal growth factor decreases expression
multiple interactions
ISO Gemcitabine results in decreased expression of EGF protein
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]; Erlotinib Hydrochloride inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; pyrazolanthrone inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; U 0126 inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]
CTD PMID:20531411 PMID:21613822 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
JBrowse link
G Egfr epidermal growth factor receptor decreases expression
increases phosphorylation
increases degradation
increases expression
multiple interactions
ISO Gemcitabine results in decreased expression of EGFR mRNA; Gemcitabine results in decreased expression of EGFR protein
Gemcitabine results in increased phosphorylation of EGFR protein
Gemcitabine results in increased degradation of EGFR protein
Gemcitabine results in increased expression of EGFR mRNA
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein]; EGFR gene mutant form results in increased susceptibility to [Gemcitabine co-treated with Cisplatin co-treated with Erlotinib Hydrochloride]; Gefitinib inhibits the reaction [Gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein]; Gemcitabine promotes the reaction [HER3 protein binds to EGFR protein]
CTD PMID:17146438 PMID:20103597 PMID:20726858 PMID:21541241 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Egr1 early growth response 1 increases expression ISO Gemcitabine results in increased expression of EGR1 mRNA CTD PMID:17039268 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO Gemcitabine binds to and results in decreased activity of ESR1 protein CTD PMID:25752796 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Etv1 ets variant 1 increases expression ISO Gemcitabine results in increased expression of ETV1 mRNA CTD PMID:17039268 NCBI chr12:38,829,655...38,920,484
Ensembl chr12:38,829,379...38,920,483
JBrowse link
G Evi2b ecotropic viral integration site 2b decreases expression ISO Gemcitabine results in decreased expression of EVI2B mRNA CTD PMID:17039268 NCBI chr11:79,404,211...79,414,588
Ensembl chr11:79,405,882...79,414,588
JBrowse link
G F7 coagulation factor VII decreases expression ISO Gemcitabine results in decreased expression of F7 protein CTD PMID:20531411 NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
JBrowse link
G Fas Fas cell surface death receptor increases expression ISO Gemcitabine results in increased expression of FAS mRNA; Gemcitabine results in increased expression of FAS protein CTD PMID:11138460 PMID:17159604 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fbxo25 F-box protein 25 increases expression ISO Gemcitabine results in increased expression of FBXO25 mRNA CTD PMID:17039268 NCBI chr 8:13,957,667...13,992,862
Ensembl chr 8:13,957,803...13,990,522
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
increases expression
ISO [Gemcitabine co-treated with IFNA2 protein] results in increased expression of FGF2 protein
Gemcitabine results in increased expression of FGF2 protein
CTD PMID:12738744 PMID:20531411 NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
JBrowse link
G Fgg fibrinogen gamma chain affects expression ISO Gemcitabine affects the expression of FGG mRNA CTD PMID:17039268 NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
JBrowse link
G Fosl2 fos-like antigen 2 decreases expression ISO Gemcitabine results in decreased expression of FOSL2 mRNA CTD PMID:17039268 NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 increases expression ISO Gemcitabine results in increased expression of FXYD3 mRNA CTD PMID:17039268 NCBI chr 7:30,769,960...30,776,122
Ensembl chr 7:30,767,597...30,776,129
JBrowse link
G Gal3st1 galactose-3-O-sulfotransferase 1 decreases expression ISO Gemcitabine results in decreased expression of GAL3ST1 mRNA CTD PMID:17039268 NCBI chr11:3,933,636...3,949,328
Ensembl chr11:3,933,636...3,949,326
JBrowse link
G Gas1 growth arrest specific 1 decreases expression ISO Gemcitabine results in decreased expression of GAS1 mRNA CTD PMID:17039268 NCBI chr13:60,322,219...60,325,179
Ensembl chr13:60,322,219...60,325,179
JBrowse link
G Gask1b golgi associated kinase 1B decreases expression ISO Gemcitabine results in decreased expression of GASK1B mRNA CTD PMID:17039268 NCBI chr 3:79,791,795...79,853,585
Ensembl chr 3:79,791,840...79,853,587
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions ISO [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of GDF15 protein CTD PMID:24979617 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
JBrowse link
G Gipc1 GIPC PDZ domain containing family, member 1 affects response to substance ISO GIPC1 affects the susceptibility to Gemcitabine CTD PMID:25469510 NCBI chr 8:84,376,037...84,391,418
Ensembl chr 8:84,379,306...84,391,323
JBrowse link
G Gli2 GLI-Kruppel family member GLI2 affects expression ISO Gemcitabine affects the expression of GLI2 mRNA CTD PMID:20103597 NCBI chr 1:118,761,791...118,987,578
Ensembl chr 1:118,761,862...118,981,349
JBrowse link
G Glrx glutaredoxin increases expression ISO Gemcitabine results in increased expression of GLRX mRNA CTD PMID:17039268 NCBI chr13:75,988,004...75,998,270
Ensembl chr13:75,987,987...75,998,273
JBrowse link
G Gpc3 glypican 3 increases expression ISO Gemcitabine results in increased expression of GPC3 mRNA CTD PMID:17039268 NCBI chr  X:51,361,303...51,702,851
Ensembl chr  X:51,361,303...51,702,827
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta increases phosphorylation ISO Gemcitabine results in increased phosphorylation of GSK3B protein CTD PMID:16570353 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
JBrowse link
G Gtf2a1 general transcription factor II A, 1 affects expression ISO Gemcitabine affects the expression of GTF2A1 mRNA CTD PMID:17039268 NCBI chr12:91,522,036...91,559,102
Ensembl chr12:91,522,036...91,557,261
JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions
ISO Gemcitabine results in increased expression of H2AX protein; Gemcitabine results in increased expression of H2AX protein modified form
PIF1 protein inhibits the reaction [Gemcitabine results in increased expression of H2AX protein]; Thymidine inhibits the reaction [PIF1 protein inhibits the reaction [Gemcitabine results in increased expression of H2AX protein]]
CTD PMID:20798217 PMID:37183367 PMID:38000456 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G H4c14 H4 clustered histone 14 decreases expression ISO Gemcitabine results in decreased expression of H4C3 mRNA CTD PMID:17039268 NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627
JBrowse link
G Hdac9 histone deacetylase 9 increases expression ISO Gemcitabine results in increased expression of HDAC9 mRNA CTD PMID:17039268 NCBI chr12:34,097,579...34,967,094
Ensembl chr12:34,097,579...34,967,094
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit affects response to substance ISO HIF1A protein affects the susceptibility to Gemcitabine CTD PMID:16628086 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO CASC9 protein affects the reaction [Gemcitabine results in increased expression of HMOX1 mRNA]; CASC9 protein affects the reaction [Gemcitabine results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Gemcitabine results in increased expression of HMOX1 mRNA]
Gemcitabine results in increased expression of HMOX1 mRNA; Gemcitabine results in increased expression of HMOX1 protein
CTD PMID:35913601 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hoxb2 homeobox B2 increases expression ISO Gemcitabine results in increased expression of HOXB2 mRNA CTD PMID:17039268 NCBI chr11:96,242,458...96,244,846
Ensembl chr11:96,241,351...96,244,838
JBrowse link
G Hspa1l heat shock protein 1-like decreases expression ISO Gemcitabine results in decreased expression of HSPA1L mRNA CTD PMID:17039268 NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
JBrowse link
G Hspa5 heat shock protein 5 increases expression ISO Gemcitabine results in increased expression of HSPA5 mRNA CTD PMID:17039268 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression
multiple interactions
ISO
EXP
Gemcitabine results in decreased expression of ICAM1 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of ICAM1 protein
CTD PMID:17440100 PMID:20531411 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Ifng interferon gamma decreases expression ISO Gemcitabine results in decreased expression of IFNG protein CTD PMID:20531411 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Igf1r insulin-like growth factor I receptor decreases expression ISO Gemcitabine results in decreased expression of IGF1R mRNA CTD PMID:20103597 NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 affects expression ISO Gemcitabine affects the expression of IGFBP3 mRNA CTD PMID:20103597 NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
JBrowse link
G Il10 interleukin 10 decreases expression ISO Gemcitabine results in decreased expression of IL10 protein CTD PMID:20531411 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il13 interleukin 13 increases expression ISO Gemcitabine results in increased expression of IL13 protein CTD PMID:20531411 NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
JBrowse link
G Il15 interleukin 15 decreases expression ISO Gemcitabine results in decreased expression of IL15 protein CTD PMID:20531411 NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
JBrowse link
G Il16 interleukin 16 increases expression ISO Gemcitabine results in increased expression of IL16 protein CTD PMID:20531411 NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
JBrowse link
G Il1a interleukin 1 alpha decreases expression ISO Gemcitabine results in decreased expression of IL1A protein CTD PMID:20531411 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
ISO [Oleanolic Acid co-treated with Gemcitabine] inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]; [Oleanolic Acid co-treated with Gemcitabine] inhibits the reaction [IL1B protein results in increased expression of CD274 protein]; Gemcitabine inhibits the reaction [IL1B protein results in increased expression of CD274 mRNA]; Gemcitabine inhibits the reaction [IL1B protein results in increased expression of CD274 protein]
Gemcitabine results in decreased expression of IL1B protein
CTD PMID:20531411 PMID:32894642 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il4 interleukin 4 decreases expression ISO Gemcitabine results in decreased expression of IL4 protein CTD PMID:20531411 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il6 interleukin 6 increases secretion
decreases expression
increases expression
ISO Gemcitabine results in increased secretion of IL6 protein
Gemcitabine results in decreased expression of IL6 protein
Gemcitabine results in increased expression of IL6 mRNA
CTD PMID:17039268 PMID:20531411 PMID:28007550 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Ilk integrin linked kinase affects response to substance ISO ILK protein affects the susceptibility to Gemcitabine CTD PMID:15867245 NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
JBrowse link
G Ins2 insulin II increases expression ISO Gemcitabine results in increased expression of INS protein CTD PMID:20531411 NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
JBrowse link
G Insig1 insulin induced gene 1 increases expression ISO Gemcitabine results in increased expression of INSIG1 mRNA CTD PMID:17039268 NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
JBrowse link
G Iqgap1 IQ motif containing GTPase activating protein 1 increases expression ISO Gemcitabine results in increased expression of IQGAP1 mRNA CTD PMID:17039268 NCBI chr 7:80,361,331...80,453,288
Ensembl chr 7:80,361,331...80,475,722
JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 increases expression ISO Gemcitabine results in increased expression of IRAK2 mRNA CTD PMID:17039268 NCBI chr 6:113,615,428...113,671,987
Ensembl chr 6:113,615,428...113,671,987
JBrowse link
G Irf3 interferon regulatory factor 3 decreases expression ISO Gemcitabine results in decreased expression of IRF3 mRNA CTD PMID:17039268 NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
JBrowse link
G Itgav integrin alpha V multiple interactions ISO [ITGB6 co-treated with ITGAV] affects the susceptibility to Gemcitabine CTD PMID:20150628 NCBI chr 2:83,554,796...83,637,261
Ensembl chr 2:83,554,741...83,637,260
JBrowse link
G Itgb6 integrin beta 6 multiple interactions ISO [ITGB6 co-treated with ITGAV] affects the susceptibility to Gemcitabine CTD PMID:20150628 NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
JBrowse link
G Itsn2 intersectin 2 increases expression ISO Gemcitabine results in increased expression of ITSN2 mRNA CTD PMID:17039268 NCBI chr12:4,642,792...4,763,952
Ensembl chr12:4,642,638...4,763,962
JBrowse link
G Jam3 junction adhesion molecule 3 decreases expression ISO Gemcitabine results in decreased expression of JAM3 mRNA CTD PMID:17039268 NCBI chr 9:27,008,680...27,066,739
Ensembl chr 9:27,008,680...27,066,717
JBrowse link
G Jun jun proto-oncogene multiple interactions ISO [Copper co-treated with Disulfiram co-treated with Gemcitabine] results in increased expression of and results in increased phosphorylation of JUN protein CTD PMID:23033007 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Kctd12 potassium channel tetramerisation domain containing 12 decreases expression ISO Gemcitabine results in decreased expression of KCTD12 mRNA CTD PMID:17039268 NCBI chr14:103,214,017...103,220,073
Ensembl chr14:103,214,017...103,220,073
JBrowse link
G Kitl kit ligand decreases expression
multiple interactions
ISO Gemcitabine results in decreased expression of KITLG protein
[Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of KITLG protein
CTD PMID:20531411 PMID:24979617 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Klf8 Kruppel-like transcription factor 8 increases expression ISO Gemcitabine results in increased expression of KLF8 mRNA CTD PMID:17039268 NCBI chr  X:152,008,335...152,181,921
Ensembl chr  X:152,020,462...152,179,128
JBrowse link
G Krt8 keratin 8 decreases expression ISO Gemcitabine results in decreased expression of KRT8 mRNA CTD PMID:17039268 NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
JBrowse link
G Larp4b La ribonucleoprotein 4B increases expression ISO Gemcitabine results in increased expression of LARP4B mRNA CTD PMID:17039268 NCBI chr13:9,143,643...9,224,487
Ensembl chr13:9,143,917...9,224,487
JBrowse link
G Lep leptin decreases expression ISO Gemcitabine results in decreased expression of LEP protein CTD PMID:20531411 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lifr LIF receptor alpha increases expression ISO Gemcitabine results in increased expression of LIFR mRNA CTD PMID:17039268 NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970
JBrowse link
G Lpar6 lysophosphatidic acid receptor 6 decreases expression ISO Gemcitabine results in decreased expression of LPAR6 mRNA CTD PMID:17039268 NCBI chr14:73,475,331...73,477,798
Ensembl chr14:73,475,335...73,480,734
JBrowse link
G Lrrc28 leucine rich repeat containing 28 increases expression ISO Gemcitabine results in increased expression of LRRC28 mRNA CTD PMID:17039268 NCBI chr 7:67,163,158...67,295,084
Ensembl chr 7:67,163,158...67,295,016
JBrowse link
G Lta lymphotoxin A increases expression ISO Gemcitabine results in increased expression of LTA protein CTD PMID:20531411 NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
JBrowse link
G Lyz2 lysozyme 2 decreases expression ISO Gemcitabine results in decreased expression of LYZ mRNA CTD PMID:17039268 NCBI chr10:117,113,446...117,118,177
Ensembl chr10:117,113,236...117,118,226
JBrowse link
G Maf MAF bZIP transcription factor increases expression ISO Gemcitabine results in increased expression of MAF mRNA CTD PMID:17039268 NCBI chr 8:116,429,992...116,433,633
Ensembl chr 8:116,409,681...116,434,533
JBrowse link
G Magea10 MAGE family member A10 decreases expression ISO Gemcitabine results in decreased expression of MAGEA10 mRNA CTD PMID:17039268 NCBI chr  X:71,425,476...71,430,464
Ensembl chr  X:71,425,476...71,430,464
JBrowse link
G Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 increases expression ISO Gemcitabine results in increased expression of MAGI1 mRNA CTD PMID:17039268 NCBI chr 6:93,652,434...94,260,906
Ensembl chr 6:93,652,436...94,260,898
JBrowse link
G Map2k3 mitogen-activated protein kinase kinase 3 increases phosphorylation ISO Gemcitabine results in increased phosphorylation of MAP2K3 protein CTD PMID:15003513 NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637
JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 increases phosphorylation ISO Gemcitabine results in increased phosphorylation of MAP2K6 protein CTD PMID:15003513 NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation
ISO [Copper co-treated with Disulfiram co-treated with Gemcitabine] results in increased phosphorylation of MAPK1 protein
Gemcitabine results in increased phosphorylation of MAPK1 protein
CTD PMID:15476743 PMID:23033007 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation
ISO [Copper co-treated with Disulfiram co-treated with Gemcitabine] results in increased phosphorylation of MAPK3 protein
Gemcitabine results in increased phosphorylation of MAPK3 protein
CTD PMID:15476743 PMID:23033007 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate increases expression
increases phosphorylation
ISO Gemcitabine results in increased expression of MARCKS mRNA
Gemcitabine results in increased phosphorylation of MARCKS protein
CTD PMID:9523737 PMID:17039268 NCBI chr10:37,009,239...37,014,922
Ensembl chr10:37,009,371...37,014,916
JBrowse link
G Mars1 methionine-tRNA synthetase 1 increases expression ISO Gemcitabine results in increased expression of MARS1 mRNA CTD PMID:17039268 NCBI chr10:127,132,090...127,147,655
Ensembl chr10:127,132,090...127,147,655
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 increases expression
decreases expression
ISO Gemcitabine results in increased expression of MDM2 mRNA
Gemcitabine results in decreased expression of MDM2 mRNA
CTD PMID:17039268 PMID:20103597 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases expression ISO Gemcitabine results in decreased expression of MGMT mRNA CTD PMID:17039268 NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
JBrowse link
G Mir222 microRNA 222 affects response to substance EXP MIR222 mRNA affects the susceptibility to Gemcitabine CTD PMID:35974258 NCBI chr  X:19,013,132...19,013,210
Ensembl chr  X:19,013,132...19,013,210
JBrowse link
G Mir24-2 microRNA 24-2 multiple interactions ISO MIR24-2 mRNA affects the susceptibility to [Betulinic Acid co-treated with Gemcitabine] CTD PMID:25841339 NCBI chr 8:84,935,444...84,935,550
Ensembl chr 8:84,935,444...84,935,550
JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 multiple interactions
decreases expression
EXP
ISO
[Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein
Gemcitabine results in decreased expression of MKI67 protein
CTD PMID:17440100 PMID:38000456 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
JBrowse link
G Mmp3 matrix metallopeptidase 3 decreases expression ISO Gemcitabine results in decreased expression of MMP3 protein CTD PMID:20531411 NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO
EXP
[Gemcitabine co-treated with IFNA2 protein] results in increased expression of MMP9 protein
[Curcumin co-treated with Gemcitabine] results in decreased expression of MMP9 protein
CTD PMID:12738744 PMID:17440100 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mpo myeloperoxidase increases expression ISO Gemcitabine results in increased expression of MPO protein CTD PMID:20531411 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Msln mesothelin multiple interactions ISO Gemcitabine results in decreased expression of and results in decreased secretion of MSLN protein alternative form CTD PMID:25347530 NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352
JBrowse link
G mt-Co3 cytochrome c oxidase III, mitochondrial multiple interactions
decreases response to substance
ISO Sodium Azide inhibits the reaction [COX3 protein results in decreased susceptibility to Gemcitabine] CTD PMID:17428446 NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
JBrowse link
G Mxi1 MAX interactor 1, dimerization protein increases expression ISO Gemcitabine results in increased expression of MXI1 mRNA CTD PMID:17039268 NCBI chr19:53,298,509...53,361,724
Ensembl chr19:53,298,949...53,364,241
JBrowse link
G Myb myeloblastosis oncogene increases expression ISO Gemcitabine results in increased expression of MYB mRNA CTD PMID:17039268 NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
JBrowse link
G Myc myelocytomatosis oncogene multiple interactions
affects response to substance
EXP
ISO
[Curcumin co-treated with Gemcitabine] results in decreased expression of MYC protein
MYC affects the susceptibility to Gemcitabine
[Oligonucleotides binds to MYC gene] which results in increased susceptibility to Gemcitabine
CTD PMID:17440100 PMID:23681918 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Nanog Nanog homeobox decreases expression ISO Gemcitabine results in decreased expression of NANOG mRNA CTD PMID:25605917 PMID:35063459 NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592
JBrowse link
G Ncbp1 nuclear cap binding protein subunit 1 increases expression ISO Gemcitabine results in increased expression of NCBP1 mRNA CTD PMID:17039268 NCBI chr 4:46,138,732...46,172,403
Ensembl chr 4:46,138,613...46,172,403
JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 increases expression ISO Gemcitabine results in increased expression of NEDD9 mRNA CTD PMID:17039268 NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
JBrowse link
G Neu1 neuraminidase 1 increases expression ISO Gemcitabine results in increased expression of NEU1 mRNA CTD PMID:17039268 NCBI chr17:35,150,229...35,156,273
Ensembl chr17:35,150,229...35,154,929
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 decreases response to substance
increases expression
multiple interactions
ISO NFE2L2 protein results in decreased susceptibility to Gemcitabine
Gemcitabine results in increased expression of NFE2L2 mRNA; Gemcitabine results in increased expression of NFE2L2 protein
CASC9 protein affects the reaction [Gemcitabine results in increased expression of NFE2L2 mRNA]; CASC9 protein affects the reaction [Gemcitabine results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [Gemcitabine results in increased expression of CASC9 mRNA]; NFE2L2 protein affects the reaction [Gemcitabine results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Gemcitabine results in increased expression of NQO1 mRNA]
CTD PMID:21489257 PMID:35913601 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkb2 nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 affects expression ISO Gemcitabine affects the expression of NFKB2 mRNA CTD PMID:17039268 NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions ISO [Mastic Resin co-treated with Gemcitabine] results in increased expression of NFKBIA protein CTD PMID:20523344 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nfkbie nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon affects expression ISO Gemcitabine affects the expression of NFKBIE mRNA CTD PMID:17039268 NCBI chr17:45,866,626...45,874,095
Ensembl chr17:45,866,629...45,874,095
JBrowse link
G Nnmt nicotinamide N-methyltransferase increases expression ISO Gemcitabine results in increased expression of NNMT mRNA CTD PMID:17039268 NCBI chr 9:48,448,905...48,518,958
Ensembl chr 9:48,503,177...48,516,453
JBrowse link
G Notch1 notch 1 increases expression
multiple interactions
ISO Gemcitabine results in increased expression of NOTCH1 protein
sulforaphane inhibits the reaction [Gemcitabine results in increased expression of NOTCH1 protein]
CTD PMID:20940707 NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
JBrowse link
G Npepps aminopeptidase puromycin sensitive decreases expression ISO Gemcitabine results in decreased expression of NPEPPS mRNA CTD PMID:17039268 NCBI chr11:97,096,668...97,171,503
Ensembl chr11:97,096,668...97,171,464
JBrowse link
G Npm1 nucleophosmin 1 decreases response to substance ISO NPM1 protein results in decreased susceptibility to Gemcitabine CTD PMID:24736981 NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 increases expression
multiple interactions
ISO Gemcitabine results in increased expression of NQO1 mRNA; Gemcitabine results in increased expression of NQO1 protein
CASC9 protein affects the reaction [Gemcitabine results in increased expression of NQO1 mRNA]; CASC9 protein affects the reaction [Gemcitabine results in increased expression of NQO1 protein]; NFE2L2 protein affects the reaction [Gemcitabine results in increased expression of NQO1 mRNA]
CTD PMID:35913601 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 increases expression ISO Gemcitabine results in increased expression of NR4A3 mRNA CTD PMID:17039268 NCBI chr 4:48,045,098...48,086,446
Ensembl chr 4:48,045,153...48,086,447
JBrowse link
G Nrg1 neuregulin 1 increases expression ISO Gemcitabine results in increased expression of NRG1 mRNA CTD PMID:17039268 NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825
Ensembl chr 8:32,304,579...33,374,825
JBrowse link
G Nrp1 neuropilin 1 decreases response to substance ISO NRP1 protein results in decreased susceptibility to Gemcitabine CTD PMID:15956974 NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844
JBrowse link
G Nupr1 nuclear protein transcription regulator 1 decreases expression
affects response to substance
ISO Gemcitabine results in decreased expression of NUPR1 mRNA
NUPR1 affects the susceptibility to Gemcitabine
CTD PMID:16397047 NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033
JBrowse link
G Or4d6 olfactory receptor family 4 subfamily D member 6 affects response to substance ISO OR4D6 gene SNP affects the susceptibility to Gemcitabine CTD PMID:26378035 NCBI chr19:12,085,964...12,093,192
Ensembl chr19:12,085,080...12,093,261
JBrowse link
G Osm oncostatin M multiple interactions ISO [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of OSM protein CTD PMID:24979617 NCBI chr11:4,186,831...4,191,027
Ensembl chr11:4,186,420...4,191,026
JBrowse link
G Pappa pregnancy-associated plasma protein A decreases expression ISO Gemcitabine results in decreased expression of PAPPA protein CTD PMID:20531411 NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746
JBrowse link
G Paqr8 progestin and adipoQ receptor family member VIII increases expression ISO Gemcitabine results in increased expression of PAQR8 mRNA CTD PMID:17039268 NCBI chr 1:20,960,772...21,009,874
Ensembl chr 1:20,960,830...21,009,874
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 multiple interactions
increases cleavage
ISO [alvocidib co-treated with Gemcitabine] results in increased cleavage of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; SFN protein inhibits the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; YAP1 protein affects the reaction [Gemcitabine results in increased cleavage of PARP1 protein] CTD PMID:15770523 PMID:17146438 PMID:26894857 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Parp2 poly (ADP-ribose) polymerase family, member 2 decreases response to substance ISO PARP2 protein results in decreased susceptibility to Gemcitabine CTD PMID:20798217 NCBI chr14:51,045,347...51,058,758
Ensembl chr14:51,045,298...51,058,758
JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 increases expression ISO Gemcitabine results in increased expression of PCSK9 mRNA CTD PMID:17039268 NCBI chr 4:106,299,531...106,321,522
Ensembl chr 4:106,299,526...106,321,526
JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase 1 decreases response to substance ISO PDPK1 protein modified form results in decreased susceptibility to Gemcitabine CTD PMID:16782806 NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898
JBrowse link
G Pdzk1ip1 PDZK1 interacting protein 1 increases expression ISO Gemcitabine results in increased expression of PDZK1IP1 mRNA CTD PMID:17039268 NCBI chr 4:114,945,905...114,951,091
Ensembl chr 4:114,945,905...114,951,096
JBrowse link
G Pecam1 platelet/endothelial cell adhesion molecule 1 multiple interactions EXP Gemcitabine promotes the reaction [Curcumin results in decreased expression of PECAM1 protein] CTD PMID:17440100 NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
JBrowse link
G Pgr progesterone receptor multiple interactions ISO Gemcitabine binds to and results in decreased activity of PGR protein CTD PMID:25752796 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Pif1 PIF1 5'-to-3' DNA helicase affects response to substance
multiple interactions
decreases response to substance
ISO PIF1 protein affects the susceptibility to Gemcitabine
PIF1 protein affects the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP3 protein]; PIF1 protein inhibits the reaction [Gemcitabine results in increased expression of H2AX protein]; Thymidine inhibits the reaction [PIF1 protein inhibits the reaction [Gemcitabine results in increased expression of H2AX protein]]
PIF1 protein results in decreased susceptibility to Gemcitabine
CTD PMID:37183367 NCBI chr 9:65,494,432...65,503,249
Ensembl chr 9:65,494,442...65,503,249
JBrowse link
G Pja2 praja ring finger ubiquitin ligase 2 increases expression ISO Gemcitabine results in increased expression of PJA2 mRNA CTD PMID:17039268 NCBI chr17:64,588,001...64,638,878
Ensembl chr17:64,588,000...64,638,911
JBrowse link
G Pkm pyruvate kinase, muscle affects response to substance ISO PKM protein alternative form affects the susceptibility to Gemcitabine CTD PMID:38000456 NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
JBrowse link
G Plau plasminogen activator, urokinase increases expression ISO Gemcitabine results in increased expression of PLAU mRNA CTD PMID:17039268 NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
JBrowse link
G Plk1 polo like kinase 1 affects response to substance
decreases expression
multiple interactions
ISO PLK1 protein affects the susceptibility to Gemcitabine
Gemcitabine results in decreased expression of PLK1; Gemcitabine results in decreased expression of PLK1 mRNA
[Gemcitabine results in decreased expression of PLK1] which results in increased susceptibility to Gemcitabine; ON 01910 promotes the reaction [PLK1 protein affects the susceptibility to Gemcitabine]
CTD PMID:20103597 NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096
JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 decreases expression ISO Gemcitabine results in decreased expression of POU5F1 mRNA CTD PMID:35063459 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha affects expression EXP Gemcitabine affects the expression of PPARA mRNA CTD PMID:19427843 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Ppard peroxisome proliferator activator receptor delta affects expression EXP Gemcitabine affects the expression of PPARD mRNA CTD PMID:19427843 NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma affects expression EXP Gemcitabine affects the expression of PPARG mRNA CTD PMID:19427843 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppfia4 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 increases expression ISO Gemcitabine results in increased expression of PPFIA4 mRNA CTD PMID:17039268 NCBI chr 1:134,224,521...134,272,493
Ensembl chr 1:134,224,521...134,260,666
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression ISO Gemcitabine results in increased expression of PPP1R15A mRNA CTD PMID:17039268 NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
JBrowse link
G Psat1 phosphoserine aminotransferase 1 increases expression ISO Gemcitabine results in increased expression of PSAT1 mRNA CTD PMID:17039268 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Ptch1 patched 1 affects expression ISO Gemcitabine affects the expression of PTCH1 mRNA CTD PMID:20103597 NCBI chr13:63,656,142...63,721,274
Ensembl chr13:63,656,142...63,721,412
JBrowse link
G Pten phosphatase and tensin homolog affects expression ISO Gemcitabine affects the expression of PTEN mRNA CTD PMID:17039268 NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases expression ISO Gemcitabine results in decreased expression of PTGS1 mRNA CTD PMID:17039268 NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP [Curcumin co-treated with Gemcitabine] results in decreased expression of PTGS2 protein CTD PMID:17440100 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 decreases response to substance ISO PTK2 protein results in decreased susceptibility to Gemcitabine CTD PMID:14623342 NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 affects expression ISO Gemcitabine affects the expression of PTPN11 mRNA CTD PMID:17039268 NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
JBrowse link
G Rab8a RAB8A, member RAS oncogene family decreases expression ISO Gemcitabine results in decreased expression of RAB8A mRNA CTD PMID:17039268 NCBI chr 8:72,915,044...72,935,210
Ensembl chr 8:72,915,044...72,937,748
JBrowse link
G Rbm17 RNA binding motif protein 17 decreases response to substance ISO RBM17 protein results in decreased susceptibility to Gemcitabine CTD PMID:16061639 NCBI chr 2:11,590,250...11,608,061
Ensembl chr 2:11,590,248...11,608,964
JBrowse link
G Reg3b regenerating islet-derived 3 beta decreases expression ISO Gemcitabine results in decreased expression of REG3A mRNA CTD PMID:16570353 NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
JBrowse link
G Rel reticuloendotheliosis oncogene multiple interactions
decreases expression
ISO sulforaphane promotes the reaction [Gemcitabine results in decreased expression of REL protein] CTD PMID:20940707 NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases expression
increases phosphorylation
ISO
EXP
[Gemcitabine co-treated with Doxorubicin co-treated with Paclitaxel] affects the localization of RELA protein; [Gemcitabine co-treated with Doxorubicin co-treated with Paclitaxel] results in increased expression of RELA protein; licoricidin inhibits the reaction [Gemcitabine results in increased phosphorylation of RELA protein]; Mastic Resin inhibits the reaction [Gemcitabine results in increased expression of RELA protein]
[Curcumin co-treated with Gemcitabine] results in decreased expression of RELA protein
CTD PMID:17039268 PMID:17440100 PMID:20523344 PMID:29782821 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Rgs2 regulator of G-protein signaling 2 increases expression ISO Gemcitabine results in increased expression of RGS2 mRNA CTD PMID:17039268 NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
JBrowse link
G Rnf149 ring finger protein 149 increases expression ISO Gemcitabine results in increased expression of RNF149 mRNA CTD PMID:17039268 NCBI chr 1:39,590,375...39,616,885
Ensembl chr 1:39,590,377...39,616,486
JBrowse link
G Rpl37 ribosomal protein L37 increases expression ISO Gemcitabine results in increased expression of RPL37 mRNA CTD PMID:17039268 NCBI chr15:5,146,127...5,148,626
Ensembl chr15:5,146,127...5,148,622
JBrowse link
G Rragd Ras-related GTP binding D increases expression ISO Gemcitabine results in increased expression of RRAGD mRNA CTD PMID:17039268 NCBI chr 4:32,982,998...33,022,180
Ensembl chr 4:32,983,037...33,022,180
JBrowse link
G Rrm1 ribonucleotide reductase M1 affects response to substance
multiple interactions
ISO RRM1 protein affects the susceptibility to Gemcitabine
[Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of RRM1 mRNA; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of RRM1 protein
CTD PMID:25189999 PMID:26894857 NCBI chr 7:102,090,902...102,118,978
Ensembl chr 7:102,090,902...102,118,978
JBrowse link
G Rrm2 ribonucleotide reductase M2 affects response to substance
multiple interactions
ISO RRM2 protein affects the susceptibility to Gemcitabine
[Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of RRM2 protein
CTD PMID:25189999 PMID:26894857 NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
JBrowse link
G Rsl24d1 ribosomal L24 domain containing 1 increases expression ISO Gemcitabine results in increased expression of RSL24D1 mRNA CTD PMID:17039268 NCBI chr 9:73,020,751...73,030,615
Ensembl chr 9:73,020,708...73,030,615
JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 increases expression ISO Gemcitabine results in increased expression of SAT1 mRNA CTD PMID:17039268 NCBI chr  X:153,996,128...153,999,345
Ensembl chr  X:153,996,128...153,999,445
JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 increases expression ISO Gemcitabine results in increased expression of SCD mRNA CTD PMID:17039268 NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
JBrowse link
G Sfn stratifin increases methylation
multiple interactions
affects response to substance
decreases response to substance
ISO Gemcitabine results in increased methylation of SFN gene
[DNMT1 protein binds to SFN promoter] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; [Gemcitabine results in decreased susceptibility to Gemcitabine] inhibits the reaction [DNMT1 protein binds to SFN promoter]; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in decreased methylation of SFN gene; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN mRNA; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN protein; [UHRF1 protein promotes the reaction [DNMT1 protein binds to SFN promoter]] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]]; SFN protein inhibits the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; SFN protein inhibits the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; SFN protein promotes the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]
SFN protein affects the susceptibility to Gemcitabine
CTD PMID:25189999 PMID:26894857 NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
JBrowse link
G Shh sonic hedgehog decreases expression ISO Gemcitabine results in decreased expression of SHH mRNA CTD PMID:20103597 NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
JBrowse link
G Slc25a29 solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 increases expression ISO Gemcitabine results in increased expression of SLC25A29 mRNA CTD PMID:17039268 NCBI chr12:108,791,804...108,801,802
Ensembl chr12:108,791,799...108,801,809
JBrowse link
G Slc28a1 solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 multiple interactions ISO Gemcitabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]
Gemcitabine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine]
CTD PMID:8713072 PMID:10772724 NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
JBrowse link
G Slc29a1 solute carrier family 29 (nucleoside transporters), member 1 increases uptake
affects response to substance
multiple interactions
decreases response to substance
increases response to substance
ISO SLC29A1 protein results in increased uptake of Gemcitabine
SLC29A1 protein affects the susceptibility to Gemcitabine
4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Gemcitabine]; [S 1 (combination) results in increased expression of SLC29A1 mRNA] which results in increased uptake of Gemcitabine; Fluorouracil promotes the reaction [SLC29A1 protein results in increased uptake of Gemcitabine]
SLC29A1 protein results in decreased susceptibility to Gemcitabine
SLC29A1 mRNA results in increased susceptibility to Gemcitabine; SLC29A1 protein results in increased susceptibility to Gemcitabine
CTD PMID:15501974 PMID:16868479 PMID:17695509 PMID:18383843 PMID:18452103 More... NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
JBrowse link
G Slc29a3 solute carrier family 29 (nucleoside transporters), member 3 affects transport ISO SLC29A3 protein affects the transport of Gemcitabine CTD PMID:19164483 NCBI chr10:60,547,851...60,588,624
Ensembl chr10:60,547,851...60,588,573
JBrowse link
G Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 increases expression ISO Gemcitabine results in increased expression of SLC2A3 mRNA CTD PMID:17039268 NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
JBrowse link
G Slc43a3 solute carrier family 43, member 3 decreases expression ISO Gemcitabine results in decreased expression of SLC43A3 mRNA CTD PMID:17039268 NCBI chr 2:84,766,943...84,788,853
Ensembl chr 2:84,766,923...84,788,853
JBrowse link
G Slitrk2 SLIT and NTRK-like family, member 2 increases expression ISO Gemcitabine results in increased expression of SLITRK2 mRNA CTD PMID:17039268 NCBI chr  X:65,692,535...65,705,008
Ensembl chr  X:65,692,924...65,704,999
JBrowse link
G Smg1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase decreases response to substance
multiple interactions
ISO SMG1 protein results in decreased susceptibility to Gemcitabine
SMG1 protein inhibits the reaction [Gemcitabine results in increased activity of CASP3 protein]; SMG1 protein inhibits the reaction [Gemcitabine results in increased activity of CASP9 protein]
CTD PMID:21418860 NCBI chr 7:117,730,531...117,843,026
Ensembl chr 7:117,730,531...117,842,893
JBrowse link
G Smo smoothened, frizzled class receptor increases expression ISO Gemcitabine results in increased expression of SMO mRNA CTD PMID:25605917 NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
JBrowse link
G Sox2 SRY (sex determining region Y)-box 2 increases expression ISO Gemcitabine results in increased expression of SOX2 mRNA CTD PMID:25605917 NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO Gemcitabine results in increased expression of SPP1 mRNA CTD PMID:17039268 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Src Rous sarcoma oncogene multiple interactions
decreases response to substance
affects response to substance
ISO [AG 1879 co-treated with SRC] results in increased susceptibility to Gemcitabine
SRC protein modified form results in decreased susceptibility to Gemcitabine; SRC protein results in decreased susceptibility to Gemcitabine
SRC protein affects the susceptibility to Gemcitabine
CTD PMID:15073106 PMID:15194078 NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
JBrowse link
G Stat3 signal transducer and activator of transcription 3 decreases activity ISO Gemcitabine results in decreased activity of STAT3 protein CTD PMID:22348037 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein decreases expression ISO Gemcitabine results in decreased expression of SYNCRIP mRNA CTD PMID:17039268 NCBI chr 9:88,331,417...88,364,645
Ensembl chr 9:88,329,062...88,364,627
JBrowse link
G Szrd1 SUZ RNA binding domain containing 1 decreases expression ISO Gemcitabine results in decreased expression of SZRD1 mRNA CTD PMID:17039268 NCBI chr 4:140,840,326...140,867,110
Ensembl chr 4:140,840,312...140,867,086
JBrowse link
G Tceal9 transcription elongation factor A like 9 increases expression ISO Gemcitabine results in increased expression of TCEAL9 mRNA CTD PMID:17039268 NCBI chr  X:135,145,829...135,147,888
Ensembl chr  X:135,145,828...135,147,888
JBrowse link
G Tcof1 treacle ribosome biogenesis factor 1 decreases expression ISO Gemcitabine results in decreased expression of TCOF1 mRNA CTD PMID:17039268 NCBI chr18:60,946,827...60,982,055
Ensembl chr18:60,946,827...60,982,043
JBrowse link
G Tert telomerase reverse transcriptase decreases activity
multiple interactions
ISO Gemcitabine results in decreased activity of TERT protein
[Fluorouracil co-treated with Gemcitabine] results in decreased activity of TERT protein
CTD PMID:16929163 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
G Tfap2a transcription factor AP-2, alpha multiple interactions
increases response to substance
ISO [TFAP2A protein co-treated with TP53 gene mutant form] results in decreased susceptibility to Gemcitabine
TFAP2A protein results in increased susceptibility to Gemcitabine
CTD PMID:21489314 NCBI chr13:40,867,278...40,891,715
Ensembl chr13:40,868,778...40,891,852
JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases response to substance
multiple interactions
ISO TGFB1 results in decreased susceptibility to Gemcitabine
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]; Erlotinib Hydrochloride inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; pyrazolanthrone inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]; U 0126 inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to Gemcitabine]]
CTD PMID:21613822 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tgfb2 transforming growth factor, beta 2 increases expression ISO Gemcitabine results in increased expression of TGFB2 mRNA CTD PMID:17039268 NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
JBrowse link
G Thpo thrombopoietin increases expression ISO Gemcitabine results in increased expression of THPO protein CTD PMID:20531411 NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
JBrowse link
G Tnf tumor necrosis factor affects expression
increases expression
ISO Gemcitabine affects the expression of TNF mRNA
Gemcitabine results in increased expression of TNF protein
CTD PMID:17039268 PMID:20531411 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfaip3 tumor necrosis factor, alpha-induced protein 3 increases expression ISO Gemcitabine results in increased expression of TNFAIP3 mRNA CTD PMID:17039268 NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
JBrowse link
G Tnfrsf11b tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) increases expression ISO Gemcitabine results in increased expression of TNFRSF11B mRNA CTD PMID:17039268 NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 multiple interactions ISO [TNFSF10 co-treated with Gemcitabine] affects the localization of BAX protein; [TNFSF10 co-treated with Gemcitabine] results in increased activity of CASP8 protein CTD PMID:17671697 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tnfsf8 tumor necrosis factor (ligand) superfamily, member 8 multiple interactions ISO [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of TNFSF8 protein CTD PMID:24979617 NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
JBrowse link
G Traf1 TNF receptor-associated factor 1 affects expression ISO Gemcitabine affects the expression of TRAF1 mRNA CTD PMID:17039268 NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784
JBrowse link
G Trp53 transformation related protein 53 increases expression
multiple interactions
affects activity
ISO Gemcitabine results in increased expression of TP53 protein
[TFAP2A protein co-treated with TP53 gene mutant form] results in decreased susceptibility to Gemcitabine; Nicotine inhibits the reaction [Gemcitabine results in increased expression of TP53 protein]
Gemcitabine affects the activity of TP53 protein
CTD PMID:12082016 PMID:16601104 PMID:17671697 PMID:21489314 PMID:35435491 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trp53bp1 transformation related protein 53 binding protein 1 increases expression ISO Gemcitabine results in increased expression of TP53BP1 mRNA CTD PMID:17039268 NCBI chr 2:121,025,316...121,126,830
Ensembl chr 2:121,023,762...121,101,888
JBrowse link
G Trp53inp1 transformation related protein 53 inducible nuclear protein 1 increases expression ISO Gemcitabine results in increased expression of TP53INP1 mRNA CTD PMID:16570353 PMID:17039268 NCBI chr 4:11,156,441...11,174,379
Ensembl chr 4:11,156,431...11,174,379
JBrowse link
G Tube1 tubulin, epsilon 1 increases expression ISO Gemcitabine results in increased expression of TUBE1 mRNA CTD PMID:17039268 NCBI chr10:39,009,946...39,035,863
Ensembl chr10:39,009,972...39,028,538
JBrowse link
G Tymp thymidine phosphorylase affects response to substance
multiple interactions
ISO TYMP protein affects the susceptibility to Gemcitabine
[TYMP protein co-treated with DPYD protein] affects the susceptibility to Gemcitabine; TYMP protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]
CTD PMID:18728667 NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
JBrowse link
G Tyrp1 tyrosinase-related protein 1 affects expression ISO Gemcitabine affects the expression of TYRP1 mRNA CTD PMID:17039268 NCBI chr 4:80,752,360...80,769,973
Ensembl chr 4:80,752,360...80,769,956
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C decreases expression ISO Gemcitabine results in decreased expression of UBE2C mRNA CTD PMID:17039268 NCBI chr 2:164,611,849...164,614,822
Ensembl chr 2:164,611,818...164,620,742
JBrowse link
G Uggt2 UDP-glucose glycoprotein glucosyltransferase 2 increases expression ISO Gemcitabine results in increased expression of UGGT2 mRNA CTD PMID:17039268 NCBI chr14:119,219,177...119,337,208
Ensembl chr14:119,222,451...119,336,842
JBrowse link
G Uhrf1 ubiquitin-like, containing PHD and RING finger domains, 1 multiple interactions ISO [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in decreased expression of UHRF1 protein; [UHRF1 protein promotes the reaction [DNMT1 protein binds to SFN promoter]] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; UHRF1 protein inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine] CTD PMID:25189999 NCBI chr17:56,610,405...56,630,486
Ensembl chr17:56,610,321...56,630,486
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 decreases expression ISO Gemcitabine results in decreased expression of VCAM1 protein CTD PMID:20531411 NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases expression
EXP
ISO
[Curcumin co-treated with Gemcitabine] results in decreased expression of VEGFA protein
Gemcitabine results in increased expression of VEGFA mRNA
CTD PMID:17039268 PMID:17440100 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vgf VGF nerve growth factor inducible decreases expression ISO Gemcitabine results in decreased expression of VGF mRNA CTD PMID:17039268 NCBI chr 5:137,054,156...137,062,205
Ensembl chr 5:137,055,246...137,062,205
JBrowse link
G Vldlr very low density lipoprotein receptor increases expression ISO Gemcitabine results in increased expression of VLDLR mRNA CTD PMID:17039268 NCBI chr19:27,190,070...27,231,631
Ensembl chr19:27,193,884...27,231,631
JBrowse link
G Vmp1 vacuole membrane protein 1 increases expression ISO Gemcitabine results in increased expression of VMP1 CTD PMID:20299819 NCBI chr11:86,474,684...86,574,662
Ensembl chr11:86,474,691...86,574,662
JBrowse link
G Vwf Von Willebrand factor decreases expression ISO Gemcitabine results in decreased expression of VWF protein CTD PMID:20531411 NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
JBrowse link
G Wnt5a wingless-type MMTV integration site family, member 5A decreases expression ISO Gemcitabine results in decreased expression of WNT5A mRNA CTD PMID:17039268 NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405
JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions ISO Gemcitabine promotes the reaction [1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1H-indole results in increased expression of XBP1 mRNA]; Gemcitabine promotes the reaction [arachidonylcyclopropylamide results in increased expression of XBP1 mRNA]; Gemcitabine promotes the reaction [Rimonabant results in increased expression of XBP1 mRNA] CTD PMID:21525939 NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
JBrowse link
G Xiap X-linked inhibitor of apoptosis affects response to substance ISO XIAP affects the susceptibility to Gemcitabine CTD PMID:16628085 NCBI chr  X:41,148,483...41,198,541
Ensembl chr  X:41,148,556...41,198,533
JBrowse link
G Yap1 yes-associated protein 1 multiple interactions
affects response to substance
ISO SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]]; YAP1 protein affects the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; YAP1 protein affects the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]
YAP1 protein affects the susceptibility to Gemcitabine
CTD PMID:26894857 NCBI chr 9:7,932,000...8,004,890
Ensembl chr 9:7,932,000...8,004,597
JBrowse link
G Zfp110 zinc finger protein 110 increases expression ISO Gemcitabine results in increased expression of ZNF274 mRNA CTD PMID:17039268 NCBI chr 7:12,565,225...12,584,513
Ensembl chr 7:12,568,688...12,584,504
JBrowse link
G Zfp449 zinc finger protein 449 increases expression ISO Gemcitabine results in increased expression of ZNF449 mRNA CTD PMID:17039268 NCBI chr  X:55,391,757...55,411,034
Ensembl chr  X:55,391,760...55,411,034
JBrowse link
G Zfp521 zinc finger protein 521 decreases expression ISO Gemcitabine results in decreased expression of ZNF521 mRNA CTD PMID:17039268 NCBI chr18:13,820,070...14,105,812
Ensembl chr18:13,820,070...14,105,844
JBrowse link
lamivudine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acadsb acyl-Coenzyme A dehydrogenase, short/branched chain multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ACADSB mRNA CTD PMID:18313992 NCBI chr 7:131,012,330...131,047,940
Ensembl chr 7:131,012,330...131,050,673
JBrowse link
G Acsl6 acyl-CoA synthetase long-chain family member 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ACSL6 mRNA CTD PMID:18313992 NCBI chr11:54,194,580...54,255,582
Ensembl chr11:54,194,624...54,255,582
JBrowse link
G Acta2 actin alpha 2, smooth muscle, aorta decreases expression ISO Lamivudine results in decreased expression of ACTA2 protein CTD PMID:11738102 NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA CTD PMID:16931933 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Aebp1 AE binding protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of AEBP1 mRNA CTD PMID:16931933 NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088
JBrowse link
G Afap1 actin filament associated protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of AFAP1 mRNA CTD PMID:15784690 NCBI chr 5:36,050,713...36,161,267
Ensembl chr 5:36,050,663...36,161,267
JBrowse link
G Alb albumin affects binding ISO Lamivudine binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ALOX5AP mRNA CTD PMID:16931933 NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
JBrowse link
G Aqp9 aquaporin 9 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of AQP9 mRNA CTD PMID:18313992 NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
JBrowse link
G Arpp21 cyclic AMP-regulated phosphoprotein, 21 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ARPP21 mRNA CTD PMID:16931933 NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006
JBrowse link
G Asic2 acid-sensing ion channel 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA CTD PMID:16931933 NCBI chr11:80,770,989...81,859,222
Ensembl chr11:80,770,995...81,859,283
JBrowse link
G Asns asparagine synthetase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ASNS mRNA CTD PMID:15784690 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
JBrowse link
G Ass1 argininosuccinate synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ASS1 mRNA CTD PMID:15784690 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ATF3 mRNA CTD PMID:15784690 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA CTD PMID:11706060 NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
JBrowse link
G Atp5f1c ATP synthase F1 subunit gamma multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5F1C mRNA CTD PMID:18313992 NCBI chr 2:10,060,841...10,085,321
Ensembl chr 2:10,060,827...10,085,321
JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5MC3 mRNA CTD PMID:18313992 NCBI chr 2:73,738,791...73,742,793
Ensembl chr 2:73,738,791...73,741,670
JBrowse link
G Atp5mf ATP synthase membrane subunit f multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5MF mRNA CTD PMID:18313992 NCBI chr 5:145,120,514...145,128,351
Ensembl chr 5:145,120,508...145,128,872
JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PD mRNA CTD PMID:18313992 NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
JBrowse link
G Atp5pf ATP synthase peripheral stalk subunit F6 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PF mRNA CTD PMID:18313992 NCBI chr16:84,624,754...84,632,495
Ensembl chr16:84,624,754...84,632,513
JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5PO mRNA CTD PMID:18313992 NCBI chr16:91,722,111...91,728,518
Ensembl chr16:91,722,102...91,728,575
Ensembl chr16:91,722,102...91,728,575
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA CTD PMID:18313992 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like increases expression ISO Lamivudine results in increased expression of BNIP3L protein CTD PMID:23640862 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326
JBrowse link
G C1rb complement component 1, r subcomponent B multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C1R mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C1R mRNA CTD PMID:16931933 NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
JBrowse link
G C3ar1 complement component 3a receptor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of C3AR1 mRNA CTD PMID:16931933 NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CARS1 mRNA CTD PMID:15784690 NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein] CTD PMID:36309141 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Cat catalase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein CTD PMID:34118364 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccna2 cyclin A2 multiple interactions
decreases expression
ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CCNA2 mRNA
Lamivudine results in decreased expression of CCNA2 mRNA
CTD PMID:15784690 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnc cyclin C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CCNC mRNA CTD PMID:15784690 NCBI chr 4:21,727,705...21,759,917
Ensembl chr 4:21,727,701...21,759,922
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CCND1 mRNA CTD PMID:15784690 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccnd2 cyclin D2 decreases expression
multiple interactions
ISO Lamivudine results in decreased expression of CCND2 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of CCND2 mRNA
CTD PMID:15784690 NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
JBrowse link
G Ccne2 cyclin E2 multiple interactions
decreases expression
ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CCNE2 mRNA
Lamivudine results in decreased expression of CCNE2 mRNA
CTD PMID:15784690 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Cd36 CD36 molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CD36 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CD36 mRNA CTD PMID:16931933 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cd44 CD44 antigen multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CD44 mRNA CTD PMID:15784690 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G Cd83 CD83 antigen multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CD83 mRNA CTD PMID:15784690 NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
JBrowse link
G Cdk7 cyclin dependent kinase 7 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CDK7 mRNA CTD PMID:15784690 NCBI chr13:100,833,532...100,867,454
Ensembl chr13:100,839,139...100,867,447
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A decreases expression
multiple interactions
ISO Lamivudine results in decreased expression of CDKN1A mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1A mRNA
CTD PMID:15784690 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn1c cyclin dependent kinase inhibitor 1C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1C mRNA CTD PMID:15784690 NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
JBrowse link
G Cdkn2c cyclin dependent kinase inhibitor 2C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN2C mRNA CTD PMID:15784690 NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
JBrowse link
G Cfd complement factor D multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CFD mRNA CTD PMID:16931933 NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CIDEC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CIDEC mRNA CTD PMID:16931933 NCBI chr 6:113,401,595...113,412,721
Ensembl chr 6:113,401,595...113,412,721
JBrowse link
G Clcn3 chloride channel, voltage-sensitive 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of CLCN3 mRNA CTD PMID:16931933 NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
JBrowse link
G Clec2i C-type lectin domain family 2, member i multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CLEC2I mRNA CTD PMID:16931933 NCBI chr 6:128,864,550...128,875,131
Ensembl chr 6:128,864,551...128,875,130
JBrowse link
G Col3a1 collagen, type III, alpha 1 decreases expression ISO Lamivudine results in decreased expression of COL3A1 protein CTD PMID:11738102 NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of COMT mRNA CTD PMID:15784690 NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
JBrowse link
G Cox5a cytochrome c oxidase subunit 5A multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of COX5A mRNA CTD PMID:18313992 NCBI chr 9:57,423,012...57,439,710
Ensembl chr 9:57,428,557...57,439,709
JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX5B mRNA CTD PMID:18313992 NCBI chr 1:36,730,568...36,732,469
Ensembl chr 1:36,730,530...36,732,762
JBrowse link
G Cox6a1 cytochrome c oxidase subunit 6A1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX6A1 mRNA CTD PMID:18313992 NCBI chr 5:115,483,711...115,487,017
Ensembl chr 5:115,483,701...115,487,040
JBrowse link
G Cox6c cytochrome c oxidase subunit 6C multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX6C mRNA CTD PMID:18313992 NCBI chr15:35,932,122...35,938,392
Ensembl chr15:35,926,032...35,938,392
JBrowse link
G Cox7c cytochrome c oxidase subunit 7C multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX7C mRNA CTD PMID:18313992 NCBI chr13:86,192,917...86,194,914
Ensembl chr13:86,192,935...86,195,023
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1a, liver multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CPT1A mRNA CTD PMID:18313992 NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
JBrowse link
G Crat carnitine acetyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA CTD PMID:18313992 NCBI chr 2:30,290,483...30,305,602
Ensembl chr 2:30,290,483...30,305,825
JBrowse link
G Cul7 cullin 7 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of CUL7 mRNA CTD PMID:18313992 NCBI chr17:46,961,264...46,975,290
Ensembl chr17:46,961,263...46,975,290
JBrowse link
G Cyb5a cytochrome b5 type A (microsomal) multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CYB5A mRNA CTD PMID:18313992 NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of CYP11A1 mRNA CTD PMID:18313992 NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
JBrowse link
G Dck deoxycytidine kinase multiple interactions ISO DCK protein results in increased phosphorylation of and results in increased activity of Lamivudine CTD PMID:17530837 NCBI chr 5:88,912,872...88,931,136
Ensembl chr 5:88,912,855...88,931,140
JBrowse link
G Dcn decorin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DCN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DCN mRNA CTD PMID:16931933 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions
ISO Lamivudine results in increased expression of DDIT3 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of DDIT3 mRNA
CTD PMID:15784690 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Dhfr dihydrofolate reductase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of DHFR mRNA CTD PMID:15784690 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
JBrowse link
G Dlst dihydrolipoamide S-succinyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of DLST mRNA CTD PMID:18313992 NCBI chr12:85,157,597...85,180,865
Ensembl chr12:85,157,607...85,181,619
JBrowse link
G Dnaja3 DnaJ heat shock protein family (Hsp40) member A3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA CTD PMID:18313992 NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
JBrowse link
G Dusp3 dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of DUSP3 mRNA CTD PMID:16931933 NCBI chr11:101,861,967...101,877,839
Ensembl chr11:101,861,969...101,877,839
JBrowse link
G Echs1 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ECHS1 mRNA CTD PMID:18313992 NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
JBrowse link
G Eci1 enoyl-Coenzyme A delta isomerase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ECI1 mRNA CTD PMID:18313992 NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322
JBrowse link
G Edn1 endothelin 1 multiple interactions
increases secretion
ISO coenzyme Q10 inhibits the reaction [Lamivudine results in increased secretion of EDN1 protein] CTD PMID:23640862 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of EIF4EBP1 mRNA CTD PMID:15784690 NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 NCBI chr19:46,120,336...46,124,133
Ensembl chr19:46,120,336...46,124,133
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ESR2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ESR2 mRNA CTD PMID:16931933 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Etv6 ets variant 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ETV6 mRNA CTD PMID:16931933 NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Faim Fas apoptotic inhibitory molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of FAIM mRNA CTD PMID:16931933 NCBI chr 9:98,868,426...98,884,076
Ensembl chr 9:98,868,426...98,884,074
JBrowse link
G Fasn fatty acid synthase multiple interactions EXP [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of FASN mRNA CTD PMID:11741158 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
JBrowse link
G Fdxr ferredoxin reductase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of FDXR mRNA CTD PMID:18313992 NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876
JBrowse link
G Fh1 fumarate hydratase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of FH1 mRNA CTD PMID:18313992 NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
JBrowse link
G G0s2 G0/G1 switch gene 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of G6PC1 mRNA CTD PMID:16931933 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
JBrowse link
G Ganc glucosidase, alpha; neutral C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of GANC mRNA CTD PMID:16931933 NCBI chr 2:120,234,377...120,291,347
Ensembl chr 2:120,234,377...120,292,181
JBrowse link
G Gars1 glycyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of GARS1 mRNA CTD PMID:15784690 NCBI chr 6:55,014,986...55,056,489
Ensembl chr 6:55,014,992...55,056,485
JBrowse link
G Gas1 growth arrest specific 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of GAS1 mRNA CTD PMID:15784690 NCBI chr13:60,322,219...60,325,179
Ensembl chr13:60,322,219...60,325,179
JBrowse link
G Grhl2 grainyhead like transcription factor 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of GRHL2 mRNA CTD PMID:16931933 NCBI chr15:37,233,065...37,363,813
Ensembl chr15:37,233,280...37,363,813
JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of GUCY1B1 mRNA CTD PMID:16931933 NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996
JBrowse link
G Gypa glycophorin A multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased mutagenesis of GYPA gene CTD PMID:17358027 NCBI chr 8:81,220,674...81,237,414
Ensembl chr 8:81,220,410...81,237,171
JBrowse link
G H4c8 H4 clustered histone 8 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of H4C9 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of H4C9 mRNA CTD PMID:16931933 NCBI chr13:23,715,214...23,715,648
Ensembl chr13:23,715,220...23,715,689
JBrowse link
G Hadh hydroxyacyl-Coenzyme A dehydrogenase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of HADH mRNA CTD PMID:16931933 NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of HADHA mRNA CTD PMID:18313992 NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
JBrowse link
G Hax1 HCLS1 associated X-1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of HAX1 mRNA CTD PMID:15784690 NCBI chr 3:89,902,753...89,906,023
Ensembl chr 3:89,902,753...89,906,087
JBrowse link
G Hcn1 hyperpolarization activated cyclic nucleotide gated potassium channel 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of HCN1 mRNA CTD PMID:16931933 NCBI chr13:117,738,856...118,117,564
Ensembl chr13:117,738,856...118,123,954
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HMGCS2 mRNA CTD PMID:18313992 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
JBrowse link
G Hrk harakiri, BCL2 interacting protein (contains only BH3 domain) multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of HRK mRNA CTD PMID:16931933 NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B2 mRNA CTD PMID:18313992 NCBI chr 3:98,618,423...98,631,859
Ensembl chr 3:98,616,571...98,631,859
JBrowse link
G Hsd3b3 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B3 mRNA CTD PMID:18313992 NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443
JBrowse link
G Hsd3b5 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B5 mRNA CTD PMID:18313992 NCBI chr 3:98,525,952...98,552,850
Ensembl chr 3:98,525,950...98,537,568
JBrowse link
G Idh2 isocitrate dehydrogenase 2 (NADP+), mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of IDH2 mRNA CTD PMID:18313992 NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
JBrowse link
G Idh3a isocitrate dehydrogenase 3 (NAD+) alpha multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of IDH3A mRNA CTD PMID:18313992 NCBI chr 9:54,493,795...54,511,946
Ensembl chr 9:54,493,618...54,511,945
JBrowse link
G Idh3g isocitrate dehydrogenase 3 (NAD+), gamma multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of IDH3G mRNA CTD PMID:18313992 NCBI chr  X:72,822,569...72,830,471
Ensembl chr  X:72,822,569...72,830,503
JBrowse link
G Ifng interferon gamma increases expression ISO Lamivudine results in increased expression of IFNG protein CTD PMID:16250037 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of IKZF4 mRNA CTD PMID:16931933 NCBI chr10:128,466,708...128,505,668
Ensembl chr10:128,466,712...128,505,227
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein] CTD PMID:36309141 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il27ra interleukin 27 receptor, alpha multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA CTD PMID:15784690 NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
JBrowse link
G Inpp5e inositol polyphosphate-5-phosphatase E multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of INPP5E mRNA CTD PMID:18313992 NCBI chr 2:26,286,261...26,299,313
Ensembl chr 2:26,286,261...26,299,215
JBrowse link
G Kcng1 potassium voltage-gated channel, subfamily G, member 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KCNG1 mRNA CTD PMID:15784690 NCBI chr 2:168,102,037...168,123,453
Ensembl chr 2:168,102,037...168,123,656
JBrowse link
G Kifc2 kinesin family member C2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of KIFC2 mRNA CTD PMID:16931933 NCBI chr15:76,543,984...76,552,396
Ensembl chr15:76,544,058...76,552,396
JBrowse link
G Klf4 Kruppel-like transcription factor 4 (gut) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KLF4 mRNA CTD PMID:15784690 NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466
JBrowse link
G Klhl28 kelch-like 28 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of KLHL28 mRNA CTD PMID:16931933 NCBI chr12:64,985,603...65,012,365
Ensembl chr12:64,985,607...65,012,308
JBrowse link
G Krt7 keratin 7 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KRT7 mRNA CTD PMID:15784690 NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
JBrowse link
G Kynu kynureninase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA CTD PMID:15784690 NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
JBrowse link
G Lamb3 laminin, beta 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of LAMB3 mRNA CTD PMID:15784690 NCBI chr 1:192,976,661...193,026,186
Ensembl chr 1:192,890,007...193,026,186
JBrowse link
G Lamc2 laminin, gamma 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LAMC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LAMC2 mRNA CTD PMID:16931933 NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEF1 mRNA CTD PMID:16931933 NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
JBrowse link
G Lep leptin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LEP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEP mRNA CTD PMID:16931933 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lpl lipoprotein lipase decreases expression
multiple interactions
EXP Lamivudine results in decreased expression of LPL mRNA
[Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA; [Stavudine co-treated with Lamivudine] affects the expression of LPL mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA
CTD PMID:11741158 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Ly6f lymphocyte antigen 6 family member F multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LY6F mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6F mRNA CTD PMID:16931933 NCBI chr15:75,140,221...75,144,086
Ensembl chr15:75,140,270...75,144,084
JBrowse link
G Ly6i lymphocyte antigen 6 family member I multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LY6I mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6I mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of LY6I mRNA CTD PMID:16931933 NCBI chr15:74,851,383...74,855,279
Ensembl chr15:74,851,383...74,855,279
JBrowse link
G Mars1 methionine-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA CTD PMID:15784690 NCBI chr10:127,132,090...127,147,655
Ensembl chr10:127,132,090...127,147,655
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic multiple interactions
increases expression
EXP [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of ME1 mRNA; [Stavudine co-treated with Lamivudine] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine] affects the expression of ME1 mRNA
Lamivudine results in increased expression of ME1 mRNA
CTD PMID:11741158 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Mfn1 mitofusin 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of MFN1 mRNA CTD PMID:18313992 NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
JBrowse link
G Mfn2 mitofusin 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of MFN2 mRNA CTD PMID:18313992 NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
JBrowse link
G Mgat4c MGAT4 family, member C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MGAT4C mRNA CTD PMID:16931933 NCBI chr10:101,517,348...102,227,712
Ensembl chr10:101,517,348...102,227,330
JBrowse link
G Mmp1b matrix metallopeptidase 1b (interstitial collagenase) increases expression ISO Lamivudine results in increased expression of MMP1 protein CTD PMID:15309715 NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein CTD PMID:34118364 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of MRAP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of MRAP mRNA CTD PMID:16931933 NCBI chr16:90,535,095...90,546,673
Ensembl chr16:90,535,095...90,546,673
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of COX1 mRNA CTD PMID:17526437 PMID:18313992 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of COX2 mRNA CTD PMID:18313992 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G mt-Co3 cytochrome c oxidase III, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX3 mRNA CTD PMID:17526437 PMID:18313992 NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
JBrowse link
G mt-Nd2 NADH dehydrogenase 2, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ND2 mRNA CTD PMID:18313992 NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
JBrowse link
G mt-Nd5 NADH dehydrogenase 5, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ND5 mRNA CTD PMID:17526437 PMID:18313992 NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of MTHFD2 mRNA CTD PMID:15784690 NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890
JBrowse link
G Myod1 myogenic differentiation 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MYOD1 mRNA CTD PMID:16931933 NCBI chr 7:46,025,898...46,028,516
Ensembl chr 7:46,025,898...46,028,523
JBrowse link
G Nap1l5 nucleosome assembly protein 1-like 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NAP1L5 mRNA CTD PMID:16931933 NCBI chr 6:58,882,218...58,884,111
Ensembl chr 6:58,882,218...58,884,061
JBrowse link
G Ndufa4 Ndufa4, mitochondrial complex associated multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFA4 mRNA CTD PMID:18313992 NCBI chr 6:11,900,371...11,907,449
Ensembl chr 6:11,900,291...11,907,496
JBrowse link
G Ndufab1 NADH:ubiquinone oxidoreductase subunit AB1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA CTD PMID:18313992 NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109
JBrowse link
G Ndufaf1 NADH:ubiquinone oxidoreductase complex assembly factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAF1 mRNA CTD PMID:18313992 NCBI chr 2:119,485,927...119,493,302
Ensembl chr 2:119,485,927...119,493,308
JBrowse link
G Ndufb3 NADH:ubiquinone oxidoreductase subunit B3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB3 mRNA CTD PMID:18313992 NCBI chr 1:58,625,556...58,635,123
Ensembl chr 1:58,625,543...58,635,123
JBrowse link
G Ndufb5 NADH:ubiquinone oxidoreductase subunit B5 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB5 mRNA CTD PMID:18313992 NCBI chr 3:32,791,206...32,805,708
Ensembl chr 3:32,791,139...32,805,715
JBrowse link
G Ndufb9 NADH:ubiquinone oxidoreductase subunit B9 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFB9 mRNA CTD PMID:18313992 NCBI chr15:58,805,650...58,811,365
Ensembl chr15:58,805,605...58,811,337
JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFC1 mRNA CTD PMID:18313992 NCBI chr 3:51,312,876...51,323,167
Ensembl chr 3:51,312,098...51,316,409
JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFS1 mRNA CTD PMID:18313992 NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992
JBrowse link
G Niban1 niban apoptosis regulator 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of NIBAN1 mRNA CTD PMID:15784690 NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
JBrowse link
G Noct nocturnin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of NOCT mRNA CTD PMID:16931933 NCBI chr 3:51,131,868...51,159,075
Ensembl chr 3:51,131,868...51,159,065
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions
decreases phosphorylation
ISO coenzyme Q10 inhibits the reaction [Lamivudine results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Nppa natriuretic peptide type A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA CTD PMID:11706060 NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
JBrowse link
G Nup210 nucleoporin 210 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NUP210 mRNA CTD PMID:16931933 NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811
JBrowse link
G Nxnl2 nucleoredoxin-like 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NXNL2 mRNA CTD PMID:16931933 NCBI chr13:51,324,256...51,329,227
Ensembl chr13:51,325,058...51,329,224
JBrowse link
G Oaz3 ornithine decarboxylase antizyme 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OAZ3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OAZ3 mRNA CTD PMID:16931933 NCBI chr 3:94,340,694...94,343,958
Ensembl chr 3:94,339,721...94,351,222
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of OGT mRNA CTD PMID:15784690 NCBI chr  X:100,683,617...100,727,957
Ensembl chr  X:100,683,666...100,727,957
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of OPA1 mRNA CTD PMID:18313992 NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
JBrowse link
G Oprl1 opioid receptor-like 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of OPRL1 mRNA CTD PMID:16931933 NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
JBrowse link
G Or8g37 olfactory receptor family 8 subfamily G member 37 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OR8G37 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OR8G37 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of OR8G37 mRNA CTD PMID:16931933 NCBI chr 9:39,730,937...39,731,872
Ensembl chr 9:39,720,156...39,732,293
JBrowse link
G Pcdh15 protocadherin 15 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PCDH15 mRNA CTD PMID:16931933 NCBI chr10:72,932,003...74,485,663
Ensembl chr10:72,935,174...74,485,569
JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of PCK2 mRNA CTD PMID:15784690 NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PFKFB3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PFKFB3 mRNA CTD PMID:16931933 NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888
JBrowse link
G Pgap6 post-glycosylphosphatidylinositol attachment to proteins 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of PGAP6 mRNA CTD PMID:16931933 NCBI chr17:26,332,290...26,342,228
Ensembl chr17:26,332,273...26,342,228
JBrowse link
G Phf6 PHD finger protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of PHF6 mRNA CTD PMID:16931933 NCBI chr  X:52,001,091...52,045,838
Ensembl chr  X:52,001,143...52,045,820
JBrowse link
G Pidd1 p53 induced death domain protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIDD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIDD1 mRNA CTD PMID:16931933 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
JBrowse link
G Piwil2 piwi-like RNA-mediated gene silencing 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PIWIL2 mRNA CTD PMID:16931933 NCBI chr14:70,609,926...70,674,338
Ensembl chr14:70,609,926...70,666,832
JBrowse link
G Porcn porcupine O-acyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PPN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PPN mRNA CTD PMID:16931933 NCBI chr  X:8,060,085...8,072,794
Ensembl chr  X:8,060,087...8,072,764
JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of POU5F1 mRNA CTD PMID:16931933 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRDM1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRDM1 mRNA CTD PMID:16931933 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
JBrowse link
G Prl2c2 prolactin family 2, subfamily c, member 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C2 mRNA CTD PMID:16931933 NCBI chr13:13,170,705...13,179,978
Ensembl chr13:13,170,710...13,179,968
JBrowse link
G Prl2c3 prolactin family 2, subfamily c, member 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C3 mRNA CTD PMID:16931933 NCBI chr13:12,805,705...12,814,982
Ensembl chr13:12,805,705...12,814,968
JBrowse link
G Prl2c4 prolactin family 2, subfamily c, member 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C4 mRNA CTD PMID:16931933 Ensembl chr13:12,805,705...12,814,968 JBrowse link
G Psat1 phosphoserine aminotransferase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA CTD PMID:15784690 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Rabepk Rab9 effector protein with kelch motifs multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of RABEPK mRNA CTD PMID:15784690 NCBI chr 2:34,662,946...34,690,200
Ensembl chr 2:34,667,568...34,689,924
JBrowse link
G Rbl1 RB transcriptional corepressor like 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA CTD PMID:15784690 NCBI chr 2:156,987,813...157,046,454
Ensembl chr 2:156,987,813...157,046,454
JBrowse link
G Rbl2 RB transcriptional corepressor like 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL2 mRNA CTD PMID:15784690 NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
JBrowse link
G Reep6 receptor accessory protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of REEP6 mRNA CTD PMID:16931933 NCBI chr10:80,165,831...80,172,275
Ensembl chr10:80,165,787...80,172,275
JBrowse link
G Ripk2 receptor (TNFRSF)-interacting serine-threonine kinase 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA CTD PMID:15784690 NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647
JBrowse link
G Rnf151 ring finger protein 151 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of RNF151 mRNA CTD PMID:16931933 NCBI chr17:24,934,813...24,937,031
Ensembl chr17:24,934,813...24,937,037
JBrowse link
G Rpain RPA interacting protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of RPAIN mRNA CTD PMID:16931933 NCBI chr11:70,860,403...70,868,759
Ensembl chr11:70,861,039...70,868,659
JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of S100A8 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of S100A8 mRNA CTD PMID:16931933 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
JBrowse link
G Sdhb succinate dehydrogenase complex, subunit B, iron sulfur (Ip) multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SDHB mRNA CTD PMID:18313992 NCBI chr 4:140,688,582...140,706,509
Ensembl chr 4:140,688,514...140,706,504
JBrowse link
G Serinc1 serine incorporator 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SERINC1 mRNA CTD PMID:16931933 NCBI chr10:57,391,870...57,408,573
Ensembl chr10:57,391,870...57,408,626
JBrowse link
G Serpina1a serine (or cysteine) peptidase inhibitor, clade A, member 1A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SERPINA1A mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SERPINA1A mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SERPINA1A mRNA CTD PMID:16931933 NCBI chr12:103,819,554...103,829,878
Ensembl chr12:103,819,848...103,829,821
JBrowse link
G Sfxn1 sideroflexin 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN1 mRNA CTD PMID:18313992 NCBI chr13:54,225,675...54,262,365
Ensembl chr13:54,225,888...54,262,361
JBrowse link
G Sfxn2 sideroflexin 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA CTD PMID:18313992 NCBI chr19:46,561,798...46,585,340
Ensembl chr19:46,561,804...46,586,505
JBrowse link
G Sfxn4 sideroflexin 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN4 mRNA CTD PMID:18313992 NCBI chr19:60,824,747...60,850,222
Ensembl chr19:60,825,715...60,849,917
JBrowse link
G Sgpp1 sphingosine-1-phosphate phosphatase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SGPP1 mRNA CTD PMID:18313992 NCBI chr12:75,761,022...75,782,503
Ensembl chr12:75,761,023...75,782,503
JBrowse link
G Slc1a4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A4 mRNA CTD PMID:15784690 NCBI chr11:20,252,180...20,282,713
Ensembl chr11:20,252,180...20,282,713
JBrowse link
G Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 5 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A5 mRNA CTD PMID:15784690 NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
JBrowse link
G Slc22a1 solute carrier family 22 (organic cation transporter), member 1 increases uptake ISO SLC22A1 protein results in increased uptake of Lamivudine CTD PMID:19141712 NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
JBrowse link
G Slc22a2 solute carrier family 22 (organic cation transporter), member 2 increases uptake ISO SLC22A2 protein results in increased uptake of Lamivudine CTD PMID:19141712 NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
JBrowse link
G Slc22a3 solute carrier family 22 (organic cation transporter), member 3 increases uptake ISO SLC22A3 protein results in increased uptake of Lamivudine CTD PMID:19141712 NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591
JBrowse link
G Slc25a12 solute carrier family 25 (mitochondrial carrier, Aralar), member 12 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA CTD PMID:18313992 NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
JBrowse link
G Slc25a15 solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A15 mRNA CTD PMID:18313992 NCBI chr 8:22,865,566...22,888,637
Ensembl chr 8:22,865,567...22,888,613
JBrowse link
G Slc25a19 solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 multiple interactions ISO
EXP
SLC25A19 protein affects the susceptibility to [Stavudine co-treated with Lamivudine co-treated with Indinavir]; SLC25A19 protein affects the susceptibility to [Zidovudine co-treated with Lamivudine co-treated with Indinavir]
[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A19 mRNA
CTD PMID:15951836 PMID:18313992 NCBI chr11:115,504,991...115,519,122
Ensembl chr11:115,505,004...115,519,121
JBrowse link
G Slc25a2 solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A2 mRNA CTD PMID:18313992 NCBI chr18:37,770,431...37,771,776
Ensembl chr18:37,770,431...37,771,776
JBrowse link
G Slc25a20 solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A20 mRNA CTD PMID:18313992 NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
JBrowse link
G Slc25a29 solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A29 mRNA CTD PMID:18313992 NCBI chr12:108,791,804...108,801,802
Ensembl chr12:108,791,799...108,801,809
JBrowse link
G Slc25a3 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A3 mRNA CTD PMID:18313992 NCBI chr10:90,952,436...90,959,902
Ensembl chr10:90,952,436...90,959,921
JBrowse link
G Slc25a4 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A4 mRNA CTD PMID:18313992 NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
JBrowse link
G Slc28a1 solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 multiple interactions ISO Lamivudine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine] CTD PMID:10772724 NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
JBrowse link
G Slc31a1 solute carrier family 31, member 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006
JBrowse link
G Slc3a2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC3A2 mRNA CTD PMID:15784690 NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC40A1 mRNA CTD PMID:18313992 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
JBrowse link
G Slc6a4 solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 multiple interactions
increases expression
ISO [Lamivudine co-treated with IFNA2 protein] results in increased expression of SLC6A4 mRNA; Lamivudine promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin]; Lamivudine results in increased expression of and results in increased activity of SLC6A4 protein
Lamivudine results in increased expression of SLC6A4 mRNA
CTD PMID:16476009 NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SPINK5 mRNA CTD PMID:16931933 NCBI chr18:44,092,612...44,155,554
Ensembl chr18:44,096,302...44,155,568
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of STAR mRNA CTD PMID:18313992 NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of STC2 mRNA CTD PMID:15784690 NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
JBrowse link
G Sub1 SUB1 homolog, transcriptional regulator multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SUB1 mRNA CTD PMID:16931933 NCBI chr15:11,981,422...11,996,091
Ensembl chr15:11,981,425...11,997,069
JBrowse link
G Sval2 seminal vesicle antigen-like 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SVAL2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SVAL2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SVAL2 mRNA CTD PMID:16931933 NCBI chr 6:41,837,241...41,841,347
Ensembl chr 6:41,829,923...41,841,347
JBrowse link
G Tcea1 transcription elongation factor A (SII) 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of TCEA1 mRNA CTD PMID:15784690 NCBI chr 1:4,927,917...4,968,132
Ensembl chr 1:4,928,037...4,968,132
JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression ISO Lamivudine results in decreased expression of TGFB1 protein CTD PMID:15309715 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Timm17b translocase of inner mitochondrial membrane 17b multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of TIMM17B mRNA CTD PMID:18313992 NCBI chr  X:7,765,575...7,773,891
Ensembl chr  X:7,765,596...7,776,168
JBrowse link
G Timm23 translocase of inner mitochondrial membrane 23 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of TIMM23 mRNA CTD PMID:18313992 NCBI chr14:31,902,123...31,923,848
Ensembl chr14:31,902,119...31,923,855
JBrowse link
G Timp1 tissue inhibitor of metalloproteinase 1 decreases expression ISO Lamivudine results in decreased expression of TIMP1 protein CTD PMID:15309715 NCBI chr  X:20,736,524...20,740,972
Ensembl chr  X:20,736,405...20,740,974
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TIMP2 mRNA CTD PMID:16931933 NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
JBrowse link
G Tk2 thymidine kinase 2, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of TK2 mRNA CTD PMID:18313992 NCBI chr 8:104,953,323...104,975,224
Ensembl chr 8:104,953,317...104,975,190
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein] CTD PMID:36309141 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of TRIB3 mRNA CTD PMID:15784690 NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
JBrowse link
G Trim42 tripartite motif-containing 42 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TRIM42 mRNA CTD PMID:16931933 NCBI chr 9:97,231,615...97,252,011
Ensembl chr 9:97,231,615...97,252,011
JBrowse link
G Twnk twinkle mtDNA helicase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of TWNK mRNA CTD PMID:18313992 NCBI chr19:44,994,102...45,001,203
Ensembl chr19:44,994,102...45,001,201
JBrowse link
G Tyms thymidylate synthase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of TYMS mRNA CTD PMID:15784690 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Tyrp1 tyrosinase-related protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of TYRP1 mRNA CTD PMID:15784690 NCBI chr 4:80,752,360...80,769,973
Ensembl chr 4:80,752,360...80,769,956
JBrowse link
G Uqcrb ubiquinol-cytochrome c reductase binding protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA CTD PMID:18313992 NCBI chr13:67,048,640...67,053,414
Ensembl chr13:67,048,681...67,053,442
JBrowse link
G Uqcrc1 ubiquinol-cytochrome c reductase core protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRC1 mRNA CTD PMID:17526437 PMID:18313992 NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691
JBrowse link
G Uqcrc2 ubiquinol cytochrome c reductase core protein 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of UQCRC2 mRNA CTD PMID:18313992 NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VDAC1 mRNA CTD PMID:18313992 NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
JBrowse link
G Vdr vitamin D (1,25-dihydroxyvitamin D3) receptor multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
JBrowse link
G Vps4b vacuolar protein sorting 4B multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VPS4B mRNA CTD PMID:16931933 NCBI chr 1:106,698,518...106,724,455
Ensembl chr 1:106,691,801...106,724,458
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of WARS1 mRNA CTD PMID:15784690 NCBI chr12:108,825,956...108,860,095
Ensembl chr12:108,825,956...108,860,100
JBrowse link
G Wnt10a wingless-type MMTV integration site family, member 10A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of WNT10A mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of WNT10A mRNA CTD PMID:16931933 NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA CTD PMID:15784690 NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400
JBrowse link
ledipasvir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) affects binding ISO ledipasvir binds to ABCG2 protein CTD PMID:33954893 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Klrc1 killer cell lectin-like receptor subfamily C, member 1 decreases expression ISO ledipasvir co-treated with sofosbuvir decreases expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 6:129,642,978...129,659,815
Ensembl chr 6:129,642,978...129,655,936
JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 affects expression ISO ledipasvir co-treated sofosbuvir with affects expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163
JBrowse link
lopinavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 multiple interactions
decreases activity
ISO Lopinavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Lopinavir results in decreased activity of ABCB11 protein
CTD PMID:20829430 PMID:23956101 PMID:24014644 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 increases abundance
increases secretion
ISO ABCC2 protein alternative form results in increased abundance of Lopinavir
ABCC2 protein results in increased secretion of Lopinavir
CTD PMID:22027652 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Lopinavir results in decreased expression of ADIPOQ protein] CTD PMID:17668557 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Cat catalase multiple interactions ISO CAT protein inhibits the reaction [Lopinavir results in decreased activity of CYP3A4 protein] CTD PMID:15523003 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
ISO diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of CCL2 protein] CTD PMID:17668557 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Lopinavir results in increased expression of CCL3 protein CTD PMID:17668557 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
ISO Lopinavir results in increased expression of HMOX1 mRNA; Lopinavir results in increased expression of HMOX1 protein
Lopinavir promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Lopinavir results in increased expression of HMOX1 mRNA]
CTD PMID:26968795 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO Lopinavir results in increased expression of ICAM1 protein CTD PMID:26968795 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Lopinavir results in increased expression of IL1B protein CTD PMID:17668557 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
ISO diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of IL6 protein] CTD PMID:17668557 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Lep leptin multiple interactions
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Lopinavir results in decreased expression of LEP protein] CTD PMID:17668557 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lmna lamin A increases farnesylation ISO Lopinavir results in increased farnesylation of LMNA protein alternative form CTD PMID:18230615 NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
JBrowse link
G Rb1 RB transcriptional corepressor 1 affects phosphorylation ISO Lopinavir affects the phosphorylation of RB1 protein CTD PMID:20596751 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Tnf tumor necrosis factor increases expression ISO Lopinavir results in increased expression of TNF protein CTD PMID:17668557 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Zmpste24 zinc metallopeptidase, STE24 decreases activity ISO Lopinavir results in decreased activity of ZMPSTE24 protein CTD PMID:18230615 NCBI chr 4:120,916,434...120,955,452
Ensembl chr 4:120,916,434...120,955,438
JBrowse link
maraviroc term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Actn2 actinin alpha 2 multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of ACTN2 mRNA; [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of ACTN2 protein CTD PMID:31023824 NCBI chr13:12,284,312...12,355,613
Ensembl chr13:12,284,312...12,355,641
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO maraviroc inhibits the reaction [CCL3 protein binds to CCR5 protein] CTD PMID:15644495 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO maraviroc inhibits the reaction [CCL5 protein binds to CCR5 protein] CTD PMID:15644495 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions ISO maraviroc binds to and results in decreased activity of CCR5 protein; maraviroc inhibits the reaction [CCL3 protein binds to CCR5 protein]; maraviroc inhibits the reaction [CCL5 protein binds to CCR5 protein] CTD PMID:15644495 PMID:21128663 NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
JBrowse link
G Col1a1 collagen, type I, alpha 1 multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in decreased expression of COL1A1 mRNA CTD PMID:31023824 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G Col1a2 collagen, type I, alpha 2 multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in decreased expression of COL1A2 mRNA CTD PMID:31023824 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of MYH6 mRNA CTD PMID:31023824 NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
JBrowse link
G Ryr2 ryanodine receptor 2, cardiac multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of RYR2 mRNA CTD PMID:31023824 NCBI chr13:11,567,985...12,121,831
Ensembl chr13:11,567,988...12,121,831
JBrowse link
G Tnnt2 troponin T2, cardiac multiple interactions EXP [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of TNNT2 mRNA; [BX 471 co-treated with C 021 compound co-treated with Maraviroc] results in increased expression of TNNT2 protein CTD PMID:31023824 NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
JBrowse link
N-acetyl-L-cysteine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1bg alpha-1-B glycoprotein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of A1BG mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA] CTD PMID:22129741 NCBI chr15:60,789,438...60,793,119
Ensembl chr15:60,768,708...60,794,861
JBrowse link
G Abca1 ATP-binding cassette, sub-family A member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased methylation of ABCA1 promoter] CTD PMID:31150806 NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
JBrowse link
G Abca5 ATP-binding cassette, sub-family A member 5 multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA5 mRNA] CTD PMID:31004932 NCBI chr11:110,160,195...110,228,542
Ensembl chr11:110,160,195...110,228,542
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A multiple interactions ISO Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of ABCB1 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ABCB1]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein]
CTD PMID:10636889 PMID:18474546 PMID:22914566 PMID:23867903 PMID:25824409 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcc1 ATP-binding cassette, sub-family C member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC1 mRNA]; Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein]; Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; Buthionine Sulfoximine analog inhibits the reaction [Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]] CTD PMID:11820781 PMID:15473893 PMID:22914566 PMID:23867903 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 multiple interactions ISO Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC2 mRNA]
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]
CTD PMID:22914566 PMID:23867903 PMID:34303734 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC3 protein] CTD PMID:11820781 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO Acetylcysteine results in decreased expression of ABCG1 mRNA CTD PMID:16084531 NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA] CTD PMID:22129741 NCBI chr 9:44,184,485...44,199,953
Ensembl chr 9:44,184,485...44,199,912
JBrowse link
G Abl1 c-abl oncogene 1, non-receptor tyrosine kinase multiple interactions EXP Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of ABL1 protein] CTD PMID:16481037 NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
JBrowse link
G Ache acetylcholinesterase multiple interactions
affects response to substance
ISO
EXP
[Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Cadmium results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of ACHE protein]
ACHE protein affects the susceptibility to Acetylcysteine
Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of ACHE mRNA alternative form]; Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of ACHE protein]
CTD PMID:20399762 PMID:20688495 PMID:26769589 PMID:27087133 PMID:27163631 More... NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
JBrowse link
G Acp3 acid phosphatase 3 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACP3 mRNA CTD PMID:22129741 NCBI chr 9:104,165,439...104,214,921
Ensembl chr 9:104,165,450...104,214,947
JBrowse link
G Acsm5 acyl-CoA synthetase medium-chain family member 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSM5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA] CTD PMID:22129741 NCBI chr 7:119,125,354...119,142,583
Ensembl chr 7:119,118,686...119,144,774
JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA CTD PMID:22129741 NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420
JBrowse link
G Acta2 actin alpha 2, smooth muscle, aorta multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ACTA2 mRNA]
Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ACTA2 protein]
CTD PMID:16757516 PMID:21134390 PMID:32659284 PMID:33131013 PMID:35622622 More... NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
JBrowse link
G Adam33 a disintegrin and metallopeptidase domain 33 multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ADAM33 mRNA] CTD PMID:29753051 NCBI chr 2:130,892,739...130,905,734
Ensembl chr 2:130,892,511...130,905,734
JBrowse link
G Adgrb2 adhesion G protein-coupled receptor B2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB2 mRNA CTD PMID:22129741 NCBI chr 4:129,878,566...129,916,426
Ensembl chr 4:129,878,663...129,916,426
JBrowse link
G Adgrb3 adhesion G protein-coupled receptor B3 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB3 mRNA CTD PMID:22129741 NCBI chr 1:25,106,557...25,869,338
Ensembl chr 1:25,106,557...25,868,788
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) multiple interactions ISO Acetylcysteine inhibits the reaction [Ethanol results in increased expression of ADH1 mRNA] CTD PMID:20705415 NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]] CTD PMID:17471172 PMID:21912612 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]] CTD PMID:21912612 NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
JBrowse link
G Agt angiotensinogen multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein]
Acetylcysteine inhibits the reaction [AGT protein modified form results in increased abundance of Reactive Oxygen Species]
CTD PMID:15849355 PMID:30703374 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions EXP Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of AGTR1 mRNA] CTD PMID:23603059 NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
JBrowse link
G Ahr aryl-hydrocarbon receptor increases expression
multiple interactions
EXP
ISO
Acetylcysteine results in increased expression of AHR protein
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of and affects the localization of AHR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of AHR protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1A enhancer]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1B enhancer]
CTD PMID:18022818 PMID:21569840 PMID:31551408 PMID:35123993 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions EXP Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of AIF1 protein]] CTD PMID:36762617 NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
JBrowse link
G Aifm1 apoptosis-inducing factor, mitochondrion-associated 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Cadmium Chloride affects the localization of AIFM1 protein]
Acetylcysteine inhibits the reaction [bisphenol A affects the localization of AIFM1 protein]
Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of AIFM1 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone affects the localization of AIFM1 protein]
CTD PMID:18034189 PMID:18412143 PMID:18506790 PMID:18951928 PMID:19679660 More... NCBI chr  X:47,563,821...47,602,440
Ensembl chr  X:47,563,821...47,602,440
JBrowse link
G Aimp1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 decreases expression ISO Acetylcysteine results in decreased expression of AIMP1 mRNA CTD PMID:16084531 NCBI chr 3:132,366,259...132,390,151
Ensembl chr 3:132,366,242...132,390,131
JBrowse link
G Akr1c18 aldo-keto reductase family 1, member C18 multiple interactions ISO Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AKR1C3 mRNA] CTD PMID:18829485 PMID:21787718 NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of AKT1 protein]; [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of and affects the localization of AKT1 protein]; Acetylcysteine inhibits the reaction [arsenic trichloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E affects the phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cyadox results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [divinyl sulfone analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Morpholines analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [morusin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [N-arachidonoylalanine results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [oenothein B results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Oligopeptides analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [synaptamide results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of AKT1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of AKT1 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of AKT1 protein
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased phosphorylation of AKT1 protein]
Acetylcysteine inhibits the reaction [cadmium acetate results in decreased expression of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of AKT1 mRNA]
CTD PMID:12168106 PMID:12614848 PMID:16137721 PMID:16731823 PMID:18442981 More... NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Alad aminolevulinate, delta-, dehydratase multiple interactions ISO Acetylcysteine promotes the reaction [Zinc Sulfate inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein]] CTD PMID:16959597 NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
JBrowse link
G Alb albumin multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of ALB protein]; Acetylcysteine inhibits the reaction [ALB protein modified form results in decreased expression of MFN2 protein]; Acetylcysteine inhibits the reaction [ALB protein modified form results in increased abundance of Hydrogen Peroxide]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Acetylcysteine inhibits the reaction [Mustard Gas results in increased expression of ALB protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]] CTD PMID:11428623 PMID:20804811 PMID:24485406 PMID:27997345 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Nitroglycerin results in decreased activity of ALDH2 protein] CTD PMID:17585900 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
JBrowse link
G Alk anaplastic lymphoma kinase multiple interactions ISO Acetylcysteine affects the phosphorylation of and affects the activity of ALK protein mutant form CTD PMID:19503098 NCBI chr17:72,174,206...72,911,719
Ensembl chr17:72,175,967...72,911,622
JBrowse link
G Alkbh5 alkB homolog 5, RNA demethylase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ALKBH5 mRNA]
Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of ALKBH5 mRNA]
CTD PMID:31004932 PMID:34425375 NCBI chr11:60,428,509...60,449,338
Ensembl chr11:60,427,207...60,449,338
JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney multiple interactions EXP Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA] CTD PMID:34547296 NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
JBrowse link
G Amacr alpha-methylacyl-CoA racemase multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AMACR mRNA] CTD PMID:18829485 NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712
JBrowse link
G Ang angiogenin, ribonuclease, RNase A family, 5 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of ANG protein] CTD PMID:26138014 NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
JBrowse link
G Angpt1 angiopoietin 1 decreases secretion ISO Acetylcysteine results in decreased secretion of ANGPT1 protein CTD PMID:19622383 NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANGPTL4 mRNA CTD PMID:22129741 NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
JBrowse link
G Ankrd29 ankyrin repeat domain 29 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANKRD29 mRNA CTD PMID:22129741 NCBI chr18:12,385,414...12,439,067
Ensembl chr18:12,385,419...12,438,854
JBrowse link
G Anxa5 annexin A5 multiple interactions ISO Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ANXA5 protein]; Acetylcysteine inhibits the reaction [Tin Fluorides results in increased expression of ANXA5 protein] CTD PMID:22093110 NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
JBrowse link
G Aoc1 amine oxidase, copper-containing 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Methotrexate results in increased activity of AOC1 protein] CTD PMID:20885979 NCBI chr 6:48,872,189...48,886,122
Ensembl chr 6:48,849,830...48,886,122
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of APAF1 mRNA]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein]
Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of APAF1 protein]
CTD PMID:15877105 PMID:19477266 PMID:35396826 NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of APEX1 protein]
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of APEX1 mRNA]
CTD PMID:12231548 PMID:17938202 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
JBrowse link
G Apex2 apurinic/apyrimidinic endonuclease 2 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA]
Acetylcysteine results in decreased expression of APEX2 mRNA
CTD PMID:26332274 NCBI chr  X:149,286,625...149,371,175
Ensembl chr  X:149,302,515...149,372,864
JBrowse link
G Aph1b aph1 homolog B, gamma secretase subunit multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of APH1B mRNA CTD PMID:22129741 NCBI chr 9:66,682,484...66,704,671
Ensembl chr 9:66,682,484...66,702,772
JBrowse link
G Apoe apolipoprotein E increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of APOE mRNA
Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of APOE mRNA]
CTD PMID:33188856 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
JBrowse link
G App amyloid beta precursor protein multiple interactions ISO Acetylcysteine inhibits the reaction [APP protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of NLRP3 protein] CTD PMID:12684028 PMID:28004443 NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
JBrowse link
G Aqp2 aquaporin 2 increases expression ISO Acetylcysteine results in increased expression of AQP2 protein CTD PMID:23183129 NCBI chr15:99,476,937...99,482,426
Ensembl chr15:99,476,936...99,482,428
JBrowse link
G Ar androgen receptor multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the activity of AR protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR mRNA]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR protein] CTD PMID:16928829 PMID:18829485 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Arl13a ADP-ribosylation factor-like 13A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARL13A mRNA CTD PMID:22129741 NCBI chr  X:133,088,250...133,108,779
Ensembl chr  X:133,088,250...133,108,777
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO Acetylcysteine inhibits the reaction [Curcumin results in increased degradation of ARNT protein] CTD PMID:16880289 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
JBrowse link
G Arrdc3 arrestin domain containing 3 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARRDC3 mRNA CTD PMID:22129741 NCBI chr13:81,031,508...81,044,161
Ensembl chr13:81,031,503...81,044,161
JBrowse link
G Art4 ADP-ribosyltransferase 4 decreases expression ISO Acetylcysteine results in decreased expression of ART4 mRNA CTD PMID:16084531 NCBI chr 6:136,825,449...136,834,598
Ensembl chr 6:136,825,449...136,834,731
JBrowse link
G Asns asparagine synthetase multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASNS mRNA CTD PMID:22129741 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
JBrowse link
G Astl astacin like metalloendopeptidase multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASTL mRNA CTD PMID:22129741 NCBI chr 2:127,180,559...127,199,575
Ensembl chr 2:127,180,559...127,199,571
JBrowse link
G Atf2 activating transcription factor 2 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of ATF2 protein]
Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of ATF2 protein]
CTD PMID:19654923 PMID:22288910 NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions EXP Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of ATF3 protein] CTD PMID:25531190 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Atf4 activating transcription factor 4 multiple interactions
decreases expression
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased expression of ATF4 protein]
[Acetylcysteine co-treated with Trichloroethylene] results in increased expression of ATF4 mRNA; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ATF4 protein]
Acetylcysteine results in decreased expression of ATF4 protein
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ATF4 protein]; Acetylcysteine promotes the reaction [perfluorooctanoic acid results in increased expression of ATF4 mRNA]
Acetylcysteine results in increased expression of ATF4 protein
CTD PMID:15788408 PMID:19722195 PMID:21266191 PMID:24291486 PMID:25451595 More... NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
JBrowse link
G Atf6 activating transcription factor 6 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine results in increased metabolism of and results in increased activity of ATF6 protein
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein]
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein]
CTD PMID:18077580 PMID:19722195 PMID:21198628 PMID:21911445 PMID:24291486 More... NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
JBrowse link
G Atg10 autophagy related 10 multiple interactions EXP Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG10 mRNA] CTD PMID:24614525 NCBI chr13:91,083,467...91,372,189
Ensembl chr13:91,083,475...91,372,087
JBrowse link
G Atg12 autophagy related 12 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG12 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]]
Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG12 mRNA]
CTD PMID:20543569 PMID:24614525 PMID:29307831 PMID:30205151 PMID:33146789 More... NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
JBrowse link
G Atg14 autophagy related 14 multiple interactions ISO Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA] CTD PMID:34439521 NCBI chr14:47,778,350...47,805,891
Ensembl chr14:47,778,350...47,808,106
JBrowse link
G Atg16l1 autophagy related 16 like 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG16L1 protein] CTD PMID:30205151 NCBI chr 1:87,683,730...87,720,150
Ensembl chr 1:87,683,592...87,720,150
JBrowse link
G Atg16l2 autophagy related 16 like 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG16L2 mRNA] CTD PMID:33146789 NCBI chr 7:100,935,521...100,951,474
Ensembl chr 7:100,912,241...100,951,458
JBrowse link
G Atg4a autophagy related 4A, cysteine peptidase multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ATG4A protein] CTD PMID:29179951 NCBI chr  X:139,854,594...139,947,190
Ensembl chr  X:139,857,656...139,947,266
JBrowse link
G Atg4c autophagy related 4C, cysteine peptidase multiple interactions EXP Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of ATG4C mRNA] CTD PMID:34425375 NCBI chr 4:99,077,181...99,185,495
Ensembl chr 4:99,082,171...99,148,024
JBrowse link
G Atg5 autophagy related 5 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG5 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA]
CTD PMID:20543569 PMID:24614525 PMID:28600122 PMID:29307831 PMID:30205151 More... NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA] CTD PMID:29247770 PMID:29307831 PMID:30205151 PMID:31319114 PMID:33462182 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
JBrowse link
G Atm ataxia telangiectasia mutated multiple interactions
increases phosphorylation
ISO
EXP
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATM protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of ATM protein modified form]; Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK2 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased phosphorylation of ATM protein]
Acetylcysteine affects the reaction [yttrium chloride affects the expression of ATM protein]
Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of ATM protein]
Acetylcysteine results in increased phosphorylation of ATM protein
CTD PMID:15489221 PMID:23274516 PMID:24792323 PMID:26451628 PMID:31168028 More... NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
JBrowse link
G Atox1 antioxidant 1 copper chaperone multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATOX1 mRNA] CTD PMID:36315628 NCBI chr11:55,337,463...55,352,034
Ensembl chr11:55,337,467...55,352,065
JBrowse link
G Atp1a1 ATPase, Na+/K+ transporting, alpha 1 polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP1A1 protein] CTD PMID:10506578 NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
JBrowse link
G Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 increases expression
multiple interactions
ISO
EXP
Acetylcysteine results in increased expression of ATP2A2 mRNA
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATP2A2 mRNA]
Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein]
CTD PMID:10625299 PMID:16084531 PMID:17005195 PMID:36315628 NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP5F1A mRNA] CTD PMID:36493885 NCBI chr18:77,861,468...77,870,569
Ensembl chr18:77,861,429...77,870,569
JBrowse link
G Atp6v0d1 ATPase, H+ transporting, lysosomal V0 subunit D1 multiple interactions ISO Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA] CTD PMID:29307831 PMID:31319114 NCBI chr 8:106,251,093...106,292,696
Ensembl chr 8:106,251,097...106,292,679
JBrowse link
G Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 multiple interactions ISO
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA
[Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]
CTD PMID:22129741 PMID:30742845 NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605
JBrowse link
G Atr ataxia telangiectasia and Rad3 related multiple interactions ISO Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATR protein] CTD PMID:26451628 NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
JBrowse link
G Atxn1 ataxin 1 affects localization
multiple interactions
ISO Acetylcysteine affects the localization of ATXN1 protein mutant form
Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of ATXN1 protein mutant form]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]
CTD PMID:12893416 NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484
JBrowse link
G Aurkb aurora kinase B multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of AURKB protein] CTD PMID:28343997 NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
JBrowse link
G B2m beta-2 microglobulin decreases response to substance
multiple interactions
ISO Acetylcysteine results in decreased susceptibility to B2M protein modified form
Acetylcysteine inhibits the reaction [B2M protein modified form results in increased abundance of Reactive Oxygen Species]
CTD PMID:21864514 NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
JBrowse link
G B3galt5 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GALT5 mRNA CTD PMID:22129741 NCBI chr16:96,037,001...96,121,059
Ensembl chr16:96,037,001...96,121,059
JBrowse link
G B3gnt9 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GNT9 mRNA CTD PMID:22129741 NCBI chr 8:105,979,270...105,981,895
Ensembl chr 8:105,979,270...105,981,785
JBrowse link
G Bach1 BTB and CNC homology 1, basic leucine zipper transcription factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of BACH1 protein] CTD PMID:19350554 NCBI chr16:87,495,842...87,530,234
Ensembl chr16:87,495,833...87,530,234
JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAD protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAD protein]
Acetylcysteine results in increased expression of BAD mRNA
CTD PMID:21310227 PMID:22245127 PMID:26332274 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
JBrowse link
G Bag3 BCL2-associated athanogene 3 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of BAG3 mRNA] CTD PMID:18723479 NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 protein]
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1]
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAK1 mRNA]
CTD PMID:21533816 PMID:21549813 PMID:22085843 PMID:23339468 PMID:28296042 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
JBrowse link
G Barx2 BarH-like homeobox 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BARX2 mRNA CTD PMID:22129741 NCBI chr 9:31,757,340...31,824,581
Ensembl chr 9:31,757,340...31,824,758
JBrowse link
G Bax BCL2-associated X protein multiple interactions
increases expression
decreases expression
EXP
ISO
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased activity of BAX protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of BAX protein]]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases expression of BAX protein in the stomach)
Acetylcysteine affects the reaction [lead acetate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of BAX protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of BAX mRNA]
Acetylcysteine results in increased expression of BAX mRNA
Acetylcysteine results in decreased expression of BAX protein
4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in decreased expression of BAX protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BAX protein]; Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of and results in increased activity of BAX protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [gingerol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [glabridin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [perfosfamide affects the folding of BAX protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of BAX]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Propofol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BAX protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased expression of BAX protein]
Acetylcysteine results in increased expression of BAX protein
CTD
RGD
PMID:11166918 PMID:11341981 PMID:15496615 PMID:15735709 PMID:16169029 More... RGD:127284846 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bbc3 BCL2 binding component 3 multiple interactions ISO Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA]
Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of BBC3 protein]
CTD PMID:24291486 PMID:32540572 NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
JBrowse link
G Bcas1 brain enriched myelin associated protein 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCAS1 mRNA CTD PMID:22129741 NCBI chr 2:170,188,911...170,270,292
Ensembl chr 2:170,188,911...170,269,765
JBrowse link
G Bche butyrylcholinesterase multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of BCHE protein]
Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of BCHE protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of BCHE protein]
CTD PMID:27087133 PMID:34425170 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression
multiple interactions
decreases response to substance
ISO
EXP
Acetylcysteine results in decreased expression of BCL2 protein
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases expression of BCL2 protein in the stomach)
Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of BCL2 protein]
4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; [saikosaponin D co-treated with Acetylcysteine] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [glabridin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Malathion results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BCL2 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in decreased expression of BCL2 protein]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of BCL2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]]
BCL2 results in decreased susceptibility to Acetylcysteine
CTD
RGD
PMID:11341981 PMID:17041759 PMID:17395010 PMID:17542780 PMID:18077580 More... RGD:127284846 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein]
Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2L1 protein]
Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [fucoxanthin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2L1 protein]
CTD PMID:18281123 PMID:18483861 PMID:20594983 PMID:21310227 PMID:22085843 More... NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Bcl2l11 BCL2 like 11 multiple interactions ISO Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein] CTD PMID:15173094 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
JBrowse link
G Bcl6 B cell leukemia/lymphoma 6 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA CTD PMID:22129741 NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
JBrowse link
G Bdkrb1 bradykinin receptor, beta 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA] CTD PMID:22264228 NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
JBrowse link
G Bdnf brain derived neurotrophic factor multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of BDNF protein]
CTD PMID:16553631 PMID:26138014 NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
JBrowse link
G Becn1 beclin 1, autophagy related multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [brazilin results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased expression of and results in increased phosphorylation of BECN1 protein]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Vorinostat results in increased expression of BECN1 protein]
Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of BECN1 protein]
Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [[CASP2 protein affects the susceptibility to Rotenone] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of BECN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Trichloroethylene results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of BECN1 protein]
CTD PMID:20543569 PMID:21216964 PMID:24614525 PMID:26588882 PMID:26804764 More... NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
JBrowse link
G Bglap bone gamma carboxyglutamate protein multiple interactions EXP Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BGLAP mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BGLAP protein] CTD PMID:34547296 NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [sanguinarine results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BID protein]
Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BID protein]
CTD PMID:16169029 PMID:17574045 PMID:21310227 PMID:23660334 PMID:23711929 More... NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
JBrowse link
G Bik BCL2-interacting killer multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of BIK protein] CTD PMID:31313457 NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC2 protein] CTD PMID:19679660 NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC3 protein] CTD PMID:19679660 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein] CTD PMID:21741372 PMID:23711929 PMID:25034532 PMID:31837377 PMID:34599545 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA CTD PMID:22129741 NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA CTD PMID:22129741 NCBI chr 9:75,682,647...75,807,598
Ensembl chr 9:75,682,646...75,807,592
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions ISO [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of BMP7 mRNA CTD PMID:21051528 NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
JBrowse link
G Bnip3 BCL2/adenovirus E1B interacting protein 3 multiple interactions EXP Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of BNIP3 protein]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 PMID:36739042 NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of BNIP3L protein] CTD PMID:34861471 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326
JBrowse link
G Bpgm 2,3-bisphosphoglycerate mutase decreases expression ISO Acetylcysteine results in decreased expression of BPGM mRNA CTD PMID:16084531 NCBI chr 6:34,453,291...34,482,071
Ensembl chr 6:34,453,142...34,482,548
JBrowse link
G Btg1 BTG anti-proliferation factor 1 decreases expression ISO Acetylcysteine results in decreased expression of BTG1 mRNA CTD PMID:16084531 NCBI chr10:96,452,863...96,458,675
Ensembl chr10:96,452,868...96,458,671
JBrowse link
G C3 complement component 3 multiple interactions ISO [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of C3 protein modified form]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C3 protein] CTD PMID:20946910 PMID:32924446 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G Cacna1g calcium channel, voltage-dependent, T type, alpha 1G subunit multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA CTD PMID:22129741 NCBI chr11:94,299,217...94,365,226
Ensembl chr11:94,299,217...94,365,024
JBrowse link
G Capn1 calpain 1 multiple interactions EXP Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of CAPN1 protein] CTD PMID:25451595 NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927
JBrowse link
G Capn2 calpain 2 multiple interactions EXP Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of CAPN2 protein] CTD PMID:25451595 NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
JBrowse link
G Casp1 caspase 1 multiple interactions
increases cleavage
ISO
EXP
[Acetylcysteine co-treated with Cobalt] results in decreased expression of CASP1 protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Cobalt results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [Ethanol results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of and results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]]
Acetylcysteine results in increased cleavage of CASP1 protein
Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of CASP1 protein]
Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein]
CTD PMID:23940760 PMID:24337744 PMID:24885895 PMID:25929180 PMID:26079697 More... NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp12 caspase 12 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of and results in increased activity of CASP12 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP12 protein]]
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP12 protein]
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP12 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP12 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP12 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP12 protein]
CTD PMID:18077580 PMID:21145380 PMID:21616140 PMID:25451595 PMID:28296042 More... NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
JBrowse link
G Casp14 caspase 14 multiple interactions ISO Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CASP14 protein] CTD PMID:16137721 NCBI chr10:78,547,829...78,554,181
Ensembl chr10:78,547,825...78,554,128
JBrowse link
G Casp2 caspase 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP2 protein]
Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP2 protein]
Acetylcysteine inhibits the reaction [[CASP2 protein affects the susceptibility to Rotenone] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased cleavage of CASP2 protein]
CTD PMID:15158148 PMID:17041759 PMID:21216964 PMID:30408460 NCBI chr 6:42,241,942...42,259,442
Ensembl chr 6:42,241,919...42,259,442
JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases activity
increases expression
decreases activity
ISO
EXP
Acetylcysteine results in increased cleavage of CASP3 protein
N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid increases cleavage of CASP3 protein in stomach]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP3 protein in the stomach)
Acetylcysteine results in increased activity of CASP3 protein
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [arsenite results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Carmustine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Estradiol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Lead results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [menadione epoxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Pilocarpine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of CASP3 protein modified form]
[Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone analog results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [6-iodo-5-hydroxy-eicosatrienoic acid, delta-lactone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Naphthalimides co-treated with Spermidine] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[Pentachlorophenol co-treated with copper-1,10-phenanthroline] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Vitamin K 2 co-treated with Arsenic Trioxide] results in increased expression of CASP3]; Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [aristolochic acid I results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [butein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [chelerythrine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [crocin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [dimethoxycurcumin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Eosine I Bluish results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [fenpyroximate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [glabridin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [manumycin results in increased activity of CASP3]; Acetylcysteine inhibits the reaction [menadione epoxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Paraquat results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [platycodin D results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Prodigiosin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Soot analog results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased cleavage of CASP3 protein]; Acetylcysteine promotes the reaction [brazilin results in increased activity of CASP3 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP3 protein]; Acetylcysteine promotes the reaction [sinularin results in increased cleavage of CASP3 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of CASP3 protein]; Oxygen deficiency affects the reaction [Acetylcysteine results in increased activity of CASP3 protein]
Acetylcysteine results in increased expression of CASP3 protein modified form
Acetylcysteine results in decreased activity of CASP3 protein
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]; Acetylcysteine affects the reaction [nonylphenol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [mancozeb results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [nitrofen results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [POMC protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Acetylcysteine results in increased expression of CASP3 protein modified form]
CTD
RGD
PMID:11969376 PMID:12168106 PMID:12750841 PMID:12754411 PMID:14660655 More... RGD:127284886, RGD:127284846 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp4 caspase 4, apoptosis-related cysteine peptidase multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CASP4 mRNA]
Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP4 mRNA]
CTD PMID:16137721 PMID:19477266 PMID:22922937 PMID:25341683 NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
JBrowse link
G Casp6 caspase 6 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP6 protein]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased cleavage of and results in increased activity of CASP6 protein]
Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein]
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP6 protein]
CTD PMID:15158148 PMID:19954742 PMID:24157283 PMID:37146930 NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
JBrowse link
G Casp7 caspase 7 multiple interactions
decreases expression
EXP
ISO
Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP7 mRNA]
Acetylcysteine results in decreased expression of CASP7 protein modified form
Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP7 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP7 protein]
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]
CTD PMID:17136323 PMID:19771260 PMID:20594983 PMID:21145380 PMID:21549813 More... NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
JBrowse link
G Casp8 caspase 8 multiple interactions EXP
ISO
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of CASP8 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of CASP8 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of CASP8 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of CASP8 protein]]; Acetylcysteine inhibits the reaction [cannabidiol hydroxyquinone results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP8 protein]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP8 protein in the stomach)
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of CASP8 protein]; [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased expression of CASP8 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP8 protein]
Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP8 mRNA]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP8 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP8 protein]
CTD
RGD
PMID:16169029 PMID:17574045 PMID:18791325 PMID:19014919 PMID:19477266 More... RGD:127284846 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression
EXP
ISO
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP9 protein]
N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid increases cleavage of CASP9 protein in stomach]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP9 protein in the stomach)
Acetylcysteine results in increased expression of CASP9 protein; Acetylcysteine results in increased expression of CASP9 protein modified form
Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein]
[Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [saikosaponin D co-treated with Acetylcysteine] results in decreased expression of CASP9 protein; Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein]; Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [oenothein B results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Soot analog results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP9 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein]
CTD
RGD
PMID:15158148 PMID:15496615 PMID:16169029 PMID:17309078 PMID:17574045 More... RGD:127284886, RGD:127284846 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G Cat catalase multiple interactions
decreases activity
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Carmustine results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Diclofenac results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dimethylnitrosamine results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Zinc results in decreased expression of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Particulate Matter results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Chlorine results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos affects the activity of CAT protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Propofol results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Smoke analog results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of CAT mRNA]; CAT protein inhibits the reaction [Acetylcysteine results in increased abundance of Hydrogen Peroxide]
Acetylcysteine results in decreased activity of CAT protein
Acetylcysteine results in increased expression of CAT protein
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of CAT protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased activity of CAT protein]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased activity of CAT protein]
CTD PMID:7491977 PMID:16169029 PMID:19840221 PMID:19853593 PMID:20332008 More... NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Cav1 caveolin 1, caveolae protein decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of CAV1
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]; Acetylcysteine inhibits the reaction [Rosiglitazone results in increased expression of CAV1]; Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein; Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein]
CTD PMID:18507034 PMID:21148404 PMID:35349355 NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
JBrowse link
G Cbs cystathionine beta-synthase multiple interactions EXP Acetylcysteine inhibits the reaction [Rotenone results in decreased expression of CBS protein] CTD PMID:25086357 NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCL11 mRNA
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CCL11 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL11 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL11 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CCL11 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CCL11 protein]
CTD PMID:12576300 PMID:22129741 PMID:26138014 NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
JBrowse link
G Ccl17 C-C motif chemokine ligand 17 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL17 protein] CTD PMID:26138014 NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CCL2 mRNA]
Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]]
Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in increased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL2 mRNA]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein]]
CTD PMID:10541287 PMID:11124598 PMID:15139008 PMID:17529908 PMID:18303122 More... NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Acetylcysteine results in decreased expression of CCL20 mRNA CTD PMID:22385246 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions ISO Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CCL22 mRNA] CTD PMID:19350554 NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
JBrowse link
G Ccl24 C-C motif chemokine ligand 24 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CCL24 protein] CTD PMID:26138014 NCBI chr 5:135,598,789...135,601,977
Ensembl chr 5:135,598,791...135,601,903
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
decreases secretion
EXP [Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CCL3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL3 mRNA]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased secretion of CCL3 protein]]; Acetylcysteine promotes the reaction [Polymyxin B results in decreased secretion of CCL3 protein]; MYD88 protein affects the reaction [[Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL3 mRNA]]; Polymyxin B promotes the reaction [Acetylcysteine results in decreased secretion of CCL3 protein] CTD PMID:21765237 PMID:28555929 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CCL5 mRNA]
CTD PMID:10495789 PMID:11167962 PMID:26138014 PMID:33146789 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
JBrowse link
G Ccl8 C-C motif chemokine ligand 8 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL8 protein] CTD PMID:26138014 NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions
increases expression
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein]; Cycloheximide inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein]
Acetylcysteine results in increased expression of CCN1 mRNA; Acetylcysteine results in increased expression of CCN1 protein
CTD PMID:21055460 NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of CCN2 protein] CTD PMID:17270171 NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
JBrowse link
G Ccna1 cyclin A1 multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CCNA1 protein] CTD PMID:20654705 NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
JBrowse link
G Ccna2 cyclin A2 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCNA2 protein]
Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased expression of CCNA2 protein]
CTD PMID:24909818 PMID:28506552 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnb1 cyclin B1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CCNB1 protein]; Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CCNB1 protein]
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CCNB1 protein]; Acetylcysteine inhibits the reaction [sinularin results in decreased phosphorylation of CCNB1 protein]
CTD PMID:24909818 PMID:25633853 PMID:28548367 PMID:29128613 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
ISO
EXP
Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [[Vorinostat co-treated with Butyrates] results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of CCND1 protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of CCND1 protein]
Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of CCND1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CCND1 protein]
Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in decreased expression of CCND1 protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of CCND1 protein]
CTD PMID:15173093 PMID:15897899 PMID:17602960 PMID:18563748 PMID:19409983 More... NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccnd2 cyclin D2 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of CCND2 protein]; Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CCND2 mRNA]
Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND2 protein]
Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA]
CTD PMID:19615393 PMID:26332274 PMID:33485121 PMID:34627931 NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
JBrowse link
G Ccnd3 cyclin D3 multiple interactions ISO Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND3 protein] CTD PMID:34627931 NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
JBrowse link
G Ccne1 cyclin E1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of CCNE1 mRNA]
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCNE1 protein]
CTD PMID:15945272 PMID:24909818 NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
JBrowse link
G Ccne2 cyclin E2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCNE2 mRNA CTD PMID:22129741 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Cd14 CD14 antigen multiple interactions ISO Acetylcysteine inhibits the reaction [Iron deficiency results in increased expression of CD14 protein] CTD PMID:20368581 NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
JBrowse link
G Cd36 CD36 molecule multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CD36 mRNA]
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 protein]
Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 protein]; CD36 mRNA promotes the reaction [Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased uptake of malondialdehyde-low density lipoprotein, human]]
CTD PMID:22824115 PMID:26187465 PMID:33007364 PMID:35622622 PMID:36534932 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cd40lg CD40 ligand multiple interactions ISO Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CD40LG mRNA]
Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein]
CTD PMID:19477266 PMID:27634759 NCBI chr  X:56,257,448...56,269,402
Ensembl chr  X:56,257,503...56,269,402
JBrowse link
G Cd86 CD86 antigen multiple interactions ISO Acetylcysteine affects the reaction [Dinitrochlorobenzene affects the expression of CD86 protein]; Acetylcysteine inhibits the reaction [1,10-phenanthroline results in increased expression of CD86 mRNA]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein] CTD PMID:19033392 PMID:19641517 PMID:20417223 PMID:20457211 PMID:30842373 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions EXP Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CDC25C protein modified form] CTD PMID:25633853 NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
JBrowse link
G Cdh1 cadherin 1 multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CDH1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH1 protein]; Acetylcysteine inhibits the reaction [DDT results in decreased expression of CDH1 mRNA]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased methylation of CDH1 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of CDH1 protein]
Acetylcysteine results in increased expression of CDH1 protein
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in decreased expression of CDH1 protein]
CTD PMID:18791180 PMID:22648416 PMID:24820114 PMID:28284859 PMID:32659284 More... NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdh11 cadherin 11 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDH11 mRNA CTD PMID:22129741 NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274
JBrowse link
G Cdh13 cadherin 13 decreases expression ISO Acetylcysteine results in decreased expression of CDH13 mRNA CTD PMID:16084531 NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660
JBrowse link
G Cdh2 cadherin 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein]
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CDH2 mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of CDH2 mRNA]
CTD PMID:23876460 PMID:24820114 PMID:28284859 NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
JBrowse link
G Cdh5 cadherin 5 multiple interactions ISO Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in decreased expression of CDH5 protein] CTD PMID:33131013 NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
JBrowse link
G Cdk1 cyclin dependent kinase 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CDK1 protein]
Acetylcysteine inhibits the reaction [sinularin results in decreased phosphorylation of CDK1 protein]
CTD PMID:25633853 PMID:28548367 NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
JBrowse link
G Cdk4 cyclin dependent kinase 4 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA]
Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of CDK4 protein]
CTD PMID:18442981 PMID:19615393 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
JBrowse link
G Cdk7 cyclin dependent kinase 7 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CDK7 mRNA] CTD PMID:33971260 NCBI chr13:100,833,532...100,867,454
Ensembl chr13:100,839,139...100,867,447
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
decreases expression
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [camphorquinone results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of CDKN1A]; Acetylcysteine inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [ethylenimine quinone results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1A enhancer]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]]
Acetylcysteine results in decreased expression of CDKN1A mRNA
Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CDKN1A protein]
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDKN1A mRNA; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CDKN1A protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1A protein]
CTD PMID:8943236 PMID:9343371 PMID:12208374 PMID:15496615 PMID:15978937 More... NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of CDKN1B protein
Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of CDKN1B protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1B enhancer]
Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein]
CTD PMID:17602960 PMID:18022818 PMID:30917517 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN2A protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN2A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN2A protein]
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [DNMT1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [EZH2 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [TET1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN2A protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]]
CTD PMID:31551408 PMID:32473187 PMID:35303175 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein]
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CEBPA protein]
CTD PMID:27117918 PMID:35622622 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions EXP Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] CTD PMID:21220312 NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon multiple interactions ISO Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]] CTD PMID:29945211 NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631
JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions ISO Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of CFLAR protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] CTD PMID:25034532 PMID:25619640 PMID:34599545 NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
JBrowse link
G Cftr cystic fibrosis transmembrane conductance regulator multiple interactions ISO Acetylcysteine inhibits the reaction [Ozone results in decreased expression of CFTR mRNA]; Acetylcysteine inhibits the reaction [Ozone results in decreased expression of CFTR protein] CTD PMID:19061877 NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
JBrowse link
G Chat choline acetyltransferase increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of CHAT protein
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]
CTD PMID:25891525 NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CHEK1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]]
Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CHEK1 protein modified form]
CTD PMID:15489221 PMID:25633853 PMID:33971260 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of CHEK2 protein modified form]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of CHEK2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased phosphorylation of CHEK2 protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of CHEK2 protein]
Acetylcysteine results in increased expression of CHEK2 protein
CTD PMID:15489221 PMID:23274516 PMID:24792323 PMID:24933654 PMID:31715134 NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
JBrowse link
G Chka choline kinase alpha multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHKA mRNA CTD PMID:22129741 NCBI chr19:3,901,585...3,944,368
Ensembl chr19:3,901,773...3,944,369
JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2, cardiac multiple interactions ISO
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHRM2 mRNA
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM2 mRNA]
CTD PMID:22129741 PMID:29253600 NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3, cardiac multiple interactions EXP Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA] CTD PMID:29253600 NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 multiple interactions EXP Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM4 mRNA] CTD PMID:29253600 NCBI chr 2:91,752,531...91,760,180
Ensembl chr 2:91,757,594...91,759,033
JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase decreases activity ISO Acetylcysteine results in decreased activity of CHUK protein CTD PMID:17395010 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
JBrowse link
G Cish cytokine inducible SH2-containing protein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CISH mRNA CTD PMID:22129741 NCBI chr 9:107,173,858...107,179,983
Ensembl chr 9:107,173,225...107,179,983
JBrowse link
G Ckb creatine kinase, brain multiple interactions ISO [Deferoxamine co-treated with Acetylcysteine] inhibits the reaction [Acetaminophen results in decreased activity of CKB protein]; [Deferoxamine co-treated with Acetylcysteine] inhibits the reaction [Carbon Tetrachloride results in decreased activity of CKB protein] CTD PMID:19688255 NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
JBrowse link
G Ckm creatine kinase, muscle multiple interactions
decreases secretion
ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CKM mRNA]
Acetylcysteine results in decreased secretion of CKM protein
CTD PMID:9689591 PMID:21912612 NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766
JBrowse link
G Cldn1 claudin 1 multiple interactions ISO
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLDN1 mRNA; Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein]
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN1 mRNA]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of CLDN1 protein]
CTD PMID:22129741 PMID:28115242 PMID:29235125 PMID:32687961 PMID:33485121 More... NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
JBrowse link
G Cldn4 claudin 4 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN4 mRNA]
CTD PMID:23816505 PMID:33485121 NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
JBrowse link
G Cldn5 claudin 5 multiple interactions ISO Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of and affects the localization of CLDN5 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of CLDN5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] CTD PMID:28115242 PMID:34391839 NCBI chr16:18,595,597...18,597,012
Ensembl chr16:18,595,597...18,597,012
JBrowse link
G Clec9a C-type lectin domain family 9, member a multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLEC9A mRNA CTD PMID:22129741 NCBI chr 6:129,385,825...129,401,727
Ensembl chr 6:129,385,825...129,401,726
JBrowse link
G Clk1 CDC-like kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of CLK1 mRNA] CTD PMID:18723479 NCBI chr 1:58,451,147...58,463,247
Ensembl chr 1:58,449,348...58,463,225
JBrowse link
G Clu clusterin multiple interactions ISO Acetylcysteine promotes the reaction [Chlorine results in increased expression of CLU protein] CTD PMID:35065218 NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G Cma1 chymase 1, mast cell multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CMA1 mRNA CTD PMID:22129741 NCBI chr14:56,178,908...56,182,132
Ensembl chr14:56,178,908...56,182,132
JBrowse link
G Cntf ciliary neurotrophic factor multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CNTF protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]] CTD PMID:16896058 PMID:26138014 NCBI chr19:12,740,892...12,742,996
Ensembl chr19:12,741,024...12,742,996
JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 protein] CTD PMID:13679210 NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
JBrowse link
G Col1a1 collagen, type I, alpha 1 decreases expression
multiple interactions
ISO
EXP
Acetylcysteine results in decreased expression of COL1A1 mRNA
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of COL1A1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of COL1A1 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of COL1A1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of COL1A1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of COL1A1 protein]
Acetylcysteine results in decreased expression of COL1A1 mRNA; Acetylcysteine results in decreased expression of COL1A1 protein
CTD PMID:11710721 PMID:17602960 PMID:32659284 PMID:34547296 PMID:36493885 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G Col1a2 collagen, type I, alpha 2 decreases expression ISO Acetylcysteine results in decreased expression of COL1A2 mRNA CTD PMID:11710721 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G Col4a1 collagen, type IV, alpha 1 decreases expression ISO Acetylcysteine results in decreased expression of COL4A1 mRNA CTD PMID:16084531 NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
JBrowse link
G Colq collagen like tail subunit of asymmetric acetylcholinesterase multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of COLQ mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA] CTD PMID:22129741 NCBI chr14:31,245,039...31,299,820
Ensembl chr14:31,245,039...31,313,300
JBrowse link
G Copg1 coatomer protein complex, subunit gamma 1 multiple interactions EXP Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of COPG1 mRNA] CTD PMID:34425375 NCBI chr 6:87,864,801...87,890,577
Ensembl chr 6:87,864,796...87,890,577
JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4I1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of COX4I1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of COX4I1 mRNA] CTD PMID:35403558 PMID:36493885 NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
JBrowse link
G Cpe carboxypeptidase E decreases expression ISO Acetylcysteine results in decreased expression of CPE mRNA CTD PMID:16084531 NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088
JBrowse link
G Cplx1 complexin 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPLX1 mRNA CTD PMID:22129741 NCBI chr 5:108,666,420...108,697,893
Ensembl chr 5:108,666,420...108,697,890
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1a, liver multiple interactions ISO [Acetylcysteine co-treated with Dietary Fats] results in increased expression of CPT1A mRNA CTD PMID:21051528 NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
JBrowse link
G Cpt1b carnitine palmitoyltransferase 1b, muscle multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA CTD PMID:22129741 NCBI chr15:89,300,608...89,310,065
Ensembl chr15:89,300,608...89,310,066
JBrowse link
G Cradd CASP2 and RIPK1 domain containing adaptor with death domain decreases expression ISO Acetylcysteine results in decreased expression of CRADD mRNA CTD PMID:16084531 NCBI chr10:95,010,601...95,160,000
Ensembl chr10:95,010,608...95,159,995
JBrowse link
G Crat carnitine acetyltransferase multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA CTD PMID:22129741 NCBI chr 2:30,290,483...30,305,602
Ensembl chr 2:30,290,483...30,305,825
JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of CREB1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of CREB1 protein]
Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of CREB1 protein]
CTD PMID:18375950 PMID:32433928 PMID:36813253 NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
JBrowse link
G Crem cAMP responsive element modulator multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CREM mRNA] CTD PMID:25381014 NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
JBrowse link
G Cry1 cryptochrome circadian regulator 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CRY1 mRNA] CTD PMID:33971260 NCBI chr10:84,967,564...85,020,918
Ensembl chr10:84,967,564...85,020,928
JBrowse link
G Cryab crystallin, alpha B multiple interactions ISO Acetylcysteine inhibits the reaction [arsenite results in increased expression of CRYAB protein] CTD PMID:15175009 NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
JBrowse link
G Cryga crystallin, gamma A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRYGA mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA] CTD PMID:22129741 NCBI chr 1:65,139,552...65,142,532
Ensembl chr 1:65,139,548...65,142,532
JBrowse link
G Cs citrate synthase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of CS mRNA]
Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of CS protein]]
Acetylcysteine promotes the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein]
CTD PMID:21775390 PMID:27385396 PMID:36762617 NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) multiple interactions EXP Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CSF1 mRNA] CTD PMID:35123994 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions EXP [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] CTD PMID:30742845 NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] CTD PMID:10645887 PMID:19460412 PMID:26138014 PMID:29753051 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G Csf3r colony stimulating factor 3 receptor multiple interactions ISO Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]] CTD PMID:29945211 NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
JBrowse link
G Cst3 cystatin C multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CST3 protein] CTD PMID:35020164 NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein]
Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [GSK3B protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of and results in increased activity of CTNNB1 protein]; Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased cleavage of CTNNB1 protein]; Acetylcysteine inhibits the reaction [quinocetone results in decreased expression of CTNNB1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CTNNB1 protein]
CTD PMID:16282376 PMID:19436114 PMID:24961358 PMID:24968063 PMID:28321046 More... NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Ctrc chymotrypsin C multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CTRC mRNA CTD PMID:22129741 NCBI chr 4:141,565,550...141,573,598
Ensembl chr 4:141,565,550...141,573,670
JBrowse link
G Ctrl chymotrypsin-like multiple interactions ISO Acetylcysteine inhibits the reaction [plumbagin results in decreased activity of CTRL protein] CTD PMID:31276663 NCBI chr 8:106,658,626...106,660,494
Ensembl chr 8:106,658,635...106,660,494
JBrowse link
G Ctsb cathepsin B multiple interactions ISO Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CTSB mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CTSB mRNA] CTD PMID:29307831 PMID:31319114 NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
JBrowse link
G Ctsd cathepsin D multiple interactions ISO Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA] CTD PMID:35550146 NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
JBrowse link
G Ctsk cathepsin K multiple interactions EXP [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] CTD PMID:30742845 NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
JBrowse link
G Ctsl cathepsin L multiple interactions ISO Acetylcysteine inhibits the reaction [Berberine results in decreased cleavage of CTSL protein] CTD PMID:36070022 NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
JBrowse link
G Cux2 cut-like homeobox 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] CTD PMID:22129741 NCBI chr 5:121,996,025...122,188,522
Ensembl chr 5:121,994,429...122,188,165
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of CXCL1 protein
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CXCL1 protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]
CTD PMID:17395010 PMID:18257742 NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CXCL12 protein]
Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CXCL12 mRNA]
CTD PMID:26138014 PMID:35123994 NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of CXCL8 mRNA
Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [acetylleucyl-leucyl-norleucinal results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Anthralin results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL8 mRNA]]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of CXCL8]; Acetylcysteine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [citral results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [ethylenediamine results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Ethylmercuric Chloride results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Eugenol results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [lactacystin results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [MG 262 results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CXCL8]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein]
CTD PMID:8123758 PMID:9628260 PMID:9707512 PMID:10022265 PMID:10202011 More... NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of CXCL2 mRNA]; Acetylcysteine inhibits the reaction [Vanadates results in increased expression of CXCL2 mRNA]
Acetylcysteine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CXCL2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CXCL2 protein]
CTD PMID:10718115 PMID:16919916 PMID:19350554 PMID:21507677 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression
multiple interactions
ISO
EXP
Acetylcysteine results in decreased expression of CXCL1 protein
Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]
CTD PMID:17395010 PMID:24316229 PMID:28555929 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
JBrowse link
G Cxcl5 C-X-C motif chemokine ligand 5 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CXCL6 protein] CTD PMID:26138014 NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
JBrowse link
G Cyba cytochrome b-245, alpha polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBA protein] CTD PMID:21195169 NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
JBrowse link
G Cybb cytochrome b-245, beta polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] CTD PMID:21195169 PMID:29087013 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010
JBrowse link
G Cycs cytochrome c, somatic multiple interactions
decreases expression
ISO
EXP
Acetylcysteine inhibits the reaction [dimethoxycurcumin affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [surfactin peptide affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein]
Acetylcysteine results in decreased expression of CYCS protein
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CYCS mRNA]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of CYCS mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds affects the localization of CYCS protein]
CTD PMID:18483861 PMID:19536524 PMID:19954742 PMID:21145380 PMID:21221209 More... NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
JBrowse link
G Cyct cytochrome c, testis multiple interactions ISO Acetylcysteine inhibits the reaction [Estradiol results in increased expression of CYCT protein] CTD PMID:15545282 NCBI chr 2:76,184,286...76,190,797
Ensembl chr 2:76,184,286...76,190,794
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of CYP11A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 protein] CTD PMID:26769589 PMID:29567110 NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions ISO Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of CYP11B2 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of CYP11B2 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of CYP11B2 mRNA] CTD PMID:25617244 NCBI chr15:74,722,467...74,728,080
Ensembl chr15:74,722,859...74,728,167
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein] CTD PMID:29567110 NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
ISO
EXP
[Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA; Acetylcysteine affects the reaction [Curcumin affects the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]]; Acetylcysteine inhibits the reaction [1-(4-chlorophenyl)-benzo-2,5-quinone results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]
Acetylcysteine results in increased expression of CYP1A1 protein
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of CYP1A1 mRNA; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CYP1A1 mRNA]
[Acetylcysteine co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]; Acetylcysteine affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Acetylcysteine affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased activity of CYP1A1 protein]; Acetylcysteine inhibits the reaction [beta-Naphthoflavone results in decreased activity of CYP1A1 protein]; Acetylcysteine inhibits the reaction [chromium trioxide results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Acetylcysteine promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]
CTD PMID:15044633 PMID:15621696 PMID:16274885 PMID:19033395 PMID:20801209 More... NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein]; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA]
[CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite
CTD PMID:21424224 PMID:22129741 PMID:23159886 PMID:27989148 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA]
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA]
CTD PMID:21703343 PMID:22129741 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Cyp26c1 cytochrome P450, family 26, subfamily c, polypeptide 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP26C1 mRNA CTD PMID:22129741 NCBI chr19:37,673,560...37,681,774
Ensembl chr19:37,674,029...37,681,846
JBrowse link
G Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5 multiple interactions EXP Acetylcysteine inhibits the reaction [Ethanol results in increased expression of and results in increased activity of CYP2A5 protein] CTD PMID:22552773 NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 multiple interactions ISO [CYP2C19 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CTD PMID:27989148 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 multiple interactions ISO Acetylcysteine affects the reaction [CYP2C9 protein results in increased hydroxylation of bromfenac] CTD PMID:31815452 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO
EXP
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein]; Acetylcysteine inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP2E1 mRNA]; Acetylcysteine promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA]
Acetylcysteine inhibits the reaction [Ethanol results in increased expression of CYP2E1 mRNA]
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein]
CTD PMID:21424224 PMID:23159886 PMID:26332274 PMID:30423402 PMID:35713687 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Cyp4a12b cytochrome P450, family 4, subfamily a, polypeptide 12B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA; Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] CTD PMID:19647067 PMID:22129741 NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231
JBrowse link
G Dapk1 death associated protein kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] CTD PMID:19477266 NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005
JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DDHD1 mRNA CTD PMID:22129741 NCBI chr14:45,830,628...45,895,600
Ensembl chr14:45,825,924...45,895,600
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
decreases expression
multiple interactions
ISO
EXP
Acetylcysteine results in increased expression of DDIT3 mRNA; Acetylcysteine results in increased expression of DDIT3 protein
Acetylcysteine results in decreased expression of DDIT3 protein
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of DDIT3 protein]
4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3]; Acetylcysteine inhibits the reaction [CSC-3436 results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [discretamine results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [plumbagin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [raspberry ketone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [rhododendrol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tanshinone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Ursolic Acid results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased expression of DDIT3 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]]
Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein]; Acetylcysteine promotes the reaction [perfluorooctanoic acid results in increased expression of DDIT3 mRNA]
CTD PMID:16084531 PMID:17171638 PMID:18077580 PMID:18384088 PMID:19722195 More... NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions ISO Acetylcysteine inhibits the reaction [withaferin A results in increased expression of DDIT4 protein] CTD PMID:21266191 NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
JBrowse link
G Defb12 defensin beta 12 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB12 mRNA CTD PMID:22129741 NCBI chr 8:19,161,947...19,164,850
Ensembl chr 8:19,161,947...19,164,866
JBrowse link
G Defb18 defensin beta 18 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB18 mRNA CTD PMID:22129741 NCBI chr 1:18,306,626...18,307,700
Ensembl chr 1:18,306,697...18,307,667
JBrowse link
G Defb4 defensin beta 4 decreases expression ISO Acetylcysteine results in decreased expression of DEFB4A mRNA CTD PMID:22385246 NCBI chr 8:19,248,720...19,251,563
Ensembl chr 8:19,248,722...19,251,561
JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of DGAT2 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of DGAT2 protein] CTD PMID:33007364 NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
JBrowse link
G Dhfr dihydrofolate reductase multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of DHFR mRNA] CTD PMID:36315628 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
JBrowse link
G Dhh desert hedgehog multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DHH mRNA CTD PMID:22129741 NCBI chr15:98,779,496...98,796,443
Ensembl chr15:98,789,033...98,796,421
JBrowse link
G Dio2 deiodinase, iodothyronine, type II multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]] CTD PMID:18420745 NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812
JBrowse link
G Dio3 deiodinase, iodothyronine type III multiple interactions ISO Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Sodium Selenite] promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]] CTD PMID:18420745 NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA] CTD PMID:28321046 NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065
JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 protein] CTD PMID:27624276 PMID:28153600 NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348
JBrowse link
G Dmrt1 doublesex and mab-3 related transcription factor 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DMRT1 mRNA CTD PMID:22129741 NCBI chr19:25,483,070...25,581,692
Ensembl chr19:25,482,982...25,581,693
JBrowse link
G Dnah3 dynein, axonemal, heavy chain 3 multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA] CTD PMID:22129741 NCBI chr 7:119,520,555...119,694,520
Ensembl chr 7:119,521,894...119,694,503
JBrowse link
G Dnai1 dynein axonemal intermediate chain 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DNAI1 mRNA CTD PMID:22129741 NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA] CTD PMID:18723479 NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282
JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA] CTD PMID:18723479 NCBI chr 3:151,887,217...151,915,720
Ensembl chr 3:151,884,148...151,915,939
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO Acetylcysteine results in increased expression of DNAJB9 mRNA CTD PMID:16084531 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
JBrowse link
G Dnm1l dynamin 1-like multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 affects the reaction [DNM1L protein binds to DNM1L protein binds to DNM1L protein binds to DNM1L protein]]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of DNM1L protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of DNM1L protein]
Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of and results in increased phosphorylation of DNM1L protein]
Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate affects the localization of DNM1L protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the phosphorylation of DNM1L protein]
CTD PMID:20307494 PMID:30641872 PMID:31408635 PMID:37084995 PMID:37499777 NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions ISO [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased expression of DNMT1 mRNA; [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased methylation of DNMT1 promoter; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [DNMT1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DNMT1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DNMT1 protein] CTD PMID:29854080 PMID:31150806 PMID:31551408 NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
JBrowse link
G Dnmt3b DNA methyltransferase 3B multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT3B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of DNMT3B protein] CTD PMID:26942697 PMID:31551408 NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
JBrowse link
G Dsp desmoplakin multiple interactions ISO Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA] CTD PMID:21051528 NCBI chr13:38,335,357...38,382,553
Ensembl chr13:38,335,270...38,382,553
JBrowse link
G Dspp dentin sialophosphoprotein increases expression ISO Acetylcysteine results in increased expression of DSPP mRNA CTD PMID:20951298 NCBI chr 5:104,318,569...104,327,993
Ensembl chr 5:104,318,578...104,327,993
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DUSP1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DUSP1 protein] CTD PMID:18573614 NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
JBrowse link
G Dusp4 dual specificity phosphatase 4 increases expression ISO Acetylcysteine results in increased expression of DUSP4 mRNA CTD PMID:16084531 NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048
JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions ISO Acetylcysteine inhibits the reaction [beta-hydroxyisovalerylshikonin results in decreased phosphorylation of and results in decreased activity of DUT protein] CTD PMID:18078828 NCBI chr 2:125,089,168...125,100,969
Ensembl chr 2:125,089,110...125,100,528
JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of E2F1 protein] CTD PMID:16497787 NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
JBrowse link
G Edn1 endothelin 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased secretion of EDN1 protein]
Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]
Acetylcysteine inhibits the reaction [Paraquat results in increased expression of EDN1 mRNA]
CTD PMID:14623829 PMID:16261333 PMID:21765237 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Efcab3 EF-hand calcium binding domain 3 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA CTD PMID:22129741 NCBI chr11:104,576,533...105,008,365
Ensembl chr11:104,576,533...105,008,220
Ensembl chr11:104,576,533...105,008,220
JBrowse link
G Efna1 ephrin A1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA CTD PMID:22129741 NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
JBrowse link
G Efnb2 ephrin B2 decreases expression ISO Acetylcysteine results in decreased expression of EFNB2 mRNA CTD PMID:16084531 NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242
JBrowse link
G Egf epidermal growth factor multiple interactions ISO Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of HSPD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of EGF protein]; Acetylcysteine inhibits the reaction [cyadox results in increased expression of EGF]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA mRNA]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA protein]
Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]; Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides]
CTD PMID:11158190 PMID:11214823 PMID:26138014 PMID:30265530 PMID:32092105 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGFR mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of EGFR protein]
Acetylcysteine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of EGFR protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein]
Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of EGFR protein]
CTD PMID:10640773 PMID:14660655 PMID:15520183 PMID:15849355 PMID:16261333 More... NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of EGLN1 mRNA] CTD PMID:36315628 NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
JBrowse link
G Egr1 early growth response 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of EGR1 mRNA]
Acetylcysteine inhibits the reaction [platycodin D results in increased expression of EGR1 mRNA]
CTD PMID:10625299 PMID:18804340 PMID:19010381 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
JBrowse link
G Egr2 early growth response 2 multiple interactions ISO Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of EGR2 mRNA] CTD PMID:19350554 NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018
JBrowse link
G Ei24 etoposide induced 2.4 mRNA multiple interactions EXP Acetylcysteine promotes the reaction [Tobacco Smoke Pollution results in increased expression of EI24 mRNA] CTD PMID:16137721 NCBI chr 9:36,690,449...36,708,630
Ensembl chr 9:36,690,455...36,708,689
JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased phosphorylation of EIF2A protein]]
Acetylcysteine inhibits the reaction [Cadmium results in decreased phosphorylation of EIF2A protein]
CTD PMID:21616140 PMID:25451595 PMID:27658547 PMID:29373603 NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
decreases expression
ISO
EXP
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pendulone results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine results in increased phosphorylation of and results in increased activity of EIF2AK3 protein
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2AK3 protein modified form]
Acetylcysteine results in decreased expression of EIF2AK3 protein modified form
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein]
CTD PMID:19722195 PMID:25341683 PMID:25451595 PMID:27484784 PMID:27784618 More... NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased phosphorylation of EIF2S1 protein]
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2S1 protein modified form]
Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of EIF2S1 protein]
CTD PMID:15788408 PMID:16324875 PMID:21911445 PMID:24291486 PMID:25568320 More... NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]
Acetylcysteine inhibits the reaction [frenolicin B results in decreased phosphorylation of EIF4EBP1 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased phosphorylation of EIF4EBP1 protein]
CTD PMID:21195169 PMID:24299490 PMID:26804764 PMID:30661989 PMID:36709824 NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
JBrowse link
G Emilin2 elastin microfibril interfacer 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA CTD PMID:22129741 NCBI chr17:71,559,167...71,618,551
Ensembl chr17:71,559,167...71,618,973
JBrowse link
G Endog endonuclease G multiple interactions ISO [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of ENDOG protein] CTD PMID:17309078 PMID:18034189 NCBI chr 2:30,061,525...30,064,057
Ensembl chr 2:30,061,505...30,064,081
JBrowse link
G Eng endoglin increases expression ISO Acetylcysteine results in increased expression of ENG mRNA; Acetylcysteine results in increased expression of ENG protein CTD PMID:32947957 NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Toluene 2,4-Diisocyanate results in increased secretion of ENPP2 protein] CTD PMID:26072274 NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
JBrowse link
G Enpp7 ectonucleotide pyrophosphatase/phosphodiesterase 7 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENPP7 mRNA CTD PMID:22129741 NCBI chr11:118,879,007...118,884,047
Ensembl chr11:118,879,014...118,884,047
JBrowse link
G Entrep1 endosomal transmembrane epsin interactor 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENTREP1 mRNA CTD PMID:22129741 NCBI chr19:23,950,114...24,008,800
Ensembl chr19:23,950,114...24,008,383
JBrowse link
G Ep300 E1A binding protein p300 multiple interactions ISO Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]] CTD PMID:19281832 NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
JBrowse link
G Epas1 endothelial PAS domain protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of EPAS1 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein] CTD PMID:23958427 NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 multiple interactions ISO [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in decreased expression of EPB41 protein] CTD PMID:20946910 NCBI chr 4:131,650,724...131,802,824
Ensembl chr 4:131,650,724...131,802,632
JBrowse link
G Ephb1 Eph receptor B1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPHB1 mRNA CTD PMID:22129741 NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892
JBrowse link
G Eps8 epidermal growth factor receptor pathway substrate 8 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPS8 mRNA CTD PMID:22129741 NCBI chr 6:137,454,242...137,626,262
Ensembl chr 6:137,454,243...137,631,874
JBrowse link
G Ercc1 excision repair cross-complementing rodent repair deficiency, complementation group 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of ERCC1 mRNA] CTD PMID:33971260 NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
JBrowse link
G Ercc8 excision repaiross-complementing rodent repair deficiency, complementation group 8 multiple interactions ISO Acetylcysteine inhibits the reaction [dicrotophos results in decreased expression of ERCC8 protein] CTD PMID:28302478 NCBI chr13:108,295,246...108,337,738
Ensembl chr13:108,295,265...108,331,898
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 multiple interactions
decreases phosphorylation
ISO
EXP
Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ERN1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ERN1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased phosphorylation of ERN1 protein]
Acetylcysteine results in decreased phosphorylation of ERN1 protein
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ERN1 protein modified form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ERN1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]
CTD PMID:21198628 PMID:24394546 PMID:25451595 PMID:27784618 PMID:29373603 More... NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of ESR1 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR1 mRNA]
Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ESR1 protein]
CTD PMID:18829485 PMID:26149760 PMID:32402895 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR2 mRNA] CTD PMID:18829485 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Esrra estrogen related receptor, alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein] CTD PMID:30104959 NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
JBrowse link
G Ets1 E26 avian leukemia oncogene 1, 5' domain multiple interactions ISO Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ETS1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of ETS1 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETS1 mRNA] CTD PMID:21635667 NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [EZH2 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of EZH2 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of EZH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of EZH2 protein] CTD PMID:24582688 PMID:31551408 NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
JBrowse link
G F13a1 coagulation factor XIII, A1 subunit multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA CTD PMID:22129741 NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
JBrowse link
G F3 coagulation factor III multiple interactions ISO Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA] CTD PMID:23114885 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte multiple interactions EXP Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein] CTD PMID:27117918 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
JBrowse link
G Fadd Fas associated via death domain multiple interactions ISO
EXP
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased expression of FADD protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of FADD mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of FADD protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of FADD mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of FADD protein]]
CTD PMID:20946910 PMID:35833596 NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA CTD PMID:22129741 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A1 mRNA CTD PMID:22129741 NCBI chr 5:65,127,459...65,199,217
Ensembl chr 5:65,127,414...65,199,229
JBrowse link
G Fam114a2 family with sequence similarity 114, member A2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA CTD PMID:22129741 NCBI chr11:57,373,816...57,409,482
Ensembl chr11:57,373,819...57,409,443
JBrowse link
G Fam13a family with sequence similarity 13, member A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM13A mRNA CTD PMID:22129741 NCBI chr 6:58,910,521...59,001,487
Ensembl chr 6:58,909,075...59,001,534
JBrowse link
G Fam186a family with sequence similarity 186, member A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM186A mRNA CTD PMID:22129741 NCBI chr15:99,816,226...99,864,974
Ensembl chr15:99,816,229...99,864,942
JBrowse link
G Far1 fatty acyl CoA reductase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAR1 mRNA CTD PMID:22129741 NCBI chr 7:113,113,008...113,170,713
Ensembl chr 7:113,113,041...113,170,718
JBrowse link
G Fas Fas cell surface death receptor multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of FAS mRNA]
Acetylcysteine results in increased expression of FAS mRNA
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of FAS protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of FAS protein]
CTD PMID:9227460 PMID:15382040 PMID:16169029 PMID:19014919 PMID:19477266 More... NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fasl Fas ligand multiple interactions
increases expression
ISO
EXP
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of FASLG mRNA; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased expression of FASLG protein]
Acetylcysteine results in increased expression of FASLG mRNA
[Atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein]
Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein]
CTD PMID:11864783 PMID:17574045 PMID:19644561 PMID:19720122 PMID:19760616 More... NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Fbxo32 F-box protein 32 multiple interactions EXP Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 NCBI chr15:58,039,275...58,078,288
Ensembl chr15:58,039,275...58,078,328
JBrowse link
G Fen1 flap structure specific endonuclease 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of FEN1 mRNA] CTD PMID:33971260 NCBI chr19:10,176,496...10,181,757
Ensembl chr19:10,176,496...10,181,533
JBrowse link
G Fer1l5 fer-1 like family member 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FER1L5 mRNA CTD PMID:22129741 NCBI chr 1:36,411,264...36,461,191
Ensembl chr 1:36,411,372...36,461,191
JBrowse link
G Fgf12 fibroblast growth factor 12 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF12 mRNA CTD PMID:22129741 NCBI chr16:27,976,535...28,571,995
Ensembl chr16:27,978,850...28,571,820
JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of FGF2 mRNA
Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein]
CTD PMID:16084531 PMID:19176594 NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
JBrowse link
G Fgf21 fibroblast growth factor 21 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF21 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA]
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of FGF21 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased secretion of FGF21 protein]
CTD PMID:22129741 PMID:22917661 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914
JBrowse link
G Fgf6 fibroblast growth factor 6 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF6 protein] CTD PMID:26138014 NCBI chr 6:126,992,505...127,001,681
Ensembl chr 6:126,992,549...127,005,150
JBrowse link
G Fgf7 fibroblast growth factor 7 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein] CTD PMID:26138014 NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105
JBrowse link
G Fhit fragile histidine triad gene multiple interactions ISO Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of FHIT protein] CTD PMID:16585223 NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681
JBrowse link
G Filip1l filamin A interacting protein 1-like decreases expression ISO Acetylcysteine results in decreased expression of FILIP1L mRNA CTD PMID:16084531 NCBI chr16:57,173,376...57,393,167
Ensembl chr16:57,173,456...57,393,489
JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of FIS1 protein]
Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of FIS1 protein]
CTD PMID:37084995 PMID:37499777 NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
JBrowse link
G Fkbp5 FK506 binding protein 5 multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA] CTD PMID:18829485 NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
JBrowse link
G Flg filaggrin multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FLG mRNA CTD PMID:22129741 NCBI chr 3:93,180,853...93,200,996
Ensembl chr 3:93,180,830...93,200,993
JBrowse link
G Flna filamin, alpha multiple interactions ISO Acetylcysteine inhibits the reaction [arsenic trichloride results in increased phosphorylation of FLNA protein] CTD PMID:25944616 NCBI chr  X:73,267,067...73,293,787
Ensembl chr  X:73,267,067...73,293,426
JBrowse link
G Flt1 FMS-like tyrosine kinase 1 increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of FLT1 protein
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of FLT1 mRNA]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of FLT1 mRNA]
CTD PMID:17992120 PMID:29408318 NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
JBrowse link
G Flt3l FMS-like tyrosine kinase 3 ligand multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FLT3LG protein] CTD PMID:26138014 NCBI chr 7:44,780,607...44,785,914
Ensembl chr 7:44,779,212...44,785,856
JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 multiple interactions ISO Acetylcysteine promotes the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] CTD PMID:27385396 NCBI chr  X:67,722,144...67,761,569
Ensembl chr  X:67,722,147...67,761,569
JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein]
Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP10 protein]; Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP3 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of FN1 mRNA]
CTD PMID:16632126 PMID:17395008 PMID:22245600 PMID:22648416 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
JBrowse link
G Fos FBJ osteosarcoma oncogene multiple interactions
decreases activity
ISO
EXP
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOS]; Acetylcysteine inhibits the reaction [Etoposide results in increased expression of FOS]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased activity of FOS protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of FOS]
Acetylcysteine results in decreased activity of FOS protein
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of and results in increased phosphorylation of FOS protein]; Acetylcysteine promotes the reaction [bis(maltolato)oxovanadium(IV) results in decreased activity of [FOS protein binds to JUN protein]]
Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of FOS mRNA]
CTD PMID:7743507 PMID:8825185 PMID:8853906 PMID:9043100 PMID:9525474 More... NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
JBrowse link
G Fosl1 fos-like antigen 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOSL1 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOSL1 mRNA]
CTD PMID:15520183 PMID:19010381 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
JBrowse link
G Foxd2 forkhead box D2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA CTD PMID:22129741 NCBI chr 4:114,763,477...114,766,095
Ensembl chr 4:114,763,479...114,766,070
JBrowse link
G Foxd4 forkhead box D4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD4 mRNA CTD PMID:22129741 NCBI chr19:24,876,307...24,878,380
Ensembl chr19:24,876,600...24,878,561
JBrowse link
G Foxm1 forkhead box M1 multiple interactions ISO Acetylcysteine inhibits the reaction [Thiostrepton results in decreased expression of FOXM1 protein] CTD PMID:22761781 NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
JBrowse link
G Foxo1 forkhead box O1 multiple interactions EXP Acetylcysteine inhibits the reaction [Cyclosporine results in increased expression of and affects the localization of FOXO1 protein modified form]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein] CTD PMID:23765110 PMID:33450223 NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
JBrowse link
G Foxo3 forkhead box O3 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Simvastatin results in increased phosphorylation of FOXO3 protein]
Acetylcysteine inhibits the reaction [tomentosin results in increased expression of FOXO3 protein]
Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of FOXO3 protein]
CTD PMID:20883752 PMID:23159718 PMID:25471227 PMID:30104959 PMID:30917517 More... NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
JBrowse link
G Foxp3 forkhead box P3 multiple interactions ISO Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of FOXP3 protein] CTD PMID:31900833 NCBI chr  X:7,445,915...7,461,482
Ensembl chr  X:7,439,883...7,461,484
JBrowse link
G Fshb follicle stimulating hormone beta multiple interactions ISO Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of FSHB protein] CTD PMID:30633982 NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
JBrowse link
G Fth1 ferritin heavy polypeptide 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Rotenone results in increased expression of FTH1 mRNA]
Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of FTH1 protein]
CTD PMID:18325346 PMID:32687844 NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
JBrowse link
G Ftl1 ferritin light polypeptide 1 multiple interactions ISO Acetylcysteine inhibits the reaction [arsenite results in increased expression of FTL1 protein] CTD PMID:15175009 NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
JBrowse link
G Fto FTO alpha-ketoglutarate dependent dioxygenase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FTO mRNA]
Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of FTO mRNA]
CTD PMID:31004932 PMID:34425375 NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
JBrowse link
G Fxn frataxin affects response to substance
multiple interactions
EXP
ISO
Acetylcysteine affects the susceptibility to FXN protein mutant form
Acetylcysteine affects the reaction [Ethanol affects the expression of FXN protein]
CTD PMID:16120311 PMID:33017621 NCBI chr19:24,236,909...24,257,954
Ensembl chr19:24,238,817...24,257,969
JBrowse link
G Fyn Fyn proto-oncogene multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of FYN protein]
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of FYN protein]
CTD PMID:12902192 PMID:20850416 NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC1 mRNA CTD PMID:22129741 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked multiple interactions
increases activity
ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of G6PD mRNA]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA]
Acetylcysteine results in increased activity of G6PD protein
CTD PMID:3099627 PMID:12717738 PMID:15225644 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha multiple interactions
decreases expression
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [Formaldehyde results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [raspberry ketone results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [rhododendrol results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of GADD45A mRNA]
Acetylcysteine results in decreased expression of GADD45A mRNA
Acetylcysteine results in increased expression of GADD45A mRNA
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45A mRNA; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA]
CTD PMID:18849615 PMID:22129741 PMID:24291486 PMID:26332274 PMID:26867644 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible 45 gamma multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA
Acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G mRNA]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G protein]
CTD PMID:22129741 PMID:23313378 NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504
JBrowse link
G Galntl5 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GALNTL5 mRNA CTD PMID:22129741 NCBI chr 5:25,386,438...25,425,295
Ensembl chr 5:25,386,458...25,425,295
JBrowse link
G Gap43 growth associated protein 43 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] CTD PMID:18375950 NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [arsenite results in decreased expression of GAPDH protein]
Acetylcysteine results in decreased expression of GAPDH mRNA
CTD PMID:11108245 PMID:15175009 NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
JBrowse link
G Gata1 GATA binding protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] CTD PMID:10656287 NCBI chr  X:7,825,504...7,842,844
Ensembl chr  X:7,825,499...7,844,310
JBrowse link
G Gbp2b guanylate binding protein 2b decreases expression ISO Acetylcysteine results in decreased expression of GBP1 mRNA CTD PMID:16084531 NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of GCLC mRNA]
Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC protein]
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA]
CTD PMID:11820781 PMID:11909699 PMID:16631525 PMID:17540521 PMID:17980396 More... NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit multiple interactions
affects response to substance
ISO
EXP
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA]
GCLM protein affects the susceptibility to Acetylcysteine
Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLM mRNA]
CTD PMID:17584759 PMID:18723479 PMID:19328227 PMID:19350554 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
JBrowse link
G Gdf1 growth differentiation factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein] CTD PMID:33360347 NCBI chr 8:70,768,425...70,784,242
Ensembl chr 8:70,768,425...70,784,242
Ensembl chr 8:70,768,425...70,784,242
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions EXP Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GDF15 mRNA] CTD PMID:35123994 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
JBrowse link
G Gdnf glial cell line derived neurotrophic factor multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GDNF mRNA
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of GDNF protein]
CTD PMID:22129741 PMID:26138014 NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein]
Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein]
CTD PMID:28499986 PMID:31173782 NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GGT1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased secretion of GGT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GGT1 protein]; Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of GGT1 protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]] CTD PMID:12030384 PMID:22129741 PMID:24485406 PMID:24634002 PMID:27387968 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of GJA1 protein] CTD PMID:34906888 NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression ISO Acetylcysteine results in decreased expression of GJA4 mRNA CTD PMID:16084531 NCBI chr 4:127,205,213...127,207,832
Ensembl chr 4:127,205,214...127,207,832
JBrowse link
G Gjb1 gap junction protein, beta 1 multiple interactions EXP Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of GJB1 mRNA] CTD PMID:32142722 NCBI chr  X:100,419,982...100,429,235
Ensembl chr  X:100,419,984...100,429,235
JBrowse link
G Gk glycerol kinase multiple interactions ISO Acetylcysteine inhibits the reaction [Malathion results in increased activity of GK protein] CTD PMID:25449180 NCBI chr  X:84,745,543...84,820,425
Ensembl chr  X:84,745,543...84,820,425
JBrowse link
G Gkn2 gastrokine 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GKN2 mRNA CTD PMID:22129741 NCBI chr 6:87,350,347...87,356,476
Ensembl chr 6:87,350,339...87,356,479
JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased activity of GLB1 protein]; Acetylcysteine inhibits the reaction [lopinavir-ritonavir drug combination results in increased activity of GLB1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] CTD PMID:20884875 PMID:31551408 NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
JBrowse link
G Glcci1 glucocorticoid induced transcript 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GLCCI1 mRNA CTD PMID:22129741 NCBI chr 6:8,509,600...8,597,549
Ensembl chr 6:8,509,600...8,597,548
JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions ISO Acetylcysteine inhibits the reaction [Oleic Acid results in increased degradation of and results in decreased expression of GLP1R protein] CTD PMID:22925809 NCBI chr17:31,120,841...31,155,484
Ensembl chr17:31,120,791...31,159,765
JBrowse link
G Glrx glutaredoxin affects response to substance ISO GLRX protein affects the susceptibility to Acetylcysteine CTD PMID:17468103 NCBI chr13:75,988,004...75,998,270
Ensembl chr13:75,987,987...75,998,273
JBrowse link
G Glud1 glutamate dehydrogenase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of GLUD1 mRNA] CTD PMID:31857147 NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222
JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions EXP
ISO
Acetylcysteine affects the reaction [IER3 protein affects the expression of GNAI2 mRNA]
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GNAI2 protein]
CTD PMID:18441196 PMID:20713914 NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566
JBrowse link
G Gnai3 G protein subunit alpha i3 multiple interactions ISO Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GNAI3 protein] CTD PMID:18441196 NCBI chr 3:108,014,591...108,053,468
Ensembl chr 3:108,014,596...108,053,462
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions ISO Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GOT1 protein] CTD PMID:27387968 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gp1ba glycoprotein 1b, alpha polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [THPO protein results in increased expression of GP1BA protein] CTD PMID:20523355 NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
JBrowse link
G Gp2 glycoprotein 2 zymogen granule membrane multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GP2 mRNA CTD PMID:22129741 NCBI chr 7:119,041,760...119,058,495
Ensembl chr 7:119,041,760...119,058,508
JBrowse link
G Gpbar1 G protein-coupled bile acid receptor 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPBAR1 mRNA CTD PMID:22129741 NCBI chr 1:74,316,269...74,318,868
Ensembl chr 1:74,317,709...74,318,783
JBrowse link
G Gpc5 glypican 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPC5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA] CTD PMID:22129741 NCBI chr14:115,329,640...116,762,604
Ensembl chr14:115,329,647...116,762,591
JBrowse link
G Gpr153 G protein-coupled receptor 153 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR153 mRNA CTD PMID:22129741 NCBI chr 4:152,358,563...152,369,798
Ensembl chr 4:152,358,689...152,369,794
JBrowse link
G Gpr20 G protein-coupled receptor 20 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR20 mRNA CTD PMID:22129741 NCBI chr15:73,560,346...73,579,354
Ensembl chr15:73,566,453...73,579,354
JBrowse link
G Gpr55 G protein-coupled receptor 55 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR55 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA] CTD PMID:22129741 NCBI chr 1:85,860,927...85,924,781
Ensembl chr 1:85,866,039...85,888,729
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [PTEN gene mutant form results in increased secretion of GPT protein]]; IL22 protein promotes the reaction [Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of GPT protein]]
[Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen affects the activity of GPT protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Glyphosate results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]]
CTD PMID:17461432 PMID:20688495 PMID:20804811 PMID:23375450 PMID:24485406 More... NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 protein]
Acetylcysteine results in increased expression of GPX1 protein
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased expression of GPX1 mRNA]; Acetylcysteine inhibits the reaction [raspberry ketone results in decreased expression of GPX1 protein]; Acetylcysteine inhibits the reaction [rhododendrol results in decreased expression of GPX1 protein]
CTD PMID:25341683 PMID:26867644 PMID:30037311 PMID:30104959 PMID:35112789 NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] CTD PMID:22129741 NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GPX4 mRNA] CTD PMID:12208374 NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
JBrowse link
G Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) multiple interactions ISO Acetylcysteine inhibits the reaction [Pilocarpine results in increased expression of GRIN2B protein] CTD PMID:22824136 NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
JBrowse link
G Grm2 glutamate receptor, metabotropic 2 increases activity ISO Acetylcysteine results in increased activity of GRM2 protein CTD PMID:19136971 NCBI chr 9:106,521,733...106,533,308
Ensembl chr 9:106,520,294...106,533,281
JBrowse link
G Grm3 glutamate receptor, metabotropic 3 increases activity ISO Acetylcysteine results in increased activity of GRM3 protein CTD PMID:19136971 NCBI chr 5:9,535,235...9,776,087
Ensembl chr 5:9,535,541...9,775,170
JBrowse link
G Grm5 glutamate receptor, metabotropic 5 increases activity ISO Acetylcysteine results in increased activity of GRM5 protein CTD PMID:19136971 NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115
JBrowse link
G Gsdmd gasdermin D multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased cleavage of GSDMD protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of GSDMD protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein]]
Acetylcysteine results in increased expression of GSDMD protein
Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of GSDMD protein]
Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD protein]
CTD PMID:30378427 PMID:34791735 PMID:36347317 PMID:36354081 PMID:36646296 More... NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of GSK3B protein]
[Acetylcysteine co-treated with Chlorpyrifos] results in increased activity of GSK3B protein; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [GSK3B protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to GSK3B protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased phosphorylation of GSK3B protein]
CTD PMID:18569013 PMID:19126599 PMID:24968063 PMID:25246272 PMID:27658547 More... NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
JBrowse link
G Gsr glutathione reductase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GSR mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in decreased expression of GSR mRNA]
Acetylcysteine inhibits the reaction [Acetaminophen results in decreased activity of GSR protein]
[Acetylcysteine co-treated with Paraquat co-treated with Maneb] results in increased activity of GSR protein; [Acetylcysteine co-treated with Paraquat] results in increased activity of GSR protein; Acetylcysteine inhibits the reaction [arsenic trioxide inhibits the reaction [GSR protein results in increased oxidation of NADP]]; Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of GSR mRNA]; Acetylcysteine inhibits the reaction [Dimethylnitrosamine results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [Paraquat results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of GSR protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in decreased activity of GSR protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]]; Acetylcysteine promotes the reaction [Zinc Sulfate inhibits the reaction [EUK-134 results in decreased activity of GSR protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in decreased activity of GSR protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]]
CTD PMID:16631525 PMID:19840221 PMID:21114986 PMID:23159886 PMID:24634002 More... NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
JBrowse link
G Gsta1 glutathione S-transferase, alpha 1 (Ya) multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTA5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA] CTD PMID:22129741 NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
JBrowse link
G Gsta4 glutathione S-transferase, alpha 4 multiple interactions ISO [Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein]; [EUK-134 co-treated with Acetylcysteine] promotes the reaction [Paraquat results in increased activity of GSTA4 protein]; [EUK-134 co-treated with Acetylcysteine] promotes the reaction [Zinc Sulfate results in increased activity of GSTA4 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [[Paraquat co-treated with Maneb] results in increased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [Maneb results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [Maneb results in increased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [Paraquat results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [Paraquat results in increased expression of GSTA4 mRNA] CTD PMID:23159886 PMID:25724285 PMID:30639957 NCBI chr 9:78,099,248...78,116,631
Ensembl chr 9:78,090,056...78,116,631
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 multiple interactions ISO Acetylcysteine inhibits the reaction [alpha-methylepinine results in increased expression of GSTM1 mRNA]
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA
CTD PMID:21871945 PMID:22129741 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstm2 glutathione S-transferase, mu 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA CTD PMID:22129741 NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA] CTD PMID:22129741 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
JBrowse link
G Gulp1 GULP, engulfment adaptor PTB domain containing 1 decreases expression ISO Acetylcysteine results in decreased expression of GULP1 mRNA CTD PMID:16084531 NCBI chr 1:44,590,540...44,835,998
Ensembl chr 1:44,590,671...44,835,998
JBrowse link
G Gypa glycophorin A multiple interactions ISO Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] CTD PMID:20523355 NCBI chr 8:81,220,674...81,237,414
Ensembl chr 8:81,220,410...81,237,171
JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [captax results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [chloropicrin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AX protein]]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [Crizotinib results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [eprenetapopt results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [gingerenone A results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [LAQ824 results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [manumycin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AX protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [PCB 180 metabolite results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [phenanthridone results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [Plant Extracts results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of H2AX protein]
Acetylcysteine results in increased expression of H2AX protein
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [aristolochic acid I results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [yttrium chloride results in increased phosphorylation of H2AX protein]
Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased activity of H2AX protein]
CTD PMID:15173094 PMID:15489221 PMID:18852132 PMID:19409983 PMID:21135414 More... NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G Has2 hyaluronan synthase 2 multiple interactions EXP Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] CTD PMID:21220312 NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HAVCR1 protein] CTD PMID:35020164 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Hax1 HCLS1 associated X-1 multiple interactions ISO Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of HAX1 protein] CTD PMID:19679660 NCBI chr 3:89,902,753...89,906,023
Ensembl chr 3:89,902,753...89,906,087
JBrowse link
G Hbegf heparin-binding EGF-like growth factor multiple interactions ISO Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA] CTD PMID:12676768 NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
JBrowse link
G Hc hemolytic complement multiple interactions ISO Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C5 protein] CTD PMID:32924446 NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
JBrowse link
G Hectd4 HECT domain E3 ubiquitin protein ligase 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Ethanol results in increased expression of HECTD4 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of HECTD4 mRNA] CTD PMID:31004932 PMID:35713687 NCBI chr 5:121,357,323...121,506,633
Ensembl chr 5:121,358,282...121,506,640
JBrowse link
G Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of HERPUD1 mRNA
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HERPUD1 mRNA]
CTD PMID:16084531 PMID:18723479 NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005
JBrowse link
G Hgf hepatocyte growth factor multiple interactions ISO Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of HGF protein] CTD PMID:16757516 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hhip Hedgehog-interacting protein multiple interactions ISO [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of HHIP mRNA CTD PMID:21051528 NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein]
Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Nickel analog results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of HIF1A protein]]
1-(2-chloroethyl)-1-nitrosourea inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Cisplatin affects the localization of HIF1A protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Fluorouracil affects the localization of HIF1A protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of HIF1A mRNA]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]
CTD PMID:10866824 PMID:11641398 PMID:11886167 PMID:13679210 PMID:16530163 More... NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hk2 hexokinase 2 increases expression
multiple interactions
ISO
EXP
Acetylcysteine results in increased expression of HK2 mRNA
Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of HK2 protein]]
CTD PMID:16084531 PMID:36762617 NCBI chr 6:82,702,004...82,751,437
Ensembl chr 6:82,702,006...82,751,435
JBrowse link
G Hmbs hydroxymethylbilane synthase multiple interactions ISO Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of HMBS mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA] CTD PMID:10656287 NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMGA2 protein] CTD PMID:27071802 NCBI chr10:120,197,173...120,312,374
Ensembl chr10:120,197,180...120,312,374
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HMGB1 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of HMGB1 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein] CTD PMID:26079697 PMID:30977640 PMID:36055550 NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
JBrowse link
G Hmgb2 high mobility group box 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA CTD PMID:22129741 NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase multiple interactions ISO Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA] CTD PMID:19931295 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
affects activity
EXP
ISO
Acetylcysteine results in increased expression of HMOX1 protein
[Acetylcysteine results in increased abundance of Glutathione] inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of HMOX1 protein]; Acetylcysteine affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-butenal results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-xylene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[[[15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and results in increased activity of HMOX1 protein] which results in increased abundance of Iron] which results in increased abundance of Reactive Oxygen Species] which results in increased expression of MMP1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[tin protoporphyrin IX results in decreased activity of HMOX1 protein] which results in increased chemical synthesis of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [camphorquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [chloropicrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [gallium nitrate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Mercury results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [lipopolysaccharide A results in increased expression of HMOX1 protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Silicon analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Silver analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [tetrathiomolybdate analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of HMOX1 mRNA]
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of HMOX1 protein]; Acetylcysteine affects the reaction [Glucose affects the expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [oxophenylarsine results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein]
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [2,2'-dihydroxychalcone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide results in increased abundance of Peroxides] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[chromium trioxide co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Curcumin co-treated with piperine] results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid results in increased abundance of Peroxides] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [carnosol results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [chromium trioxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal results in increased expression of HMOX1]; Acetylcysteine inhibits the reaction [Hemin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HMOX1 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HMOX1 protein]]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Quercetin analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Urea results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein]; Polymyxin B inhibits the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA]]
Acetylcysteine affects the activity of HMOX1 protein
Acetylcysteine results in increased expression of HMOX1 mRNA; Acetylcysteine results in increased expression of HMOX1 protein
CTD PMID:7538129 PMID:9152014 PMID:9545559 PMID:9747510 PMID:10975858 More... NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hnf4g hepatocyte nuclear factor 4, gamma multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HNF4G mRNA CTD PMID:22129741 NCBI chr 3:3,573,090...3,724,863
Ensembl chr 3:3,573,084...3,724,860
JBrowse link
G Hras Harvey rat sarcoma virus oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA]
Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite]
CTD PMID:15945272 PMID:25199681 NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Hsbp1 heat shock factor binding protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Thioacetamide results in increased expression of HSBP1 protein] CTD PMID:17103249 NCBI chr 8:120,071,277...120,075,668
Ensembl chr 8:120,071,227...120,075,661
JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD11B2 mRNA] CTD PMID:18829485 NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
JBrowse link
G Hsd17b3 hydroxysteroid (17-beta) dehydrogenase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD17B3 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of HSD17B3 mRNA] CTD PMID:26769589 PMID:29567110 NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
JBrowse link
G Hsd17b8 hydroxysteroid 17-beta dehydrogenase 8 multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA] CTD PMID:18829485 NCBI chr17:34,245,007...34,247,029
Ensembl chr17:34,245,007...34,247,034
JBrowse link
G Hsd3b3 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD3B3 mRNA] CTD PMID:26769589 NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443
JBrowse link
G Hsf1 heat shock factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of HSF1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter affects the localization of HSF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HSF1 promoter]]; Acetylcysteine inhibits the reaction [Vehicle Emissions affects the localization of HSF1 protein] CTD PMID:10403520 PMID:17922515 PMID:30309986 NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
JBrowse link
G Hsp90b1 heat shock protein 90, beta (Grp94), member 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSP90B1 mRNA]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSP90B1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSP90B1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSP90B1 protein]
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HSP90B1 protein]
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of HSP90B1 protein]
CTD PMID:21145380 PMID:21533816 PMID:21911445 PMID:25451595 PMID:25950987 More... NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373
JBrowse link
G Hspa1a heat shock protein 1A multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1A mRNA]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of HSPA1A protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of HSPA1A mRNA]
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA1A protein]
CTD PMID:12231548 PMID:16324719 PMID:18723479 PMID:36813253 NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
JBrowse link
G Hspa1b heat shock protein 1B multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1B mRNA]
Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPA1B protein]
CTD PMID:15175009 PMID:18723479 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
JBrowse link
G Hspa5 heat shock protein 5 increases expression
multiple interactions
decreases expression
ISO
EXP
Acetylcysteine results in increased expression of HSPA5 protein
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of HSPA5 protein]
Acetylcysteine results in decreased expression of HSPA5 protein
4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [discretamine results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Ethylmercury Compounds affects the expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Ursolic Acid results in increased expression of HSPA5 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein]
CTD PMID:19722195 PMID:20493918 PMID:21145380 PMID:21198628 PMID:21533816 More... NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Hspb1 heat shock protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPB1 protein] CTD PMID:15175009 NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
JBrowse link
G Hspd1 heat shock protein 1 (chaperonin) multiple interactions ISO Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of HSPD1 mRNA]; Acetylcysteine inhibits the reaction [Chlorine results in increased expression of HSPD1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of HSPD1 mRNA] CTD PMID:32092105 PMID:35065218 NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 decreases expression ISO Acetylcysteine results in decreased expression of HTATIP2 mRNA CTD PMID:16084531 NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723
JBrowse link
G Icam1 intercellular adhesion molecule 1 affects expression
multiple interactions
decreases expression
ISO
EXP
Acetylcysteine affects the expression of ICAM1
Acetylcysteine affects the reaction [Dinitrochlorobenzene affects the expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Tin Fluorides results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein]
Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of ICAM1 mRNA]
Acetylcysteine results in decreased expression of ICAM1 mRNA
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of ICAM1 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased secretion of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]
CTD PMID:10495789 PMID:10792388 PMID:11736926 PMID:17416599 PMID:17666914 More... NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Id2 inhibitor of DNA binding 2 decreases expression ISO Acetylcysteine results in decreased expression of ID2 mRNA CTD PMID:16084531 NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
JBrowse link
G Idh2 isocitrate dehydrogenase 2 (NADP+), mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein] CTD PMID:30104959 NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
JBrowse link
G Ier3 immediate early response 3 multiple interactions
affects response to substance
EXP Acetylcysteine affects the reaction [IER3 protein affects the expression of GNAI2 mRNA]
IER3 protein affects the susceptibility to Acetylcysteine
CTD PMID:20713914 NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
JBrowse link
G Ier5 immediate early response 5 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of IER5 mRNA] CTD PMID:18723479 NCBI chr 1:154,972,113...154,975,382
Ensembl chr 1:154,972,107...154,975,382
JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Dieldrin inhibits the reaction [Poly I-C results in increased expression of IFIT2 mRNA]] CTD PMID:34051100 NCBI chr19:34,527,961...34,553,934
Ensembl chr19:34,528,094...34,553,819
JBrowse link
G Ifng interferon gamma multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IFNG protein]; Acetylcysteine inhibits the reaction [Eosine I Bluish results in increased expression of IFNG mRNA]; Acetylcysteine inhibits the reaction [Formaldehyde results in decreased expression of IFNG mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IFNG protein]
Acetylcysteine inhibits the reaction [Malathion results in increased expression of IFNG mRNA]
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IFNG protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]
CTD PMID:12847270 PMID:15004186 PMID:18849615 PMID:20431929 PMID:22440610 More... NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of IFRD1 mRNA] CTD PMID:18723479 NCBI chr12:40,253,128...40,273,184
Ensembl chr12:40,251,566...40,298,503
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of IRS1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGF1 protein] CTD PMID:17458902 PMID:26138014 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G Igf1r insulin-like growth factor I receptor multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of IGF1R protein] CTD PMID:21195169 NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein]
CTD PMID:22129741 PMID:26138014 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] CTD PMID:26138014 NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of IGFBP4 protein] CTD PMID:26138014 NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218
JBrowse link
G Ikbkb inhibitor of kappaB kinase beta decreases activity
multiple interactions
ISO
EXP
Acetylcysteine results in decreased activity of IKBKB protein
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IKBKB mRNA]
Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of IKBKB protein]
CTD PMID:17395010 PMID:34310962 PMID:37458150 NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
JBrowse link
G Il10 interleukin 10 multiple interactions EXP
ISO
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL10 protein]
Acetylcysteine inhibits the reaction [Methotrexate results in decreased secretion of IL10 protein]; Acetylcysteine promotes the reaction [Doxorubicin results in increased expression of IL10 mRNA]
CTD PMID:11124598 PMID:20431929 PMID:20885979 PMID:21237301 PMID:21424515 More... NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il10rb interleukin 10 receptor, beta decreases expression ISO Acetylcysteine results in decreased expression of IL10RB mRNA CTD PMID:16084531 NCBI chr16:91,203,166...91,222,718
Ensembl chr16:91,203,052...91,222,722
JBrowse link
G Il12a interleukin 12a multiple interactions EXP Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] CTD PMID:21237301 NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
JBrowse link
G Il12b interleukin 12b multiple interactions EXP Acetylcysteine inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] CTD PMID:21237301 NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
JBrowse link
G Il13 interleukin 13 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL13 protein] CTD PMID:26138014 NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
JBrowse link
G Il15 interleukin 15 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL15 protein] CTD PMID:26138014 NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
JBrowse link
G Il16 interleukin 16 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL16 protein] CTD PMID:26138014 NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
JBrowse link
G Il17a interleukin 17A multiple interactions EXP Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL17A protein]; Acetylcysteine inhibits the reaction [Trichloroethylene results in increased expression of IL17A mRNA] CTD PMID:20431929 PMID:23993974 NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
JBrowse link
G Il17d interleukin 17D multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IL17D mRNA CTD PMID:22129741 NCBI chr14:57,762,197...57,780,623
Ensembl chr14:57,762,234...57,780,623
JBrowse link
G Il18 interleukin 18 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL18 protein]
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL18 protein]
Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL18 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL18 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased secretion of IL18 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL18 protein]]
CTD PMID:27311643 PMID:30205151 PMID:34510229 PMID:34791735 PMID:35020164 More... NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO [Acetylcysteine co-treated with IL1A protein] results in increased expression of SOD2 protein; Acetylcysteine inhibits the reaction [butylphen results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL1A mRNA]; Acetylcysteine promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]] CTD PMID:7476933 PMID:24570342 PMID:26138014 PMID:28836394 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
decreases expression
affects expression
ISO
EXP
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of IL1B protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B protein]
Acetylcysteine results in increased expression of IL1B protein
[Acetylcysteine co-treated with Cobalt] results in decreased expression of IL1B protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein modified form]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [2,4-decadienal results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cobalt results in increased expression of IL1B protein modified form]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; Acetylcysteine inhibits the reaction [IL1B protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]; Acetylcysteine inhibits the reaction [TNF protein results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [xanthohumol results in increased expression of IL1B protein]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; Acetylcysteine promotes the reaction [titanium dioxide results in increased secretion of IL1B protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of IL1B protein]
Acetylcysteine results in decreased expression of IL1B mRNA
Acetylcysteine affects the expression of IL1B protein
CTD PMID:10541287 PMID:11970852 PMID:16014734 PMID:16214328 PMID:18257742 More... NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of IL2 mRNA; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of IL2 protein]
Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of IL2 protein]
CTD PMID:22429591 PMID:22910795 PMID:31173782 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Il22b interleukin 22B multiple interactions EXP IL22 protein promotes the reaction [Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of GPT protein]] CTD PMID:23375450 NCBI chr10:118,125,534...118,130,943
Ensembl chr10:118,125,534...118,130,943
JBrowse link
G Il24 interleukin 24 decreases activity ISO Acetylcysteine results in decreased activity of IL24 protein CTD PMID:14678967 NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
JBrowse link
G Il27ra interleukin 27 receptor, alpha decreases expression ISO Acetylcysteine results in decreased expression of IL27RA mRNA CTD PMID:16084531 NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
JBrowse link
G Il2ra interleukin 2 receptor, alpha chain multiple interactions EXP Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RA protein]] CTD PMID:23134680 NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
JBrowse link
G Il3 interleukin 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL3 protein] CTD PMID:26138014 NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
JBrowse link
G Il33 interleukin 33 multiple interactions ISO Acetylcysteine promotes the reaction [Soot results in increased expression of IL33 mRNA] CTD PMID:35776887 NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
JBrowse link
G Il4 interleukin 4 multiple interactions ISO Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL4 protein] CTD PMID:26138014 PMID:27634759 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il4ra interleukin 4 receptor, alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL4R mRNA] CTD PMID:29753051 NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
JBrowse link
G Il5 interleukin 5 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL5 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL5 protein]
CTD PMID:20431929 PMID:26138014 NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
ISO
EXP
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of IL6 protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of IL6 protein]
Acetylcysteine results in decreased expression of IL6 mRNA
[Acetylcysteine co-treated with Ascorbic Acid] inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [calcium silicate results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL6 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL6 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]
CTD PMID:9378980 PMID:10022265 PMID:11970852 PMID:16757516 PMID:17922515 More... NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Il7r interleukin 7 receptor multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of IL7R mRNA alternative form]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]] CTD PMID:35303175 NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
JBrowse link
G Ins1 insulin I multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Acetylcysteine inhibits the reaction [tributyltin results in increased secretion of INS1 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Fructose results in increased expression of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]
CTD PMID:15680273 PMID:16918248 PMID:20006636 PMID:21145380 PMID:23405080 More... NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
JBrowse link
G Ins2 insulin II multiple interactions ISO Acetylcysteine inhibits the reaction [Glucose results in increased expression of INS protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]]
Acetylcysteine inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]]
CTD PMID:16505238 PMID:21888768 PMID:28180948 NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
JBrowse link
G Insig1 insulin induced gene 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA CTD PMID:22129741 NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
JBrowse link
G Insr insulin receptor multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of INSR protein]
Acetylcysteine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of INSR protein]
CTD PMID:18569013 PMID:22917016 NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
JBrowse link
G Ireb2 iron responsive element binding protein 2 multiple interactions EXP Acetylcysteine inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] CTD PMID:18073202 NCBI chr 9:54,769,942...54,819,812
Ensembl chr 9:54,771,073...54,819,814
JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein]
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA
CTD PMID:20525893 PMID:22129741 NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of IRS1 protein] CTD PMID:17458902 NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA CTD PMID:22129741 NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
JBrowse link
G Itga2 integrin alpha 2 multiple interactions ISO Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ITGA2 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of ITGA2 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ITGA2 mRNA] CTD PMID:21635667 NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636
JBrowse link
G Itga2b integrin alpha 2b multiple interactions ISO Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGA2B protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGA2B protein] CTD PMID:20523355 NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
JBrowse link
G Itgam integrin alpha M multiple interactions ISO Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]] CTD PMID:29945211 NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
JBrowse link
G Itgav integrin alpha V decreases expression ISO Acetylcysteine results in decreased expression of ITGAV mRNA CTD PMID:16084531 NCBI chr 2:83,554,796...83,637,261
Ensembl chr 2:83,554,741...83,637,260
JBrowse link
G Itgb1 integrin beta 1 (fibronectin receptor beta) multiple interactions ISO Acetylcysteine inhibits the reaction [DDT results in increased expression of ITGB1 mRNA] CTD PMID:24820114 NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
JBrowse link
G Itgb3 integrin beta 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB3 protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGB3 protein] CTD PMID:20523355 NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
JBrowse link
G Jag1 jagged 1 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of JAG1 mRNA
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of JAG1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of JAG1 mRNA]
CTD PMID:16084531 PMID:20974985 NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
JBrowse link
G Jak1 Janus kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of JAK1 protein] CTD PMID:24820114 NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
JBrowse link
G Jak2 Janus kinase 2 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]
N-acetyl-L-cysteine inhibits the reaction [hispidulin decreases phoshphorylation of JAK2 protein in colon and colorectum]
N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid decreases phosphorylation of JAK2 protein in stomach]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of JAK2 protein in the stomach)
Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of JAK2 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of JAK2 protein]
CTD
RGD
PMID:12847270 PMID:29894800 PMID:34627931 PMID:29575334 PMID:32106377 More... RGD:149735333, RGD:127284886, RGD:127284846 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
JBrowse link
G Jun jun proto-oncogene decreases activity
multiple interactions
ISO
EXP
Acetylcysteine results in decreased activity of JUN protein
Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of and results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with Disulfiram] results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [afimoxifene results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of JUN]; Acetylcysteine inhibits the reaction [darinaparsin results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [Niclosamide results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Morphine results in increased phosphorylation of and results in increased activity of JUN protein]; Acetylcysteine inhibits the reaction [Niclosamide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of JUN protein]
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased localization of and results in increased activity of JUN protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Chromium results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Oxidopamine promotes the reaction [MAPK8 protein binds to and results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]; Acetylcysteine inhibits the reaction [zinc chloride results in increased expression of JUN mRNA]
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of and results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of JUN mRNA]; Acetylcysteine promotes the reaction [bis(maltolato)oxovanadium(IV) results in decreased activity of [FOS protein binds to JUN protein]]
CTD PMID:7743507 PMID:8797811 PMID:8825185 PMID:8853906 PMID:9043100 More... NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Junb jun B proto-oncogene multiple interactions EXP Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUNB mRNA] CTD PMID:15520183 NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
JBrowse link
G Kcnh5 potassium voltage-gated channel, subfamily H (eag-related), member 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNH5 mRNA CTD PMID:22129741 NCBI chr12:74,943,991...75,224,625
Ensembl chr12:74,943,994...75,224,106
JBrowse link
G Kcnq5 potassium voltage-gated channel, subfamily Q, member 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNQ5 mRNA
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of KCNQ5 mRNA]
CTD PMID:22129741 PMID:31004932 NCBI chr 1:21,468,623...22,032,874
Ensembl chr 1:21,468,627...22,032,166
JBrowse link
G Kctd4 potassium channel tetramerisation domain containing 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCTD4 mRNA CTD PMID:22129741 NCBI chr14:76,192,443...76,202,657
Ensembl chr14:76,192,449...76,203,646
JBrowse link
G Kdm2a lysine (K)-specific demethylase 2A multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KDM2A protein]
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]]
CTD PMID:31551408 NCBI chr19:4,366,172...4,448,749
Ensembl chr19:4,364,447...4,448,313
JBrowse link
G Kdr kinase insert domain protein receptor increases expression ISO Acetylcysteine results in increased expression of KDR protein CTD PMID:17992120 NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
JBrowse link
G Keap1 kelch-like ECH-associated protein 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein]; Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]]
Acetylcysteine inhibits the reaction [Copper Sulfate results in decreased expression of KEAP1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in decreased expression of KEAP1 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of KEAP1 protein]
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 protein]
CTD PMID:11909699 PMID:19033392 PMID:30104959 PMID:37353053 PMID:37369159 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
JBrowse link
G Kif2c kinesin family member 2C multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of KIF2C protein] CTD PMID:28343997 NCBI chr 4:117,016,830...117,039,821
Ensembl chr 4:117,016,836...117,039,836
JBrowse link
G Kitl kit ligand multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of KITLG protein] CTD PMID:26138014 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Kl klotho multiple interactions
increases expression
EXP
ISO
Acetylcysteine inhibits the reaction [Cyclosporine results in decreased expression of KL protein]
Acetylcysteine results in increased expression of KL protein
Acetylcysteine inhibits the reaction [Indican results in decreased expression of KL mRNA]; Acetylcysteine inhibits the reaction [Indican results in decreased expression of KL protein]
CTD PMID:21389697 PMID:23183129 PMID:23765110 NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
JBrowse link
G Klf4 Kruppel-like transcription factor 4 (gut) multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of KLF4 mRNA] CTD PMID:36315628 NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466
JBrowse link
G Kmt2a lysine (K)-specific methyltransferase 2A multiple interactions ISO Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KMT2A protein] CTD PMID:31551408 NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog multiple interactions ISO Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Kremen2 kringle containing transmembrane protein 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KREMEN2 mRNA CTD PMID:22129741 NCBI chr17:23,960,173...23,965,305
Ensembl chr17:23,960,171...23,964,807
JBrowse link
G Krt10 keratin 10 multiple interactions EXP Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KRT10 protein] CTD PMID:31551408 NCBI chr11:99,276,080...99,288,631
Ensembl chr11:99,276,080...99,280,190
JBrowse link
G Krt6a keratin 6A multiple interactions ISO Acetylcysteine inhibits the reaction [titanium dioxide results in decreased expression of KRT6A mRNA] CTD PMID:20932892 NCBI chr15:101,598,363...101,602,746
Ensembl chr15:101,598,345...101,602,742
JBrowse link
G Krt8 keratin 8 multiple interactions ISO Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein] CTD PMID:15939799 NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]]
Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMP1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]
CTD PMID:28347754 PMID:29307831 PMID:31319114 PMID:33462182 PMID:35550146 NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
JBrowse link
G Ldha lactate dehydrogenase A multiple interactions ISO Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased secretion of LDHA protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]
Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of LDHA mRNA]
CTD PMID:21671307 PMID:30821169 PMID:31251971 PMID:31724279 PMID:36000575 NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
JBrowse link
G Ldhb lactate dehydrogenase B multiple interactions ISO Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHB protein] CTD PMID:21671307 NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683
JBrowse link
G Lgalsl galectin like multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA CTD PMID:22129741 NCBI chr11:20,773,355...20,781,916
Ensembl chr11:20,773,576...20,781,056
JBrowse link
G Lhb luteinizing hormone beta multiple interactions
increases expression
EXP
ISO
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PGR mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of TNFAIP6 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of LHB protein]
Acetylcysteine results in increased expression of LHB protein
CTD PMID:21220312 PMID:30633982 NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
JBrowse link
G Lhx8 LIM homeobox protein 8 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LHX8 mRNA CTD PMID:22129741 NCBI chr 3:154,011,925...154,036,190
Ensembl chr 3:154,011,931...154,036,296
JBrowse link
G Lipe lipase, hormone sensitive multiple interactions EXP Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of LIPE protein] CTD PMID:30648648 NCBI chr 7:25,078,952...25,097,911
Ensembl chr 7:25,078,952...25,098,135
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of LONP1 mRNA] CTD PMID:36315628 NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887
JBrowse link
G Lpin1 lipin 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LPIN1 mRNA CTD PMID:22129741 NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
JBrowse link
G Lrrk2 leucine-rich repeat kinase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased phosphorylation of LRRK2 protein]
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of LRRK2 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of LRRK2 mRNA]
CTD PMID:34816377 PMID:34897981 NCBI chr15:91,556,994...91,700,327
Ensembl chr15:91,557,378...91,700,323
JBrowse link
G Ly9 lymphocyte antigen 9 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LY9 mRNA CTD PMID:22129741 NCBI chr 1:171,416,172...171,434,917
Ensembl chr 1:171,416,192...171,434,978
JBrowse link
G Lyplal1 lysophospholipase-like 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYPLAL1 mRNA CTD PMID:22129741 NCBI chr 1:185,819,929...185,849,507
Ensembl chr 1:185,819,928...185,849,507
JBrowse link
G Lyzl4 lysozyme-like 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYZL4 mRNA CTD PMID:22129741 NCBI chr 9:121,406,907...121,471,187
Ensembl chr 9:121,406,909...121,471,162
JBrowse link
G Madcam1 mucosal vascular addressin cell adhesion molecule 1 multiple interactions EXP Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein] CTD PMID:12388057 NCBI chr10:79,500,393...79,504,376
Ensembl chr10:79,500,393...79,504,371
JBrowse link
G Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of MALAT1 mRNA] CTD PMID:18723479 NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,852,706
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased metabolism of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B mRNA]; Acetylcysteine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [dimethyl alpha-ketoglutarate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [ovatodiolide results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Vorinostat results in increased cleavage of MAP1LC3B protein]; Acetylcysteine promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein]; Cadmium Chloride promotes the reaction [Acetylcysteine results in increased expression of MAP1LC3B protein modified form]; Cadmium Chloride promotes the reaction [Acetylcysteine results in increased expression of MAP1LC3B protein]
Acetylcysteine results in increased expression of MAP1LC3B protein; Acetylcysteine results in increased expression of MAP1LC3B protein modified form
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion affects the expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form]; Acetylcysteine inhibits the reaction [Indican results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate affects the localization of MAP1LC3B protein]
Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein]
CTD PMID:20543569 PMID:25301941 PMID:27832966 PMID:28347754 PMID:28600121 More... NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
JBrowse link
G Map2 microtubule-associated protein 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA]
Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein]
CTD PMID:28153600 PMID:28499986 NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
JBrowse link
G Map2k1 mitogen-activated protein kinase kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] CTD PMID:18703135 NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
JBrowse link
G Map2k2 mitogen-activated protein kinase kinase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K2 protein] CTD PMID:18703135 NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
JBrowse link
G Map2k3 mitogen-activated protein kinase kinase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] CTD PMID:18703135 NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637
JBrowse link
G Map2k4 mitogen-activated protein kinase kinase 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K4 protein]
N-acetyl-L-cysteine inhibits the reaction [Curcumin increases phosphorylation of MAP2K4 protein in uterine cervix]
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAP2K4 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K4 protein]
CTD
RGD
PMID:18703135 PMID:22085843 PMID:25198898 RGD:150429751 NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]]
N-acetyl-L-cysteine co-treated with Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix
Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein]
CTD
RGD
PMID:16449798 PMID:18703135 PMID:20083342 PMID:22784044 PMID:33039870 More... RGD:150429751 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 increases phosphorylation
multiple interactions
decreases phosphorylation
ISO
EXP
Acetylcysteine results in increased phosphorylation of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of and results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [dihydromyricetin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [morusin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Thiostrepton results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK1 protein; Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK1 protein
Acetylcysteine affects the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[cobaltous chloride results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of and results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [raiser results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK1 protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK1 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]]
Acetylcysteine results in decreased phosphorylation of MAPK1 protein
CTD PMID:8616849 PMID:10658192 PMID:12065697 PMID:12690112 PMID:12717738 More... NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk10 mitogen-activated protein kinase 10 multiple interactions ISO Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in increased phosphorylation of and results in increased activity of MAPK10 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with vorinostat] results in increased phosphorylation of and results in increased activity of MAPK10 protein] CTD PMID:15173093 NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200
JBrowse link
G Mapk13 mitogen-activated protein kinase 13 multiple interactions ISO Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK13 protein] CTD PMID:28087840 NCBI chr17:28,988,260...28,997,678
Ensembl chr17:28,988,271...28,999,207
JBrowse link
G Mapk14 mitogen-activated protein kinase 14 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK14 protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK14 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]]
CTD PMID:12684028 PMID:14729614 PMID:15650392 PMID:17237268 PMID:18703135 More... NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 increases phosphorylation
multiple interactions
decreases phosphorylation
ISO
EXP
Acetylcysteine results in increased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of and results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [dihydromyricetin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [morusin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Thiostrepton results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK3 protein; Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK3 protein
Acetylcysteine affects the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[cobaltous chloride results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of and results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [raiser results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK3 protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK3 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]]
Acetylcysteine results in decreased phosphorylation of MAPK3 protein
CTD PMID:8616849 PMID:12065697 PMID:12690112 PMID:12717738 PMID:14516795 More... NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
decreases phosphorylation
ISO
EXP
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of MAPK8 mRNA]
N-acetyl-L-cysteine inhibits the reaction [Curcumin increases phosphorylation of MAPK8 protein in uterine cervix]
Acetylcysteine results in decreased phosphorylation of MAPK8 protein
Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Vorinostat] results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [butein results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz metabolite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [eriocitrin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [isoliensinine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Spermine results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK8 protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK8 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Oxidopamine promotes the reaction [MAPK8 protein binds to and results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein]
CTD
RGD
PMID:10397638 PMID:11306679 PMID:12684028 PMID:12902192 PMID:14687664 More... RGD:150429751 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions
decreases phosphorylation
EXP
ISO
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK9 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of MAPK9 protein]
Acetylcysteine results in decreased phosphorylation of MAPK9 protein
Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein]
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein]
CTD PMID:14687664 PMID:18412143 PMID:19654923 PMID:19760616 PMID:21135414 More... NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
JBrowse link
G Mapkapk2 MAP kinase-activated protein kinase 2 multiple interactions EXP Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of MAPKAPK2 protein] CTD PMID:21911445 NCBI chr 1:130,981,437...131,025,580
Ensembl chr 1:130,981,437...131,025,563
JBrowse link
G Mapkapk3 mitogen-activated protein kinase-activated protein kinase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA] CTD PMID:22129741 NCBI chr 9:107,132,125...107,167,082
Ensembl chr 9:107,132,126...107,167,076
JBrowse link
G Mapt microtubule-associated protein tau multiple interactions ISO Acetylcysteine inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein]
Acetylcysteine inhibits the reaction [1,2-diacetylbenzene results in increased phosphorylation of MAPT protein]
CTD PMID:24142891 PMID:28734998 NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
JBrowse link
G Mcl1 myeloid cell leukemia sequence 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Vorinostat] results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased expression of MCL1 protein]
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MCL1 mRNA]
CTD PMID:15173093 PMID:21533816 PMID:23082001 PMID:31837377 PMID:31900833 NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
JBrowse link
G Mcm8 minichromosome maintenance 8 homologous recombination repair factor multiple interactions ISO Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein] CTD PMID:32433928 NCBI chr 2:132,658,061...132,686,117
Ensembl chr 2:132,658,061...132,686,117
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ME1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA] CTD PMID:22129741 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Mettl14 methyltransferase 14, N6-adenosine-methyltransferase subunit multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein]
Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL14 mRNA]
CTD PMID:31004932 PMID:34425375 NCBI chr 3:123,161,944...123,179,639
Ensembl chr 3:123,161,946...123,179,757
JBrowse link
G Mettl3 methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL3 mRNA]
Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL3 mRNA]
CTD PMID:31004932 PMID:34425375 NCBI chr14:52,532,298...52,548,555
Ensembl chr14:52,532,298...52,542,585
JBrowse link
G Mfn1 mitofusin 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MFN1 protein]
Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of MFN1 protein]
Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of MFN1 protein]
CTD PMID:31408635 PMID:37084995 PMID:37499777 NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
JBrowse link
G Mfn2 mitofusin 2 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [ALB protein modified form results in decreased expression of MFN2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of MFN2 protein]
Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of MFN2 protein]
Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MFN2 protein]
CTD PMID:27997345 PMID:31408635 PMID:37084995 PMID:37499777 NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions
increases expression
decreases activity
ISO Acetylcysteine results in increased expression of and results in increased activity of MGMT protein
Acetylcysteine results in increased expression of MGMT mRNA
Acetylcysteine results in decreased activity of MGMT protein
CTD PMID:16950796 NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
JBrowse link
G Mir1247 microRNA 1247 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MIR1247 mRNA] CTD PMID:25092309 NCBI chr12:110,244,482...110,244,563
Ensembl chr12:110,244,482...110,244,563
JBrowse link
G Mir144 microRNA 144 multiple interactions ISO Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of MIR144 mRNA] CTD PMID:23584289 NCBI chr11:77,963,831...77,963,896
Ensembl chr11:77,963,831...77,963,896
JBrowse link
G Mir182 microRNA 182 multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR182 mRNA] CTD PMID:29662624 NCBI chr 6:30,165,917...30,165,991
Ensembl chr 6:30,165,917...30,165,991
JBrowse link
G Mir21a microRNA 21a multiple interactions ISO Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of MIR21 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions affects the expression of MIR21 mRNA] CTD PMID:23584289 PMID:27323401 NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
JBrowse link
G Mir23b microRNA 23b multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MIR23B mRNA] CTD PMID:25092309 NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371
JBrowse link
G Mir28a microRNA 28a multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MIR28 mRNA] CTD PMID:25092309 NCBI chr16:24,646,605...24,646,690
Ensembl chr16:24,646,605...24,646,690
JBrowse link
G Mir761 microRNA 761 multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of MIR761 mRNA] CTD PMID:23867156 NCBI chr 4:108,874,852...108,874,927
Ensembl chr 4:108,874,852...108,874,927
JBrowse link
G Mitf melanogenesis associated transcription factor multiple interactions EXP Acetylcysteine inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]] CTD PMID:29486182 NCBI chr 6:97,783,966...97,998,321
Ensembl chr 6:97,784,013...97,998,310
JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 multiple interactions ISO Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MKI67 protein] CTD PMID:31518672 PMID:32745510 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
JBrowse link
G Mlc1 megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MLC1 mRNA CTD PMID:22129741 NCBI chr15:88,840,087...88,863,192
Ensembl chr15:88,840,087...88,863,210
JBrowse link
G Mlh1 mutL homolog 1 multiple interactions ISO [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased expression of MLH1 mRNA; Acetylcysteine inhibits the reaction [sodium arsenite affects the expression of MLH1 protein] CTD PMID:28690196 PMID:29854080 NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859
JBrowse link
G Mlkl mixed lineage kinase domain-like multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of MLKL protein]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of MLKL protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MLKL mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MLKL protein]]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of MLKL protein]
CTD PMID:30378427 PMID:35833596 PMID:36000575 PMID:37678662 NCBI chr 8:112,037,879...112,065,081
Ensembl chr 8:112,038,429...112,064,809
JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions ISO Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP10 protein] CTD PMID:17395008 NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions EXP Acetylcysteine inhibits the reaction [Ethanol results in increased expression of MMP12 mRNA] CTD PMID:23978445 NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499
JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP13 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP13 protein]] CTD PMID:17395008 PMID:34791735 NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
JBrowse link
G Mmp1b matrix metallopeptidase 1b (interstitial collagenase) multiple interactions ISO Acetylcysteine inhibits the reaction [[[[15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and results in increased activity of HMOX1 protein] which results in increased abundance of Iron] which results in increased abundance of Reactive Oxygen Species] which results in increased expression of MMP1 protein]; Acetylcysteine inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of MMP1 mRNA] CTD PMID:17449795 PMID:19136476 PMID:21635667 PMID:29731195 NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
decreases activity
ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP2 mRNA]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP2 protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [tomentosin results in decreased activity of MMP2 protein]
Acetylcysteine results in decreased activity of MMP2 protein
CTD PMID:15451797 PMID:15962302 PMID:16213474 PMID:21540248 PMID:21635667 More... NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp25 matrix metallopeptidase 25 multiple interactions ISO Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of MMP25 mRNA] CTD PMID:21635667 NCBI chr17:23,847,289...23,864,006
Ensembl chr17:23,847,285...23,864,251
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP3 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP3 protein]] CTD PMID:17395008 PMID:34791735 NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions ISO Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of MMP7 protein]; Acetylcysteine inhibits the reaction [Tretinoin results in increased expression of MMP7 mRNA] CTD PMID:17928719 NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases activity
ISO
EXP
Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of MMP9 mRNA]
Acetylcysteine results in decreased activity of MMP9 protein
[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [RELA protein binds to MMP9 promoter]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]
Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]
CTD PMID:15451797 PMID:15557194 PMID:15962302 PMID:16213474 PMID:16251475 More... NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Moap1 modulator of apoptosis 1 decreases expression ISO Acetylcysteine results in decreased expression of MOAP1 mRNA CTD PMID:16084531 NCBI chr12:102,706,089...102,709,920
Ensembl chr12:102,708,489...102,709,920
JBrowse link
G Mov10l1 Mov10 like RISC complex RNA helicase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA CTD PMID:22129741 NCBI chr15:88,867,094...88,939,355
Ensembl chr15:88,867,112...88,939,355
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Ethanol results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Gentamicins results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Malathion results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of MPO protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Smoke results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased activity of MPO protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased activity of MPO protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]]
Acetylcysteine inhibits the reaction [arachidonyl-2-chloroethylamide results in increased activity of MPO protein]
[MPO protein co-treated with XDH protein co-treated with Acetaldehyde] promotes the reaction [Serotonin binds to Acetylcysteine]; Acetylcysteine promotes the reaction [[MPO protein results in increased oxidation of dibromoacetonitrile] which results in increased chemical synthesis of Cyanides]; Acetylcysteine promotes the reaction [MPO protein results in increased oxidation of dibromoacetonitrile]
CTD PMID:11470263 PMID:17216608 PMID:17603938 PMID:20885979 PMID:22664789 More... NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MRAP mRNA CTD PMID:22129741 NCBI chr16:90,535,095...90,546,673
Ensembl chr16:90,535,095...90,546,673
JBrowse link
G Mrc1 mannose receptor, C type 1 multiple interactions EXP [Paraquat co-treated with Acetylcysteine] results in decreased expression of MRC1 mRNA; [Paraquat co-treated with Acetylcysteine] results in decreased expression of MRC1 protein CTD PMID:34863858 NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868
JBrowse link
G Ms4a8a membrane-spanning 4-domains, subfamily A, member 8A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MS4A8A mRNA CTD PMID:22129741 NCBI chr19:11,044,835...11,058,467
Ensembl chr19:11,044,835...11,058,466
JBrowse link
G Msgn1 mesogenin 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MSGN1 mRNA CTD PMID:22129741 NCBI chr12:11,258,383...11,258,949
Ensembl chr12:11,258,361...11,258,973
JBrowse link
G Msh2 mutS homolog 2 multiple interactions ISO Acetylcysteine affects the reaction [Cadmium Chloride results in decreased expression of MSH2 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MSH2 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite affects the expression of MSH2 protein] CTD PMID:28690196 PMID:33971260 NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141
JBrowse link
G Msh6 mutS homolog 6 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of MSH6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of MSH6 protein] CTD PMID:28690196 NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320
JBrowse link
G Msrb1 methionine sulfoxide reductase B1 multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MSRB1 mRNA] CTD PMID:36315628 NCBI chr17:24,955,567...24,961,752
Ensembl chr17:24,955,616...24,961,752
JBrowse link
G Mstn myostatin decreases expression ISO Acetylcysteine results in decreased expression of MSTN mRNA; Acetylcysteine results in decreased expression of MSTN protein CTD PMID:16968467 NCBI chr 1:53,100,799...53,107,238
Ensembl chr 1:53,100,799...53,107,238
JBrowse link
G mt-Atp6 ATP synthase 6, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP6 mRNA] CTD PMID:30104959 NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
JBrowse link
G mt-Atp8 ATP synthase 8, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of ATP8 mRNA] CTD PMID:26980303 NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mRNA] CTD PMID:26980303 PMID:30104959 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G mt-Cytb cytochrome b, mitochondrial multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CYTB mRNA]
Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of CYTB mRNA]
CTD PMID:30104959 PMID:30998386 NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
JBrowse link
G mt-Nd1 NADH dehydrogenase 1, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND1 mRNA] CTD PMID:35403558 NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
JBrowse link
G mt-Nd2 NADH dehydrogenase 2, mitochondrial multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND2 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND2 mRNA]
Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND2 mRNA]
CTD PMID:30104959 PMID:30998386 PMID:35403558 NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
JBrowse link
G mt-Nd5 NADH dehydrogenase 5, mitochondrial multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND5 mRNA]
Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND5 mRNA]
CTD PMID:30104959 PMID:30998386 NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
JBrowse link
G Mt1 metallothionein 1 multiple interactions EXP
ISO
[MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin]
Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of MT1X mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MT1X mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of MT1X mRNA]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of MT1X mRNA]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of MT1X mRNA]
CTD PMID:18723479 PMID:20054154 PMID:20600803 PMID:29408318 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
JBrowse link
G Mt2 metallothionein 2 multiple interactions
decreases expression
EXP
ISO
[MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin]
Acetylcysteine results in decreased expression of MT2A mRNA
Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT2A protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [gallium nitrate results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Nickel results in increased expression of MT2A mRNA]
CTD PMID:9545559 PMID:18586083 PMID:19097988 PMID:20600803 PMID:25724285 More... NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein]
Acetylcysteine inhibits the reaction [Paraquat results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Zearalenone results in decreased phosphorylation of MTOR protein]
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of MTOR mRNA]; Acetylcysteine inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Biological Products results in decreased expression of MTOR protein modified form]; Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased phosphorylation of MTOR protein]
CTD PMID:21195169 PMID:23000059 PMID:26804764 PMID:27106530 PMID:28025121 More... NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MTR mRNA] CTD PMID:36315628 NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
JBrowse link
G Muc5ac mucin 5, subtypes A and C, tracheobronchial/gastric multiple interactions ISO Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MUC5AC mRNA]; Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MUC5AC mRNA] CTD PMID:10640773 PMID:20709182 PMID:25177032 PMID:31622892 PMID:33421718 NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
JBrowse link
G Muc5b mucin 5, subtype B, tracheobronchial multiple interactions ISO Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in increased expression of MUC5B mRNA]; Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in increased expression of MUC5B protein] CTD PMID:31622892 NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
JBrowse link
G Muc6 mucin 6, gastric multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MUC6 mRNA CTD PMID:22129741 NCBI chr 7:141,212,404...141,241,659
Ensembl chr 7:141,213,373...141,241,641
JBrowse link
G Mx1 MX dynamin-like GTPase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Dieldrin inhibits the reaction [Poly I-C results in increased expression of MX1 mRNA]] CTD PMID:34051100 NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
JBrowse link
G Myc myelocytomatosis oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of MYC protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Cisplatin] results in decreased expression of MYC protein]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of MYC protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of MYC protein]
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYC mRNA]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of MYC mRNA]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of MYC mRNA]
CTD PMID:15945272 PMID:16497787 PMID:21600978 PMID:22129741 PMID:24355586 More... NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Mycbpap MYCBP associated protein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYCBPAP mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYCBPAP mRNA] CTD PMID:22129741 NCBI chr11:94,392,173...94,423,219
Ensembl chr11:94,392,173...94,412,568
JBrowse link
G Myd88 myeloid differentiation primary response gene 88 multiple interactions EXP
ISO
[Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein; [Particulate Matter co-treated with Acetylcysteine] results in increased secretion of MYD88 protein; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of MYD88 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MYD88 mRNA]; MYD88 protein affects the reaction [[Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein]; MYD88 protein affects the reaction [[Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein]; MYD88 protein affects the reaction [[Particulate Matter co-treated with Acetylcysteine] results in increased secretion of MYD88 protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]]
Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MYD88 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of MYD88 protein]]
CTD PMID:28495615 PMID:28555929 PMID:36055550 PMID:37369159 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
JBrowse link
G Myh3 myosin, heavy polypeptide 3, skeletal muscle, embryonic multiple interactions EXP Acetylcysteine inhibits the reaction [Indican results in decreased expression of MYH3 protein] CTD PMID:29380555 NCBI chr11:66,969,101...66,993,117
Ensembl chr11:66,969,126...66,993,112
JBrowse link
G Myog myogenin multiple interactions ISO
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYOG mRNA
Acetylcysteine inhibits the reaction [Indican results in decreased expression of MYOG protein]
CTD PMID:22129741 PMID:29380555 NCBI chr 1:134,217,742...134,220,286
Ensembl chr 1:134,217,727...134,220,286
JBrowse link
G Nanog Nanog homeobox multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NANOG protein] CTD PMID:32745510 NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592
JBrowse link
G Nbn nibrin multiple interactions ISO Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]] CTD PMID:15489221 NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589
JBrowse link
G Ncam2 neural cell adhesion molecule 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA CTD PMID:22129741 NCBI chr16:80,997,501...81,425,549
Ensembl chr16:80,997,585...81,423,716
JBrowse link
G Ncf1 neutrophil cytosolic factor 1 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of NCF1 protein
Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [alpha-hexachlorocyclohexane results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of NCF1 mRNA]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF1 protein]
CTD PMID:21195169 PMID:28273962 PMID:29087013 NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
JBrowse link
G Ncf2 neutrophil cytosolic factor 2 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of NCF2 protein
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF2 protein]
CTD PMID:21195169 NCBI chr 1:152,675,904...152,712,743
Ensembl chr 1:152,675,945...152,712,742
JBrowse link
G Ncf4 neutrophil cytosolic factor 4 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]
Acetylcysteine results in decreased expression of NCF4 protein
CTD PMID:21195169 NCBI chr15:78,128,324...78,146,782
Ensembl chr15:78,129,001...78,146,780
JBrowse link
G Ncoa4 nuclear receptor coactivator 4 multiple interactions ISO Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of NCOA4 protein] CTD PMID:32687844 NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812
JBrowse link
G Ndufb6 NADH:ubiquinone oxidoreductase subunit B6 multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [Galactosamine results in decreased expression of NDUFB6 mRNA]
Acetylcysteine results in increased expression of NDUFB6 protein
CTD PMID:19523936 NCBI chr 4:40,270,591...40,279,421
Ensembl chr 4:40,270,591...40,279,421
JBrowse link
G Ndufs7 NADH:ubiquinone oxidoreductase core subunit S7 increases expression ISO Acetylcysteine results in increased expression of NDUFS7 protein CTD PMID:19523936 NCBI chr10:80,084,939...80,092,628
Ensembl chr10:80,084,955...80,092,628
JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 decreases expression ISO Acetylcysteine results in decreased expression of NEDD9 mRNA CTD PMID:16084531 NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
JBrowse link
G Nefh neurofilament, heavy polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of NEFH protein] CTD PMID:26079211 NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
JBrowse link
G Nefl neurofilament, light polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
JBrowse link
G Nek4 NIMA (never in mitosis gene a)-related expressed kinase 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA CTD PMID:22129741 NCBI chr14:30,673,334...30,710,778
Ensembl chr14:30,673,334...30,710,778
JBrowse link
G Nfatc1 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 multiple interactions EXP Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]]; Acetylcysteine affects the reaction [sodium arsenite affects the expression of NFATC1 protein] CTD PMID:30742845 NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
JBrowse link
G Nfatc3 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic affects the localization of NFATC3 protein] CTD PMID:31822296 NCBI chr 8:106,785,450...106,857,169
Ensembl chr 8:106,785,472...106,857,169
JBrowse link
G Nfe2 nuclear factor, erythroid derived 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of NFE2 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA] CTD PMID:10656287 NCBI chr15:103,156,640...103,166,809
Ensembl chr15:103,156,639...103,166,830
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions
decreases expression
increases expression
affects localization
EXP
ISO
[6-formylindolo(3,2-b)carbazole co-treated with Acetylcysteine] results in decreased expression of NFE2L2 mRNA; [Acetylcysteine co-treated with Particulate Matter] results in decreased expression of NFE2L2 mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NFE2L2 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NFE2L2 protein]]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter analog affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog affects the localization of NFE2L2 protein]
Acetylcysteine results in decreased expression of NFE2L2 mRNA
Acetylcysteine results in increased expression of NFE2L2 mRNA; Acetylcysteine results in increased expression of NFE2L2 protein
Acetylcysteine affects the localization of NFE2L2 protein
Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [dimethoxyethyl phthalate results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of NFE2L2 promoter]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]]; Acetylcysteine inhibits the reaction [Indomethacin results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [NFE2L2 protein affects the susceptibility to Silver]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Silver analog results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HSF1 promoter]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to NQO1 promoter]]; Acetylcysteine inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased phosphorylation of and results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein]
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein]; [Particulate Matter co-treated with Acetylcysteine] results in increased expression of NFE2L2 protein; Acetylcysteine affects the reaction [yttrium chloride affects the expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [aureusidin affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [triptolide affects the expression of NFE2L2 protein]; Acetylcysteine promotes the reaction [Acrylamide results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]; Sodium Fluoride promotes the reaction [Acetylcysteine affects the localization of NFE2L2 protein]
CTD PMID:11909699 PMID:15322212 PMID:16631525 PMID:16806455 PMID:16959797 More... NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfil3 nuclear factor, interleukin 3, regulated multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NFIL3 mRNA CTD PMID:22129741 NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109
JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of NFKB1 protein]]
Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA]
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of NFKB1 protein]; Acetylcysteine inhibits the reaction [phosphoaspirin results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [Sulindac analog results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency affects the localization of NFKB1 protein]
CTD PMID:11970852 PMID:18922898 PMID:19642688 PMID:21600978 PMID:21741372 More... NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
JBrowse link
G Nfkb2 nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 multiple interactions EXP Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFKB2 protein]] CTD PMID:19642688 NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions
affects expression
decreases degradation
EXP
ISO
Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein]
Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased degradation of NFKBIA protein]; Acetylcysteine inhibits the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of NFKBIA protein]
Acetylcysteine affects the expression of NFKBIA protein
Acetylcysteine results in decreased degradation of NFKBIA protein
Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [piperlongumine analog inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]]; NFKBIA protein affects the reaction [Acetylcysteine results in decreased susceptibility to hydroxyethyl methacrylate]
CTD PMID:10636889 PMID:10921504 PMID:15949477 PMID:16214328 PMID:18404532 More... NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nfkbib nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta multiple interactions ISO Acetylcysteine inhibits the reaction [oenothein B results in decreased phosphorylation of NFKBIB protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased phosphorylation of NFKBIB protein] CTD PMID:10381628 PMID:30452899 NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
JBrowse link
G Ngf nerve growth factor multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [NGF protein results in increased localization of and results in increased activity of PRKCE protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK3 protein]
Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of NGF mRNA]
CTD PMID:16603213 PMID:18375950 PMID:23472850 NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
JBrowse link
G Nlgn3 neuroligin 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NLGN3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NLGN3 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased methylation of NLGN3 promoter] CTD PMID:27624276 NCBI chr  X:100,342,785...100,364,956
Ensembl chr  X:100,342,774...100,369,569
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of NLRP3 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of and results in decreased ubiquitination of NLRP3 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]]
Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA]
Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NLRP3 protein]
Acetylcysteine results in increased expression of NLRP3 mRNA; Acetylcysteine results in increased expression of NLRP3 protein
CTD PMID:24885895 PMID:26086368 PMID:26435000 PMID:26901245 PMID:28004443 More... NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [mancozeb results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [orazipone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of NOS2 protein]
Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 protein]
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [[ferric ammonium citrate co-treated with Buthionine Sulfoximine] results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of NOS2 mRNA]
CTD PMID:7532384 PMID:9826428 PMID:9918918 PMID:16140881 PMID:18039960 More... NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS3 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]]
Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [alpha-hexachlorocyclohexane results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [TNF results in decreased expression of NOS3 protein]
Acetylcysteine results in increased expression of NOS3 protein
CTD PMID:16140881 PMID:17026986 PMID:17321519 PMID:19837105 PMID:21912612 More... NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of NOX1 mRNA] CTD PMID:16213474 NCBI chr  X:132,987,170...133,038,455
Ensembl chr  X:132,987,170...133,122,705
JBrowse link
G Nox4 NADPH oxidase 4 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [mancozeb results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of AIF1 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of CS protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of HK2 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of PKM protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [salubrinal results in increased expression of [Cisplatin results in increased expression of NOX4 protein]]
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NOX4 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NOX4 protein]
CTD PMID:21131394 PMID:21616140 PMID:24224404 PMID:30037311 PMID:36762617 NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
JBrowse link
G Npas2 neuronal PAS domain protein 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPAS2 mRNA CTD PMID:22129741 NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317
JBrowse link
G Npff neuropeptide FF-amide peptide precursor multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPFF mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NPFF mRNA] CTD PMID:22129741 NCBI chr15:102,432,274...102,433,056
Ensembl chr15:102,432,274...102,433,377
JBrowse link
G Npm1 nucleophosmin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to arsenic trioxide]; Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Bortezomib] CTD PMID:23877794 NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions
increases expression
ISO
EXP
[Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Aspirin analog results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [NQO1 protein results in increased susceptibility to 9,10-phenanthrenequinone]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to NQO1 promoter]]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NQO1 mRNA]; NQO1 protein promotes the reaction [Acetylcysteine results in decreased susceptibility to 9,10-phenanthrenequinone]
Acetylcysteine results in increased expression of NQO1 mRNA; Acetylcysteine results in increased expression of NQO1 protein
[Acetylcysteine co-treated with Sodium Fluoride] results in increased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 protein]; Acetylcysteine promotes the reaction [Sodium Fluoride results in increased expression of NQO1 protein]
[Acetylcysteine co-treated with chromium trioxide] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NQO1 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NQO1 protein]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of NQO1 mRNA]; Acetylcysteine promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 protein]
CTD PMID:12730081 PMID:15044633 PMID:16274885 PMID:16920990 PMID:19033392 More... NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr2e3 nuclear receptor subfamily 2, group E, member 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of NR2E3 protein] CTD PMID:26149760 NCBI chr 9:59,850,054...59,868,117
Ensembl chr 9:59,850,054...59,867,942
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of NR3C1 mRNA
Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of NR3C1 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of NR3C1 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of NR3C1 mRNA]
CTD PMID:16084531 PMID:25617244 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions ISO Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of NR3C2 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of NR3C2 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of NR3C2 mRNA] CTD PMID:25617244 NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
JBrowse link
G Nrf1 nuclear respiratory factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA] CTD PMID:21775390 PMID:26980303 PMID:35403558 PMID:36493885 NCBI chr 6:30,047,984...30,153,462
Ensembl chr 6:30,047,987...30,153,457
JBrowse link
G Nrxn1 neurexin I multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NRXN1 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased methylation of NRXN1 promoter] CTD PMID:27624276 NCBI chr17:90,341,072...91,400,587
Ensembl chr17:90,341,059...91,400,499
JBrowse link
G Ntf3 neurotrophin 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NTF3 protein] CTD PMID:26138014 NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
JBrowse link
G Nthl1 nth (endonuclease III)-like 1 (E.coli) multiple interactions EXP Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of NTHL1 mRNA] CTD PMID:16137721 NCBI chr17:24,851,656...24,857,812
Ensembl chr17:24,851,654...24,857,811
JBrowse link
G Ntrk1 neurotrophic tyrosine kinase, receptor, type 1 multiple interactions EXP Acetylcysteine inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of NTRK1 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased phosphorylation of and results in increased activity of NTRK1 protein] CTD PMID:23472850 NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
JBrowse link
G Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 multiple interactions EXP Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein] CTD PMID:28499986 NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
JBrowse link
G Nuak2 NUAK family, SNF1-like kinase, 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA CTD PMID:22129741 NCBI chr 1:132,243,827...132,261,233
Ensembl chr 1:132,243,864...132,261,226
JBrowse link
G Nupr1 nuclear protein transcription regulator 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUPR1 mRNA
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUPR1 mRNA]
CTD PMID:22129741 PMID:31319114 NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033
JBrowse link
G Ocln occludin multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of OCLN protein]
Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of OCLN protein]
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OCLN mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of OCLN mRNA]
CTD PMID:29235125 PMID:32683294 PMID:32687961 PMID:33485121 PMID:34906888 More... NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
JBrowse link
G Oga O-GlcNAcase decreases expression ISO Acetylcysteine results in decreased expression of OGA mRNA CTD PMID:16084531 NCBI chr19:45,738,698...45,772,274
Ensembl chr19:45,738,698...45,772,276
JBrowse link
G Olr1 oxidized low density lipoprotein (lectin-like) receptor 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of OLR1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of OLR1 protein]
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein]
CTD PMID:16055083 PMID:24145059 NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
JBrowse link
G Omg oligodendrocyte myelin glycoprotein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OMG mRNA CTD PMID:22129741 NCBI chr11:79,391,808...79,394,908
Ensembl chr11:79,391,808...79,394,910
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions ISO Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form]; Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased ubiquitination of OPA1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein]
Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of OPA1 protein]
CTD PMID:20678484 PMID:37084995 PMID:37499777 NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
JBrowse link
G Or2ak6 olfactory receptor family 2 subfamily AK member 6 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR2AK6 mRNA CTD PMID:22129741 NCBI chr11:58,592,529...58,593,449
Ensembl chr11:58,589,988...58,594,298
JBrowse link
G Or4f4b olfactory receptor family 4 subfamily F member 4B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4F4B mRNA CTD PMID:22129741 NCBI chr 2:111,313,777...111,314,673
Ensembl chr 2:111,311,164...111,314,960
JBrowse link
G Or4s2b olfactory receptor family 4 subfamily S member 2B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4S2 mRNA CTD PMID:22129741 NCBI chr 2:88,508,201...88,509,157
Ensembl chr 2:88,505,972...88,511,487
JBrowse link
G Or51e2 olfactory receptor family 51 subfamily E member 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR59 mRNA CTD PMID:22129741 NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
JBrowse link
G Or51i2 olfactory receptor family 51 subfamily I member 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR51I2 mRNA CTD PMID:22129741 NCBI chr 7:103,689,005...103,689,943
Ensembl chr 7:103,684,652...103,691,279
JBrowse link
G Or5as1 olfactory receptor family 5 subfamily AS member 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR5AS1 mRNA CTD PMID:22129741 NCBI chr 2:86,980,064...86,981,003
Ensembl chr 2:86,979,525...86,982,968
JBrowse link
G Ormdl3 ORM1-like 3 (S. cerevisiae) multiple interactions ISO Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ORMDL3 protein] CTD PMID:27784618 NCBI chr11:98,472,120...98,478,071
Ensembl chr11:98,472,082...98,478,194
JBrowse link
G Oser1 oxidative stress responsive serine rich 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of OSER1 mRNA] CTD PMID:18723479 NCBI chr 2:163,247,742...163,266,422
Ensembl chr 2:163,247,742...163,266,617
JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of OSGIN1 protein] CTD PMID:28807874 NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
JBrowse link
G Otoa otoancorin multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OTOA mRNA CTD PMID:22129741 NCBI chr 7:120,682,647...120,762,316
Ensembl chr 7:120,680,873...120,762,320
JBrowse link
G P2rx2 purinergic receptor P2X, ligand-gated ion channel, 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]]; Acetylcysteine inhibits the reaction [Rotenone promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]] CTD PMID:19793987 NCBI chr 5:110,487,678...110,491,186
Ensembl chr 5:110,487,678...110,491,078
JBrowse link
G P2rx5 purinergic receptor P2X, ligand-gated ion channel, 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA CTD PMID:22129741 NCBI chr11:73,029,164...73,063,509
Ensembl chr11:73,051,247...73,063,511
JBrowse link
G Pak6 p21 (RAC1) activated kinase 6 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA CTD PMID:22129741 NCBI chr 2:118,493,531...118,528,501
Ensembl chr 2:118,493,784...118,528,501
JBrowse link
G Paqr9 progestin and adipoQ receptor family member IX multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAQR9 mRNA CTD PMID:22129741 NCBI chr 9:95,441,687...95,450,075
Ensembl chr 9:95,441,710...95,450,076
JBrowse link
G Park7 Parkinson disease (autosomal recessive, early onset) 7 multiple interactions ISO Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased oxidation of PARK7 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased oxidation of PARK7 protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of PARK7 protein] CTD PMID:18377993 PMID:20851755 PMID:32540572 PMID:34897981 NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases cleavage
multiple interactions
decreases expression
EXP
ISO
Acetylcysteine results in increased cleavage of PARP1 protein
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of PARP protein in the stomach)
Acetylcysteine results in decreased expression of PARP1 protein modified form
Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Gentamicins results in increased activity of PARP1 protein]
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]; [Acetylcysteine results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] which results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of PARP1 mRNA]; Acetylcysteine inhibits the reaction [Acrylamide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [chloropicrin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [frenolicin B results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of PARP1]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Morpholines analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Oligopeptides analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Plant Extracts results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shikonin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [tomentosin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of PARP1 protein]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of PARP1 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of PARP1 protein]
CTD
RGD
PMID:11470263 PMID:14660655 PMID:14687664 PMID:15375156 PMID:15496615 More... RGD:127284846 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1, cytosolic multiple interactions ISO Acetylcysteine inhibits the reaction [Malathion results in increased expression of PCK1 mRNA] CTD PMID:25449180 NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
JBrowse link
G Pcmt1 protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Dopamine results in decreased expression of PCMT1 mRNA]; Acetylcysteine inhibits the reaction [Dopamine results in decreased expression of PCMT1 protein] CTD PMID:24631677 NCBI chr10:7,503,608...7,556,922
Ensembl chr10:7,505,137...7,556,900
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of PCNA protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of PCNA protein]
Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of PCNA protein]
CTD PMID:31551408 PMID:33485121 PMID:33797725 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Pdcd4 programmed cell death 4 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[tungsten carbide analog co-treated with Cobalt analog] results in decreased expression of PDCD4 protein]
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of PDCD4 mRNA]
CTD PMID:23758151 PMID:27323401 NCBI chr19:53,880,662...53,926,024
Ensembl chr19:53,880,662...53,918,291
JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein multiple interactions ISO Acetylcysteine inhibits the reaction [hesperetin results in decreased expression of PDCD6IP protein] CTD PMID:37487865 NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327
JBrowse link
G Pde6b phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDE6B mRNA CTD PMID:22129741 NCBI chr 5:108,536,239...108,579,609
Ensembl chr 5:108,536,257...108,580,263
JBrowse link
G Pdgfb platelet derived growth factor, B polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of HIF1A protein]]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PDGFB protein]
CTD PMID:22700867 PMID:26138014 NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
JBrowse link
G Pdgfrb platelet derived growth factor receptor, beta polypeptide multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PDGFRB mRNA]
Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA]]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB protein]]
CTD PMID:21134390 PMID:23392711 NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
JBrowse link
G Pdha1 pyruvate dehydrogenase E1 alpha 1 multiple interactions ISO Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of PDHA1 mRNA]; Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of PDHA1 protein] CTD PMID:31857147 NCBI chr  X:158,905,215...158,921,426
Ensembl chr  X:158,905,205...158,921,409
JBrowse link
G Pdk1 pyruvate dehydrogenase kinase, isoenzyme 1 multiple interactions ISO Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of PDK1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of PDK1 mRNA] CTD PMID:17171638 PMID:30821169 PMID:31251971 PMID:31724279 NCBI chr 2:71,703,398...71,734,202
Ensembl chr 2:71,703,568...71,734,202
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDK4 mRNA CTD PMID:22129741 NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
JBrowse link
G Pdlim5 PDZ and LIM domain 5 decreases expression ISO Acetylcysteine results in decreased expression of PDLIM5 mRNA CTD PMID:16084531 NCBI chr 3:141,945,346...142,101,480
Ensembl chr 3:141,945,351...142,101,454
JBrowse link
G Pex11a peroxisomal biogenesis factor 11 alpha multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PEX11A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PEX11A mRNA] CTD PMID:22129741 NCBI chr 7:79,385,705...79,392,879
Ensembl chr 7:79,385,705...79,392,879
JBrowse link
G Pgd phosphogluconate dehydrogenase increases activity ISO Acetylcysteine results in increased activity of PGD protein CTD PMID:3099627 NCBI chr 4:149,234,448...149,251,162
Ensembl chr 4:149,234,448...149,251,228
JBrowse link
G Pgr progesterone receptor multiple interactions
decreases secretion
ISO
EXP
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of PGR mRNA]
Acetylcysteine results in decreased secretion of PGR protein
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PGR mRNA]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein]
CTD PMID:18829485 PMID:21220312 PMID:30648648 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A increases expression ISO Acetylcysteine results in increased expression of PIGA mRNA CTD PMID:16084531 NCBI chr  X:163,202,814...163,216,912
Ensembl chr  X:163,202,783...163,216,912
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions ISO Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]] CTD PMID:28836394 NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
JBrowse link
G Pim1 proviral integration site 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIM1 mRNA CTD PMID:22129741 NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086
JBrowse link
G Pim2 proviral integration site 2 increases expression ISO Acetylcysteine results in increased expression of PIM2 mRNA CTD PMID:16084531 NCBI chr  X:7,744,545...7,749,671
Ensembl chr  X:7,744,501...7,749,671
JBrowse link
G Pink1 PTEN induced putative kinase 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein]
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA]
Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]
CTD PMID:25464205 PMID:29567065 PMID:34547296 PMID:34816377 PMID:37678662 More... NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
JBrowse link
G Pip prolactin induced protein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIP mRNA CTD PMID:22129741 NCBI chr 6:41,824,483...41,828,999
Ensembl chr 6:41,824,469...41,828,999
JBrowse link
G Pirb paired Ig-like receptor B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LILRB3 mRNA CTD PMID:22129741 NCBI chr 7:3,715,504...3,723,381
Ensembl chr 7:3,714,408...3,723,390
JBrowse link
G Piwil4 piwi-like RNA-mediated gene silencing 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIWIL4 mRNA CTD PMID:22129741 NCBI chr 9:14,613,072...14,651,968
Ensembl chr 9:14,607,526...14,652,036
JBrowse link
G Pkm pyruvate kinase, muscle multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of PKM protein]]; Acetylcysteine inhibits the reaction [quinone results in increased degradation of PKM protein]
Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA]; Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]; Acetylcysteine inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form]
CTD PMID:25437431 PMID:28284859 PMID:30821169 PMID:31251971 PMID:31724279 More... NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
JBrowse link
G Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) multiple interactions ISO Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA] CTD PMID:15683734 PMID:16603213 NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
JBrowse link
G Plau plasminogen activator, urokinase decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of PLAU mRNA
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of PLAU protein]
CTD PMID:15962302 PMID:16084531 NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
JBrowse link
G Plaur plasminogen activator, urokinase receptor multiple interactions ISO Acetylcysteine inhibits the reaction [Nicotine results in increased expression of PLAUR mRNA] CTD PMID:22261521 NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
JBrowse link
G Pld1 phospholipase D1 multiple interactions ISO Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] CTD PMID:17640750 NCBI chr 3:27,992,636...28,187,388
Ensembl chr 3:27,992,844...28,187,511
JBrowse link
G Pld2 phospholipase D2 multiple interactions ISO Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] CTD PMID:17640750 NCBI chr11:70,430,318...70,448,936
Ensembl chr11:70,430,890...70,448,936
JBrowse link
G Plin2 perilipin 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLIN2 mRNA CTD PMID:22129741 NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297
JBrowse link
G Plppr1 phospholipid phosphatase related 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA CTD PMID:22129741 NCBI chr 4:49,054,986...49,340,261
Ensembl chr 4:49,059,273...49,340,259
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [2-xylene results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of PMAIP1 mRNA] CTD PMID:18723479 PMID:21144877 NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
JBrowse link
G Pnpla3 patatin-like phospholipase domain containing 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of PNPLA3 mRNA] CTD PMID:21051528 NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
JBrowse link
G Pnpla5 patatin-like phospholipase domain containing 5 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNPLA5 mRNA CTD PMID:22129741 NCBI chr15:83,996,631...84,007,567
Ensembl chr15:83,996,557...84,007,376
JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNRC1 mRNA CTD PMID:22129741 NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163
JBrowse link
G Polr1c polymerase (RNA) I polypeptide C multiple interactions EXP Acetylcysteine inhibits the reaction [Paraquat results in decreased methylation of POLR1C mRNA] CTD PMID:34425375 NCBI chr17:46,554,846...46,558,971
Ensembl chr17:46,554,846...46,558,980
JBrowse link
G Pomc pro-opiomelanocortin-alpha multiple interactions EXP Acetylcysteine inhibits the reaction [POMC protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]] CTD PMID:24412703 NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
JBrowse link
G Pon1 paraoxonase 1 multiple interactions ISO Acetylcysteine affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of PON1 protein] CTD PMID:23644946 NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
JBrowse link
G Pon2 paraoxonase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [iron(II)-ascorbic acid complex results in increased expression of PON2 protein] CTD PMID:17916643 NCBI chr 6:5,264,620...5,298,408
Ensembl chr 6:5,264,147...5,298,455
JBrowse link
G Postn periostin, osteoblast specific factor decreases expression ISO Acetylcysteine results in decreased expression of POSTN mRNA CTD PMID:32947957 NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in decreased expression of POU5F1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of POU5F1 protein] CTD PMID:26206603 PMID:32745510 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma increases expression
multiple interactions
ISO
EXP
Acetylcysteine results in increased expression of PPARG mRNA; Acetylcysteine results in increased expression of PPARG protein
Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein]
Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]
Acetylcysteine inhibits the reaction [yttrium chloride results in decreased expression of PPARG protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein]
CTD PMID:16945329 PMID:17602960 PMID:22046279 PMID:23964924 PMID:27117918 More... NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Flavonoids results in increased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of PPARGC1A protein]
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mRNA]
CTD PMID:21775390 PMID:23063593 PMID:26980303 PMID:30104959 PMID:30641872 More... NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
JBrowse link
G Ppargc1b peroxisome proliferative activated receptor, gamma, coactivator 1 beta multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1B mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1B protein] CTD PMID:36493885 NCBI chr18:61,424,516...61,533,846
Ensembl chr18:61,431,207...61,533,502
JBrowse link
G Ppbp pro-platelet basic protein multiple interactions ISO Acetylcysteine promotes the reaction [Cadmium Chloride results in decreased secretion of PPBP protein] CTD PMID:26138014 NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions ISO Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA]
Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]]
CTD PMID:24291486 PMID:29109149 NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
JBrowse link
G Ppp2ca protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased methylation of and results in increased phosphorylation of PPP2CA protein] CTD PMID:18703135 NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
JBrowse link
G Ppp2r1b protein phosphatase 2, regulatory subunit A, beta multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein] CTD PMID:18703135 NCBI chr 9:50,767,946...50,810,625
Ensembl chr 9:50,756,601...50,805,529
JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP5C protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPP5C protein] CTD PMID:18703135 PMID:19038359 NCBI chr 7:16,738,575...16,761,812
Ensembl chr 7:16,738,565...16,761,849
JBrowse link
G Prdx1 peroxiredoxin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[frenolicin B results in decreased activity of PRDX1 protein] which results in increased abundance of Reactive Oxygen Species] CTD PMID:30661989 NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
JBrowse link
G Prdx3 peroxiredoxin 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Thiostrepton affects the expression of PRDX3 protein modified form] CTD PMID:22761781 NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
JBrowse link
G Prdx5 peroxiredoxin 5 multiple interactions EXP Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of PRDX5 protein]] CTD PMID:29753072 NCBI chr19:6,884,065...6,887,474
Ensembl chr19:6,884,065...6,887,474
JBrowse link
G Prh1 proline rich protein HaeIII subfamily 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRH1 mRNA CTD PMID:22129741 NCBI chr 6:132,546,805...132,549,364
Ensembl chr 6:132,546,772...132,549,904
JBrowse link
G Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunit multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of PRKAA1 mRNA]; Acetylcysteine inhibits the reaction [Quercetin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased phosphorylation of PRKAA1 protein]
CTD PMID:19293639 PMID:20083342 PMID:21195169 PMID:24386346 PMID:24535669 More... NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
JBrowse link
G Prkaa2 protein kinase, AMP-activated, alpha 2 catalytic subunit multiple interactions EXP Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of PRDX5 protein]]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]] CTD PMID:29753072 NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
JBrowse link
G Prkcd protein kinase C, delta multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of PRKCD protein]; Acetylcysteine inhibits the reaction [Ursodeoxycholic Acid results in increased localization of PRKCD protein]
Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of and results in increased phosphorylation of PRKCD protein]
Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of PRKCD protein]
CTD PMID:17171638 PMID:21362627 PMID:27658547 PMID:37308051 NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
JBrowse link
G Prkce protein kinase C, epsilon multiple interactions ISO Acetylcysteine inhibits the reaction [NGF protein results in increased localization of and results in increased activity of PRKCE protein] CTD PMID:18375950 NCBI chr17:86,472,631...86,965,347
Ensembl chr17:86,475,213...86,965,347
JBrowse link
G Prkdc protein kinase, DNA activated, catalytic polypeptide increases expression
multiple interactions
ISO Acetylcysteine results in increased expression of PRKDC protein
Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein]
CTD PMID:31715134 NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PRKN mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PRKN]; Acetylcysteine inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of PRKN mRNA]
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PRKN mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PRKN mRNA]
Acetylcysteine inhibits the reaction [quinone results in increased expression of PRKN protein]
CTD PMID:22872702 PMID:25464205 PMID:29567065 PMID:31368586 PMID:34547296 More... NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
JBrowse link
G Prl prolactin multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in decreased secretion of PRL protein] CTD PMID:27151894 NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
JBrowse link
G Prl2c2 prolactin family 2, subfamily c, member 2 multiple interactions EXP Acetylcysteine inhibits the reaction [Asbestos, Amosite results in increased expression of PRL2C2 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of PRL2C2 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased expression of PRL2C2 mRNA] CTD PMID:9006111 NCBI chr13:13,170,705...13,179,978
Ensembl chr13:13,170,710...13,179,968
JBrowse link
G Prlr prolactin receptor multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRLR mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRLR mRNA] CTD PMID:22129741 NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
JBrowse link
G Psat1 phosphoserine aminotransferase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA] CTD PMID:22129741 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Psmd1 proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 multiple interactions EXP Acetylcysteine inhibits the reaction [Paraquat results in decreased methylation of PSMD1 mRNA] CTD PMID:34425375 NCBI chr 1:85,992,341...86,067,017
Ensembl chr 1:85,992,109...86,066,873
JBrowse link
G Psme4 proteasome (prosome, macropain) activator subunit 4 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PSME4 mRNA] CTD PMID:18723479 NCBI chr11:30,721,753...30,831,150
Ensembl chr11:30,721,726...30,830,361
JBrowse link
G Pten phosphatase and tensin homolog multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of PTEN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PTEN protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased degradation of and results in decreased expression of PTEN protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased degradation of and results in decreased expression of PTEN protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [PTEN gene mutant form results in increased secretion of GPT protein]]
CTD PMID:21195169 PMID:24449419 PMID:27022031 PMID:35430258 NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression
multiple interactions
ISO
EXP
Acetylcysteine results in decreased expression of PTGS2 mRNA
Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol] results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [[Formaldehyde co-treated with eugenol, zinc oxide dental cavity lining] results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [acenaphthenequinone results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride affects the localization of PTGS2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [dentinol results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol] results in increased expression of PTGS2 mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Styrene results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of PTGS2 protein]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone]; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2]; Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein]; Acetylcysteine promotes the reaction [3-methylquercetin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]]
Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of PTGS2 protein]
CTD PMID:14687664 PMID:15576159 PMID:15934011 PMID:16024921 PMID:16084531 More... NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein] CTD PMID:17888894 NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
JBrowse link
G Ptk2b PTK2 protein tyrosine kinase 2 beta multiple interactions ISO Acetylcysteine inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein] CTD PMID:23774252 NCBI chr14:66,390,706...66,518,549
Ensembl chr14:66,390,706...66,518,501
JBrowse link
G Ptk6 PTK6 protein tyrosine kinase 6 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PTK6 mRNA CTD PMID:22129741 NCBI chr 2:180,836,917...180,845,408
Ensembl chr 2:180,835,514...180,844,582
JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]; Acetylcysteine inhibits the reaction [Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]; Acetylcysteine inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] CTD PMID:22917016 PMID:32337366 NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]]
Acetylcysteine results in increased expression of PYCARD protein
CTD PMID:26079697 PMID:26435000 PMID:30977640 PMID:34791735 PMID:36055550 More... NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
JBrowse link
G Pygl liver glycogen phosphorylase multiple interactions ISO Acetylcysteine inhibits the reaction [Malathion results in increased expression of PYGL mRNA] CTD PMID:25449180 NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
JBrowse link
G Rab24 RAB24, member RAS oncogene family multiple interactions ISO Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of RAB24 protein] CTD PMID:16137721 NCBI chr13:55,467,036...55,469,807
Ensembl chr13:55,467,556...55,469,759
JBrowse link
G Rab30 RAB30, member RAS oncogene family multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RAB30 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAB30 mRNA] CTD PMID:22129741 NCBI chr 7:92,390,845...92,493,743
Ensembl chr 7:92,390,811...92,493,743
JBrowse link
G Rab7 RAB7, member RAS oncogene family multiple interactions ISO Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] CTD PMID:28347754 NCBI chr 6:87,976,088...88,022,252
Ensembl chr 6:87,976,088...88,022,252
JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of RAC1 protein]
Acetylcysteine results in decreased expression of RAC1 protein
CTD PMID:21195169 NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
JBrowse link
G Rac2 Rac family small GTPase 2 multiple interactions EXP Acetylcysteine inhibits the reaction [Resveratrol affects the localization of RAC2 protein] CTD PMID:37482209 NCBI chr15:78,443,369...78,456,983
Ensembl chr15:78,443,367...78,456,983
JBrowse link
G Rack1 receptor for activated C kinase 1 multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of RACK1 mRNA] CTD PMID:36315628 NCBI chr11:48,691,187...48,697,068
Ensembl chr11:48,691,159...48,697,261
JBrowse link
G Rad1 RAD1 checkpoint DNA exonuclease multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD1 mRNA] CTD PMID:33971260 NCBI chr15:10,486,104...10,499,149
Ensembl chr15:10,486,104...10,499,149
JBrowse link
G Rad18 RAD18 E3 ubiquitin protein ligase multiple interactions ISO Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of RAD18 protein] CTD PMID:32433928 NCBI chr 6:112,596,812...112,673,650
Ensembl chr 6:112,596,811...112,673,647
JBrowse link
G Rad51b RAD51 paralog B multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD51B mRNA] CTD PMID:33971260 NCBI chr12:79,344,032...79,895,034
Ensembl chr12:79,344,056...79,861,464
JBrowse link
G Rad54l RAD54 like (S. cerevisiae) multiple interactions ISO Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of RAD54L mRNA] CTD PMID:35430258 NCBI chr 4:115,951,458...115,980,875
Ensembl chr 4:115,951,461...115,980,887
JBrowse link
G Rad9a RAD9 checkpoint clamp component A multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of RAD9A mRNA] CTD PMID:33971260 NCBI chr19:4,245,195...4,251,710
Ensembl chr19:4,245,195...4,251,661
JBrowse link
G Raf1 v-raf-leukemia viral oncogene 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [NSC 680410 results in decreased expression of RAF1 protein]
Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of RAF1 protein]
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of RAF1 mRNA
CTD PMID:16481037 PMID:18442981 PMID:22129741 NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions ISO Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of RB1 protein modified form]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased phosphorylation of RB1 protein]; Acetylcysteine inhibits the reaction [Levamisole results in decreased expression of RB1 protein]
Acetylcysteine inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of RB1 mRNA]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of RB1 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of RB1 mRNA]
CTD PMID:11139434 PMID:16497787 PMID:22927544 PMID:29859004 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Rel reticuloendotheliosis oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of REL protein]
Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of REL protein]
CTD PMID:11970852 PMID:23114885 NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases phosphorylation
decreases phosphorylation
increases activity
increases glutathionylation
EXP
ISO
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RELA mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [endotoxin, Escherichia coli affects the localization of and results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELA mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; Acetylcysteine promotes the reaction [Particulate Matter results in decreased phosphorylation of RELA protein]
Acetylcysteine results in increased phosphorylation of RELA protein
Acetylcysteine results in decreased phosphorylation of RELA protein
Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of and results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [RELA protein binds to MMP9 promoter]; Acetylcysteine inhibits the reaction [Smoke affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein affects the localization of RELA protein]
[Acetylcysteine co-treated with oenothein B] results in decreased phosphorylation of RELA protein; [Acetylcysteine co-treated with TNF protein] results in decreased activity of RELA protein; Acetylcysteine affects the localization of and results in increased activity of RELA protein; Acetylcysteine affects the reaction [[manganese chloride results in increased abundance of Manganese] which affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of RELA protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [acenaphthenequinone results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [APP protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Chloroquine results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [chrysin results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate affects the localization of and results in decreased activity of RELA protein]; Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased phosphorylation of RELA protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [mancozeb affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased acetylation of RELA protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of RELA protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased activity of RELA protein]
Acetylcysteine results in increased activity of RELA protein
Acetylcysteine results in increased glutathionylation of RELA protein
CTD PMID:7491977 PMID:8760145 PMID:11970852 PMID:15139008 PMID:17925309 More... NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Relb avian reticuloendotheliosis viral (v-rel) oncogene related B multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of RELB protein]
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELB protein]]
CTD PMID:11970852 PMID:19642688 NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363
JBrowse link
G Ren1 renin 1 structural multiple interactions ISO Acetylcysteine inhibits the reaction [ioxitalamic acid results in increased expression of REN protein] CTD PMID:19945959 NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
JBrowse link
G Rgs16 regulator of G-protein signaling 16 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA CTD PMID:22129741 NCBI chr 1:153,616,099...153,621,212
Ensembl chr 1:153,616,095...153,621,214
JBrowse link
G Rhobtb1 Rho-related BTB domain containing 1 decreases expression ISO Acetylcysteine results in decreased expression of RHOBTB1 mRNA CTD PMID:16084531 NCBI chr10:68,987,106...69,127,621
Ensembl chr10:68,987,264...69,127,621
JBrowse link
G Ripk1 receptor (TNFRSF)-interacting serine-threonine kinase 1 multiple interactions EXP [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK1 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK1 protein]]; Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of RIPK1 protein] CTD PMID:35777681 PMID:35833596 PMID:37678662 NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
JBrowse link
G Ripk2 receptor (TNFRSF)-interacting serine-threonine kinase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] CTD PMID:19477266 NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647
JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 multiple interactions EXP
ISO
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK3 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK3 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK3 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK3 protein]]; Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK3 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of RIPK3 protein]
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of RIPK3 protein]
CTD PMID:35777681 PMID:35833596 PMID:36000575 PMID:37678662 NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
JBrowse link
G Rnase2a ribonuclease, RNase A family, 2A (liver, eosinophil-derived neurotoxin) multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNASE2 mRNA CTD PMID:22129741 NCBI chr14:51,492,718...51,493,569
Ensembl chr14:51,492,719...51,493,569
JBrowse link
G Rnf125 ring finger protein 125 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA CTD PMID:22129741 NCBI chr18:21,077,672...21,120,416
Ensembl chr18:21,077,682...21,116,919
JBrowse link
G Rora RAR-related orphan receptor alpha multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA CTD PMID:22129741 NCBI chr 9:68,560,627...69,295,528
Ensembl chr 9:68,561,068...69,295,528
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Zearalenone results in decreased phosphorylation of RPS6KB1 protein]
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]
CTD PMID:14516795 PMID:18569013 PMID:21195169 PMID:24299490 PMID:26804764 More... NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
JBrowse link
G Rtp1 receptor transporter protein 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RTP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RTP1 mRNA] CTD PMID:22129741 NCBI chr16:23,247,883...23,252,710
Ensembl chr16:23,247,883...23,252,710
JBrowse link
G Runx2 runt related transcription factor 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of RUNX2 mRNA]
Acetylcysteine inhibits the reaction [Dexamethasone affects the expression of RUNX2 mRNA]
CTD PMID:19017541 PMID:24239970 NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
JBrowse link
G Rxra retinoid X receptor alpha multiple interactions ISO Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of RXRA mRNA] CTD PMID:18829485 NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
JBrowse link
G S100a11 S100 calcium binding protein A11 multiple interactions ISO Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] CTD PMID:25940438 NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
JBrowse link
G S100a4 S100 calcium binding protein A4 multiple interactions ISO Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of S100A4 mRNA] CTD PMID:21051528 NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352
JBrowse link
G S100a9 S100 calcium binding protein A9 (calgranulin B) multiple interactions ISO Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of S100A9 protein] CTD PMID:32924446 NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SAT1 mRNA] CTD PMID:18723479 NCBI chr  X:153,996,128...153,999,345
Ensembl chr  X:153,996,128...153,999,445
JBrowse link
G Scd1 stearoyl-Coenzyme A desaturase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SCD1 mRNA CTD PMID:22129741 NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions EXP Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of SEC31A mRNA] CTD PMID:34425375 NCBI chr 5:100,509,508...100,564,132
Ensembl chr 5:100,509,508...100,564,093
JBrowse link
G Sele selectin, endothelial cell decreases expression
multiple interactions
ISO
EXP
Acetylcysteine results in decreased expression of SELE mRNA
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of SELE protein]
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of SELE protein]]
CTD PMID:16084531 PMID:19642688 PMID:26901245 NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
JBrowse link
G Selenoi selenoprotein I multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SELENOI mRNA CTD PMID:22129741 NCBI chr 5:30,437,579...30,477,428
Ensembl chr 5:30,437,579...30,477,425
JBrowse link
G Serpinh1 serine (or cysteine) peptidase inhibitor, clade H, member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 protein] CTD PMID:13679210 NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
JBrowse link
G Sesn2 sestrin 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of SESN2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [erastin results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [Hemin results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased expression of SESN2 protein] CTD PMID:24535669 PMID:29662624 PMID:31054940 PMID:31323261 NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA CTD PMID:22129741 NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623
JBrowse link
G Sftpa1 surfactant associated protein A1 multiple interactions EXP
ISO
Acetylcysteine affects the reaction [Particulate Matter affects the expression of SFTPA1 protein]
Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPA1 protein]
CTD PMID:31449845 PMID:35689653 NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
JBrowse link
G Sftpb surfactant associated protein B multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPB protein]
Acetylcysteine results in increased expression of SFTPB protein
Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in decreased expression of SFTPB protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SFTPB protein]
CTD PMID:27208422 PMID:35689653 NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
JBrowse link
G Sftpc surfactant associated protein C increases expression
multiple interactions
EXP Acetylcysteine results in increased expression of SFTPC protein
Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in decreased expression of SFTPC protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SFTPC protein]
CTD PMID:27208422 NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
JBrowse link
G Shc1 src homology 2 domain-containing transforming protein C1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [SHC1 protein results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in increased expression of VIM protein]
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of SHC1 protein]
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased phosphorylation of SHC1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of SHC1 protein]
CTD PMID:32659284 PMID:33360347 NCBI chr 3:89,325,858...89,337,336
Ensembl chr 3:89,325,750...89,337,334
JBrowse link
G Shisa2 shisa family member 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SHISA2 mRNA CTD PMID:22129741 NCBI chr14:59,862,730...59,869,109
Ensembl chr14:59,862,757...59,869,109
JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SIRT1 protein]
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SIRT1 protein]
CTD PMID:21031461 PMID:30055241 PMID:33360347 PMID:36493885 NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
JBrowse link
G Sirt3 sirtuin 3 multiple interactions ISO Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of SIRT3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 protein]
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SIRT3 mRNA]
CTD PMID:30104959 PMID:30641872 PMID:35430258 NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
JBrowse link
G Sla2 Src-like-adaptor 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLA2 mRNA CTD PMID:22129741 NCBI chr 2:156,716,071...156,729,161
Ensembl chr 2:156,714,377...156,729,112
JBrowse link
G Slc12a1 solute carrier family 12, member 1 increases expression ISO Acetylcysteine results in increased expression of SLC12A1 protein CTD PMID:23183129 NCBI chr 2:124,994,430...125,071,922
Ensembl chr 2:124,994,425...125,071,922
JBrowse link
G Slc12a3 solute carrier family 12, member 3 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC12A3 mRNA CTD PMID:22129741 NCBI chr 8:95,055,737...95,092,850
Ensembl chr 8:95,055,829...95,092,842
JBrowse link
G Slc14a2 solute carrier family 14 (urea transporter), member 2 multiple interactions
increases expression
ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC14A2 mRNA
Acetylcysteine results in increased expression of SLC14A2 protein
CTD PMID:22129741 PMID:23183129 NCBI chr18:78,189,359...78,640,165
Ensembl chr18:78,189,363...78,640,157
JBrowse link
G Slc19a2 solute carrier family 19 (thiamine transporter), member 2 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC19A2 mRNA] CTD PMID:18723479 NCBI chr 1:164,076,615...164,092,954
Ensembl chr 1:164,076,615...164,092,954
JBrowse link
G Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 multiple interactions EXP Acetylcysteine affects the reaction [SLC1A1 protein affects the transport of Zinc]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the localization of SLC1A1 protein]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the metabolism of SLC1A1 protein] CTD PMID:18093171 PMID:22575539 NCBI chr19:28,812,535...28,891,360
Ensembl chr19:28,812,449...28,891,360
JBrowse link
G Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), member 2 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SLC1A2 protein]; Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]
Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 mRNA]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein]
CTD PMID:19717140 PMID:22895544 PMID:34310962 NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129
JBrowse link
G Slc22a17 solute carrier family 22 (organic cation transporter), member 17 multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SLC22A17 mRNA] CTD PMID:31004932 NCBI chr14:55,144,184...55,154,527
Ensembl chr14:55,143,761...55,150,589
JBrowse link
G Slc22a4 solute carrier family 22 (organic cation transporter), member 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Mercury results in decreased activity of SLC22A4 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased activity of SLC22A4 protein] CTD PMID:25490951 NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
JBrowse link
G Slc22a5 solute carrier family 22 (organic cation transporter), member 5 multiple interactions ISO Acetylcysteine affects the reaction [Methylmercury Compounds results in decreased transport of SLC22A5 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] CTD PMID:22900493 NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
JBrowse link
G Slc22a6 solute carrier family 22 (organic anion transporter), member 6 multiple interactions ISO adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Glutarates inhibits the reaction [SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine]]; Ketoglutaric Acids inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Probenecid inhibits the reaction [SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine]]; SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]; SLC22A6 protein results in increased transport of [Acetylcysteine co-treated with Mercury]; SLC22A6 protein results in increased transport of [Acetylcysteine co-treated with Methylmercury Compounds]; SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine] CTD PMID:12606766 PMID:15908511 NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 multiple interactions ISO SLC22A8 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine] CTD PMID:12606766 NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Slc24a2 solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC24A2 mRNA CTD PMID:22129741 NCBI chr 4:86,901,361...87,148,780
Ensembl chr 4:86,901,361...87,148,714
JBrowse link
G Slc25a20 solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 multiple interactions ISO Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SLC25A20 protein]
Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of SLC25A20 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased activity of SLC25A20 protein]
CTD PMID:23402788 PMID:25849418 NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
JBrowse link
G Slc25a47 solute carrier family 25, member 47 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA CTD PMID:22129741 NCBI chr12:108,815,740...108,822,741
Ensembl chr12:108,801,972...108,822,741
JBrowse link
G Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 multiple interactions ISO [Acetylcysteine co-treated with Dietary Fats] results in increased expression of SLC27A2 mRNA CTD PMID:21051528 NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
JBrowse link
G Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of SLC2A1 mRNA] CTD PMID:30821169 PMID:31251971 PMID:31724279 NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
JBrowse link
G Slc2a2 solute carrier family 2 (facilitated glucose transporter), member 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Pyruvaldehyde affects the localization of SLC2A2 protein] CTD PMID:22917016 NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
JBrowse link
G Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 multiple interactions ISO Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 mRNA]; Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 protein] CTD PMID:31857147 NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
JBrowse link
G Slc2a4 solute carrier family 2 (facilitated glucose transporter), member 4 multiple interactions EXP Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein] CTD PMID:27117918 NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
JBrowse link
G Slc30a1 solute carrier family 30 (zinc transporter), member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC30A1 mRNA] CTD PMID:18723479 NCBI chr 1:191,638,810...191,645,359
Ensembl chr 1:191,638,879...191,645,359
JBrowse link
G Slc35d2 solute carrier family 35, member D2 multiple interactions ISO Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of SLC35D2 mRNA] CTD PMID:33146789 NCBI chr13:64,244,122...64,277,195
Ensembl chr13:64,244,122...64,277,182
JBrowse link
G Slc38a2 solute carrier family 38, member 2 multiple interactions EXP Acetylcysteine inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] CTD PMID:22215663 NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
JBrowse link
G Slc39a14 solute carrier family 39 (zinc transporter), member 14 increases expression ISO Acetylcysteine results in increased expression of SLC39A14 mRNA CTD PMID:16084531 NCBI chr14:70,540,916...70,588,873
Ensembl chr14:70,540,918...70,588,874
JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 multiple interactions EXP Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SLC40A1 mRNA] CTD PMID:20090884 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
JBrowse link
G Slc4a1 solute carrier family 4 (anion exchanger), member 1 multiple interactions ISO [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite affects the localization of SLC4A1 protein] CTD PMID:20946910 NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029
JBrowse link
G Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5 multiple interactions ISO Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of SLC5A5 mRNA] CTD PMID:30352396 NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
JBrowse link
G Slc6a6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:22129741 NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 multiple interactions ISO Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC7A11 mRNA]
CTD PMID:18723479 PMID:19717140 NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
JBrowse link
G Slc7a14 solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC7A14 mRNA CTD PMID:22129741 NCBI chr 3:31,257,003...31,364,712
Ensembl chr 3:31,257,007...31,364,527
JBrowse link
G Smad1 SMAD family member 1 decreases phosphorylation ISO Acetylcysteine results in decreased phosphorylation of SMAD1 protein CTD PMID:32947957 NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147
JBrowse link
G Smad2 SMAD family member 2 multiple interactions
decreases phosphorylation
ISO Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of SMAD2 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of SMAD2 mRNA]
Acetylcysteine results in decreased phosphorylation of SMAD2 protein
CTD PMID:29408318 PMID:30317545 PMID:32947957 NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
JBrowse link
G Smad3 SMAD family member 3 multiple interactions
decreases phosphorylation
ISO [Acetylcysteine co-treated with Cadmium Chloride co-treated with sodium arsenite] results in decreased expression of SMAD3 mRNA; [Acetylcysteine co-treated with Cadmium] results in decreased expression of SMAD3 mRNA; [Acetylcysteine co-treated with Water Pollutants, Chemical] results in decreased expression of SMAD3 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of SMAD3 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
Acetylcysteine results in decreased phosphorylation of SMAD3 protein
CTD PMID:21131394 PMID:29408318 PMID:30317545 PMID:34687772 NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
JBrowse link
G Smc1a structural maintenance of chromosomes 1A multiple interactions ISO Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]]; Acetylcysteine inhibits the reaction [resveratrol results in increased phosphorylation of SMC1A protein] CTD PMID:15489221 PMID:24933654 NCBI chr  X:150,799,386...150,844,969
Ensembl chr  X:150,799,424...150,845,690
JBrowse link
G Snai1 snail family zinc finger 1 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNAI1 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of SNAI1 protein]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of SNAI1 mRNA]
Acetylcysteine results in decreased expression of SNAI1 protein
CTD PMID:17596522 PMID:21635667 PMID:28284859 PMID:32687844 PMID:34687772 NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
JBrowse link
G Snai2 snail family zinc finger 2 multiple interactions ISO Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of SNAI2 protein] CTD PMID:32687844 NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
JBrowse link
G Snca synuclein, alpha multiple interactions ISO Acetylcysteine inhibits the reaction [1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline results in increased expression of SNCA protein]
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SNCA mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of SNCA mRNA]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased expression of SNCA protein]
CTD PMID:15114628 PMID:27613482 PMID:34816377 NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
JBrowse link
G Sntg1 syntrophin, gamma 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SNTG1 mRNA CTD PMID:22129741 NCBI chr 1:8,429,963...9,371,882
Ensembl chr 1:8,431,699...9,370,103
JBrowse link
G Sod1 superoxide dismutase 1, soluble multiple interactions
decreases expression
increases activity
ISO
EXP
Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of SOD1]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD1 protein]; Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]
Acetylcysteine inhibits the reaction [Cadmium results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Lead results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of SOD1 protein]
[Acetylcysteine co-treated with Thapsigargin] results in decreased expression of SOD1 mRNA; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [perfluorooctanoic acid results in increased expression of SOD1 mRNA]
Acetylcysteine results in decreased expression of SOD1 mRNA
Acetylcysteine results in increased activity of SOD1 protein
CTD PMID:16101137 PMID:17309078 PMID:19264484 PMID:19409983 PMID:20674559 More... NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial multiple interactions
increases expression
EXP
ISO
[Acetylcysteine results in increased expression of SOD2 protein] which results in decreased abundance of Reactive Oxygen Species; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Cyclosporine results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 protein]
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased acetylation of SOD2 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased acetylation of SOD2 protein]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of SOD2 mRNA]
Acetylcysteine results in increased expression of SOD2 mRNA; Acetylcysteine results in increased expression of SOD2 protein
[Acetylcysteine co-treated with IL1A protein] results in increased expression of SOD2 protein; [Acetylcysteine co-treated with TNF protein] results in increased expression of SOD2 protein; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of SOD2 mRNA; Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein]; Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel]; Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [linsidomine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Peroxynitrous Acid results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the activity of AR protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AKR1C3 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AMACR mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR1 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD11B2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of KLK3 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of PGR mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of RXRA mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of TMPRSS2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2]; Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Acetylcysteine results in increased expression of SOD2 mRNA]
CTD PMID:7476933 PMID:8760145 PMID:9535218 PMID:9741582 PMID:11264281 More... NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Sod3 superoxide dismutase 3, extracellular multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SOD3 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of SOD3 protein] CTD PMID:21804221 PMID:34358621 NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
JBrowse link
G Sord sorbitol dehydrogenase multiple interactions EXP Acetylcysteine inhibits the reaction [Diclofenac results in increased secretion of SORD protein] CTD PMID:12763371 NCBI chr 2:122,065,320...122,095,818
Ensembl chr 2:122,065,230...122,095,821
JBrowse link
G Sox17 SRY (sex determining region Y)-box 17 multiple interactions ISO N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells] RGD PMID:32078435 RGD:329853329 NCBI chr 1:4,561,154...4,567,624
Ensembl chr 1:4,561,154...4,567,577
JBrowse link
G Sp1 trans-acting transcription factor 1 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of SP1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SP1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SP1 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of SP1 protein]
Acetylcysteine results in decreased expression of SP1 protein
CTD PMID:16928829 PMID:18556457 PMID:30851366 PMID:33360347 NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
JBrowse link
G Sphk1 sphingosine kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein] CTD PMID:21998146 NCBI chr11:116,421,662...116,427,502
Ensembl chr11:116,421,751...116,427,501
JBrowse link
G Spi1 Spi-1 proto-oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]] CTD PMID:29945211 NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
JBrowse link
G Spock2 sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SPOCK2 mRNA CTD PMID:22129741 NCBI chr10:59,942,079...59,971,020
Ensembl chr10:59,942,041...59,971,020
JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Allylamine results in increased expression of SPP1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of SPP1 protein] CTD PMID:15910882 PMID:19356721 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
increases expression
ISO
EXP
Acetylcysteine affects the reaction [sodium arsenite affects the expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [brazilin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased degradation of SQSTM1 protein]; Acetylcysteine inhibits the reaction [ovatodiolide results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [tri-o-cresyl phosphate results in increased expression of SQSTM1 protein]
Acetylcysteine results in increased expression of SQSTM1 protein
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in decreased expression of SQSTM1 protein]
Acetylcysteine inhibits the reaction [decamethrin results in increased expression of SQSTM1 protein]; Acetylcysteine promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein]
CTD PMID:22927544 PMID:25301941 PMID:26588882 PMID:27106530 PMID:28063998 More... NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
JBrowse link
G Src Rous sarcoma oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of SRC protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of SRC protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of SRC protein]
N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of SRC protein in the stomach)
CTD
RGD
PMID:21777978 PMID:29894800 PMID:31433961 PMID:29408335 RGD:127284846 NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
JBrowse link
G Srms src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SRMS mRNA CTD PMID:22129741 NCBI chr 2:180,847,356...180,854,964
Ensembl chr 2:180,847,355...180,854,978
JBrowse link
G Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) multiple interactions EXP [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [sodium arsenite results in increased expression of SRXN1 mRNA] CTD PMID:22003191 NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of STAR protein]
Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of STAR protein]
Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of STAR mRNA]
CTD PMID:25617244 PMID:26769589 PMID:29567110 PMID:30648648 PMID:36709824 NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased phosphorylation of STAT1 protein]; Acetylcysteine inhibits the reaction [Ozone results in increased phosphorylation of STAT1 protein]
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of STAT1 protein]
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]
CTD PMID:12847270 PMID:16896058 PMID:17607690 PMID:19061877 PMID:20525893 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
treatment
decreases phosphorylation
ISO
EXP
Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein modified form]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of and results in increased expression of STAT3 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of and results in increased activity of STAT3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of STAT3 protein]
N-acetyl-L-cysteine co-treated with Il-6 inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of STAT3 protein in the stomach)
Acetylcysteine results in decreased phosphorylation of STAT3 protein
Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]]
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of STAT3 mRNA]; Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of STAT3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of STAT3 protein]
CTD
RGD
PMID:16481037 PMID:16896058 PMID:17666914 PMID:19409983 PMID:21741372 More... RGD:127284846 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Sumo1 small ubiquitin-like modifier 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of SUMO1 mRNA] CTD PMID:33971260 NCBI chr 1:59,678,593...59,709,993
Ensembl chr 1:59,625,717...59,709,993
JBrowse link
G Syn1 synapsin I multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 protein] CTD PMID:27624276 PMID:28153600 NCBI chr  X:20,726,750...20,787,157
Ensembl chr  X:20,726,750...20,787,243
JBrowse link
G Syp synaptophysin multiple interactions EXP Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of SYP protein] CTD PMID:28499986 NCBI chr  X:7,504,819...7,519,495
Ensembl chr  X:7,504,710...7,519,495
JBrowse link
G Syt7 synaptotagmin VII multiple interactions ISO [Acetylcysteine co-treated with Dexamethasone] results in decreased expression of SYT7 mRNA CTD PMID:21888768 NCBI chr19:10,366,142...10,430,545
Ensembl chr19:10,366,454...10,430,544
JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 decreases binding ISO N-acetyl-cysteine inhibits binding of Traf6 protein to Tab2 in rat neonatal cardiomyocytes RGD PMID:27249171 RGD:155646134 NCBI chr10:7,781,412...7,832,039
Ensembl chr10:7,781,417...7,831,994
JBrowse link
G Taldo1 transaldolase 1 multiple interactions EXP Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of Glutathione]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of NADP]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of Nitric Oxide]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19436114 NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881
JBrowse link
G Tank TRAF family member-associated Nf-kappa B activator decreases expression ISO Acetylcysteine results in decreased expression of TANK mRNA CTD PMID:16084531 NCBI chr 2:61,408,901...61,484,515
Ensembl chr 2:61,408,929...61,484,515
JBrowse link
G Tardbp TAR DNA binding protein multiple interactions ISO Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]] CTD PMID:29109149 NCBI chr 4:148,696,839...148,711,672
Ensembl chr 4:148,696,839...148,711,476
JBrowse link
G Tas2r108 taste receptor, type 2, member 108 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TAS2R108 mRNA CTD PMID:22129741 NCBI chr 6:40,470,526...40,471,419
Ensembl chr 6:40,470,463...40,471,475
JBrowse link
G Tert telomerase reverse transcriptase multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TERT protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TERT protein]
Acetylcysteine results in increased expression of TERT protein
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased activity of TERT protein]; Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased activity of TERT protein]
CTD PMID:18336854 PMID:19409983 PMID:30851366 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
G Tet1 tet methylcytosine dioxygenase 1 multiple interactions
increases expression
ISO
EXP
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [TET1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of TET1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TET1 mRNA]
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Acetylcysteine] results in decreased expression of TET1 mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TET1 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TET1 mRNA]
Acetylcysteine results in increased expression of TET1 mRNA
CTD PMID:28153600 PMID:31551408 PMID:33188856 NCBI chr10:62,640,349...62,723,242
Ensembl chr10:62,640,349...62,744,775
JBrowse link
G Tet2 tet methylcytosine dioxygenase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of TET2 protein] CTD PMID:31900833 NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900
JBrowse link
G Tfam transcription factor A, mitochondrial multiple interactions ISO Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of TFAM mRNA]
Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [dimethoxyethyl phthalate results in decreased expression of TFAM protein]
CTD PMID:21775390 PMID:26980303 PMID:32142722 PMID:34214916 PMID:35403558 More... NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
JBrowse link
G Tfe3 transcription factor E3 multiple interactions ISO Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of TFE3 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased phosphorylation of and affects the localization of TFE3 protein] CTD PMID:29945972 PMID:32439580 NCBI chr  X:7,628,769...7,641,441
Ensembl chr  X:7,628,799...7,641,441
JBrowse link
G Tfeb transcription factor EB multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal affects the localization of TFEB protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of TFEB protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TFEB mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased phosphorylation of TFEB protein] CTD PMID:29307831 PMID:29945972 PMID:33462182 PMID:35550146 NCBI chr17:48,047,962...48,103,341
Ensembl chr17:48,047,955...48,103,344
JBrowse link
G Tfrc transferrin receptor multiple interactions EXP Acetylcysteine inhibits the reaction [Zinc deficiency results in increased expression of TFRC protein] CTD PMID:18073202 NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
JBrowse link
G Tgfa transforming growth factor alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TGFA mRNA] CTD PMID:15945272 NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
decreases expression
EXP
ISO
Acetylcysteine inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of TGFB1 mRNA]
Acetylcysteine results in decreased expression of TGFB1 mRNA; Acetylcysteine results in decreased expression of TGFB1 protein modified form
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 protein]
Acetylcysteine inhibits the reaction [4-cresol sulfate results in increased expression of and results in increased secretion of TGFB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of TGFB1 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of HGF protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased secretion of IL6 protein]
CTD PMID:16757516 PMID:21131394 PMID:21765237 PMID:23159718 PMID:23325087 More... NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased expression of TGFB1I1 mRNA] CTD PMID:27511942 NCBI chr 7:127,845,963...127,852,884
Ensembl chr 7:127,845,984...127,854,871
JBrowse link
G Tgfb3 transforming growth factor, beta 3 multiple interactions ISO [Acetylcysteine co-treated with Cadmium] results in decreased expression of TGFB3 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of TGFB3 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of TGFB3 mRNA] CTD PMID:29408318 NCBI chr12:86,103,517...86,125,815
Ensembl chr12:86,103,519...86,125,815
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor I decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of TGFBR1 mRNA; Acetylcysteine results in decreased expression of TGFBR1 protein
[Acetylcysteine co-treated with Cadmium] results in decreased expression of TGFBR1 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of TGFBR1 mRNA]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of TGFBR1 mRNA]
Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR1 protein]
CTD PMID:17602960 PMID:29408318 NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor II decreases expression
multiple interactions
ISO Acetylcysteine results in decreased expression of TGFBR2 mRNA; Acetylcysteine results in decreased expression of TGFBR2 protein
Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR2 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR2 protein]
CTD PMID:17602960 NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
JBrowse link
G Tgm1 transglutaminase 1, K polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter analog results in decreased activity of TGM1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in decreased activity of TGM1 protein] CTD PMID:15541757 NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383
JBrowse link
G Tgm2 transglutaminase 2, C polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter analog results in decreased activity of TGM2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in decreased activity of TGM2 protein] CTD PMID:15541757 NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356
JBrowse link
G Th tyrosine hydroxylase multiple interactions
decreases expression
ISO [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in decreased expression of TH protein; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of TH protein]
Acetylcysteine results in decreased expression of TH protein
CTD PMID:22714038 PMID:25891525 NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
JBrowse link
G Thbs1 thrombospondin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of TSP1 mRNA] CTD PMID:20524210 NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
JBrowse link
G Thpo thrombopoietin multiple interactions ISO Acetylcysteine inhibits the reaction [THPO protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of GP1BA protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGA2B protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGB3 protein] CTD PMID:20523355 NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 multiple interactions ISO Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP2 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 mRNA] CTD PMID:33188856 NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
JBrowse link
G Timp3 tissue inhibitor of metalloproteinase 3 multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP3 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TIMP3 mRNA]
Acetylcysteine results in increased expression of TIMP3 mRNA
CTD PMID:33188856 NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
JBrowse link
G Tjp1 tight junction protein 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of TJP1 protein]
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]
CTD PMID:26079211 PMID:27783111 PMID:29235125 PMID:32687961 PMID:33485121 More... NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
JBrowse link
G Tjp2 tight junction protein 2 multiple interactions EXP Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP2 protein] CTD PMID:27783111 NCBI chr19:24,071,860...24,202,492
Ensembl chr19:24,071,869...24,202,394
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions
decreases expression
EXP
ISO
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]]; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of TLR4 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TLR4 mRNA]
Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TLR4 protein]
Acetylcysteine results in decreased expression of TLR4 mRNA
CTD PMID:19627980 PMID:22385246 PMID:28495615 PMID:36055550 PMID:37369159 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
JBrowse link
G Tmem140 transmembrane protein 140 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TMEM140 mRNA CTD PMID:22129741 NCBI chr 6:34,840,081...34,851,881
Ensembl chr 6:34,840,081...34,851,881
JBrowse link
G Tnc tenascin C decreases expression ISO Acetylcysteine results in decreased expression of TNC mRNA CTD PMID:32947957 NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions
affects expression
ISO
EXP
Acetylcysteine results in decreased expression of TNF mRNA; Acetylcysteine results in decreased expression of TNF protein
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of TNF mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of TNF protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fungal Polysaccharides results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [iprodione inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Mimosine results in decreased activity of TNF protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]
[Acetylcysteine co-treated with TNF protein] results in decreased activity of RELA protein; [Acetylcysteine co-treated with TNF protein] results in increased expression of SOD2 protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [2,4-decadienal results in increased expression of and results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [butylphen results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Mimosine results in decreased activity of TNF protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [piperlongumine analog inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [TNF protein results in decreased abundance of Glutathione]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Superoxides]; Acetylcysteine inhibits the reaction [TNF protein results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of FN1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [TNF results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [TNF results in increased abundance of Malondialdehyde]; Acetylcysteine inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNF protein]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Acetylcysteine results in increased expression of SOD2 mRNA]
Acetylcysteine affects the expression of TNF protein
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of TNF protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Nitric Oxide deficiency results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Palmitates results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [TNF protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine promotes the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [Doxorubicin results in increased expression of TNF mRNA]
CTD PMID:7476933 PMID:7532384 PMID:8760145 PMID:9535218 PMID:9721806 More... NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfaip3 tumor necrosis factor, alpha-induced protein 3 multiple interactions EXP Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNFAIP3 mRNA] CTD PMID:16137721 NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
JBrowse link
G Tnfaip6 tumor necrosis factor alpha induced protein 6 multiple interactions EXP Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of TNFAIP6 mRNA] CTD PMID:21220312 NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
JBrowse link
G Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b multiple interactions ISO Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of TNFRSF10A protein]; Acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A mRNA]; Acetylcysteine inhibits the reaction [pendulone results in increased expression of TNFRSF10A protein]
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B mRNA]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B protein]
CTD PMID:21741372 PMID:24930757 PMID:27484784 PMID:35288263 NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
JBrowse link
G Tnfrsf13c tumor necrosis factor receptor superfamily, member 13c multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF13C mRNA CTD PMID:22129741 NCBI chr15:82,105,943...82,108,581
Ensembl chr15:82,105,944...82,108,570
JBrowse link
G Tnfrsf1a tumor necrosis factor receptor superfamily, member 1a multiple interactions ISO Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of TNFRSF1A protein]; Acetylcysteine inhibits the reaction [Mimosine results in increased cleavage of TNFRSF1A protein] CTD PMID:15550384 PMID:21741372 NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA CTD PMID:22129741 NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 decreases expression
decreases response to substance
multiple interactions
ISO Acetylcysteine results in decreased expression of TNFSF10 mRNA
Acetylcysteine results in decreased susceptibility to TNFSF10 protein
Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Nitrogen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased chemical synthesis of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of VDAC1 protein]
CTD PMID:16084531 PMID:20971099 PMID:23711929 PMID:25034532 PMID:25619640 More... NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tnfsf11 tumor necrosis factor (ligand) superfamily, member 11 multiple interactions EXP [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] CTD PMID:30742845 NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
JBrowse link
G Tnfsf4 tumor necrosis factor (ligand) superfamily, member 4 multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNFSF4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNFSF4 mRNA] CTD PMID:20974985 NCBI chr 1:161,223,009...161,245,777
Ensembl chr 1:161,222,980...161,245,981
JBrowse link
G Tnpo1 transportin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TNPO1] CTD PMID:19409983 NCBI chr13:98,975,527...99,062,851
Ensembl chr13:98,975,527...99,062,892
JBrowse link
G Tomm20 translocase of outer mitochondrial membrane 20 multiple interactions EXP Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of TOMM20 protein] CTD PMID:36739042 NCBI chr 8:127,657,414...127,672,671
Ensembl chr 8:127,657,417...127,672,594
JBrowse link
G Tor3a torsin family 3, member A multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TOR3A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TOR3A mRNA] CTD PMID:22129741 NCBI chr 1:156,481,187...156,501,909
Ensembl chr 1:156,481,187...156,501,926
JBrowse link
G Tpm1 tropomyosin 1, alpha multiple interactions ISO Acetylcysteine inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] CTD PMID:15910882 NCBI chr 9:66,929,872...66,956,954
Ensembl chr 9:66,929,872...66,956,688
JBrowse link
G Tpo thyroid peroxidase multiple interactions ISO Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TPO mRNA] CTD PMID:30352396 NCBI chr12:30,104,658...30,182,983
Ensembl chr12:30,104,658...30,182,623
JBrowse link
G Traf2 TNF receptor-associated factor 2 multiple interactions ISO Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]] CTD PMID:24394546 NCBI chr 2:25,407,994...25,436,952
Ensembl chr 2:25,407,994...25,436,952
JBrowse link
G Traf6 TNF receptor-associated factor 6 decreases binding
multiple interactions
ISO N-acetyl-cysteine inhibits binding of Traf6 protein to Tab2 in rat neonatal cardiomyocytes
N-acetyl-L-cysteine inhibits the reaction [angiotensin II increases expression of Traf6 protein in rat neonatal cardiomyocytes]
RGD PMID:27249171 PMID:27249171 RGD:155646134, RGD:155646134 NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
JBrowse link
G Trib1 tribbles pseudokinase 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA CTD PMID:22129741 NCBI chr15:59,520,503...59,528,948
Ensembl chr15:59,520,199...59,528,948
JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of TRIB3 mRNA]
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of TRIB3 mRNA]
CTD PMID:18723479 PMID:24291486 NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
JBrowse link
G Trim28 tripartite motif-containing 28 multiple interactions ISO Acetylcysteine inhibits the reaction [resveratrol results in increased phosphorylation of TRIM28 protein] CTD PMID:24933654 NCBI chr 7:12,758,079...12,764,959
Ensembl chr 7:12,733,041...12,764,962
JBrowse link
G Troap trophinin associated protein multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TROAP mRNA CTD PMID:22129741 NCBI chr15:98,972,854...98,981,290
Ensembl chr15:98,972,456...98,981,290
JBrowse link
G Trp53 transformation related protein 53 multiple interactions
increases expression
increases phosphorylation
decreases expression
decreases activity
EXP
ISO
Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased phosphorylation of TRP53 protein]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of TRP53 protein modified form]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased activity of TRP53 protein]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein]; Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein modified form]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of TRP53 protein]
Acetylcysteine results in increased expression of TP53 protein
Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [Aflatoxin B1 results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Quercetin analog results in decreased phosphorylation of TP53 protein]
Acetylcysteine results in increased phosphorylation of TP53 protein
Acetylcysteine results in decreased expression of TP53 protein
Acetylcysteine results in decreased activity of TP53 protein
[Acetylcysteine co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] results in decreased expression of TP53 protein]; Acetylcysteine affects the reaction [4-biphenylamine affects the expression of TP53 protein]; Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TP53 protein modified form]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with Arsenic Trioxide] results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form]; Acetylcysteine inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53]; Acetylcysteine inhibits the reaction [Cisplatin results in increased glutathionylation of TP53 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein]; Acetylcysteine inhibits the reaction [cyadox results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased expression of and results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Oxaliplatin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53]; Acetylcysteine inhibits the reaction [Phytochemicals results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Reactive Oxygen Species affects the localization of TP53 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TP53 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of TP53 protein]; Acetylcysteine promotes the reaction [Chlorine results in increased expression of TP53 protein modified form]
CTD PMID:9535218 PMID:10951577 PMID:11864783 PMID:14871840 PMID:15059885 More... NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trpa1 transient receptor potential cation channel, subfamily A, member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium] CTD PMID:27738742 NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
JBrowse link
G Trpc7 transient receptor potential cation channel, subfamily C, member 7 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRPC7 mRNA CTD PMID:22129741 NCBI chr13:56,920,911...57,043,778
Ensembl chr13:56,920,926...57,043,806
JBrowse link
G Tsc2 TSC complex subunit 2 multiple interactions ISO Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TSC2 protein] CTD PMID:21195169 NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
JBrowse link
G Tshb thyroid stimulating hormone, beta subunit multiple interactions EXP Acetylcysteine inhibits the reaction [TSHB protein results in increased abundance of Hydrogen Peroxide] CTD PMID:11108245 NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
JBrowse link
G Tslp thymic stromal lymphopoietin multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TSLP mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TSLP mRNA] CTD PMID:18049884 PMID:29753051 NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
JBrowse link
G Tspan6 tetraspanin 6 decreases expression ISO Acetylcysteine results in decreased expression of TSPAN6 mRNA CTD PMID:16084531 NCBI chr  X:132,791,817...132,801,957
Ensembl chr  X:132,791,817...132,799,178
JBrowse link
G Ttc7b tetratricopeptide repeat domain 7B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA CTD PMID:22129741 NCBI chr12:100,267,029...100,487,134
Ensembl chr12:100,267,029...100,487,085
JBrowse link
G Ttc9b tetratricopeptide repeat domain 9B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC9B mRNA CTD PMID:22129741 NCBI chr 7:27,353,349...27,355,632
Ensembl chr 7:27,353,340...27,356,771
JBrowse link
G Tubb3 tubulin, beta 3 class III multiple interactions ISO Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TUBB3 mRNA] CTD PMID:28153600 NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
JBrowse link
G Txn1 thioredoxin 1 multiple interactions
decreases expression
EXP
ISO
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of TXN protein]; Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]]
Acetylcysteine results in decreased expression of TXN protein
Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased oxidation of TXN1 protein]
CTD PMID:16449798 PMID:17959236 PMID:18023956 PMID:18922898 PMID:24157283 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Txn2 thioredoxin 2 multiple interactions EXP Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of TXN2 mRNA] CTD PMID:36315628 NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
JBrowse link
G Txndc8 thioredoxin domain containing 8 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA CTD PMID:22129741 NCBI chr 4:57,984,029...58,009,126
Ensembl chr 4:57,984,027...58,009,124
JBrowse link
G Txnip thioredoxin interacting protein multiple interactions ISO Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP protein] CTD PMID:37300869 NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
JBrowse link
G Txnl1 thioredoxin-like 1 decreases expression ISO Acetylcysteine results in decreased expression of TXNL1 mRNA CTD PMID:16084531 NCBI chr18:63,795,872...63,825,535
Ensembl chr18:63,794,165...63,841,872
JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA] CTD PMID:15652504 NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
JBrowse link
G Tymp thymidine phosphorylase multiple interactions ISO Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein] CTD PMID:11103787 NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
JBrowse link
G Tyr tyrosinase multiple interactions EXP [Acetylcysteine co-treated with 6-formylindolo(3,2-b)carbazole] results in increased activity of TYR protein; [Acetylcysteine co-treated with Benzo(a)pyrene] results in increased activity of TYR protein CTD PMID:34856342 NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720
JBrowse link
G Uba7 ubiquitin-like modifier activating enzyme 7 increases expression
multiple interactions
ISO
EXP
Acetylcysteine results in increased expression of UBA7 protein
Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of UBA7 mRNA]
Curcumin affects the reaction [Acetylcysteine results in increased expression of UBA7 protein]; epigallocatechin gallate affects the reaction [Acetylcysteine results in increased expression of UBA7 protein]; resveratrol affects the reaction [Acetylcysteine results in increased expression of UBA7 protein]
CTD PMID:25649257 PMID:34425375 NCBI chr 9:107,852,766...107,861,255
Ensembl chr 9:107,852,704...107,861,259
JBrowse link
G Ucp2 uncoupling protein 2 (mitochondrial, proton carrier) multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of UCP2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of UCP2 protein]; Acetylcysteine inhibits the reaction [pirinixic acid results in increased expression of UCP2 protein]
Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of UCP2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of UCP2 protein]
CTD PMID:18183618 PMID:29061315 PMID:30104959 PMID:36493885 NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
JBrowse link
G Ufm1 ubiquitin-fold modifier 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of UFM1 mRNA] CTD PMID:18723479 NCBI chr 3:53,760,797...53,771,228
Ensembl chr 3:53,760,797...53,771,251
JBrowse link
G Ugdh UDP-glucose dehydrogenase increases expression ISO Acetylcysteine results in increased expression of UGDH mRNA CTD PMID:16084531 NCBI chr 5:65,570,550...65,593,185
Ensembl chr 5:65,570,564...65,593,292
JBrowse link
G Ugt1a6b UDP glucuronosyltransferase 1 family, polypeptide A6B multiple interactions ISO Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA]; Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of UGT1A6 promoter] CTD PMID:15336321 PMID:22129741 NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
JBrowse link
G Uhrf1 ubiquitin-like, containing PHD and RING finger domains, 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of UHRF1 mRNA CTD PMID:22129741 NCBI chr17:56,610,405...56,630,486
Ensembl chr17:56,610,321...56,630,486
JBrowse link
G Ulk1 unc-51 like kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in decreased expression of and results in decreased phosphorylation of ULK1 protein] CTD PMID:27106530 PMID:33002460 NCBI chr 5:110,932,355...110,957,991
Ensembl chr 5:110,932,354...110,957,963
JBrowse link
G Uspl1 ubiquitin specific peptidase like 1 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of USPL1 mRNA] CTD PMID:18723479 NCBI chr 5:149,121,338...149,152,246
Ensembl chr 5:149,121,160...149,152,244
JBrowse link
G Uvrag UV radiation resistance associated gene multiple interactions ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of UVRAG mRNA] CTD PMID:29307831 NCBI chr 7:98,535,949...98,790,373
Ensembl chr 7:98,534,228...98,790,348
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions EXP
ISO
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VCAM1 protein]]
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
CTD PMID:12615669 PMID:19281832 PMID:19642688 PMID:25876056 PMID:26901245 More... NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions ISO Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of VDAC1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [VDAC1 protein binds to VDAC1 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of VDAC1 protein]; Acetylcysteine inhibits the reaction [quinocetone promotes the reaction [VDAC1 protein binds to VDAC1 protein]]; Acetylcysteine inhibits the reaction [quinocetone results in increased expression of VDAC1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of VDAC1 protein] CTD PMID:22858589 PMID:23711929 PMID:28343033 NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
JBrowse link
G Vdac2 voltage-dependent anion channel 2 multiple interactions ISO Acetylcysteine inhibits the reaction [quinocetone promotes the reaction [VDAC2 protein binds to VDAC2 protein]] CTD PMID:29229420 NCBI chr14:21,881,629...21,895,947
Ensembl chr14:21,875,306...21,895,947
JBrowse link
G Vegfa vascular endothelial growth factor A decreases secretion
multiple interactions
decreases expression
ISO
EXP
Acetylcysteine results in decreased secretion of VEGFA protein
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA]
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein]
Acetylcysteine results in decreased expression of VEGFA mRNA
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in decreased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Hydrogen Peroxide] results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [[Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA mRNA]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in decreased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein]
CTD PMID:11214823 PMID:11641398 PMID:11886167 PMID:13679210 PMID:15788408 More... NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vegfb vascular endothelial growth factor B multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA CTD PMID:22129741 NCBI chr19:6,959,840...6,965,019
Ensembl chr19:6,959,841...6,965,019
JBrowse link
G Vim vimentin multiple interactions
decreases expression
ISO
EXP
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VIM mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of VIM protein]
Acetylcysteine results in decreased expression of VIM protein
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in increased expression of VIM protein]
CTD PMID:28284859 PMID:32659284 PMID:32687844 PMID:33131013 PMID:34687772 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
JBrowse link
G Vmo1 vitelline membrane outer layer 1 homolog (chicken) multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VMO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VMO1 mRNA] CTD PMID:22129741 NCBI chr11:70,404,342...70,405,442
Ensembl chr11:70,404,342...70,405,442
JBrowse link
G Vnn1 vanin 1 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of VNN1 mRNA CTD PMID:22129741 NCBI chr10:23,770,586...23,781,242
Ensembl chr10:23,770,586...23,781,241
JBrowse link
G Wnt1 wingless-type MMTV integration site family, member 1 multiple interactions ISO Acetylcysteine inhibits the reaction [quinocetone results in decreased expression of WNT1 protein] CTD PMID:28343033 NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
JBrowse link
G Wtap WT1 associating protein multiple interactions ISO Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of WTAP mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of WTAP protein] CTD PMID:31004932 NCBI chr17:13,185,686...13,211,430
Ensembl chr17:13,185,683...13,213,056
JBrowse link
G Xbp1 X-box binding protein 1 increases splicing
multiple interactions
ISO
EXP
Acetylcysteine results in increased splicing of XBP1 mRNA
Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased splicing of XBP1 mRNA]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [arsenic trioxide results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]]
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein alternative form]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA]
CTD PMID:19722195 PMID:21138464 PMID:21145380 PMID:21911445 PMID:25451595 More... NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions ISO [MPO protein co-treated with XDH protein co-treated with Acetaldehyde] promotes the reaction [Serotonin binds to Acetylcysteine] CTD PMID:23009681 NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
JBrowse link
G Xiap X-linked inhibitor of apoptosis multiple interactions ISO Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with vorinostat] results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of XIAP protein] CTD PMID:15173093 PMID:19679660 PMID:21310227 PMID:22578287 NCBI chr  X:41,148,483...41,198,541
Ensembl chr  X:41,148,556...41,198,533
JBrowse link
G Xrcc1 X-ray repair complementing defective repair in Chinese hamster cells 1 multiple interactions ISO
EXP
Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XRCC1 mRNA]
Acetylcysteine inhibits the reaction [XRCC1 gene mutant form results in decreased abundance of Adenosine Triphosphate]; Acetylcysteine inhibits the reaction [XRCC1 gene mutant form results in increased abundance of Malondialdehyde]; Acetylcysteine promotes the reaction [XRCC1 protein results in decreased abundance of Malondialdehyde]; Acetylcysteine promotes the reaction [XRCC1 protein results in decreased oxidation of Glutathione]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased abundance of Adenosine Triphosphate]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased activity of CAT protein]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of CYTB mRNA]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND2 mRNA]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND5 mRNA]
CTD PMID:18948301 PMID:30998386 NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
JBrowse link
G Xrcc3 X-ray repair complementing defective repair in Chinese hamster cells 3 multiple interactions ISO Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of XRCC3 mRNA] CTD PMID:18948301 NCBI chr12:111,769,626...111,780,326
Ensembl chr12:111,769,626...111,780,307
JBrowse link
G Xrcc6 X-ray repair complementing defective repair in Chinese hamster cells 6 multiple interactions ISO Acetylcysteine promotes the reaction [Acrylonitrile results in increased expression of XRCC6 mRNA] CTD PMID:26332274 NCBI chr15:81,868,805...81,924,286
Ensembl chr15:81,872,036...81,924,286
JBrowse link
G Ywhah tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide multiple interactions ISO Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to GSK3B protein]] CTD PMID:33131013 NCBI chr 5:33,176,160...33,185,310
Ensembl chr 5:33,176,160...33,185,310
JBrowse link
G Yy1 YY1 transcription factor multiple interactions ISO Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 mRNA]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 protein] CTD PMID:34310962 NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074
JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA CTD PMID:22129741 NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522
JBrowse link
G Zdhhc19 zinc finger, DHHC domain containing 19 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZDHHC19 mRNA CTD PMID:22129741 NCBI chr16:32,315,059...32,326,032
Ensembl chr16:32,315,083...32,380,784
JBrowse link
G Zfand2a zinc finger, AN1-type domain 2A multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of ZFAND2A mRNA] CTD PMID:18723479 NCBI chr 5:139,456,971...139,470,246
Ensembl chr 5:139,456,966...139,470,304
JBrowse link
G Zfhx4 zinc finger homeodomain 4 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFHX4 mRNA CTD PMID:22129741 NCBI chr 3:5,276,268...5,480,921
Ensembl chr 3:5,283,586...5,480,917
JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 increases expression ISO Acetylcysteine results in increased expression of ZFP36L2 mRNA CTD PMID:16084531 NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375
JBrowse link
G Zfp395 zinc finger protein 395 multiple interactions ISO [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA CTD PMID:22129741 NCBI chr14:65,595,796...65,636,379
Ensembl chr14:65,595,838...65,636,379
JBrowse link
G Zkscan14 zinc finger with KRAB and SCAN domains 14 multiple interactions ISO Acetylcysteine inhibits the reaction [elesclomol results in increased expression of ZNF394 mRNA] CTD PMID:18723479 NCBI chr 5:145,131,756...145,140,972
Ensembl chr 5:145,131,756...145,138,678
JBrowse link
G Zmym2 zinc finger, MYM-type 2 decreases expression ISO Acetylcysteine results in decreased expression of ZMYM2 mRNA CTD PMID:16084531 NCBI chr14:57,123,986...57,199,815
Ensembl chr14:57,124,110...57,200,158
JBrowse link
N-acetyl-S-phenyl-L-cysteine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2d22 cytochrome P450, family 2, subfamily d, polypeptide 22 affects abundance ISO CYP2D6 affects the abundance of S-phenyl-N-acetylcysteine CTD PMID:10780264 NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of S-phenyl-N-acetylcysteine CTD PMID:15051535 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 multiple interactions
affects abundance
ISO [GSTM1 polymorphism co-treated with Smoke] affects the abundance of S-phenyl-N-acetylcysteine; GSTA1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine]; GSTT1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine]
GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine; GSTM1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine
CTD PMID:17056211 PMID:20100551 PMID:21300142 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstt1 glutathione S-transferase, theta 1 multiple interactions
affects abundance
affects chemical synthesis
ISO [GSTT1 gene SNP affects the metabolism of Benzene] which affects the abundance of S-phenyl-N-acetylcysteine; GSTT1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine]
GSTT1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine; GSTT1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine
GSTT1 protein polymorphism affects the chemical synthesis of S-phenyl-N-acetylcysteine
CTD PMID:15533900 PMID:15935803 PMID:20100551 PMID:21300142 PMID:30086327 NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 affects abundance ISO NQO1 affects the abundance of S-phenyl-N-acetylcysteine; NQO1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine CTD PMID:10780264 PMID:12798093 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
N-acetylneuraminic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cmas cytidine monophospho-N-acetylneuraminic acid synthetase affects abundance ISO CMAS protein affects the abundance of N-Acetylneuraminic Acid; CMAS protein affects the abundance of N-Acetylneuraminic Acid analog CTD PMID:27380425 NCBI chr 6:142,702,468...142,721,440
Ensembl chr 6:142,702,412...142,721,440
JBrowse link
G Gne glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase increases chemical synthesis ISO GNE protein results in increased chemical synthesis of N-Acetylneuraminic Acid CTD PMID:9305888 NCBI chr 4:44,034,075...44,084,177
Ensembl chr 4:44,034,075...44,084,177
JBrowse link
G Nans N-acetylneuraminic acid synthase (sialic acid synthase) increases chemical synthesis ISO NANS results in increased chemical synthesis of N-Acetylneuraminic Acid CTD PMID:27213289 NCBI chr 4:46,489,319...46,503,439
Ensembl chr 4:46,489,248...46,503,632
JBrowse link
nevirapine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP-binding cassette, sub-family B member 1A increases expression ISO Nevirapine results in increased expression of ABCB1A mRNA CTD PMID:23947594 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif 9 decreases expression ISO Nevirapine metabolite results in decreased expression of ADAMTS9 mRNA; Nevirapine results in decreased expression of ADAMTS9 mRNA CTD PMID:23947594 NCBI chr 6:92,749,680...92,921,431
Ensembl chr 6:92,749,680...92,920,473
JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 increases expression ISO Nevirapine metabolite results in increased expression of ADGRF5 mRNA CTD PMID:23947594 NCBI chr17:43,671,225...43,770,448
Ensembl chr17:43,671,342...43,770,448
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression
increases secretion
ISO Nevirapine results in increased expression of ADIPOQ mRNA
Nevirapine results in increased secretion of ADIPOQ protein
CTD PMID:21619898 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Aif1 allograft inflammatory factor 1 decreases expression ISO Nevirapine metabolite results in decreased expression of AIF1 mRNA CTD PMID:23947594 NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
JBrowse link
G Alb albumin affects binding ISO Nevirapine binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Apoa1 apolipoprotein A-I increases expression ISO Nevirapine results in increased expression of APOA1 protein CTD PMID:19667106 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
JBrowse link
G Ar androgen receptor increases expression ISO Nevirapine results in increased expression of AR mRNA; Nevirapine results in increased expression of AR protein CTD PMID:19152342 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Armcx2 armadillo repeat containing, X-linked 2 decreases expression ISO Nevirapine metabolite results in decreased expression of ARMCX2 mRNA; Nevirapine results in decreased expression of ARMCX2 mRNA CTD PMID:23947594 NCBI chr  X:133,704,891...133,709,970
Ensembl chr  X:133,704,894...133,709,970
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator increases expression ISO Nevirapine metabolite results in increased expression of ARNT mRNA CTD PMID:23947594 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
JBrowse link
G Bmp6 bone morphogenetic protein 6 increases expression ISO Nevirapine results in increased expression of BMP6 mRNA CTD PMID:32816093 NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278
JBrowse link
G Cd209b CD209b antigen increases expression ISO Nevirapine metabolite results in increased expression of CD209B mRNA CTD PMID:23947594 NCBI chr 8:3,967,655...3,976,841
Ensembl chr 8:3,967,655...3,976,844
JBrowse link
G Cd36 CD36 molecule increases expression ISO Nevirapine metabolite results in increased expression of CD36 mRNA CTD PMID:23947594 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression ISO Nevirapine results in increased expression of CEBPA mRNA CTD PMID:21619898 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO Nevirapine results in increased expression of CES2 mRNA CTD PMID:23947594 NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
JBrowse link
G Ciita class II transactivator increases expression ISO Nevirapine results in increased expression of CIITA CTD PMID:26626330 NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
JBrowse link
G Clec4a1 C-type lectin domain family 4, member a1 decreases expression ISO Nevirapine results in decreased expression of CLEC4A1 mRNA CTD PMID:23947594 NCBI chr 6:122,898,807...122,911,578
Ensembl chr 6:122,898,807...122,911,578
JBrowse link
G Clec4a3 C-type lectin domain family 4, member a3 decreases expression ISO Nevirapine results in decreased expression of CLEC4A3 mRNA CTD PMID:23947594 NCBI chr 6:122,929,474...122,946,837
Ensembl chr 6:122,929,474...122,946,834
JBrowse link
G Cotl1 coactosin like F-actin binding protein 1 decreases expression ISO Nevirapine results in decreased expression of COTL1 mRNA CTD PMID:23947594 NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283
JBrowse link
G Cux2 cut-like homeobox 2 decreases expression ISO Nevirapine metabolite results in decreased expression of CUX2 mRNA CTD PMID:23947594 NCBI chr 5:121,996,025...122,188,522
Ensembl chr 5:121,994,429...122,188,165
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 increases expression ISO Nevirapine results in increased expression of CXCL8 mRNA CTD PMID:32816093 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 multiple interactions ISO [Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2c52-ps cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene affects binding ISO Nevirapine binds to CYP2C11 protein CTD PMID:22793666 NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
JBrowse link
G Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 increases expression ISO Nevirapine results in increased expression of CYP3A9 mRNA CTD PMID:23947594 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 increases expression ISO Nevirapine metabolite results in increased expression of CYP4B1 mRNA CTD PMID:23947594 NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
JBrowse link
G Dapk1 death associated protein kinase 1 increases expression ISO Nevirapine metabolite results in increased expression of DAPK1 mRNA CTD PMID:23947594 NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005
JBrowse link
G Dbp D site albumin promoter binding protein decreases expression ISO Nevirapine metabolite results in decreased expression of DBP mRNA CTD PMID:23947594 NCBI chr 7:45,354,658...45,359,579
Ensembl chr 7:45,354,512...45,359,627
JBrowse link
G Ddhd1 DDHD domain containing 1 decreases expression ISO Nevirapine results in decreased expression of DDHD1 mRNA CTD PMID:23947594 NCBI chr14:45,830,628...45,895,600
Ensembl chr14:45,825,924...45,895,600
JBrowse link
G Dip2a disco interacting protein 2 homolog A increases expression ISO Nevirapine results in increased expression of DIP2A mRNA CTD PMID:23947594 NCBI chr10:76,098,581...76,181,194
Ensembl chr10:76,095,263...76,181,125
JBrowse link
G Dnajb5 DnaJ heat shock protein family (Hsp40) member B5 increases expression ISO Nevirapine metabolite results in increased expression of DNAJB5 mRNA CTD PMID:23947594 NCBI chr 4:42,949,866...42,959,425
Ensembl chr 4:42,949,814...42,959,425
JBrowse link
G Edem1 ER degradation enhancer, mannosidase alpha-like 1 increases expression ISO Nevirapine results in increased expression of EDEM1 mRNA CTD PMID:23947594 NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
JBrowse link
G Egf epidermal growth factor decreases expression ISO Nevirapine results in decreased expression of EGF mRNA CTD PMID:19152342 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
JBrowse link
G Egfr epidermal growth factor receptor decreases expression ISO Nevirapine results in decreased expression of EGFR mRNA CTD PMID:19152342 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1 like 3 decreases expression ISO Nevirapine results in decreased expression of EPB41L3 mRNA CTD PMID:23947594 NCBI chr17:69,382,642...69,596,986
Ensembl chr17:69,382,678...69,596,984
JBrowse link
G Ereg epiregulin increases expression ISO Nevirapine results in increased expression of EREG mRNA CTD PMID:32816093 NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
JBrowse link
G Esm1 endothelial cell-specific molecule 1 increases expression ISO Nevirapine metabolite results in increased expression of ESM1 mRNA; Nevirapine results in increased expression of ESM1 mRNA CTD PMID:23947594 NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632
JBrowse link
G Fam107a family with sequence similarity 107, member A increases expression ISO Nevirapine results in increased expression of FAM107A mRNA CTD PMID:23947594 NCBI chr14:14,152,166...14,173,503
Ensembl chr14:14,151,750...14,173,499
JBrowse link
G Fibin fin bud initiation factor homolog (zebrafish) increases expression ISO Nevirapine results in increased expression of FIBIN mRNA CTD PMID:23947594 NCBI chr 2:110,191,270...110,193,338
Ensembl chr 2:110,191,262...110,193,528
JBrowse link
G Fkbp5 FK506 binding protein 5 increases expression ISO Nevirapine metabolite results in increased expression of FKBP5 mRNA; Nevirapine results in increased expression of FKBP5 mRNA CTD PMID:23947594 NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
JBrowse link
G Fmo1 flavin containing monooxygenase 1 decreases expression ISO Nevirapine metabolite results in decreased expression of FMO1 mRNA CTD PMID:23947594 NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible 45 beta increases expression ISO Nevirapine results in increased expression of GADD45B mRNA CTD PMID:23947594 NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
JBrowse link
G Glul glutamate-ammonia ligase decreases expression ISO Nevirapine metabolite results in decreased expression of GLUL mRNA CTD PMID:23947594 NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
JBrowse link
G Gsta3 glutathione S-transferase, alpha 3 increases glutathionylation ISO GSTA3 protein results in increased glutathionylation of Nevirapine metabolite CTD PMID:27989146 NCBI chr 1:21,310,837...21,335,885
Ensembl chr 1:21,310,813...21,335,885
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 increases glutathionylation ISO GSTM1 protein results in increased glutathionylation of Nevirapine metabolite CTD PMID:27989146 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 increases glutathionylation ISO GSTP1 protein results in increased glutathionylation of Nevirapine metabolite CTD PMID:27989146 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
JBrowse link
G Gzma granzyme A decreases expression ISO Nevirapine metabolite results in decreased expression of GZMA mRNA CTD PMID:23947594 NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
JBrowse link
G Gzmf granzyme F decreases expression ISO Nevirapine metabolite results in decreased expression of GZMF mRNA CTD PMID:23947594 NCBI chr14:56,442,720...56,448,864
Ensembl chr14:56,442,720...56,448,874
JBrowse link
G Hao2 hydroxyacid oxidase 2 decreases expression ISO Nevirapine metabolite results in decreased expression of HAO2 mRNA; Nevirapine results in decreased expression of HAO2 mRNA CTD PMID:23947594 NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
JBrowse link
G Hdc histidine decarboxylase decreases expression ISO Nevirapine metabolite results in decreased expression of HDC mRNA CTD PMID:23947594 NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
JBrowse link
G Hgf hepatocyte growth factor decreases secretion ISO Nevirapine results in decreased secretion of HGF protein CTD PMID:21619898 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 increases expression ISO Nevirapine metabolite results in increased expression of HMGCS2 mRNA; Nevirapine results in increased expression of HMGCS2 mRNA CTD PMID:23947594 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
JBrowse link
G Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) increases expression ISO Nevirapine metabolite results in increased expression of HPGD mRNA CTD PMID:23947594 NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression ISO Nevirapine metabolite results in decreased expression of HSD17B2 mRNA CTD PMID:23947594 NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766
JBrowse link
G Ifng interferon gamma increases expression ISO Nevirapine results in increased expression of IFNG protein CTD PMID:23947594 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Nevirapine results in increased expression of IL1B mRNA CTD PMID:32816093 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il22ra2 interleukin 22 receptor, alpha 2 increases expression ISO Nevirapine metabolite results in increased expression of IL22RA2 mRNA CTD PMID:23947594 NCBI chr10:19,497,776...19,510,429
Ensembl chr10:19,497,746...19,510,429
JBrowse link
G Il24 interleukin 24 increases expression ISO Nevirapine results in increased expression of IL24 mRNA CTD PMID:32816093 NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
JBrowse link
G Il6 interleukin 6 decreases secretion ISO Nevirapine results in decreased secretion of IL6 protein CTD PMID:21619898 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Inhbe inhibin beta-E decreases expression ISO Nevirapine metabolite results in decreased expression of INHBE mRNA CTD PMID:23947594 NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
JBrowse link
G Inmt indolethylamine N-methyltransferase increases expression ISO Nevirapine results in increased expression of INMT mRNA CTD PMID:23947594 NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028
JBrowse link
G Insig2 insulin induced gene 2 increases expression ISO Nevirapine results in increased expression of INSIG2 mRNA CTD PMID:23947594 NCBI chr 1:121,232,082...121,260,391
Ensembl chr 1:121,232,082...121,260,318
JBrowse link
G Irgm1 immunity-related GTPase family M member 1 decreases expression ISO Nevirapine results in decreased expression of IRGM mRNA CTD PMID:23947594 NCBI chr11:48,756,072...48,762,247
Ensembl chr11:48,752,795...48,762,510
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor 1 increases expression ISO Nevirapine results in increased expression of ITPR1 mRNA CTD PMID:23947594 NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
JBrowse link
G Klf15 Kruppel-like transcription factor 15 increases expression ISO Nevirapine metabolite results in increased expression of KLF15 mRNA CTD PMID:23947594 NCBI chr 6:90,437,785...90,468,785
Ensembl chr 6:90,439,558...90,452,220
JBrowse link
G Krt18 keratin 18 increases expression ISO Nevirapine results in increased expression of KRT18 protein CTD PMID:19152342 NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
JBrowse link
G Krt23 keratin 23 increases expression ISO Nevirapine metabolite results in increased expression of KRT23 mRNA CTD PMID:23947594 NCBI chr11:99,368,799...99,383,946
Ensembl chr11:99,368,800...99,383,963
JBrowse link
G Lcat lecithin cholesterol acyltransferase increases expression ISO Nevirapine results in increased expression of LCAT protein CTD PMID:19667106 NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
JBrowse link
G Ldaf1 lipid droplet assembly factor 1 decreases expression ISO Nevirapine results in decreased expression of LDAF1 mRNA CTD PMID:23947594 NCBI chr 7:119,701,599...119,720,212
Ensembl chr 7:119,701,576...119,720,215
JBrowse link
G Lep leptin increases expression ISO Nevirapine results in increased expression of LEP mRNA CTD PMID:21619898 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lifr LIF receptor alpha increases expression ISO Nevirapine metabolite results in increased expression of LIFR mRNA CTD PMID:23947594 NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970
JBrowse link
G Lipg lipase, endothelial decreases expression ISO Nevirapine metabolite results in decreased expression of LIPG mRNA; Nevirapine results in decreased expression of LIPG mRNA CTD PMID:23947594 NCBI chr18:75,072,393...75,095,380
Ensembl chr18:75,072,393...75,094,334
JBrowse link
G Lpin1 lipin 1 increases expression ISO Nevirapine metabolite results in increased expression of LPIN1 mRNA CTD PMID:23947594 NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
JBrowse link
G Lpl lipoprotein lipase increases expression ISO Nevirapine results in increased expression of LPL mRNA CTD PMID:21619898 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 increases expression ISO Nevirapine metabolite results in increased expression of LRG1 mRNA CTD PMID:23947594 NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
JBrowse link
G Ly86 lymphocyte antigen 86 decreases expression ISO Nevirapine results in decreased expression of LY86 mRNA CTD PMID:23947594 NCBI chr13:37,529,276...37,603,012
Ensembl chr13:37,529,184...37,603,012
JBrowse link
G Meox2 mesenchyme homeobox 2 increases expression ISO Nevirapine results in increased expression of MEOX2 mRNA CTD PMID:23947594 NCBI chr12:37,158,539...37,229,533
Ensembl chr12:37,158,539...37,229,533
JBrowse link
G Met met proto-oncogene increases expression ISO Nevirapine results in increased expression of MET mRNA CTD PMID:32816093 NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
JBrowse link
G Mgp matrix Gla protein increases expression ISO Nevirapine results in increased expression of MGP mRNA CTD PMID:23947594 NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
JBrowse link
G Mrc1 mannose receptor, C type 1 increases expression ISO Nevirapine metabolite results in increased expression of MRC1 mRNA CTD PMID:23947594 NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868
JBrowse link
G Ms4a7 membrane-spanning 4-domains, subfamily A, member 7 decreases expression ISO Nevirapine results in decreased expression of MS4A7 mRNA CTD PMID:23947594 NCBI chr19:11,298,403...11,313,510
Ensembl chr19:11,298,403...11,313,510
JBrowse link
G Nampt nicotinamide phosphoribosyltransferase increases expression ISO Nevirapine metabolite results in increased expression of NAMPT mRNA CTD PMID:23947594 NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348
JBrowse link
G Ndufaf4 NADH:ubiquinone oxidoreductase complex assembly factor 4 increases expression ISO Nevirapine results in increased expression of NDUFAF4 mRNA CTD PMID:23947594 NCBI chr 4:24,898,083...24,905,001
Ensembl chr 4:24,898,083...24,905,001
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 increases expression ISO Nevirapine results in increased expression of NLRC5 CTD PMID:26626330 NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
JBrowse link
G Npas2 neuronal PAS domain protein 2 decreases expression ISO Nevirapine metabolite results in decreased expression of NPAS2 mRNA; Nevirapine results in decreased expression of NPAS2 mRNA CTD PMID:23947594 NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317
JBrowse link
G Nptx2 neuronal pentraxin 2 increases expression ISO Nevirapine results in increased expression of NPTX2 mRNA CTD PMID:23947594 NCBI chr 5:144,482,697...144,494,288
Ensembl chr 5:144,482,712...144,494,288
JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 decreases expression ISO Nevirapine metabolite results in decreased expression of NR1D1 mRNA CTD PMID:23947594 NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO [Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Nrep neuronal regeneration related protein decreases expression ISO Nevirapine metabolite results in decreased expression of NREP mRNA; Nevirapine results in decreased expression of NREP mRNA CTD PMID:23947594 NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
JBrowse link
G P2rx7 purinergic receptor P2X, ligand-gated ion channel, 7 decreases expression ISO Nevirapine results in decreased expression of P2RX7 mRNA CTD PMID:23947594 NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
JBrowse link
G Pcp4l1 Purkinje cell protein 4-like 1 decreases expression ISO Nevirapine results in decreased expression of PCP4L1 mRNA CTD PMID:23947594 NCBI chr 1:171,000,833...171,023,837
Ensembl chr 1:171,000,831...171,023,837
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 increases expression ISO Nevirapine metabolite results in increased expression of PDK4 mRNA CTD PMID:23947594 NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 increases expression ISO Nevirapine results in increased expression of PID1 mRNA CTD PMID:32816093 NCBI chr 1:84,014,014...84,317,550
Ensembl chr 1:84,014,017...84,341,901
JBrowse link
G Pik3ip1 phosphoinositide-3-kinase interacting protein 1 increases expression ISO Nevirapine results in increased expression of PIK3IP1 mRNA CTD PMID:23947594 NCBI chr11:3,280,731...3,292,971
Ensembl chr11:3,280,401...3,292,971
JBrowse link
G Pir pirin increases expression ISO Nevirapine metabolite results in increased expression of PIR mRNA CTD PMID:23947594 NCBI chr  X:163,052,427...163,156,009
Ensembl chr  X:163,052,367...163,156,007
JBrowse link
G Pira2 paired-Ig-like receptor A2 decreases expression ISO Nevirapine results in decreased expression of PIRA2 mRNA CTD PMID:23947594 NCBI chr 7:3,839,807...3,848,102
Ensembl chr 7:3,839,811...3,848,050
JBrowse link
G Pnpla2 patatin-like phospholipase domain containing 2 increases expression ISO Nevirapine metabolite results in increased expression of PNPLA2 mRNA CTD PMID:23947594 NCBI chr 7:141,035,101...141,040,656
Ensembl chr 7:141,035,111...141,040,656
JBrowse link
G Por cytochrome p450 oxidoreductase increases expression ISO Nevirapine metabolite results in increased expression of POR mRNA; Nevirapine results in increased expression of POR mRNA CTD PMID:23947594 NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma increases expression ISO Nevirapine results in increased expression of PPARG mRNA CTD PMID:21619898 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta decreases expression ISO Nevirapine metabolite results in decreased expression of PPP2R2B mRNA; Nevirapine results in decreased expression of PPP2R2B mRNA CTD PMID:23947594 NCBI chr18:42,777,811...43,192,827
Ensembl chr18:42,770,497...43,216,192
JBrowse link
G Prf1 perforin 1 (pore forming protein) decreases expression ISO Nevirapine metabolite results in decreased expression of PRF1 mRNA CTD PMID:23947594 NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
JBrowse link
G Pycr1 pyrroline-5-carboxylate reductase 1 decreases expression ISO Nevirapine metabolite results in decreased expression of PYCR1 mRNA CTD PMID:23947594 NCBI chr11:120,527,591...120,534,602
Ensembl chr11:120,526,538...120,534,595
JBrowse link
G Rbm3 RNA binding motif (RNP1, RRM) protein 3 increases expression ISO Nevirapine results in increased expression of RBM3 mRNA CTD PMID:23947594 NCBI chr  X:8,005,214...8,012,119
Ensembl chr  X:8,005,214...8,012,119
JBrowse link
G Retreg1 reticulophagy regulator 1 increases expression ISO Nevirapine metabolite results in increased expression of RETREG1 mRNA; Nevirapine results in increased expression of RETREG1 mRNA CTD PMID:23947594 NCBI chr15:25,840,795...25,973,782
Ensembl chr15:25,843,266...25,973,773
JBrowse link
G Rhbdd2 rhomboid domain containing 2 increases expression ISO Nevirapine results in increased expression of RHBDD2 mRNA CTD PMID:23947594 NCBI chr 5:135,661,508...135,675,230
Ensembl chr 5:135,661,472...135,675,302
JBrowse link
G Rprm reprimo, TP53 dependent G2 arrest mediator candidate decreases expression ISO Nevirapine metabolite results in decreased expression of RPRM mRNA CTD PMID:23947594 NCBI chr 2:53,974,105...53,975,564
Ensembl chr 2:53,974,105...53,975,564
JBrowse link
G S100a7a S100 calcium binding protein A7A increases expression ISO Nevirapine metabolite results in increased expression of S100A7A mRNA CTD PMID:23947594 NCBI chr 3:90,561,609...90,565,437
Ensembl chr 3:90,561,324...90,565,976
JBrowse link
G Scp2 sterol carrier protein 2, liver increases expression ISO Nevirapine results in increased expression of SCP2 CTD PMID:26626330 NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
JBrowse link
G Slamf9 SLAM family member 9 decreases expression ISO Nevirapine results in decreased expression of SLAMF9 mRNA CTD PMID:23947594 NCBI chr 1:172,302,927...172,305,976
Ensembl chr 1:172,302,925...172,306,142
JBrowse link
G Slc34a2 solute carrier family 34 (sodium phosphate), member 2 decreases expression ISO Nevirapine metabolite results in decreased expression of SLC34A2 mRNA CTD PMID:23947594 NCBI chr 5:53,206,695...53,229,006
Ensembl chr 5:53,195,423...53,229,006
JBrowse link
G Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5 multiple interactions ISO [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein CTD PMID:16030158 NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 increases expression ISO Nevirapine results in increased expression of SLC7A11 mRNA CTD PMID:32816093 NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression
decreases expression
ISO Nevirapine results in increased expression of SREBF1 mRNA
Nevirapine metabolite results in decreased expression of SREBF1 mRNA
CTD PMID:21619898 PMID:23947594 NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
JBrowse link
G Tg thyroglobulin increases expression ISO Nevirapine results in increased expression of TG mRNA; Nevirapine results in increased expression of TG protein CTD PMID:16030158 NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570
JBrowse link
G Tmem64 transmembrane protein 64 increases expression ISO Nevirapine metabolite results in increased expression of TMEM64 mRNA; Nevirapine results in increased expression of TMEM64 mRNA CTD PMID:23947594 NCBI chr 4:15,265,820...15,286,753
Ensembl chr 4:15,265,831...15,286,753
JBrowse link
G Tnfaip6 tumor necrosis factor alpha induced protein 6 increases expression ISO Nevirapine results in increased expression of TNFAIP6 mRNA CTD PMID:32816093 NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
JBrowse link
G Tox3 TOX high mobility group box family member 3 increases expression ISO Nevirapine results in increased expression of TOX3 mRNA CTD PMID:23947594 NCBI chr 8:90,973,665...91,075,746
Ensembl chr 8:90,973,668...91,074,971
JBrowse link
G Tpo thyroid peroxidase increases expression ISO Nevirapine results in increased expression of TPO mRNA; Nevirapine results in increased expression of TPO protein CTD PMID:16030158 NCBI chr12:30,104,658...30,182,983
Ensembl chr12:30,104,658...30,182,623
JBrowse link
G Trim24 tripartite motif-containing 24 decreases expression ISO Nevirapine results in decreased expression of TRIM24 mRNA CTD PMID:23947594 NCBI chr 6:37,846,816...37,945,380
Ensembl chr 6:37,847,746...37,943,231
JBrowse link
G Trim63 tripartite motif-containing 63 increases expression ISO Nevirapine metabolite results in increased expression of TRIM63 mRNA CTD PMID:23947594 NCBI chr 4:134,042,431...134,056,940
Ensembl chr 4:134,042,431...134,056,940
JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression ISO Nevirapine results in increased expression of TSC22D3 mRNA CTD PMID:23947594 NCBI chr  X:139,440,277...139,501,257
Ensembl chr  X:139,440,277...139,501,408
JBrowse link
G Tshb thyroid stimulating hormone, beta subunit multiple interactions ISO [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein; Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]] CTD PMID:16030158 NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
JBrowse link
G Tshr thyroid stimulating hormone receptor increases expression ISO Nevirapine results in increased expression of TSHR mRNA CTD PMID:16030158 NCBI chr12:91,367,767...91,507,283
Ensembl chr12:91,351,337...91,516,582
JBrowse link
G Tsku tsukushi, small leucine rich proteoglycan increases expression ISO Nevirapine results in increased expression of TSKU mRNA CTD PMID:23947594 NCBI chr 7:97,999,875...98,010,602
Ensembl chr 7:97,999,875...98,010,535
JBrowse link
G Ucp1 uncoupling protein 1 (mitochondrial, proton carrier) increases expression ISO Nevirapine results in increased expression of UCP1 CTD PMID:16038477 NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
JBrowse link
G Ucp3 uncoupling protein 3 (mitochondrial, proton carrier) increases expression ISO Nevirapine metabolite results in increased expression of UCP3 mRNA CTD PMID:23947594 NCBI chr 7:100,122,198...100,135,639
Ensembl chr 7:100,122,197...100,135,639
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression ISO Nevirapine metabolite results in increased expression of VCAM1 mRNA CTD PMID:23947594 NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Nevirapine results in decreased expression of VEGFA mRNA CTD PMID:19152342 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vsnl1 visinin-like 1 decreases expression ISO Nevirapine metabolite results in decreased expression of VSNL1 mRNA; Nevirapine results in decreased expression of VSNL1 mRNA CTD PMID:23947594 NCBI chr12:11,375,258...11,486,579
Ensembl chr12:11,375,243...11,486,614
JBrowse link
G Zap70 zeta-chain (TCR) associated protein kinase increases expression ISO Nevirapine results in increased expression of ZAP70 mRNA CTD PMID:23947594 NCBI chr 1:36,800,912...36,821,899
Ensembl chr 1:36,800,879...36,821,899
JBrowse link
oseltamivir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO Oseltamivir binds to and results in decreased activity of AR protein; Oseltamivir binds to and results in increased activity of AR protein CTD PMID:25752796 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Ces1d carboxylesterase 1D affects hydrolysis
multiple interactions
increases metabolic processing
ISO CES1 protein affects the hydrolysis of Oseltamivir
7,8-dihydromethysticin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; [CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate; [hirsutine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [mitragynine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [paynantheine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [Plant Extracts results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [speciogynine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; desmethoxyyangonin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; dihydrokavain inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; kavain inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; methysticin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; yangonin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]
CTD PMID:18983829 PMID:35278473 PMID:37716419 NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
JBrowse link
G Il6 interleukin 6 decreases response to substance ISO IL6 protein results in decreased susceptibility to Oseltamivir CTD PMID:17537833 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Pgr progesterone receptor multiple interactions ISO Oseltamivir binds to and results in increased activity of PGR protein CTD PMID:25752796 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 decreases expression ISO Oseltamivir results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
JBrowse link
phosphonoformic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO Foscarnet inhibits the reaction [Phosphates results in decreased expression of AKT1 mRNA] CTD PMID:23308213 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Dmp1 dentin matrix protein 1 multiple interactions ISO Foscarnet inhibits the reaction [Phosphates results in increased expression of DMP1 mRNA] CTD PMID:20185895 NCBI chr 5:104,345,441...104,361,968
Ensembl chr 5:104,350,479...104,361,968
JBrowse link
G Phex phosphate regulating endopeptidase homolog, X-linked multiple interactions ISO Foscarnet inhibits the reaction [beta-glycerophosphoric acid results in increased expression of PHEX mRNA] CTD PMID:18500657 NCBI chr  X:155,945,071...156,198,282
Ensembl chr  X:155,945,071...156,198,308
JBrowse link
G Slc16a1 solute carrier family 16 (monocarboxylic acid transporters), member 1 multiple interactions
increases import
ISO Foscarnet inhibits the reaction [SLC16A1 protein results in increased transport of Benzoic Acid]
SLC16A1 protein results in increased import of Foscarnet
CTD PMID:10579682 PMID:10714609 NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
JBrowse link
G Slc20a1 solute carrier family 20, member 1 decreases activity
multiple interactions
increases expression
ISO Foscarnet results in decreased activity of SLC20A1 protein
Foscarnet inhibits the reaction [Phosphates results in increased expression of SLC20A1 mRNA]
Foscarnet results in increased expression of SLC20A1 mRNA
CTD PMID:15641067 PMID:17438129 PMID:23308213 NCBI chr 2:129,038,662...129,053,535
Ensembl chr 2:129,040,684...129,053,536
JBrowse link
G Slc20a2 solute carrier family 20, member 2 multiple interactions ISO Foscarnet inhibits the reaction [Phosphates results in increased expression of SLC20A2 mRNA] CTD PMID:23308213 NCBI chr 8:22,966,771...23,059,632
Ensembl chr 8:22,966,804...23,059,628
JBrowse link
G Slc23a2 solute carrier family 23 (nucleobase transporters), member 2 multiple interactions EXP Foscarnet inhibits the reaction [Calcium results in increased expression of SLC23A2 mRNA]; Foscarnet inhibits the reaction [Phosphates results in increased expression of SLC23A2 mRNA] CTD PMID:12788230 NCBI chr 2:131,894,416...131,987,287
Ensembl chr 2:131,894,416...131,987,028
JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions EXP Foscarnet inhibits the reaction [Calcium results in increased expression of SPP1 mRNA]; Foscarnet inhibits the reaction [Phosphates results in increased expression of SPP1 mRNA]; Foscarnet inhibits the reaction [Phosphates results in increased expression of SPP1 protein] CTD PMID:12788230 PMID:17383965 PMID:18412142 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Stc1 stanniocalcin 1 increases expression ISO Foscarnet results in increased expression of STC1 mRNA CTD PMID:17438129 NCBI chr14:69,266,738...69,278,850
Ensembl chr14:69,266,687...69,279,253
JBrowse link
remdesivir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase increases hydrolysis ISO ACHE protein results in increased hydrolysis of remdesivir CTD PMID:34774545 NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
JBrowse link
G Atm ataxia telangiectasia mutated increases phosphorylation ISO remdesivir results in increased phosphorylation of ATM protein CTD PMID:35417658 NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
JBrowse link
G Bax BCL2-associated X protein increases expression ISO remdesivir results in increased expression of BAX protein CTD PMID:35417658 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bche butyrylcholinesterase increases hydrolysis ISO BCHE protein results in increased hydrolysis of remdesivir CTD PMID:34774545 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression ISO remdesivir results in decreased expression of BCL2 protein CTD PMID:35417658 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l11 BCL2 like 11 increases expression ISO remdesivir results in increased expression of BCL2L11 protein CTD PMID:35417658 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
JBrowse link
G Casp3 caspase 3 decreases expression ISO remdesivir results in decreased expression of CASP3 protein CTD PMID:35417658 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp7 caspase 7 decreases expression ISO remdesivir results in decreased expression of CASP7 protein CTD PMID:35417658 NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Remdesivir decreases expression of CCL2 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD PMID:32360580 RGD:30309211 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Cdx2 caudal type homeobox 2 increases expression EXP remdesivir results in increased expression of CDX2 mRNA CTD PMID:35605700 NCBI chr 5:147,237,710...147,244,059
Ensembl chr 5:147,237,615...147,244,080
JBrowse link
G Ces1d carboxylesterase 1D increases hydrolysis
multiple interactions
ISO CES1 protein results in increased hydrolysis of remdesivir
Simvastatin inhibits the reaction [CES1 protein results in increased hydrolysis of remdesivir]
CTD PMID:34774545 NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
JBrowse link
G Ctsa cathepsin A increases hydrolysis ISO CTSA protein results in increased hydrolysis of remdesivir CTD PMID:34774545 NCBI chr 2:164,674,792...164,682,952
Ensembl chr 2:164,674,793...164,682,952
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases expression ISO Remdesivir decreases expression of CXCL10 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD PMID:32360580 RGD:30309211 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
JBrowse link
G Esrrb estrogen related receptor, beta decreases expression EXP remdesivir results in decreased expression of ESRRB mRNA CTD PMID:35605700 NCBI chr12:86,407,891...86,568,402
Ensembl chr12:86,407,891...86,568,402
JBrowse link
G Foxo3 forkhead box O3 increases expression ISO remdesivir results in increased expression of FOXO3 protein CTD PMID:35417658 NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
JBrowse link
G Gata3 GATA binding protein 3 increases expression EXP remdesivir results in increased expression of GATA3 mRNA CTD PMID:35605700 NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
JBrowse link
G Gata4 GATA binding protein 4 decreases expression EXP remdesivir results in decreased expression of GATA4 mRNA CTD PMID:35605700 NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
JBrowse link
G H2ax H2A.X variant histone increases expression ISO remdesivir results in increased expression of H2AX protein CTD PMID:35417658 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G Il1b interleukin 1 beta decreases expression ISO Remdesivir decreases expression of IL1B mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD PMID:32360580 RGD:30309211 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 decreases expression ISO Remdesivir decreases expression of IL-6 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD PMID:32360580 RGD:30309211 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 decreases expression ISO remdesivir results in decreased expression of MKI67 protein CTD PMID:35417658 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
JBrowse link
G Nanog Nanog homeobox decreases expression EXP remdesivir results in decreased expression of NANOG mRNA CTD PMID:35605700 NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases expression ISO remdesivir results in increased expression of PARP1 protein CTD PMID:35417658 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Pdgfra platelet derived growth factor receptor, alpha polypeptide decreases expression EXP remdesivir results in decreased expression of PDGFRA mRNA CTD PMID:35605700 NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
JBrowse link
G Sox17 SRY (sex determining region Y)-box 17 decreases expression EXP remdesivir results in decreased expression of SOX17 mRNA CTD PMID:35605700 NCBI chr 1:4,561,154...4,567,624
Ensembl chr 1:4,561,154...4,567,577
JBrowse link
G Sox2 SRY (sex determining region Y)-box 2 decreases expression EXP remdesivir results in decreased expression of SOX2 mRNA CTD PMID:35605700 NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
JBrowse link
G Tnf tumor necrosis factor decreases expression ISO Remdesivir decreases expression of TNF mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD PMID:32360580 RGD:30309211 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
ritonavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases activity
multiple interactions
ISO Ritonavir results in decreased activity of ABCB11 protein
Ritonavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:20829430 PMID:22646477 PMID:23956101 PMID:24014644 PMID:28437613 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A multiple interactions ISO hyperforin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb4 ATP-binding cassette, sub-family B member 4 decreases expression
decreases activity
ISO Ritonavir results in decreased expression of ABCB4
Ritonavir results in decreased activity of ABCB4 protein
CTD PMID:26626330 PMID:28437613 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 affects expression ISO Ritonavir affects the expression of ACSS2 mRNA CTD PMID:17719200 NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
multiple interactions
EXP
ISO
Ritonavir results in decreased expression of ADIPOQ mRNA; Ritonavir results in decreased expression of ADIPOQ protein
rosiglitazone inhibits the reaction [Ritonavir results in decreased secretion of ADIPOQ protein]
diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein]
CTD PMID:15865214 PMID:17668557 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 increases phosphorylation EXP Ritonavir results in increased phosphorylation of AKT1 protein CTD PMID:36198369 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Alb albumin affects binding ISO Ritonavir binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression ISO Ritonavir results in increased expression of BAK1 protein CTD PMID:19386116 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression ISO Ritonavir results in decreased expression of BCL2 protein CTD PMID:19386116 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 decreases expression ISO Ritonavir results in decreased expression of BCL2L1 mRNA CTD PMID:16174765 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Ritonavir results in decreased expression of BIRC5 mRNA; Ritonavir results in decreased expression of BIRC5 protein CTD PMID:16174765 PMID:21270666 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G Casp1 caspase 1 decreases expression ISO Ritonavir results in decreased expression of CASP1 protein CTD PMID:10551732 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp3 caspase 3 decreases activity ISO Ritonavir results in decreased activity of CASP3 protein CTD PMID:10551732 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
increases secretion
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein]
Ritonavir results in decreased expression of CCL2
CTD PMID:17668557 PMID:20884875 PMID:26626330 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Ritonavir results in decreased expression of CCL20 CTD PMID:26626330 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 decreases expression
increases expression
ISO Ritonavir results in decreased expression of CCL3
Ritonavir results in increased expression of CCL3 protein
CTD PMID:17668557 PMID:26626330 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 decreases expression ISO Ritonavir results in decreased expression of CCL4 CTD PMID:26626330 NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
JBrowse link
G Ccna2 cyclin A2 decreases expression ISO Ritonavir results in decreased expression of CCNA2 mRNA CTD PMID:19386116 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO Ritonavir results in decreased expression of CCNB1 mRNA CTD PMID:19386116 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO Ritonavir results in decreased expression of CCND1 protein CTD PMID:16551874 PMID:21270666 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccnd2 cyclin D2 decreases expression ISO Ritonavir results in decreased expression of CCND2 mRNA CTD PMID:16174765 PMID:19386116 NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
JBrowse link
G Ccne2 cyclin E2 decreases expression ISO Ritonavir results in decreased expression of CCNE2 mRNA CTD PMID:19386116 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression ISO Ritonavir results in decreased expression of CDK2 mRNA; Ritonavir results in decreased expression of CDK2 protein CTD PMID:16551874 PMID:19386116 NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
JBrowse link
G Cdk3 cyclin dependent kinase 3 increases expression ISO Ritonavir results in increased expression of CDK3 mRNA CTD PMID:19386116 NCBI chr11:116,106,828...116,111,113
Ensembl chr11:116,106,829...116,111,113
JBrowse link
G Cdk4 cyclin dependent kinase 4 decreases expression ISO Ritonavir results in decreased expression of CDK4 mRNA; Ritonavir results in decreased expression of CDK4 protein CTD PMID:16551874 PMID:19386116 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
JBrowse link
G Cdk5 cyclin dependent kinase 5 decreases expression ISO Ritonavir results in decreased expression of CDK5 mRNA CTD PMID:19386116 NCBI chr 5:24,612,595...24,628,737
Ensembl chr 5:24,623,239...24,628,528
JBrowse link
G Cdk6 cyclin dependent kinase 6 decreases expression ISO Ritonavir results in decreased expression of CDK6 mRNA; Ritonavir results in decreased expression of CDK6 protein CTD PMID:16551874 PMID:19386116 NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
increases expression
ISO manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of CDKN1A protein]
Ritonavir results in increased expression of CDKN1A mRNA; Ritonavir results in increased expression of CDKN1A protein
CTD PMID:19386116 PMID:20884875 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B increases expression ISO Ritonavir results in increased expression of CDKN1B mRNA CTD PMID:19386116 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn2b cyclin dependent kinase inhibitor 2B increases expression ISO Ritonavir results in increased expression of CDKN2B mRNA CTD PMID:19386116 NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions EXP Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] CTD PMID:11101056 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Ciita class II transactivator increases expression ISO Ritonavir results in increased expression of CIITA CTD PMID:26626330 NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression ISO Ritonavir results in decreased expression of CROT mRNA CTD PMID:17719200 NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Ritonavir results in decreased expression of CXCL1 CTD PMID:26626330 NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases expression ISO Ritonavir results in decreased expression of CXCL10 CTD PMID:26626330 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression ISO Ritonavir results in decreased expression of CXCL12 CTD PMID:26626330 NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 multiple interactions
decreases expression
increases secretion
ISO Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CXCL8 protein]
Ritonavir results in decreased expression of CXCL8
CTD PMID:20884875 PMID:26626330 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression ISO Ritonavir results in decreased expression of CXCL2 CTD PMID:26626330 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Ritonavir results in decreased expression of CXCL1 CTD PMID:26626330 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
JBrowse link
G Cxcl5 C-X-C motif chemokine ligand 5 decreases expression ISO Ritonavir results in decreased expression of CXCL6 CTD PMID:26626330 NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 affects expression ISO Ritonavir affects the expression of CYB5R3 mRNA CTD PMID:17719200 NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
decreases activity
ISO Ritonavir results in increased expression of CYP1A1 mRNA
Ritonavir results in decreased activity of CYP1A1 protein
CTD PMID:11918509 PMID:33814510 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression
decreases expression
ISO Ritonavir results in increased expression of CYP1A2 mRNA
Ritonavir results in decreased expression of CYP1A2 mRNA
CTD PMID:11918509 PMID:17719200 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO Ritonavir results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 increases activity
increases expression
ISO Ritonavir results in increased activity of CYP2B6 protein
Ritonavir results in increased expression of CYP2B6 protein
CTD PMID:14977870 PMID:26626330 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2c29 cytochrome P450, family 2, subfamily c, polypeptide 29 decreases activity ISO Ritonavir results in decreased activity of CYP2C8 protein CTD PMID:15601807 NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 increases expression ISO Ritonavir results in increased expression of CYP2C19 mRNA CTD PMID:11918509 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 increases activity
increases expression
ISO Ritonavir results in increased activity of CYP2C9 protein
Ritonavir results in increased expression of CYP2C9 mRNA
CTD PMID:11918509 PMID:19202563 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2d22 cytochrome P450, family 2, subfamily d, polypeptide 22 affects metabolic processing ISO CYP2D6 protein affects the metabolism of Ritonavir CTD PMID:15286053 NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
JBrowse link
G Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 multiple interactions
decreases activity
ISO Ritonavir inhibits the reaction [CYP3A7 protein results in increased oxidation of Dehydroepiandrosterone Sulfate]
Ritonavir results in decreased activity of CYP3A5 protein
CTD PMID:15523003 PMID:33821626 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 affects expression
decreases expression
ISO Ritonavir affects the expression of CYP4B1 mRNA
Ritonavir results in decreased expression of CYP4B1 mRNA
CTD PMID:17719200 NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Ritonavir results in increased expression of CYP51 mRNA CTD PMID:17719200 NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 decreases expression ISO Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:17719200 PMID:26626330 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
JBrowse link
G Cyp8b1 cytochrome P450, family 8, subfamily b, polypeptide 1 decreases expression ISO Ritonavir results in decreased expression of CYP8B1
Ritonavir results in decreased expression of CYP8B1 mRNA
CTD PMID:17719200 PMID:26626330 NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase affects expression ISO Ritonavir affects the expression of DHCR7 mRNA CTD PMID:17719200 NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
JBrowse link
G E2f1 E2F transcription factor 1 decreases expression ISO Ritonavir results in decreased expression of E2F1 mRNA; Ritonavir results in decreased expression of E2F1 protein CTD PMID:19386116 NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
JBrowse link
G E2f2 E2F transcription factor 2 decreases expression ISO Ritonavir results in decreased expression of E2F2 mRNA CTD PMID:19386116 NCBI chr 4:135,899,585...135,923,368
Ensembl chr 4:135,899,705...135,923,368
JBrowse link
G E2f3 E2F transcription factor 3 decreases expression ISO Ritonavir results in decreased expression of E2F3 mRNA CTD PMID:19386116 NCBI chr13:30,090,558...30,171,172
Ensembl chr13:30,090,558...30,170,046
JBrowse link
G Ehhadh enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase affects expression ISO Ritonavir affects the expression of EHHADH mRNA CTD PMID:17719200 NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
JBrowse link
G Esr1 estrogen receptor 1 (alpha) decreases expression ISO Ritonavir results in decreased expression of ESR1 protein CTD PMID:16551874 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Fasl Fas ligand decreases expression ISO Ritonavir results in decreased expression of FASLG protein CTD PMID:10551732 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Fasn fatty acid synthase affects expression ISO Ritonavir affects the expression of FASN mRNA CTD PMID:17719200 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
JBrowse link
G Fgf15 fibroblast growth factor 15 increases expression ISO Ritonavir results in increased expression of FGF19 mRNA CTD PMID:26626330 NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
JBrowse link
G Fos FBJ osteosarcoma oncogene increases expression ISO Ritonavir results in increased expression of FOS protein CTD PMID:15504750 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions
increases activity
ISO Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; FTI 277 inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] CTD PMID:20884875 NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) multiple interactions EXP Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein] CTD PMID:11101056 NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Bilirubin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]; NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [Atazanavir Sulfate results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Lopinavir results in increased expression of HMOX1 mRNA]; Rotenone inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; tricarbonyldichlororuthenium (II) dimer promotes the reaction [Ritonavir results in increased expression of HMOX1 protein]
Ritonavir results in increased expression of HMOX1 mRNA; Ritonavir results in increased expression of HMOX1 protein
CTD PMID:15504750 PMID:26968795 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hsp90aa1 heat shock protein 90, alpha (cytosolic), class A member 1 affects response to substance EXP HSP90AA1 protein affects the susceptibility to Ritonavir CTD PMID:16551874 NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
JBrowse link
G Hsph1 heat shock 105kDa/110kDa protein 1 increases expression ISO Ritonavir results in increased expression of HSPH1 protein CTD PMID:26626330 NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
multiple interactions
ISO Ritonavir results in increased expression of ICAM1 protein
HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]
CTD PMID:26968795 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Ifng interferon gamma multiple interactions ISO Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein] CTD PMID:10551732 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
increases secretion
ISO
EXP
diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of IL6 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of IL6 protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
rosiglitazone inhibits the reaction [Ritonavir results in increased expression of IL6 mRNA]
Ritonavir results in increased expression of IL6 mRNA; Ritonavir results in increased expression of IL6 protein
CTD PMID:15388451 PMID:15865214 PMID:17668557 PMID:20884875 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Il7 interleukin 7 decreases expression ISO Ritonavir results in decreased expression of IL7 CTD PMID:26626330 NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
JBrowse link
G Ins1 insulin I multiple interactions EXP Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein]; Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] CTD PMID:11101056 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
JBrowse link
G Jun jun proto-oncogene increases expression ISO Ritonavir results in increased expression of JUN protein CTD PMID:15504750 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Lep leptin multiple interactions
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of LEP protein] CTD PMID:17668557 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lif leukemia inhibitory factor decreases expression ISO Ritonavir results in decreased expression of LIF CTD PMID:26626330 NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514
JBrowse link
G Lmna lamin A increases expression
increases farnesylation
ISO Ritonavir results in increased expression of LMNA protein
Ritonavir results in increased farnesylation of LMNA protein alternative form
CTD PMID:18230615 PMID:20884875 NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
JBrowse link
G Lpl lipoprotein lipase affects expression EXP Ritonavir affects the expression of LPL mRNA CTD PMID:11741158 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Myc myelocytomatosis oncogene decreases expression ISO Ritonavir results in decreased expression of MYC mRNA CTD PMID:16174765 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 increases expression
multiple interactions
ISO Ritonavir results in increased expression of NFE2L2 protein
NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]
CTD PMID:26968795 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 decreases activity ISO Ritonavir results in decreased activity of NFKB1 protein CTD PMID:16174765 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of NFKBIA protein CTD PMID:16174765 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 decreases expression ISO Ritonavir results in decreased expression of NLRC5 CTD PMID:26626330 NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions
decreases expression
ISO Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] CTD PMID:22037733 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Notch4 notch 4 decreases expression
multiple interactions
ISO Ritonavir results in decreased expression of NOTCH4 protein
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
CTD PMID:20722969 NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 increases expression ISO Ritonavir increases expression of NR1H3 mRNA in macrophages RGD PMID:18849545 RGD:401842387 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 increases expression ISO Ritonavir results in increased expression of NR1H4 mRNA CTD PMID:26626330 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions
increases activity
ISO Ritonavir binds to and results in increased activity of NR1I2 protein
Ritonavir results in increased activity of NR1I2 protein
CTD PMID:14977870 PMID:15849716 PMID:27732639 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases cleavage ISO Ritonavir results in increased cleavage of PARP1 protein CTD PMID:19386116 PMID:21270666 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Pon1 paraoxonase 1 decreases activity ISO Ritonavir results in decreased activity of PON1 protein CTD PMID:27378623 NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions
increases expression
EXP
ISO
Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]
Ritonavir results in increased expression of PPARG mRNA
CTD PMID:11101056 PMID:17879945 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Prkca protein kinase C, alpha multiple interactions
increases activity
increases expression
EXP Ritonavir binds to and affects the localization of PRKCA protein
Ritonavir results in increased activity of PRKCA protein
Ritonavir results in increased expression of PRKCA protein
CTD PMID:22020176 NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
JBrowse link
G Psma1 proteasome subunit alpha 1 affects expression ISO Ritonavir affects the expression of PSMA1 mRNA CTD PMID:17719200 NCBI chr 7:113,863,785...113,875,351
Ensembl chr 7:113,863,841...113,875,353
JBrowse link
G Psmb3 proteasome (prosome, macropain) subunit, beta type 3 affects expression ISO Ritonavir affects the expression of PSMB3 mRNA CTD PMID:17719200 NCBI chr11:97,594,260...97,604,326
Ensembl chr11:97,594,225...97,604,326
JBrowse link
G Psmb5 proteasome (prosome, macropain) subunit, beta type 5 increases expression ISO Ritonavir results in increased expression of PSMB5 mRNA CTD PMID:20213465 NCBI chr14:54,851,577...54,855,452
Ensembl chr14:54,851,576...54,855,479
JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases phosphorylation
increases expression
ISO Ritonavir results in decreased phosphorylation of RB1 protein
Ritonavir results in increased expression of RB1 mRNA
CTD PMID:16551874 PMID:19386116 PMID:21270666 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
JBrowse link
G Rbl1 RB transcriptional corepressor like 1 increases expression ISO Ritonavir results in increased expression of RBL1 mRNA CTD PMID:19386116 NCBI chr 2:156,987,813...157,046,454
Ensembl chr 2:156,987,813...157,046,454
JBrowse link
G Rbl2 RB transcriptional corepressor like 2 decreases expression ISO Ritonavir results in decreased expression of RBL2 mRNA CTD PMID:19386116 NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
JBrowse link
G Rel reticuloendotheliosis oncogene decreases activity ISO Ritonavir results in decreased activity of REL protein CTD PMID:16174765 NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) decreases activity ISO Ritonavir results in decreased activity of RELA protein CTD PMID:16174765 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions
increases expression
ISO Estradiol inhibits the reaction [Ritonavir results in increased expression of SCARB1 protein]
Ritonavir results in increased expression of SCARB1 mRNA
CTD PMID:17879945 NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
JBrowse link
G Scp2 sterol carrier protein 2, liver decreases expression ISO Ritonavir results in decreased expression of SCP2 CTD PMID:26626330 NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
JBrowse link
G Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 decreases expression ISO Ritonavir results in decreased expression of SLC10A1 CTD PMID:26626330 NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
JBrowse link
G Slc51a solute carrier family 51, alpha subunit decreases expression ISO Ritonavir results in decreased expression of SLC51A CTD PMID:26626330 NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
JBrowse link
G Src Rous sarcoma oncogene decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of SRC protein CTD PMID:21270666 NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions EXP Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] CTD PMID:11101056 NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
JBrowse link
G Stat3 signal transducer and activator of transcription 3 decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of STAT3 protein CTD PMID:21270666 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Tjp1 tight junction protein 1 decreases expression
multiple interactions
ISO Ritonavir results in decreased expression of TJP1 protein
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]
CTD PMID:20722969 NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
JBrowse link
G Tnf tumor necrosis factor decreases secretion
multiple interactions
increases expression
ISO
EXP
Ritonavir results in decreased secretion of TNF protein
rosiglitazone inhibits the reaction [Ritonavir results in increased expression of TNF mRNA]
Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
Ritonavir results in increased expression of TNF mRNA; Ritonavir results in increased expression of TNF protein
CTD PMID:10551732 PMID:15388451 PMID:15865214 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 multiple interactions
increases expression
ISO FTI 277 inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased expression of TP53 protein] CTD PMID:19386116 PMID:20884875 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase 1 family, polypeptide A1 affects expression ISO Ritonavir affects the expression of UGT1A1 mRNA CTD PMID:15849716 NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
JBrowse link
G Zmpste24 zinc metallopeptidase, STE24 decreases activity ISO Ritonavir results in decreased activity of ZMPSTE24 protein CTD PMID:18230615 NCBI chr 4:120,916,434...120,955,452
Ensembl chr 4:120,916,434...120,955,438
JBrowse link
saquinavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 multiple interactions
decreases activity
ISO Saquinavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Saquinavir results in decreased activity of ABCB11 protein
CTD PMID:20829430 PMID:23956101 PMID:24014644 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A affects export
affects uptake
increases export
ISO
EXP
ABCB1 protein affects the export of Saquinavir
ABCB1A protein affects the uptake of Saquinavir
ABCB1 protein results in increased export of Saquinavir
CTD PMID:10562306 PMID:15832500 PMID:18535159 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B affects uptake EXP ABCB1B protein affects the uptake of Saquinavir CTD PMID:10562306 NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
JBrowse link
G Abcc1 ATP-binding cassette, sub-family C member 1 increases export ISO ABCC1 protein results in increased export of Saquinavir CTD PMID:18535159 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 affects export
multiple interactions
increases export
ISO ABCC2 protein affects the export of Saquinavir
montelukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir]
CTD PMID:15832500 PMID:18535159 PMID:19952419 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
multiple interactions
EXP Saquinavir results in decreased expression of ADIPOQ mRNA; Saquinavir results in decreased expression of ADIPOQ protein
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA; rosiglitazone inhibits the reaction [Saquinavir results in decreased secretion of ADIPOQ protein]
CTD PMID:15865214 PMID:16931933 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Aebp1 AE binding protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of AEBP1 mRNA CTD PMID:16931933 NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088
JBrowse link
G Alb albumin affects binding ISO Saquinavir binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA CTD PMID:16931933 NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
JBrowse link
G Arpp21 cyclic AMP-regulated phosphoprotein, 21 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA CTD PMID:16931933 NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006
JBrowse link
G Asic2 acid-sensing ion channel 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA CTD PMID:16931933 NCBI chr11:80,770,989...81,859,222
Ensembl chr11:80,770,995...81,859,283
JBrowse link
G Atf6 activating transcription factor 6 increases expression ISO Saquinavir results in increased expression of ATF6 protein CTD PMID:19147209 NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
JBrowse link
G C1rb complement component 1, r subcomponent B multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C1R mRNA CTD PMID:16931933 NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
JBrowse link
G C3ar1 complement component 3a receptor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C3AR1 mRNA CTD PMID:16931933 NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
JBrowse link
G Casp9 caspase 9 increases cleavage ISO Saquinavir results in increased cleavage of CASP9 protein CTD PMID:19147209 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G Cd36 CD36 molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CD36 mRNA CTD PMID:16931933 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cfd complement factor D multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CFD mRNA CTD PMID:16931933 NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CIDEC mRNA CTD PMID:16931933 NCBI chr 6:113,401,595...113,412,721
Ensembl chr 6:113,401,595...113,412,721
JBrowse link
G Clcn3 chloride channel, voltage-sensitive 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CLCN3 mRNA CTD PMID:16931933 NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
JBrowse link
G Cybb cytochrome b-245, beta polypeptide multiple interactions EXP Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] CTD PMID:14871405 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression ISO Saquinavir results in increased expression of CYP1A1 mRNA CTD PMID:9860486 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Dcn decorin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DCN mRNA CTD PMID:16931933 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
JBrowse link
G Dusp3 dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DUSP3 mRNA CTD PMID:16931933 NCBI chr11:101,861,967...101,877,839
Ensembl chr11:101,861,969...101,877,839
JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 NCBI chr19:46,120,336...46,124,133
Ensembl chr19:46,120,336...46,124,133
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ESR2 mRNA CTD PMID:16931933 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Etv6 ets variant 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ETV6 mRNA CTD PMID:16931933 NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Faim Fas apoptotic inhibitory molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of FAIM mRNA CTD PMID:16931933 NCBI chr 9:98,868,426...98,884,076
Ensembl chr 9:98,868,426...98,884,074
JBrowse link
G G0s2 G0/G1 switch gene 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
JBrowse link
G Ganc glucosidase, alpha; neutral C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of GANC mRNA CTD PMID:16931933 NCBI chr 2:120,234,377...120,291,347
Ensembl chr 2:120,234,377...120,292,181
JBrowse link
G Gm7030 predicted gene 7030 affects expression ISO Saquinavir affects the expression of HLA-F mRNA CTD PMID:25811541 NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317
JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of GUCY1B1 mRNA CTD PMID:16931933 NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996
JBrowse link
G H2-Oa histocompatibility 2, O region alpha locus affects expression ISO Saquinavir affects the expression of HLA-DOA mRNA CTD PMID:25811541 NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208
JBrowse link
G H4c8 H4 clustered histone 8 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of H4C9 mRNA CTD PMID:16931933 NCBI chr13:23,715,214...23,715,648
Ensembl chr13:23,715,220...23,715,689
JBrowse link
G Hadh hydroxyacyl-Coenzyme A dehydrogenase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of HADH mRNA CTD PMID:16931933 NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
JBrowse link
G Hcn1 hyperpolarization activated cyclic nucleotide gated potassium channel 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of HCN1 mRNA CTD PMID:16931933 NCBI chr13:117,738,856...118,117,564
Ensembl chr13:117,738,856...118,123,954
JBrowse link
G Hspa5 heat shock protein 5 increases expression ISO Saquinavir results in increased expression of HSPA5 protein CTD PMID:19147209 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA CTD PMID:16931933 NCBI chr10:128,466,708...128,505,668
Ensembl chr10:128,466,712...128,505,227
JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions
EXP
ISO
Saquinavir results in increased expression of IL6 mRNA; Saquinavir results in increased expression of IL6 protein
rosiglitazone inhibits the reaction [Saquinavir results in increased expression of IL6 mRNA]
Saquinavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
CTD PMID:15388451 PMID:15865214 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Ins2 insulin II multiple interactions ISO Saquinavir inhibits the reaction [INS protein results in increased import of Glucose] CTD PMID:11786383 NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
JBrowse link
G Klhl28 kelch-like 28 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of KLHL28 mRNA CTD PMID:16931933 NCBI chr12:64,985,603...65,012,365
Ensembl chr12:64,985,607...65,012,308
JBrowse link
G Lamc2 laminin, gamma 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LAMC2 mRNA CTD PMID:16931933 NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEF1 mRNA CTD PMID:16931933 NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
JBrowse link
G Lep leptin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEP mRNA CTD PMID:16931933 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lpl lipoprotein lipase decreases activity
decreases expression
EXP Saquinavir results in decreased activity of LPL protein
Saquinavir results in decreased expression of LPL mRNA
CTD PMID:11741158 PMID:11786383 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Ly6f lymphocyte antigen 6 family member F multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6F mRNA CTD PMID:16931933 NCBI chr15:75,140,221...75,144,086
Ensembl chr15:75,140,270...75,144,084
JBrowse link
G Ly6i lymphocyte antigen 6 family member I multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6I mRNA CTD PMID:16931933 NCBI chr15:74,851,383...74,855,279
Ensembl chr15:74,851,383...74,855,279
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic decreases expression EXP Saquinavir results in decreased expression of ME1 mRNA CTD PMID:11741158 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Mgat4c MGAT4 family, member C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MGAT4C mRNA CTD PMID:16931933 NCBI chr10:101,517,348...102,227,712
Ensembl chr10:101,517,348...102,227,330
JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of MRAP mRNA CTD PMID:16931933 NCBI chr16:90,535,095...90,546,673
Ensembl chr16:90,535,095...90,546,673
JBrowse link
G Myod1 myogenic differentiation 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MYOD1 mRNA CTD PMID:16931933 NCBI chr 7:46,025,898...46,028,516
Ensembl chr 7:46,025,898...46,028,523
JBrowse link
G Nap1l5 nucleosome assembly protein 1-like 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NAP1L5 mRNA CTD PMID:16931933 NCBI chr 6:58,882,218...58,884,111
Ensembl chr 6:58,882,218...58,884,061
JBrowse link
G Noct nocturnin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA CTD PMID:16931933 NCBI chr 3:51,131,868...51,159,075
Ensembl chr 3:51,131,868...51,159,065
JBrowse link
G Notch4 notch 4 multiple interactions
decreases expression
ISO [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
Saquinavir results in decreased expression of NOTCH4 protein
CTD PMID:20722969 NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of Saquinavir] CTD PMID:18799805 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nup210 nucleoporin 210 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA CTD PMID:16931933 NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811
JBrowse link
G Oaz3 ornithine decarboxylase antizyme 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OAZ3 mRNA CTD PMID:16931933 NCBI chr 3:94,340,694...94,343,958
Ensembl chr 3:94,339,721...94,351,222
JBrowse link
G Or8g37 olfactory receptor family 8 subfamily G member 37 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OR8G37 mRNA CTD PMID:16931933 NCBI chr 9:39,730,937...39,731,872
Ensembl chr 9:39,720,156...39,732,293
JBrowse link
G Pcdh15 protocadherin 15 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PCDH15 mRNA CTD PMID:16931933 NCBI chr10:72,932,003...74,485,663
Ensembl chr10:72,935,174...74,485,569
JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PFKFB3 mRNA CTD PMID:16931933 NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888
JBrowse link
G Phf6 PHD finger protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PHF6 mRNA CTD PMID:16931933 NCBI chr  X:52,001,091...52,045,838
Ensembl chr  X:52,001,143...52,045,820
JBrowse link
G Pidd1 p53 induced death domain protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIDD1 mRNA CTD PMID:16931933 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
JBrowse link
G Piwil2 piwi-like RNA-mediated gene silencing 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIWIL2 mRNA CTD PMID:16931933 NCBI chr14:70,609,926...70,674,338
Ensembl chr14:70,609,926...70,666,832
JBrowse link
G Pon1 paraoxonase 1 decreases activity ISO Saquinavir results in decreased activity of PON1 protein CTD PMID:27378623 NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
JBrowse link
G Porcn porcupine O-acyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PPN mRNA CTD PMID:16931933 NCBI chr  X:8,060,085...8,072,794
Ensembl chr  X:8,060,087...8,072,764
JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA CTD PMID:16931933 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRDM1 mRNA CTD PMID:16931933 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
JBrowse link
G Prl2c2 prolactin family 2, subfamily c, member 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C2 mRNA CTD PMID:16931933 NCBI chr13:13,170,705...13,179,978
Ensembl chr13:13,170,710...13,179,968
JBrowse link
G Prl2c3 prolactin family 2, subfamily c, member 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C3 mRNA CTD PMID:16931933 NCBI chr13:12,805,705...12,814,982
Ensembl chr13:12,805,705...12,814,968
JBrowse link
G Prl2c4 prolactin family 2, subfamily c, member 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C4 mRNA CTD PMID:16931933 Ensembl chr13:12,805,705...12,814,968 JBrowse link
G Reep6 receptor accessory protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of REEP6 mRNA CTD PMID:16931933 NCBI chr10:80,165,831...80,172,275
Ensembl chr10:80,165,787...80,172,275
JBrowse link
G Rnf151 ring finger protein 151 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of RNF151 mRNA CTD PMID:16931933 NCBI chr17:24,934,813...24,937,031
Ensembl chr17:24,934,813...24,937,037
JBrowse link
G Rpain RPA interacting protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of RPAIN mRNA CTD PMID:16931933 NCBI chr11:70,860,403...70,868,759
Ensembl chr11:70,861,039...70,868,659
JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of S100A8 mRNA CTD PMID:16931933 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
JBrowse link
G Serpina1a serine (or cysteine) peptidase inhibitor, clade A, member 1A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SERPINA1A mRNA CTD PMID:16931933 NCBI chr12:103,819,554...103,829,878
Ensembl chr12:103,819,848...103,829,821
JBrowse link
G Slco1a5 solute carrier organic anion transporter family, member 1a5 affects uptake ISO SLCO1A2 protein affects the uptake of Saquinavir CTD PMID:15832500 NCBI chr 6:142,179,953...142,268,707
Ensembl chr 6:142,179,953...142,268,707
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial multiple interactions EXP Saquinavir inhibits the reaction [Morphine results in increased expression of SOD2 protein] CTD PMID:14871405 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA CTD PMID:16931933 NCBI chr18:44,092,612...44,155,554
Ensembl chr18:44,096,302...44,155,568
JBrowse link
G Sv2b synaptic vesicle glycoprotein 2b affects response to substance ISO SV2B gene SNP affects the susceptibility to Saquinavir CTD PMID:25622337 NCBI chr 7:74,764,642...74,959,143
Ensembl chr 7:74,764,642...74,959,010
JBrowse link
G Sval2 seminal vesicle antigen-like 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SVAL2 mRNA CTD PMID:16931933 NCBI chr 6:41,837,241...41,841,347
Ensembl chr 6:41,829,923...41,841,347
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TIMP2 mRNA CTD PMID:16931933 NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
JBrowse link
G Tjp1 tight junction protein 1 multiple interactions
decreases expression
ISO [Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]
Saquinavir results in decreased expression of TJP1 protein
CTD PMID:20722969 NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
ISO
EXP
Saquinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
Saquinavir results in increased expression of TNF mRNA; Saquinavir results in increased expression of TNF protein
rosiglitazone inhibits the reaction [Saquinavir results in increased expression of TNF mRNA]
CTD PMID:15388451 PMID:15865214 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trim42 tripartite motif-containing 42 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TRIM42 mRNA CTD PMID:16931933 NCBI chr 9:97,231,615...97,252,011
Ensembl chr 9:97,231,615...97,252,011
JBrowse link
G Wnt10a wingless-type MMTV integration site family, member 10A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of WNT10A mRNA CTD PMID:16931933 NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
JBrowse link
seliciclib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ccng1 cyclin G1 decreases expression ISO roscovitine decreases expression of Ccng1 in rat brain injury lesions RGD PMID:18612315 RGD:151356935 NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
JBrowse link
G Cdk1 cyclin dependent kinase 1 decreases activity ISO Roscovitine decreases activity of Cdk1 protein in oocytes RGD PMID:15695611 RGD:2301352 NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
JBrowse link
G Cdk2 cyclin dependent kinase 2 increases expression ISO roscovitine (seliciclib) increases expression of mRNA inhibiting the reaction [camptothecin increases kinase activity] in rat cerebellar granule neurons RGD PMID:19151707 RGD:10053571 NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
JBrowse link
G Cdk6 cyclin dependent kinase 6 increases expression ISO roscovitine (seliciclib) increases expression of mRNA inhibiting the reaction [camptothecin increases kinase activity] in rat cerebellar granule neurons RGD PMID:19151707 RGD:10053571 NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
JBrowse link
sofosbuvir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Klrc1 killer cell lectin-like receptor subfamily C, member 1 decreases expression ISO sofosbuvir co-treated with ledipasvir decreased expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 6:129,642,978...129,659,815
Ensembl chr 6:129,642,978...129,655,936
JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 affects expression ISO sofosbuvir co-treated with ledipasvir affects expression of NCR1 protein in natural killer cells RGD PMID:31218578 RGD:40400920 NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163
JBrowse link
telbivudine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Calcb calcitonin-related polypeptide, beta increases expression ISO Telbivudine results in increased expression of CALCB mRNA CTD PMID:37852574 NCBI chr 7:114,315,790...114,322,603
Ensembl chr 7:114,317,878...114,322,600
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression ISO Telbivudine results in increased expression of CEBPB mRNA CTD PMID:37852574 NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
JBrowse link
G Ddx3y DEAD box helicase 3, Y-linked increases expression ISO Telbivudine results in increased expression of DDX3Y mRNA CTD PMID:37852574 NCBI chr  Y:1,260,715...1,286,630
Ensembl chr  Y:1,260,771...1,286,629
JBrowse link
G Kdm5d lysine demethylase 5D increases expression ISO Telbivudine results in increased expression of KDM5D mRNA CTD PMID:37852574 NCBI chr  Y:897,566...946,316
Ensembl chr  Y:897,788...956,786
JBrowse link
G Mc2r melanocortin 2 receptor decreases expression ISO Telbivudine results in decreased expression of MC2R mRNA CTD PMID:37852574 NCBI chr18:68,539,970...68,562,391
Ensembl chr18:68,539,978...68,562,391
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial decreases expression EXP
ISO
Telbivudine results in decreased expression of COX2 protein CTD PMID:37659625 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G Mtarc1 mitochondrial amidoxime reducing component 1 decreases expression ISO Telbivudine results in decreased expression of MTARC1 mRNA CTD PMID:37852574 NCBI chr 1:184,518,964...184,543,622
Ensembl chr 1:184,518,964...184,543,394
JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 decreases expression ISO
EXP
Telbivudine results in decreased expression of NDUFB8 protein CTD PMID:37659625 NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1, cytosolic decreases expression ISO Telbivudine results in decreased expression of PCK1 mRNA CTD PMID:37852574 NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
JBrowse link
tenofovir disoproxil fumarate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb4 ATP-binding cassette, sub-family B member 4 decreases activity ISO Tenofovir results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
G Acacb acetyl-Coenzyme A carboxylase beta affects expression ISO Tenofovir affects the expression of ACACB mRNA CTD PMID:20032539 NCBI chr 5:114,284,748...114,388,822
Ensembl chr 5:114,284,596...114,388,822
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like increases expression ISO Tenofovir results in increased expression of BNIP3L protein CTD PMID:23640862 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein] CTD PMID:36309141 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Cat catalase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein CTD PMID:34118364 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression
multiple interactions
ISO Tenofovir results in increased expression of CCL20 mRNA
Tenofovir results in increased expression of and results in increased secretion of CCL20 protein
CTD PMID:24205323 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A increases expression
multiple interactions
ISO Tenofovir results in increased expression of CDKN1A protein
[Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein
CTD PMID:31545371 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 multiple interactions
increases expression
ISO Tenofovir results in increased expression of and results in increased secretion of CXCL8 protein
Tenofovir results in increased expression of CXCL8 mRNA
CTD PMID:24205323 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 decreases activity ISO Tenofovir results in decreased activity of CYP2C9 protein CTD PMID:17162464 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity ISO Tenofovir results in decreased activity of CYP2E1 protein CTD PMID:17162464 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Ddx3y DEAD box helicase 3, Y-linked increases expression ISO Tenofovir results in increased expression of DDX3Y mRNA CTD PMID:37852574 NCBI chr  Y:1,260,715...1,286,630
Ensembl chr  Y:1,260,771...1,286,629
JBrowse link
G Edn1 endothelin 1 increases secretion
multiple interactions
ISO Tenofovir results in increased secretion of EDN1 protein
coenzyme Q10 inhibits the reaction [Tenofovir results in increased secretion of EDN1 protein]
CTD PMID:23640862 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha affects phosphorylation ISO Tenofovir affects the phosphorylation of EIF2S1 protein CTD PMID:27041070 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
JBrowse link
G Fgb fibrinogen beta chain decreases expression ISO Tenofovir results in decreased expression of FGB mRNA CTD PMID:37852574 NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
JBrowse link
G Gjc2 gap junction protein, gamma 2 increases expression ISO Tenofovir results in increased expression of GJC2 mRNA CTD PMID:37852574 NCBI chr11:59,066,390...59,074,039
Ensembl chr11:59,066,394...59,074,039
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions
increases secretion
ISO Tenofovir inhibits the reaction [cidofovir results in increased secretion of HAVCR1 protein]
Tenofovir results in increased secretion of HAVCR1 protein
CTD PMID:29738843 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 affects expression ISO Tenofovir affects the expression of HSD11B1 mRNA CTD PMID:20032539 NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
JBrowse link
G Hspd1 heat shock protein 1 (chaperonin) affects expression ISO Tenofovir affects the expression of HSPD1 protein CTD PMID:27041070 NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein] CTD PMID:36309141 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Irf4 interferon regulatory factor 4 decreases expression ISO Tenofovir results in decreased expression of IRF4 mRNA CTD PMID:37852574 NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
JBrowse link
G Kdm5d lysine demethylase 5D increases expression ISO Tenofovir results in increased expression of KDM5D mRNA CTD PMID:37852574 NCBI chr  Y:897,566...946,316
Ensembl chr  Y:897,788...956,786
JBrowse link
G Klf15 Kruppel-like transcription factor 15 decreases expression ISO Tenofovir results in decreased expression of KLF15 mRNA CTD PMID:37852574 NCBI chr 6:90,437,785...90,468,785
Ensembl chr 6:90,439,558...90,452,220
JBrowse link
G Lipe lipase, hormone sensitive affects expression ISO Tenofovir affects the expression of LIPE mRNA CTD PMID:20032539 NCBI chr 7:25,078,952...25,097,911
Ensembl chr 7:25,078,952...25,098,135
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial affects expression ISO Tenofovir affects the expression of LONP1 protein CTD PMID:27041070 NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887
JBrowse link
G Lpin1 lipin 1 decreases expression ISO Tenofovir results in decreased expression of LPIN1 mRNA CTD PMID:37852574 NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 affects phosphorylation ISO Tenofovir affects the phosphorylation of MAPK8 protein CTD PMID:27041070 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO [efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein CTD PMID:34118364 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial multiple interactions ISO Tenofovir promotes the reaction [Didanosine results in decreased expression of COX2 mRNA] CTD PMID:16940060 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha decreases expression ISO Tenofovir results in decreased expression of NFKBIA protein CTD PMID:27899301 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nos2 nitric oxide synthase 2, inducible increases expression ISO Tenofovir results in increased expression of NOS2 mRNA; Tenofovir results in increased expression of NOS2 protein CTD PMID:27899301 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions
decreases phosphorylation
ISO coenzyme Q10 inhibits the reaction [Tenofovir results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects expression ISO Tenofovir affects the expression of NR3C1 mRNA CTD PMID:20032539 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
JBrowse link
G Nt5e 5' nucleotidase, ecto increases expression ISO Tenofovir results in increased expression of NT5E mRNA CTD PMID:24205323 NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145
JBrowse link
G Nt5m 5',3'-nucleotidase, mitochondrial decreases expression ISO Tenofovir results in decreased expression of NT5M mRNA CTD PMID:24205323 NCBI chr11:59,730,233...59,767,359
Ensembl chr11:59,730,273...59,771,794
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma affects expression ISO Tenofovir affects the expression of PPARG mRNA CTD PMID:20032539 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions ISO [Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein CTD PMID:31545371 NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression ISO Tenofovir results in increased expression of PTGS2 mRNA; Tenofovir results in increased expression of PTGS2 protein CTD PMID:27899301 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) affects localization
increases expression
multiple interactions
ISO Tenofovir affects the localization of RELA protein
Tenofovir results in increased expression of RELA mRNA
Melatonin inhibits the reaction [Tenofovir affects the localization of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of and results in increased activity of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of RELA mRNA]; Tenofovir results in increased expression of and results in increased activity of RELA protein
CTD PMID:27899301 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Sirt3 sirtuin 3 increases expression ISO Tenofovir results in increased expression of SIRT3 protein CTD PMID:27041070 NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
JBrowse link
G Slc22a6 solute carrier family 22 (organic anion transporter), member 6 increases response to substance
increases import
multiple interactions
ISO SLC22A6 protein results in increased susceptibility to Tenofovir
SLC22A6 protein results in increased import of Tenofovir
Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to Tenofovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to Tenofovir; Tenofovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD PMID:23856525 PMID:25448811 PMID:29738843 NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 increases response to substance
increases import
ISO SLC22A8 protein results in increased susceptibility to Tenofovir
SLC22A8 protein results in increased import of Tenofovir
CTD PMID:25448811 PMID:29738843 NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions
increases expression
ISO Tenofovir results in decreased expression of TNF mRNA
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein]
Tenofovir results in increased expression of TNF mRNA; Tenofovir results in increased expression of TNF protein
CTD PMID:24205323 PMID:27899301 PMID:36309141 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 multiple interactions
increases expression
ISO [Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein
Tenofovir results in increased expression of TP53 protein
CTD PMID:31545371 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Usp18 ubiquitin specific peptidase 18 increases expression ISO Tenofovir results in increased expression of USP18 mRNA CTD PMID:37852574 NCBI chr 6:121,222,865...121,247,876
Ensembl chr 6:121,222,865...121,247,876
JBrowse link
tipranavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases activity
multiple interactions
ISO tipranavir results in decreased activity of ABCB11 protein
tipranavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:24014644 PMID:28437613 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb4 ATP-binding cassette, sub-family B member 4 decreases activity ISO tipranavir results in decreased activity of ABCB4 protein CTD PMID:28437613 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
trifluridine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 multiple interactions ISO CA 074 methyl ester inhibits the reaction [Trifluridine results in increased cleavage of CASP3 protein]; Trifluridine results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:19816940 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp8 caspase 8 increases cleavage ISO Trifluridine results in increased cleavage of CASP8 protein CTD PMID:19816940 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Casp9 caspase 9 increases cleavage ISO Trifluridine results in increased cleavage of CASP9 protein CTD PMID:19816940 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G Ctsb cathepsin B increases cleavage
multiple interactions
ISO Trifluridine results in increased cleavage of CTSB protein
CA 074 methyl ester inhibits the reaction [Trifluridine results in increased cleavage of CTSB protein]
CTD PMID:19816940 NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions ISO Trifluridine inhibits the reaction [Estradiol results in increased activity of ESR2 protein] CTD PMID:30818834 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Esrra estrogen related receptor, alpha multiple interactions ISO Trifluridine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 increases activity ISO Trifluridine results in increased activity of NFE2L2 protein CTD PMID:30818834 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
multiple interactions
ISO Trifluridine results in increased activity of NR1I2 protein
[Trifluridine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD PMID:25455453 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO Trifluridine inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased activity of NR1I3 protein] CTD PMID:30818834 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases cleavage ISO Trifluridine results in increased cleavage of PARP1 protein CTD PMID:19816940 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Trp53 transformation related protein 53 affects activity ISO Trifluridine affects the activity of TP53 protein CTD PMID:35435491 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
zalcitabine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 5730455P16Rik RIKEN cDNA 5730455P16 gene multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of C10H17ORF75 mRNA CTD PMID:18606552 NCBI chr11:80,251,318...80,268,860
Ensembl chr11:80,251,319...80,268,860
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 affects phosphorylation ISO Zalcitabine affects the phosphorylation of AKT1 protein CTD PMID:19781600 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Alb albumin affects binding ISO Zalcitabine binds to ALB protein CTD PMID:15814459 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Ano3 anoctamin 3 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ANO3 mRNA CTD PMID:18606552 NCBI chr 2:110,485,546...110,780,854
Ensembl chr 2:110,485,546...110,781,268
JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 increases response to substance ISO APEX1 protein mutant form results in increased susceptibility to Zalcitabine CTD PMID:17259346 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of ARNT2 mRNA CTD PMID:18606552 NCBI chr 7:83,895,486...84,059,201
Ensembl chr 7:83,895,486...84,059,384
JBrowse link
G Atp2b4 ATPase, Ca++ transporting, plasma membrane 4 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of ATP2B4 mRNA CTD PMID:18606552 NCBI chr 1:133,630,416...133,728,755
Ensembl chr 1:133,627,195...133,728,779
JBrowse link
G Bptf bromodomain PHD finger transcription factor multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of BPTF mRNA CTD PMID:18606552 NCBI chr11:106,923,907...107,022,982
Ensembl chr11:106,923,907...107,022,953
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Zalcitabine results in increased expression of CCL2 protein CTD PMID:17761732 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 increases expression ISO Zalcitabine results in increased expression of CXCL12 mRNA CTD PMID:17292584 NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 increases expression ISO Zalcitabine results in increased expression of CXCR4 mRNA CTD PMID:17292584 NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
JBrowse link
G Dck deoxycytidine kinase affects response to substance ISO DCK protein affects the susceptibility to Zalcitabine CTD PMID:11952160 NCBI chr 5:88,912,872...88,931,136
Ensembl chr 5:88,912,855...88,931,140
JBrowse link
G Depdc1b DEP domain containing 1B multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of DEPDC1B mRNA CTD PMID:18606552 NCBI chr13:108,452,592...108,526,100
Ensembl chr13:108,452,866...108,544,316
JBrowse link
G Dlg5 discs large MAGUK scaffold protein 5 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of DLG5 mRNA CTD PMID:18606552 NCBI chr14:24,184,021...24,295,988
Ensembl chr14:24,184,021...24,295,988
JBrowse link
G Esrrg estrogen-related receptor gamma multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ESRRG mRNA CTD PMID:18606552 NCBI chr 1:187,340,707...187,947,082
Ensembl chr 1:187,340,988...187,947,082
JBrowse link
G Fam81a family with sequence similarity 81, member A multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of FAM81A mRNA CTD PMID:18606552 NCBI chr 9:69,996,586...70,049,840
Ensembl chr 9:69,995,793...70,049,842
JBrowse link
G Fpgt fucose-1-phosphate guanylyltransferase multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of FPGT mRNA CTD PMID:18606552 NCBI chr 3:154,790,552...154,799,024
Ensembl chr 3:154,790,555...154,799,040
JBrowse link
G Gla galactosidase, alpha multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of GLA mRNA CTD PMID:18606552 NCBI chr  X:133,488,912...133,501,707
Ensembl chr  X:133,488,898...133,501,874
JBrowse link
G Htr2a 5-hydroxytryptamine (serotonin) receptor 2A increases response to substance
increases expression
multiple interactions
EXP
ISO
HTR2A gene results in increased susceptibility to Zalcitabine
Zalcitabine results in increased expression of HTR2A protein
[alpha-phenyl-1-(2-phenylethyl)-4-piperidinemethanol binds to and results in decreased activity of HTR2A protein] which results in decreased susceptibility to Zalcitabine
CTD PMID:17888573 NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
JBrowse link
G Il2ra interleukin 2 receptor, alpha chain decreases expression
multiple interactions
ISO Zalcitabine results in decreased expression of IL2RA mRNA; Zalcitabine results in decreased expression of IL2RA protein
Zidovudine promotes the reaction [Zalcitabine results in decreased expression of IL2RA mRNA]; Zidovudine promotes the reaction [Zalcitabine results in decreased expression of IL2RA protein]
CTD PMID:7606800 NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of IRF7 mRNA CTD PMID:18606552 NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
JBrowse link
G Kif5a kinesin family member 5A multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of KIF5A mRNA CTD PMID:18606552 NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217
JBrowse link
G Lama5 laminin, alpha 5 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of LAMA5 mRNA CTD PMID:18606552 NCBI chr 2:179,818,166...179,867,652
Ensembl chr 2:179,818,166...179,867,652
JBrowse link
G Luzp2 leucine zipper protein 2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of LUZP2 mRNA CTD PMID:18606552 NCBI chr 7:54,484,936...54,918,636
Ensembl chr 7:54,485,246...54,918,633
JBrowse link
G Midn midnolin multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of MIDN mRNA CTD PMID:18606552 NCBI chr10:79,984,106...79,994,202
Ensembl chr10:79,984,106...79,994,202
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial decreases expression
multiple interactions
ISO
EXP
Zalcitabine results in decreased expression of COX1 protein
Uridine inhibits the reaction [Zalcitabine results in decreased expression of COX1 protein]
CTD PMID:17187420 PMID:18823003 PMID:20032772 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial decreases expression ISO Zalcitabine results in decreased expression of COX2 mRNA CTD PMID:19781600 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G mt-Co3 cytochrome c oxidase III, mitochondrial decreases expression ISO Zalcitabine results in decreased expression of COX3 protein CTD PMID:17508937 NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
JBrowse link
G Ndufb11 NADH:ubiquinone oxidoreductase subunit B11 multiple interactions ISO Zalcitabine inhibits the reaction [Cyclic AMP results in increased phosphorylation of NDUFB11 protein] CTD PMID:17904600 NCBI chr  X:20,481,565...20,483,858
Ensembl chr  X:20,481,565...20,483,858
JBrowse link
G Necab1 N-terminal EF-hand calcium binding protein 1 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of NECAB1 mRNA CTD PMID:18606552 NCBI chr 4:14,952,245...15,149,804
Ensembl chr 4:14,952,245...15,149,794
JBrowse link
G Nkiras1 NFKB inhibitor interacting Ras-like protein 1 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of NKIRAS1 mRNA CTD PMID:18606552 NCBI chr14:4,185,693...4,198,560
Ensembl chr14:4,185,693...4,198,560
JBrowse link
G Notch1 notch 1 increases mutagenesis EXP Zalcitabine results in increased mutagenesis of NOTCH1 gene CTD PMID:18798262 NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
JBrowse link
G Npy neuropeptide Y multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of NPY mRNA CTD PMID:18606552 NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
JBrowse link
G Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of NTRK2 mRNA alternative form CTD PMID:18606552 NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
JBrowse link
G Per2 period circadian clock 2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of PER2 mRNA CTD PMID:18606552 NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
JBrowse link
G Rab27b RAB27B, member RAS oncogene family multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of RAB27B mRNA CTD PMID:18606552 NCBI chr18:70,112,202...70,274,704
Ensembl chr18:70,112,202...70,274,676
JBrowse link
G Reg3b regenerating islet-derived 3 beta multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of REG3B mRNA; [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of REG3B protein CTD PMID:18606552 NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
JBrowse link
G Robo2 roundabout guidance receptor 2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ROBO2 mRNA CTD PMID:18606552 NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,208,713
JBrowse link
G Sanbr SANT and BTB domain regulator of CSR multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SANBR mRNA CTD PMID:18606552 NCBI chr11:23,514,949...23,596,409
Ensembl chr11:23,514,961...23,583,631
JBrowse link
G Scube1 signal peptide, CUB domain, EGF-like 1 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of SCUBE1 mRNA CTD PMID:18606552 NCBI chr15:83,486,784...83,609,252
Ensembl chr15:83,489,200...83,609,222
JBrowse link
G Senp5 SUMO/sentrin specific peptidase 5 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SENP5 mRNA CTD PMID:18606552 NCBI chr16:31,778,488...31,829,388
Ensembl chr16:31,778,490...31,822,105
JBrowse link
G Slc28a1 solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 multiple interactions
increases uptake
ISO Zalcitabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zalcitabine promotes the reaction [SLC28A1 protein results in increased export of Uridine]
SLC28A1 protein results in increased uptake of Zalcitabine
CTD PMID:8027026 PMID:8700147 PMID:8713072 NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
JBrowse link
G Slc29a3 solute carrier family 29 (nucleoside transporters), member 3 affects transport ISO SLC29A3 protein affects the transport of Zalcitabine CTD PMID:19164483 NCBI chr10:60,547,851...60,588,624
Ensembl chr10:60,547,851...60,588,573
JBrowse link
G Slc35g2 solute carrier family 35, member G2 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SLC35G2 mRNA CTD PMID:18606552 NCBI chr 9:100,431,178...100,453,138
Ensembl chr 9:100,434,241...100,453,143
JBrowse link
G Slc4a8 solute carrier family 4 (anion exchanger), member 8 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of SLC4A8 mRNA CTD PMID:18606552 NCBI chr15:100,659,628...100,721,852
Ensembl chr15:100,659,628...100,721,849
JBrowse link
G St8sia3 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of ST8SIA3 mRNA CTD PMID:18606552 NCBI chr18:64,387,430...64,409,217
Ensembl chr18:64,387,430...64,412,682
JBrowse link
G Sv2b synaptic vesicle glycoprotein 2b multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SV2B mRNA CTD PMID:18606552 NCBI chr 7:74,764,642...74,959,143
Ensembl chr 7:74,764,642...74,959,010
JBrowse link
G Tfam transcription factor A, mitochondrial affects expression ISO Zalcitabine affects the expression of TFAM protein CTD PMID:7849699 NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO Zalcitabine results in decreased expression of TK1 mRNA; Zalcitabine results in decreased expression of TK1 protein CTD PMID:14659972 NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
JBrowse link
G Tk2 thymidine kinase 2, mitochondrial decreases expression ISO Zalcitabine results in decreased expression of TK2 mRNA CTD PMID:14659972 NCBI chr 8:104,953,323...104,975,224
Ensembl chr 8:104,953,317...104,975,190
JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 increases response to substance ISO TRPV4 protein results in increased susceptibility to Zalcitabine CTD PMID:18234883 NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
JBrowse link
G Tymp thymidine phosphorylase increases expression ISO Zalcitabine results in increased expression of TYMP protein CTD PMID:16457948 NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
JBrowse link
G Vgf VGF nerve growth factor inducible multiple interactions ISO [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of VGF mRNA CTD PMID:18606552 NCBI chr 5:137,054,156...137,062,205
Ensembl chr 5:137,055,246...137,062,205
JBrowse link
zidovudine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca3 ATP-binding cassette, sub-family A member 3 increases expression ISO Zidovudine results in increased expression of ABCA3 mRNA CTD PMID:24292225 NCBI chr17:24,570,997...24,629,178
Ensembl chr17:24,570,924...24,629,175
JBrowse link
G Abca7 ATP-binding cassette, sub-family A member 7 decreases expression
increases expression
ISO Zidovudine results in decreased expression of ABCA7 mRNA
Zidovudine results in increased expression of ABCA7 mRNA
CTD PMID:24292225 NCBI chr10:79,832,328...79,851,406
Ensembl chr10:79,832,328...79,851,406
JBrowse link
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases expression ISO Zidovudine results in decreased expression of ABCB11 mRNA CTD PMID:27765674 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A increases expression ISO Zidovudine results in increased expression of ABCB1 mRNA; Zidovudine results in increased expression of ABCB1 protein CTD PMID:9148857 PMID:15456083 PMID:18310046 PMID:24292225 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb9 ATP-binding cassette, sub-family B member 9 increases expression ISO Zidovudine results in increased expression of ABCB9 mRNA CTD PMID:24292225 NCBI chr 5:124,199,920...124,234,009
Ensembl chr 5:124,199,593...124,233,861
JBrowse link
G Abcc1 ATP-binding cassette, sub-family C member 1 increases expression ISO Zidovudine results in increased expression of ABCC1 mRNA CTD PMID:24292225 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
JBrowse link
G Abcc10 ATP-binding cassette, sub-family C member 10 increases expression ISO Zidovudine results in increased expression of ABCC10 mRNA CTD PMID:24292225 NCBI chr17:46,614,146...46,638,954
Ensembl chr17:46,614,147...46,639,278
JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 increases expression
decreases expression
ISO Zidovudine results in increased expression of ABCC3 mRNA
Zidovudine results in decreased expression of ABCC3 mRNA
CTD PMID:24292225 PMID:27765674 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
JBrowse link
G Abcc4 ATP-binding cassette, sub-family C member 4 affects abundance
increases expression
increases export
ISO ABCC4 protein affects the abundance of Zidovudine
Zidovudine results in increased expression of ABCC4 mRNA
ABCC4 protein results in increased export of Zidovudine
CTD PMID:15456083 PMID:18364470 PMID:18535159 NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
JBrowse link
G Abcc5 ATP-binding cassette, sub-family C member 5 increases export
increases expression
ISO ABCC5 protein results in increased export of Zidovudine
Zidovudine results in increased expression of ABCC5 mRNA
CTD PMID:15456083 PMID:18535159 PMID:24292225 NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
JBrowse link
G Abcc6 ATP-binding cassette, sub-family C member 6 increases expression ISO Zidovudine results in increased expression of ABCC6 mRNA CTD PMID:24292225 NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
JBrowse link
G Abcd1 ATP-binding cassette, sub-family D member 1 increases expression ISO Zidovudine results in increased expression of ABCD1 mRNA CTD PMID:24292225 NCBI chr  X:72,760,203...72,782,140
Ensembl chr  X:72,760,203...72,782,140
JBrowse link
G Abcf2 ATP-binding cassette, sub-family F member 2 increases expression ISO Zidovudine results in increased expression of ABCF2 mRNA CTD PMID:24292225 NCBI chr 5:24,770,339...24,782,465
Ensembl chr 5:24,770,343...24,782,465
JBrowse link
G Abcf3 ATP-binding cassette, sub-family F member 3 increases expression ISO Zidovudine results in increased expression of ABCF3 mRNA CTD PMID:24292225 NCBI chr16:20,367,309...20,380,357
Ensembl chr16:20,367,327...20,380,129
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions
increases expression
decreases expression
increases export
decreases export
EXP
ISO
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in decreased export of Zidovudine]; 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of Zidovudine]; Elacridar inhibits the reaction [ABCG2 protein results in decreased export of Zidovudine]; Elacridar inhibits the reaction [ABCG2 protein results in increased export of Zidovudine]; Nelfinavir inhibits the reaction [ABCG2 protein results in increased export of Zidovudine]; pluronic block copolymer p85 inhibits the reaction [ABCG2 protein results in increased export of Zidovudine]
Zidovudine results in increased expression of ABCG2 protein
Zidovudine results in decreased expression of ABCG2 mRNA
Zidovudine results in increased expression of ABCG2 mRNA
CTD PMID:17437964 PMID:19056916 PMID:24292225 PMID:27765674 PMID:28705594 More... NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 decreases expression ISO Zidovudine results in decreased expression of ABCG8 mRNA CTD PMID:27765674 NCBI chr17:84,983,730...85,007,761
Ensembl chr17:84,983,730...85,007,761
JBrowse link
G Acaca acetyl-Coenzyme A carboxylase alpha affects expression ISO Zidovudine affects the expression of ACACA mRNA CTD PMID:20032539 NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
JBrowse link
G Acacb acetyl-Coenzyme A carboxylase beta affects expression ISO Zidovudine affects the expression of ACACB mRNA CTD PMID:20032539 NCBI chr 5:114,284,748...114,388,822
Ensembl chr 5:114,284,596...114,388,822
JBrowse link
G Acadsb acyl-Coenzyme A dehydrogenase, short/branched chain multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ACADSB mRNA CTD PMID:18313992 NCBI chr 7:131,012,330...131,047,940
Ensembl chr 7:131,012,330...131,050,673
JBrowse link
G Acsl6 acyl-CoA synthetase long-chain family member 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ACSL6 mRNA CTD PMID:18313992 NCBI chr11:54,194,580...54,255,582
Ensembl chr11:54,194,624...54,255,582
JBrowse link
G Ada adenosine deaminase increases expression ISO Zidovudine results in increased expression of ADA protein CTD PMID:2261134 NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of ADIPOQ protein
Zidovudine results in decreased expression of ADIPOQ mRNA; Zidovudine results in decreased expression of ADIPOQ protein
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA
CTD PMID:15865214 PMID:16931933 PMID:17503663 PMID:17668557 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Aebp1 AE binding protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of AEBP1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of AEBP1 mRNA CTD PMID:16931933 NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088
JBrowse link
G Afap1 actin filament associated protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of AFAP1 mRNA CTD PMID:15784690 NCBI chr 5:36,050,713...36,161,267
Ensembl chr 5:36,050,663...36,161,267
JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 increases expression
multiple interactions
ISO Zidovudine results in increased expression of AGPAT3 mRNA
[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]
CTD PMID:28619387 NCBI chr10:78,105,008...78,188,335
Ensembl chr10:78,105,012...78,188,323
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 increases phosphorylation ISO Zidovudine results in increased phosphorylation of AKT1 protein CTD PMID:29594326 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Alb albumin affects binding ISO Zidovudine binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ALOX5AP mRNA CTD PMID:16931933 NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
JBrowse link
G Apoa5 apolipoprotein A-V decreases expression
multiple interactions
ISO Zidovudine results in decreased expression of APOA5 mRNA
[Zidovudine co-treated with Isoniazid] results in decreased expression of APOA5 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of APOA5 mRNA]
CTD PMID:28619387 NCBI chr 9:46,179,906...46,183,219
Ensembl chr 9:46,179,931...46,183,217
JBrowse link
G Aprt adenine phosphoribosyl transferase increases mutagenesis ISO Zidovudine results in increased mutagenesis of APRT gene CTD PMID:10970446 NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648
JBrowse link
G Aqp9 aquaporin 9 multiple interactions ISO
EXP
[Zidovudine co-treated with IFNA1 protein] results in increased expression of AQP9 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of AQP9 mRNA
CTD PMID:18313992 PMID:20370541 NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
JBrowse link
G Arpp21 cyclic AMP-regulated phosphoprotein, 21 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ARPP21 mRNA CTD PMID:16931933 NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006
JBrowse link
G Asic2 acid-sensing ion channel 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA CTD PMID:16931933 NCBI chr11:80,770,989...81,859,222
Ensembl chr11:80,770,995...81,859,283
JBrowse link
G Asl argininosuccinate lyase increases activity
multiple interactions
ISO Zidovudine results in increased activity of ASL protein
[Isoniazid co-treated with Zidovudine] results in increased activity of ASL protein; silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased activity of ASL protein]
CTD PMID:28619387 NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088
JBrowse link
G Asns asparagine synthetase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ASNS mRNA CTD PMID:15784690 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
JBrowse link
G Ass1 argininosuccinate synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ASS1 mRNA CTD PMID:15784690 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of ATF3 mRNA CTD PMID:15784690 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA CTD PMID:11706060 NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
JBrowse link
G Atp5f1c ATP synthase F1 subunit gamma multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5F1C mRNA CTD PMID:18313992 NCBI chr 2:10,060,841...10,085,321
Ensembl chr 2:10,060,827...10,085,321
JBrowse link
G Atp5f1d ATP synthase F1 subunit delta decreases expression ISO Zidovudine results in decreased expression of ATP5F1D mRNA CTD PMID:16894629 NCBI chr10:79,974,451...79,981,662
Ensembl chr10:79,974,466...79,981,652
JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of ATP5MC3 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5MC3 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 2:73,738,791...73,742,793
Ensembl chr 2:73,738,791...73,741,670
JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO Zidovudine results in increased expression of ATP5ME mRNA CTD PMID:16894629 NCBI chr 5:108,581,112...108,582,265
Ensembl chr 5:108,581,110...108,582,314
JBrowse link
G Atp5mf ATP synthase membrane subunit f multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5MF mRNA CTD PMID:18313992 NCBI chr 5:145,120,514...145,128,351
Ensembl chr 5:145,120,508...145,128,872
JBrowse link
G Atp5mg ATP synthase membrane subunit g increases expression ISO Zidovudine results in increased expression of ATP5MG mRNA CTD PMID:16894629 NCBI chr 9:44,824,546...44,832,470
Ensembl chr 9:44,823,855...44,832,040
JBrowse link
G Atp5pb ATP synthase peripheral stalk-membrane subunit b increases expression ISO Zidovudine results in increased expression of ATP5PB mRNA CTD PMID:16894629 NCBI chr 3:105,850,014...105,866,579
Ensembl chr 3:105,850,014...105,867,415
JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PD mRNA CTD PMID:18313992 NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
JBrowse link
G Atp5pf ATP synthase peripheral stalk subunit F6 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of ATP5PF mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of ATP5PF mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr16:84,624,754...84,632,495
Ensembl chr16:84,624,754...84,632,513
JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of ATP5PO mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5PO mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr16:91,722,111...91,728,518
Ensembl chr16:91,722,102...91,728,575
Ensembl chr16:91,722,102...91,728,575
JBrowse link
G Atp8b1 ATPase, class I, type 8B, member 1 decreases expression ISO Zidovudine results in decreased expression of ATP8B1 mRNA CTD PMID:16894629 NCBI chr18:64,662,050...64,794,342
Ensembl chr18:64,662,038...64,794,338
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 affects response to substance
increases expression
multiple interactions
decreases expression
ISO
EXP
BCL2 protein affects the susceptibility to Zidovudine
Zidovudine results in increased expression of BCL2 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA
Drugs, Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA]
CTD PMID:9850737 PMID:17696246 PMID:18313992 PMID:29594326 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like increases expression ISO Zidovudine results in increased expression of BNIP3L protein CTD PMID:23640862 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326
JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of BST2 mRNA CTD PMID:20370541 NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO Zidovudine results in increased expression of BTG2 mRNA CTD PMID:23675285 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
JBrowse link
G C1rb complement component 1, r subcomponent B multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C1R mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C1R mRNA CTD PMID:16931933 NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
JBrowse link
G C3ar1 complement component 3a receptor 1 multiple interactions ISO
EXP
[Zidovudine co-treated with IFNA1 protein] results in increased expression of C3AR1 mRNA
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of C3AR1 mRNA
CTD PMID:16931933 PMID:20370541 NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CARS1 mRNA CTD PMID:15784690 NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827
JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
increases expression
increases activity
ISO
EXP
[Acrolein co-treated with Zidovudine] results in increased cleavage of CASP3 protein; Drugs, Chinese Herbal promotes the reaction [Zidovudine results in increased expression of CASP3 mRNA]
Zidovudine results in increased cleavage of CASP3 protein
Zidovudine results in increased expression of CASP3 protein
Zidovudine results in increased activity of CASP3 protein
2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine inhibits the reaction [Zidovudine results in increased expression of CASP3 protein]; glutapyrone inhibits the reaction [Zidovudine results in increased expression of CASP3 protein]; tauropyrone inhibits the reaction [Zidovudine results in increased expression of CASP3 protein]
CTD PMID:16601281 PMID:17696246 PMID:17943461 PMID:18801031 PMID:27238871 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp8 caspase 8 increases cleavage
multiple interactions
ISO Zidovudine results in increased cleavage of CASP8 protein
Acrolein promotes the reaction [Zidovudine results in increased cleavage of CASP8 protein]; Zidovudine promotes the reaction [Acrolein results in increased cleavage of CASP8 protein]
CTD PMID:27238871 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Cat catalase decreases response to substance EXP CAT protein results in decreased susceptibility to Zidovudine CTD PMID:19398959 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Zidovudine results in increased expression of CCL2 protein CTD PMID:17668557 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccna2 cyclin A2 multiple interactions
decreases expression
ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNA2 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of CCNA2 mRNA
Zidovudine results in decreased expression of CCNA2 mRNA
CTD PMID:15784690 PMID:20370541 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNB1 mRNA CTD PMID:20370541 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnc cyclin C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CCNC mRNA CTD PMID:15784690 NCBI chr 4:21,727,705...21,759,917
Ensembl chr 4:21,727,701...21,759,922
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression
ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CCND1 mRNA
Zidovudine results in increased expression of CCND1 mRNA
CTD PMID:15784690 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccnd2 cyclin D2 multiple interactions
decreases expression
ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CCND2 mRNA
Zidovudine results in decreased expression of CCND2 mRNA
CTD PMID:15784690 NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
JBrowse link
G Ccne2 cyclin E2 decreases expression
multiple interactions
ISO Zidovudine results in decreased expression of CCNE2 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of CCNE2 mRNA
CTD PMID:15784690 NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
JBrowse link
G Ccnl2 cyclin L2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNL2 mRNA CTD PMID:20370541 NCBI chr 4:155,894,468...155,909,005
Ensembl chr 4:155,896,946...155,909,000
JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCR5 mRNA CTD PMID:20370541 NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
JBrowse link
G Cd36 CD36 molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CD36 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CD36 mRNA CTD PMID:16931933 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cd44 CD44 antigen multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CD44 mRNA CTD PMID:15784690 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G Cd83 CD83 antigen multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CD83 mRNA CTD PMID:15784690 NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
JBrowse link
G Cdc25a cell division cycle 25A multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDC25A mRNA CTD PMID:20370541 NCBI chr 9:109,704,545...109,722,963
Ensembl chr 9:109,704,647...109,722,963
JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CDCA8 mRNA CTD PMID:20370541 NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
JBrowse link
G Cdk1 cyclin dependent kinase 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK1 mRNA CTD PMID:20370541 NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
JBrowse link
G Cdk4 cyclin dependent kinase 4 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK4 mRNA CTD PMID:20370541 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
JBrowse link
G Cdk6 cyclin dependent kinase 6 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CDK6 mRNA CTD PMID:20370541 NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
JBrowse link
G Cdk7 cyclin dependent kinase 7 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of CDK7 mRNA CTD PMID:15784690 NCBI chr13:100,833,532...100,867,454
Ensembl chr13:100,839,139...100,867,447
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
affects expression
decreases expression
ISO
EXP
[Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1A mRNA
Zidovudine affects the expression of CDKN1A protein
Zidovudine results in decreased expression of CDKN1A mRNA
CTD PMID:15784690 PMID:18389896 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cdkn1c cyclin dependent kinase inhibitor 1C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1C mRNA CTD PMID:15784690 NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A increases expression
affects expression
ISO
EXP
Zidovudine results in increased expression of CDKN2A mRNA; Zidovudine results in increased expression of CDKN2A protein
Zidovudine affects the expression of CDKN2A protein
CTD PMID:16797627 PMID:18389896 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
JBrowse link
G Cdkn2c cyclin dependent kinase inhibitor 2C multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN2C mRNA CTD PMID:15784690 NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression EXP Zidovudine results in decreased expression of CEBPA protein CTD PMID:15722030 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Cfd complement factor D multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CFD mRNA CTD PMID:16931933 NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
JBrowse link
G Chek1 checkpoint kinase 1 increases phosphorylation
decreases expression
ISO Zidovudine results in increased phosphorylation of CHEK1 protein
Zidovudine results in decreased expression of CHEK1 protein
CTD PMID:19541796 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
JBrowse link
G Chek2 checkpoint kinase 2 decreases expression
increases phosphorylation
ISO Zidovudine results in decreased expression of CHEK2 protein
Zidovudine results in increased phosphorylation of CHEK2 protein
CTD PMID:19541796 NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
JBrowse link
G Chn1 chimerin 1 decreases expression ISO Zidovudine results in decreased expression of CHN1 mRNA CTD PMID:16894629 NCBI chr 2:73,441,004...73,605,723
Ensembl chr 2:73,441,004...73,605,690
JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CIDEC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CIDEC mRNA CTD PMID:16931933 NCBI chr 6:113,401,595...113,412,721
Ensembl chr 6:113,401,595...113,412,721
JBrowse link
G Clcn3 chloride channel, voltage-sensitive 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CLCN3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of CLCN3 mRNA CTD PMID:16931933 NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
JBrowse link
G Clec2i C-type lectin domain family 2, member i multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CLEC2I mRNA CTD PMID:16931933 NCBI chr 6:128,864,550...128,875,131
Ensembl chr 6:128,864,551...128,875,130
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of COMT mRNA CTD PMID:15784690 NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
JBrowse link
G Cox11 cytochrome c oxidase assembly protein 11, copper chaperone decreases expression ISO Zidovudine results in decreased expression of COX11 mRNA CTD PMID:16894629 NCBI chr11:90,529,010...90,536,803
Ensembl chr11:90,528,999...90,535,757
JBrowse link
G Cox15 cytochrome c oxidase assembly protein 15 decreases expression ISO Zidovudine results in decreased expression of COX15 mRNA CTD PMID:16894629 NCBI chr19:43,721,693...43,741,439
Ensembl chr19:43,721,693...43,741,439
JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of COX5A protein
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX5A mRNA
CTD PMID:7807166 PMID:18313992 NCBI chr 9:57,423,012...57,439,710
Ensembl chr 9:57,428,557...57,439,709
JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions
decreases expression
EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of COX5B mRNA
Zidovudine results in decreased expression of COX5B protein
CTD PMID:7807166 PMID:18313992 NCBI chr 1:36,730,568...36,732,469
Ensembl chr 1:36,730,530...36,732,762
JBrowse link
G Cox6a1 cytochrome c oxidase subunit 6A1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of COX6A1 mRNA CTD PMID:18313992 NCBI chr 5:115,483,711...115,487,017
Ensembl chr 5:115,483,701...115,487,040
JBrowse link
G Cox6c cytochrome c oxidase subunit 6C decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of COX6C protein
[Zidovudine co-treated with Lamivudine] results in increased expression of COX6C mRNA
CTD PMID:7807166 PMID:18313992 NCBI chr15:35,932,122...35,938,392
Ensembl chr15:35,926,032...35,938,392
JBrowse link
G Cox7a1 cytochrome c oxidase subunit 7A1 decreases expression ISO Zidovudine results in decreased expression of COX7A1 protein CTD PMID:7807166 NCBI chr 7:29,883,596...29,885,455
Ensembl chr 7:29,883,569...29,885,503
JBrowse link
G Cox7a2 cytochrome c oxidase subunit 7A2 increases expression ISO Zidovudine results in increased expression of COX7A2 mRNA CTD PMID:16894629 NCBI chr 9:79,662,523...79,667,135
Ensembl chr 9:79,662,643...79,667,160
JBrowse link
G Cox7b cytochrome c oxidase subunit 7B increases expression
decreases expression
ISO Zidovudine results in increased expression of COX7B mRNA
Zidovudine results in decreased expression of COX7B protein
CTD PMID:7807166 PMID:16894629 NCBI chr  X:105,059,306...105,066,056
Ensembl chr  X:105,059,306...105,066,056
JBrowse link
G Cox7c cytochrome c oxidase subunit 7C decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of COX7C protein
[Zidovudine co-treated with Lamivudine] results in increased expression of COX7C mRNA
CTD PMID:7807166 PMID:18313992 NCBI chr13:86,192,917...86,194,914
Ensembl chr13:86,192,935...86,195,023
JBrowse link
G Cpne5 copine V multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CPNE5 mRNA CTD PMID:20370541 NCBI chr17:29,375,495...29,456,764
Ensembl chr17:29,374,530...29,457,141
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1a, liver multiple interactions
increases expression
EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CPT1A mRNA
Zidovudine results in increased expression of CPT1A mRNA
CTD PMID:14576092 PMID:18313992 NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
JBrowse link
G Crat carnitine acetyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA CTD PMID:18313992 NCBI chr 2:30,290,483...30,305,602
Ensembl chr 2:30,290,483...30,305,825
JBrowse link
G Cs citrate synthase affects expression
decreases expression
ISO Zidovudine affects the expression of CS mRNA
Zidovudine results in decreased expression of CS protein
CTD PMID:1892364 PMID:20032539 NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) multiple interactions EXP [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of CSF2RA mRNA]; [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of IL3RA mRNA] CTD PMID:12084393 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G Csf2ra colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) multiple interactions
decreases expression
EXP [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of CSF2RA mRNA] CTD PMID:12084393 NCBI chr19:61,205,629...61,221,141
Ensembl chr19:61,212,395...61,216,867
JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of CSGALNACT1 mRNA CTD PMID:20370541 NCBI chr 8:68,809,433...69,188,270
Ensembl chr 8:68,809,433...69,187,798
JBrowse link
G Cul7 cullin 7 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of CUL7 mRNA CTD PMID:18313992 NCBI chr17:46,961,264...46,975,290
Ensembl chr17:46,961,263...46,975,290
JBrowse link
G Cyb5a cytochrome b5 type A (microsomal) multiple interactions
decreases expression
EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of CYB5A mRNA
[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA]
Zidovudine results in decreased expression of CYB5A mRNA
CTD PMID:18313992 PMID:28619387 NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of CYP11A1 mRNA CTD PMID:18313992 NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CYP1B1 mRNA CTD PMID:20370541 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Dcn decorin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DCN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DCN mRNA CTD PMID:16931933 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
ISO [Zidovudine co-treated with Lamivudine] results in increased expression of DDIT3 mRNA
Zidovudine results in increased expression of DDIT3 mRNA
CTD PMID:15784690 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G Ddr2 discoidin domain receptor family, member 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of DDR2 mRNA CTD PMID:20370541 NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
JBrowse link
G Dhfr dihydrofolate reductase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of DHFR mRNA CTD PMID:15784690 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
JBrowse link
G Dlst dihydrolipoamide S-succinyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of DLST mRNA CTD PMID:18313992 NCBI chr12:85,157,597...85,180,865
Ensembl chr12:85,157,607...85,181,619
JBrowse link
G Dmd dystrophin, muscular dystrophy affects localization EXP Zidovudine affects the localization of DMD protein CTD PMID:17943461 NCBI chr  X:81,858,244...84,248,656
Ensembl chr  X:81,992,476...84,249,747
JBrowse link
G Dna2 DNA replication helicase/nuclease 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of DNA2 mRNA CTD PMID:20370541 NCBI chr10:62,782,762...62,809,967
Ensembl chr10:62,782,805...62,809,964
JBrowse link
G Dnaja3 DnaJ heat shock protein family (Hsp40) member A3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA CTD PMID:18313992 NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
JBrowse link
G Dnm1l dynamin 1-like affects localization
multiple interactions
ISO Zidovudine affects the localization of DNM1L protein
[DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of and affects the phosphorylation of DNM1L protein; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of DNM1L mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the localization of DNM1L protein
CTD PMID:28683400 NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
JBrowse link
G Dtx3l deltex 3-like, E3 ubiquitin ligase multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of DTX3L mRNA CTD PMID:20370541 NCBI chr16:35,746,885...35,759,397
Ensembl chr16:35,746,881...35,759,521
JBrowse link
G Dtymk deoxythymidylate kinase multiple interactions
affects response to substance
ISO [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of and affects the phosphorylation of DNM1L protein; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of DNM1L mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of MFF mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of MFF protein; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 protein; [DTYMK protein affects the susceptibility to Zidovudine] which affects the localization of DNM1L protein; DTYMK gene mutant form results in increased phosphorylation of and results in increased susceptibility to Zidovudine CTD PMID:17375075 PMID:28683400 NCBI chr 1:93,720,298...93,730,246
Ensembl chr 1:93,720,298...93,729,656
JBrowse link
G Dusp3 dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DUSP3 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of DUSP3 mRNA CTD PMID:16931933 NCBI chr11:101,861,967...101,877,839
Ensembl chr11:101,861,969...101,877,839
JBrowse link
G Echs1 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of ECHS1 mRNA CTD PMID:18313992 NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
JBrowse link
G Eci1 enoyl-Coenzyme A delta isomerase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of ECI1 mRNA CTD PMID:18313992 NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322
JBrowse link
G Edn1 endothelin 1 multiple interactions
increases secretion
ISO coenzyme Q10 inhibits the reaction [Zidovudine results in increased secretion of EDN1 protein] CTD PMID:23640862 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Egr1 early growth response 1 multiple interactions ISO [Zidovudine co-treated with Arsenic Trioxide] results in increased expression of EGR1 mRNA CTD PMID:29910624 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
JBrowse link
G Ehf ets homologous factor multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of EHF mRNA CTD PMID:20370541 NCBI chr 2:103,093,776...103,133,620
Ensembl chr 2:103,093,778...103,133,623
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha increases phosphorylation ISO Zidovudine results in increased phosphorylation of EIF2S1 protein CTD PMID:27041070 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of EIF4EBP1 mRNA CTD PMID:15784690 NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of ELOVL3 mRNA CTD PMID:16931933 NCBI chr19:46,120,336...46,124,133
Ensembl chr19:46,120,336...46,124,133
JBrowse link
G Epo erythropoietin increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of EPO protein
EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA]; EPO protein inhibits the reaction [Zidovudine results in decreased expression of FOS mRNA]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA]]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of FOS mRNA]]; Zidovudine inhibits the reaction [EPO protein binds to EPOR protein]; Zidovudine promotes the reaction [Staphylococcal Protein A results in increased expression of EPO protein]
CTD PMID:1549625 PMID:1889487 PMID:3422548 PMID:7646543 PMID:9735323 NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
JBrowse link
G Epor erythropoietin receptor multiple interactions
decreases expression
EXP EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA]]; Zidovudine inhibits the reaction [EPO protein binds to EPOR protein]
Zidovudine results in decreased expression of EPOR mRNA; Zidovudine results in decreased expression of EPOR protein
CTD PMID:1417927 PMID:7646543 NCBI chr 9:21,870,193...21,874,915
Ensembl chr 9:21,870,193...21,874,802
JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of EPSTI1 mRNA CTD PMID:20370541 NCBI chr14:78,141,679...78,240,096
Ensembl chr14:78,141,679...78,240,097
JBrowse link
G Esr1 estrogen receptor 1 (alpha) affects localization ISO Zidovudine affects the localization of ESR1 protein CTD PMID:15531092 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ESR2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ESR2 mRNA CTD PMID:16931933 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Etv6 ets variant 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ETV6 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of ETV6 mRNA CTD PMID:16931933 NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte affects expression ISO Zidovudine affects the expression of FABP4 mRNA CTD PMID:20032539 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Faim Fas apoptotic inhibitory molecule multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of FAIM mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of FAIM mRNA CTD PMID:16931933 NCBI chr 9:98,868,426...98,884,076
Ensembl chr 9:98,868,426...98,884,074
JBrowse link
G Fas Fas cell surface death receptor increases expression EXP Zidovudine results in increased expression of FAS protein CTD PMID:17943461 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fasl Fas ligand increases expression
multiple interactions
EXP
ISO
Zidovudine results in increased expression of FASLG protein
Zidovudine results in increased expression of FASLG mRNA
Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]; Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]
[Acrolein co-treated with Zidovudine] results in increased expression of FASLG protein; Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]; Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]; Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]
CTD PMID:17943461 PMID:27238871 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Fasn fatty acid synthase multiple interactions
decreases expression
affects expression
EXP
ISO
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of FASN mRNA
Zidovudine results in decreased expression of FASN protein
Zidovudine affects the expression of FASN mRNA
CTD PMID:11741158 PMID:15722030 PMID:20032539 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
JBrowse link
G Fcgr1 Fc receptor, IgG, high affinity I multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of FCGR1A mRNA CTD PMID:20370541 NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
JBrowse link
G Fdxr ferredoxin reductase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of FDXR mRNA CTD PMID:18313992 NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876
JBrowse link
G Fgl2 fibrinogen-like protein 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of FGL2 mRNA CTD PMID:20370541 NCBI chr 5:21,577,671...21,583,384
Ensembl chr 5:21,577,640...21,583,372
JBrowse link
G Fh1 fumarate hydratase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of FH1 mRNA CTD PMID:18313992 NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
JBrowse link
G Fos FBJ osteosarcoma oncogene multiple interactions
decreases expression
EXP EPO protein inhibits the reaction [Zidovudine results in decreased expression of FOS mRNA]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of FOS mRNA]] CTD PMID:7646543 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
JBrowse link
G Foxp3 forkhead box P3 multiple interactions ISO [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of FOXP3 mRNA CTD PMID:23962110 NCBI chr  X:7,445,915...7,461,482
Ensembl chr  X:7,439,883...7,461,484
JBrowse link
G G0s2 G0/G1 switch gene 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of G6PC1 mRNA CTD PMID:16931933 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
JBrowse link
G Ganc glucosidase, alpha; neutral C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of GANC mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of GANC mRNA CTD PMID:16931933 NCBI chr 2:120,234,377...120,291,347
Ensembl chr 2:120,234,377...120,292,181
JBrowse link
G Gars1 glycyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of GARS1 mRNA CTD PMID:15784690 NCBI chr 6:55,014,986...55,056,489
Ensembl chr 6:55,014,992...55,056,485
JBrowse link
G Gas1 growth arrest specific 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of GAS1 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of GAS1 mRNA CTD PMID:15784690 PMID:20370541 NCBI chr13:60,322,219...60,325,179
Ensembl chr13:60,322,219...60,325,179
JBrowse link
G Gata1 GATA binding protein 1 decreases activity
decreases expression
ISO Zidovudine results in decreased activity of GATA1 protein
Zidovudine results in decreased expression of GATA1 mRNA
CTD PMID:8599995 PMID:10651068 NCBI chr  X:7,825,504...7,842,844
Ensembl chr  X:7,825,499...7,844,310
JBrowse link
G Gbp2b guanylate binding protein 2b multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP1 mRNA CTD PMID:20370541 NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
JBrowse link
G Gbp3 guanylate binding protein 3 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP4 mRNA CTD PMID:20370541 NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions
increases activity
ISO Isoniazid promotes the reaction [Zidovudine results in increased activity of GPT protein]; Silybin inhibits the reaction [Isoniazid promotes the reaction [Zidovudine results in increased activity of GPT protein]] CTD PMID:28619387 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Grb7 growth factor receptor bound protein 7 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of GRB7 mRNA CTD PMID:20370541 NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199
JBrowse link
G Grhl2 grainyhead like transcription factor 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of GRHL2 mRNA CTD PMID:16931933 NCBI chr15:37,233,065...37,363,813
Ensembl chr15:37,233,280...37,363,813
JBrowse link
G Gtf2h1 general transcription factor II H, polypeptide 1 increases expression ISO Zidovudine results in increased expression of GTF2H1 mRNA; Zidovudine results in increased expression of GTF2H1 protein CTD PMID:21192964 NCBI chr 7:46,445,518...46,473,224
Ensembl chr 7:46,445,527...46,473,224
JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of GUCY1B1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of GUCY1B1 mRNA CTD PMID:16931933 NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996
JBrowse link
G Gypa glycophorin A multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased mutagenesis of GYPA gene CTD PMID:17358027 NCBI chr 8:81,220,674...81,237,414
Ensembl chr 8:81,220,410...81,237,171
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 affects expression ISO Zidovudine affects the expression of HLA-B mRNA CTD PMID:25811541 NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G H2-Q1 histocompatibility 2, Q region locus 1 affects expression ISO Zidovudine affects the expression of HLA-A mRNA CTD PMID:25811541 NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
JBrowse link
G H2ax H2A.X variant histone increases phosphorylation ISO Zidovudine results in increased phosphorylation of H2AX protein CTD PMID:34510228 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G H4c14 H4 clustered histone 14 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of H4C3 mRNA CTD PMID:20370541 NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627
JBrowse link
G H4c8 H4 clustered histone 8 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of H4C9 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of H4C9 mRNA CTD PMID:16931933 NCBI chr13:23,715,214...23,715,648
Ensembl chr13:23,715,220...23,715,689
JBrowse link
G H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) affects expression ISO Zidovudine affects the expression of H6PD mRNA CTD PMID:20032539 NCBI chr 4:150,063,931...150,093,480
Ensembl chr 4:150,063,932...150,093,480
JBrowse link
G Hadh hydroxyacyl-Coenzyme A dehydrogenase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of HADH mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of HADH mRNA CTD PMID:16931933 NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of HADHA mRNA CTD PMID:18313992 NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
JBrowse link
G Hax1 HCLS1 associated X-1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of HAX1 mRNA CTD PMID:15784690 NCBI chr 3:89,902,753...89,906,023
Ensembl chr 3:89,902,753...89,906,087
JBrowse link
G Hbb-b1 hemoglobin, beta adult major chain decreases expression ISO Zidovudine results in decreased expression of HBB mRNA CTD PMID:10651068
G Hcn1 hyperpolarization activated cyclic nucleotide gated potassium channel 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of HCN1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of HCN1 mRNA CTD PMID:16931933 NCBI chr13:117,738,856...118,117,564
Ensembl chr13:117,738,856...118,123,954
JBrowse link
G Hdlbp high density lipoprotein (HDL) binding protein decreases expression ISO Zidovudine results in decreased expression of HDLBP mRNA CTD PMID:16894629 NCBI chr 1:93,333,662...93,406,639
Ensembl chr 1:93,333,662...93,406,537
JBrowse link
G Herc6 hect domain and RLD 6 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of HERC6 mRNA CTD PMID:20370541 NCBI chr 6:57,557,977...57,642,121
Ensembl chr 6:57,557,985...57,641,617
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HMGCS2 mRNA CTD PMID:18313992 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Zidovudine results in increased expression of HMOX1 mRNA CTD PMID:29594326 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases mutagenesis ISO Zidovudine results in increased mutagenesis of HPRT1 exon CTD PMID:10526209 NCBI chr  X:52,076,955...52,110,537
Ensembl chr  X:52,077,014...52,110,536
JBrowse link
G Hras Harvey rat sarcoma virus oncogene multiple interactions EXP [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene CTD PMID:9766437 NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Hrk harakiri, BCL2 interacting protein (contains only BH3 domain) multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of HRK mRNA CTD PMID:16931933 NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 affects expression ISO Zidovudine affects the expression of HSD11B1 mRNA CTD PMID:20032539 NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B2 mRNA CTD PMID:18313992 NCBI chr 3:98,618,423...98,631,859
Ensembl chr 3:98,616,571...98,631,859
JBrowse link
G Hsd3b3 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B3 mRNA CTD PMID:18313992 NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443
JBrowse link
G Hsd3b5 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of HSD3B5 mRNA CTD PMID:18313992 NCBI chr 3:98,525,952...98,552,850
Ensembl chr 3:98,525,950...98,537,568
JBrowse link
G Hspd1 heat shock protein 1 (chaperonin) affects expression ISO Zidovudine affects the expression of HSPD1 protein CTD PMID:27041070 NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
JBrowse link
G Idh2 isocitrate dehydrogenase 2 (NADP+), mitochondrial multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of IDH2 mRNA CTD PMID:18313992 NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
JBrowse link
G Idh3a isocitrate dehydrogenase 3 (NAD+) alpha multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of IDH3A mRNA CTD PMID:18313992 NCBI chr 9:54,493,795...54,511,946
Ensembl chr 9:54,493,618...54,511,945
JBrowse link
G Idh3g isocitrate dehydrogenase 3 (NAD+), gamma multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of IDH3G mRNA CTD PMID:18313992 NCBI chr  X:72,822,569...72,830,471
Ensembl chr  X:72,822,569...72,830,503
JBrowse link
G Ifi211 interferon activated gene 211 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of MNDA mRNA CTD PMID:20370541 NCBI chr 1:173,723,907...173,740,650
Ensembl chr 1:173,723,911...173,740,612
JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI27 mRNA CTD PMID:20370541 NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
JBrowse link
G Ifi35 interferon-induced protein 35 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI35 mRNA CTD PMID:20370541 NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524
JBrowse link
G Ifi44l interferon-induced protein 44 like multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI44L mRNA CTD PMID:20370541 NCBI chr 3:151,464,374...151,468,528
Ensembl chr 3:151,464,374...151,468,529
JBrowse link
G Ifih1 interferon induced with helicase C domain 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIH1 mRNA CTD PMID:20370541 NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT2 mRNA CTD PMID:20370541 NCBI chr19:34,527,961...34,553,934
Ensembl chr19:34,528,094...34,553,819
JBrowse link
G Ifitm1 interferon induced transmembrane protein 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFITM1 mRNA CTD PMID:20370541 NCBI chr 7:140,547,342...140,549,740
Ensembl chr 7:140,547,134...140,549,738
JBrowse link
G Ifna1 interferon alpha 1 affects expression
multiple interactions
ISO Zidovudine affects the expression of IFNA1 protein
[Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of FOXP3 mRNA; [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL10 mRNA; [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL10 protein; [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL4 mRNA; [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in increased expression of IL2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CD1C mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CDCA8 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CDK6 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CYP1B1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of DDR2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of GAS1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of GRB7 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of H4C3 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of LGALS1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of MVD mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PGR mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PIERCE1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PKMYT1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RAB17 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RAB3B mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RASSF7 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of SAPCD2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TMEM97 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TNC mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TRDMT1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TRIQK mRNA; [Zidovudine co-treated with IFNA1 protein] results in decreased expression of WDR62 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of AQP9 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of BST2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of C3AR1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNA2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNB1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCNL2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCR5 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDC25A mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CPNE5 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of CSGALNACT1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of DDX60L mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of DNA2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of DTX3L mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of EHF mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of EPSTI1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of ERV3-2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of FCGR1A mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of FGL2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of HERC6 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI27 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI35 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI44L mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI6 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIH1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT5 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFITM1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF7 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of ISG15 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of ITIH4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of JAK2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LAMP3 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LAP3 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LGALS9 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRA1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRB3 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRB4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of LY6E mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MNDA mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MOV10 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MT1G mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MT2A mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MX1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of MX2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of NEXN mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of NT5C3A mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of NUB1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of NUF2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS3 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of PARP9 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of PCNA mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of PF4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of PIK3AP1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of PLSCR1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of RGS6 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of RNF213 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of RPT4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of RSAD2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SAMD9L mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SCIMP mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SERPING1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SHFL mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SIGLEC1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC22A23 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC24A4 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC7A7 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of STAT1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of STAT2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TCN1 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TCN2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TLR7 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF10 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF13B mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNNI2 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TRIM22 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TRMT44 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TTC21A mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of TXLNGY mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of USP18 mRNA; [Zidovudine co-treated with IFNA1 protein] results in increased expression of ZNF629 mRNA; IRF4 protein results in decreased susceptibility to [Zidovudine co-treated with IFNA1 protein]; REL protein results in decreased susceptibility to [Zidovudine co-treated with IFNA1 protein]
CTD PMID:9612607 PMID:17138822 PMID:20370541 PMID:23962110 NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
JBrowse link
G Ifng interferon gamma affects expression
multiple interactions
ISO Zidovudine affects the expression of IFNG protein
[Arsenic co-treated with Zidovudine co-treated with IFNG protein] results in increased expression of IL2 mRNA
CTD PMID:9612607 PMID:23962110 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Ikzf4 IKAROS family zinc finger 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of IKZF4 mRNA CTD PMID:16931933 NCBI chr10:128,466,708...128,505,668
Ensembl chr10:128,466,712...128,505,227
JBrowse link
G Il10 interleukin 10 multiple interactions ISO [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL10 mRNA; [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL10 protein CTD PMID:23962110 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Zidovudine results in increased expression of IL1A protein CTD PMID:7979221 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Zidovudine results in increased expression of IL1B mRNA; Zidovudine results in increased expression of IL1B protein CTD PMID:9184656 PMID:17668557 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in increased expression of IL2 mRNA; [Arsenic co-treated with Zidovudine co-treated with IFNG protein] results in increased expression of IL2 mRNA CTD PMID:23962110 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Il27ra interleukin 27 receptor, alpha multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA CTD PMID:15784690 NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
JBrowse link
G Il2ra interleukin 2 receptor, alpha chain multiple interactions
decreases expression
ISO Zidovudine promotes the reaction [Zalcitabine results in decreased expression of IL2RA mRNA]; Zidovudine promotes the reaction [Zalcitabine results in decreased expression of IL2RA protein]
Zidovudine results in decreased expression of IL2RA mRNA; Zidovudine results in decreased expression of IL2RA protein
CTD PMID:7606800 NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
JBrowse link
G Il3 interleukin 3 multiple interactions EXP [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of CSF2RA mRNA]; [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of IL3RA mRNA]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA]]; IL3 protein promotes the reaction [EPO protein inhibits the reaction [Zidovudine results in decreased expression of FOS mRNA]] CTD PMID:7646543 PMID:12084393 NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
JBrowse link
G Il3ra interleukin 3 receptor, alpha chain multiple interactions
decreases expression
EXP [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of IL3RA mRNA] CTD PMID:12084393 NCBI chr14:8,114,270...8,123,851
Ensembl chr14:8,113,752...8,123,488
JBrowse link
G Il4 interleukin 4 multiple interactions ISO [Arsenic co-treated with Zidovudine co-treated with IFNA1 protein] results in decreased expression of IL4 mRNA CTD PMID:23962110 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il6 interleukin 6 increases expression ISO Zidovudine results in increased expression of IL6 protein CTD PMID:17668557 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Inpp5e inositol polyphosphate-5-phosphatase E multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of INPP5E mRNA CTD PMID:18313992 NCBI chr 2:26,286,261...26,299,313
Ensembl chr 2:26,286,261...26,299,215
JBrowse link
G Irf2 interferon regulatory factor 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF2 mRNA CTD PMID:20370541 NCBI chr 8:47,192,751...47,300,493
Ensembl chr 8:47,192,767...47,300,493
JBrowse link
G Irf4 interferon regulatory factor 4 multiple interactions ISO IRF4 protein results in decreased susceptibility to [Zidovudine co-treated with IFNA1 protein] CTD PMID:17138822 NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF7 mRNA CTD PMID:20370541 NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of ISG15 mRNA CTD PMID:20370541 NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253
JBrowse link
G Itih4 inter alpha-trypsin inhibitor, heavy chain 4 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of ITIH4 mRNA CTD PMID:20370541 NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
JBrowse link
G Jak2 Janus kinase 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of JAK2 mRNA CTD PMID:20370541 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
JBrowse link
G Kcng1 potassium voltage-gated channel, subfamily G, member 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KCNG1 mRNA CTD PMID:15784690 NCBI chr 2:168,102,037...168,123,453
Ensembl chr 2:168,102,037...168,123,656
JBrowse link
G Kifc2 kinesin family member C2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of KIFC2 mRNA CTD PMID:16931933 NCBI chr15:76,543,984...76,552,396
Ensembl chr15:76,544,058...76,552,396
JBrowse link
G Klf4 Kruppel-like transcription factor 4 (gut) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KLF4 mRNA CTD PMID:15784690 NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466
JBrowse link
G Klhl28 kelch-like 28 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of KLHL28 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of KLHL28 mRNA CTD PMID:16931933 NCBI chr12:64,985,603...65,012,365
Ensembl chr12:64,985,607...65,012,308
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog increases mutagenesis EXP Zidovudine results in increased mutagenesis of KRAS gene CTD PMID:18800350 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Krt7 keratin 7 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KRT7 mRNA CTD PMID:15784690 NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
JBrowse link
G Kynu kynureninase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA CTD PMID:15784690 NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
JBrowse link
G Lamb3 laminin, beta 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of LAMB3 mRNA CTD PMID:15784690 NCBI chr 1:192,976,661...193,026,186
Ensembl chr 1:192,890,007...193,026,186
JBrowse link
G Lamc2 laminin, gamma 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LAMC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LAMC2 mRNA CTD PMID:16931933 NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 decreases expression ISO Zidovudine results in decreased expression of LAMP2 protein CTD PMID:29594326 NCBI chr  X:37,488,524...37,545,337
Ensembl chr  X:37,490,234...37,545,331
JBrowse link
G Lamp3 lysosomal-associated membrane protein 3 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LAMP3 mRNA CTD PMID:20370541 NCBI chr16:19,472,131...19,525,115
Ensembl chr16:19,472,128...19,525,125
JBrowse link
G Lap3 leucine aminopeptidase 3 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LAP3 mRNA CTD PMID:20370541 NCBI chr 5:45,650,716...45,670,033
Ensembl chr 5:45,650,716...45,670,033
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEF1 mRNA CTD PMID:16931933 NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
JBrowse link
G Lep leptin decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of LEP protein
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LEP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEP mRNA
CTD PMID:16931933 PMID:17668557 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lgals1 lectin, galactose binding, soluble 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of LGALS1 mRNA CTD PMID:20370541 NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
JBrowse link
G Lgals9 lectin, galactose binding, soluble 9 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LGALS9 mRNA CTD PMID:20370541 NCBI chr11:78,853,805...78,875,750
Ensembl chr11:78,853,800...78,875,772
JBrowse link
G Lilrb4b leukocyte immunoglobulin-like receptor, subfamily B, member 4B multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRB4 mRNA CTD PMID:20370541 NCBI chr10:51,356,757...51,362,417
Ensembl chr10:51,356,728...51,362,799
JBrowse link
G Lipe lipase, hormone sensitive affects expression ISO Zidovudine affects the expression of LIPE mRNA CTD PMID:20032539 NCBI chr 7:25,078,952...25,097,911
Ensembl chr 7:25,078,952...25,098,135
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial affects expression ISO Zidovudine affects the expression of LONP1 protein CTD PMID:27041070 NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887
JBrowse link
G Lpl lipoprotein lipase decreases expression
multiple interactions
affects expression
ISO
EXP
Zidovudine results in decreased expression of LPL mRNA
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA
Zidovudine affects the expression of LPL mRNA
CTD PMID:11741158 PMID:16894629 PMID:20032539 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Ly6e lymphocyte antigen 6 family member E multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LY6E mRNA CTD PMID:20370541 NCBI chr15:74,826,874...74,831,753
Ensembl chr15:74,826,900...74,831,752
JBrowse link
G Ly6f lymphocyte antigen 6 family member F multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LY6F mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6F mRNA CTD PMID:16931933 NCBI chr15:75,140,221...75,144,086
Ensembl chr15:75,140,270...75,144,084
JBrowse link
G Ly6i lymphocyte antigen 6 family member I multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of LY6I mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LY6I mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of LY6I mRNA CTD PMID:16931933 NCBI chr15:74,851,383...74,855,279
Ensembl chr15:74,851,383...74,855,279
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO Zidovudine results in increased phosphorylation of MAPK8 protein CTD PMID:27041070 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Mars1 methionine-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA CTD PMID:15784690 NCBI chr10:127,132,090...127,147,655
Ensembl chr10:127,132,090...127,147,655
JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 increases expression ISO Zidovudine results in increased expression of MDM2 protein CTD PMID:16797627 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic multiple interactions
decreases expression
EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ME1 mRNA; [Zidovudine co-treated with Lamivudine] affects the expression of ME1 mRNA
Zidovudine results in decreased expression of ME1 mRNA
CTD PMID:11741158 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Mff mitochondrial fission factor multiple interactions ISO [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of MFF mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of MFF protein CTD PMID:28683400 NCBI chr 1:82,702,599...82,730,111
Ensembl chr 1:82,702,611...82,730,115
JBrowse link
G Mfn1 mitofusin 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of MFN1 mRNA CTD PMID:18313992 NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
JBrowse link
G Mfn2 mitofusin 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of MFN2 mRNA CTD PMID:18313992 NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
JBrowse link
G Mgat4c MGAT4 family, member C multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MGAT4C mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MGAT4C mRNA CTD PMID:16931933 NCBI chr10:101,517,348...102,227,712
Ensembl chr10:101,517,348...102,227,330
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 mRNA]; Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 protein]; Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP2 protein] CTD PMID:14662518 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] CTD PMID:14662518 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mmut methylmalonyl-Coenzyme A mutase affects expression
increases expression
ISO Zidovudine affects the expression of MMUT mRNA mutant form; Zidovudine affects the expression of MMUT protein mutant form
Zidovudine results in increased expression of MMUT mRNA; Zidovudine results in increased expression of MMUT protein
CTD PMID:19199343 PMID:19427250 NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
JBrowse link
G Mov10 Mov10 RISC complex RNA helicase multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of MOV10 mRNA CTD PMID:20370541 NCBI chr 3:104,702,144...104,725,935
Ensembl chr 3:104,702,152...104,725,879
JBrowse link
G Mr1 major histocompatibility complex, class I-related affects expression ISO Zidovudine affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr 1:155,003,620...155,022,560
Ensembl chr 1:155,003,023...155,022,560
JBrowse link
G Mrap melanocortin 2 receptor accessory protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of MRAP mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of MRAP mRNA CTD PMID:16931933 NCBI chr16:90,535,095...90,546,673
Ensembl chr16:90,535,095...90,546,673
JBrowse link
G mt-Atp6 ATP synthase 6, mitochondrial increases expression ISO Zidovudine results in increased expression of ATP6 mRNA CTD PMID:16894629 NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial increases expression
decreases expression
multiple interactions
EXP
ISO
Zidovudine results in increased expression of COX1 mRNA
Zidovudine results in decreased expression of COX1 protein
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX1 mRNA; Uridine inhibits the reaction [Zidovudine results in decreased expression of COX1 protein]
CTD PMID:7528833 PMID:17526437 PMID:18163507 PMID:18313992 PMID:20032772 More... NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial decreases expression
multiple interactions
increases expression
ISO
EXP
Zidovudine results in decreased expression of COX2 protein
[Zidovudine co-treated with Lamivudine] results in decreased expression of COX2 mRNA
Zidovudine results in increased expression of COX2 mRNA
CTD PMID:7807166 PMID:10912924 PMID:16894629 PMID:18313992 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
JBrowse link
G mt-Co3 cytochrome c oxidase III, mitochondrial affects expression
multiple interactions
decreases expression
increases expression
ISO
EXP
Zidovudine affects the expression of COX3 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of COX3 mRNA
Zidovudine results in decreased expression of COX3 mRNA
Zidovudine results in increased expression of COX3 mRNA
CTD PMID:8828681 PMID:9799652 PMID:16894629 PMID:17526437 PMID:18313992 More... NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
JBrowse link
G mt-Cytb cytochrome b, mitochondrial affects expression
decreases expression
increases expression
ISO
EXP
Zidovudine affects the expression of CYTB mRNA
Zidovudine results in decreased expression of CYTB mRNA
Zidovudine results in increased expression of CYTB mRNA
CTD PMID:1715447 PMID:7528833 PMID:20032539 NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
JBrowse link
G mt-Nd1 NADH dehydrogenase 1, mitochondrial increases expression ISO Zidovudine results in increased expression of ND1 mRNA CTD PMID:16894629 NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
JBrowse link
G mt-Nd2 NADH dehydrogenase 2, mitochondrial increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of ND2 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of ND2 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
JBrowse link
G mt-Nd4 NADH dehydrogenase 4, mitochondrial increases expression
affects expression
ISO Zidovudine results in increased expression of ND4 mRNA
Zidovudine affects the expression of ND4 mRNA
CTD PMID:16894629 PMID:20032539 NCBI chr MT:10,167...11,544
Ensembl chr MT:10,167...11,544
JBrowse link
G mt-Nd5 NADH dehydrogenase 5, mitochondrial increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of ND5 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of ND5 mRNA
CTD PMID:16894629 PMID:17526437 PMID:18313992 NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
JBrowse link
G Mt2 metallothionein 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of MT2A mRNA CTD PMID:20370541 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of MTHFD2 mRNA CTD PMID:15784690 NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890
JBrowse link
G Mtor mechanistic target of rapamycin kinase increases phosphorylation ISO Zidovudine results in increased phosphorylation of MTOR protein CTD PMID:29594326 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
JBrowse link
G Mvd mevalonate (diphospho) decarboxylase multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of MVD mRNA CTD PMID:20370541 NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161
JBrowse link
G Mx1 MX dynamin-like GTPase 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of MX1 mRNA CTD PMID:20370541 NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
JBrowse link
G Mx2 MX dynamin-like GTPase 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of MX2 mRNA CTD PMID:20370541 NCBI chr16:97,337,281...97,362,101
Ensembl chr16:97,336,508...97,362,100
JBrowse link
G Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta increases expression ISO Zidovudine results in increased expression of MYH7 mRNA; Zidovudine results in increased expression of MYH7 protein CTD PMID:9799652 NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
JBrowse link
G Myod1 myogenic differentiation 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MYOD1 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of MYOD1 mRNA CTD PMID:16931933 NCBI chr 7:46,025,898...46,028,516
Ensembl chr 7:46,025,898...46,028,523
JBrowse link
G Nap1l5 nucleosome assembly protein 1-like 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NAP1L5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NAP1L5 mRNA CTD PMID:16931933 NCBI chr 6:58,882,218...58,884,111
Ensembl chr 6:58,882,218...58,884,061
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) multiple interactions
decreases expression
ISO [Zidovudine co-treated with Isoniazid] results in decreased expression of NAT2 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of NAT2 mRNA]
Zidovudine results in decreased expression of NAT2 mRNA
CTD PMID:28619387 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
JBrowse link
G Ndufa4 Ndufa4, mitochondrial complex associated multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFA4 mRNA CTD PMID:18313992 NCBI chr 6:11,900,371...11,907,449
Ensembl chr 6:11,900,291...11,907,496
JBrowse link
G Ndufa6 NADH:ubiquinone oxidoreductase subunit A6 increases expression ISO Zidovudine results in increased expression of NDUFA6 mRNA CTD PMID:16894629 NCBI chr15:82,234,342...82,238,438
Ensembl chr15:82,234,341...82,238,523
JBrowse link
G Ndufa9 NADH:ubiquinone oxidoreductase subunit A9 increases expression ISO Zidovudine results in increased expression of NDUFA9 mRNA CTD PMID:16894629 NCBI chr 6:126,798,826...126,826,107
Ensembl chr 6:126,798,684...126,826,099
JBrowse link
G Ndufab1 NADH:ubiquinone oxidoreductase subunit AB1 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of NDUFAB1 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109
JBrowse link
G Ndufaf1 NADH:ubiquinone oxidoreductase complex assembly factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAF1 mRNA CTD PMID:18313992 NCBI chr 2:119,485,927...119,493,302
Ensembl chr 2:119,485,927...119,493,308
JBrowse link
G Ndufb11 NADH:ubiquinone oxidoreductase subunit B11 multiple interactions ISO Zidovudine inhibits the reaction [Cyclic AMP results in increased phosphorylation of NDUFB11 protein] CTD PMID:17904600 NCBI chr  X:20,481,565...20,483,858
Ensembl chr  X:20,481,565...20,483,858
JBrowse link
G Ndufb3 NADH:ubiquinone oxidoreductase subunit B3 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of NDUFB3 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB3 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 1:58,625,556...58,635,123
Ensembl chr 1:58,625,543...58,635,123
JBrowse link
G Ndufb5 NADH:ubiquinone oxidoreductase subunit B5 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of NDUFB5 mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB5 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 3:32,791,206...32,805,708
Ensembl chr 3:32,791,139...32,805,715
JBrowse link
G Ndufb6 NADH:ubiquinone oxidoreductase subunit B6 increases expression ISO Zidovudine results in increased expression of NDUFB6 mRNA CTD PMID:16894629 NCBI chr 4:40,270,591...40,279,421
Ensembl chr 4:40,270,591...40,279,421
JBrowse link
G Ndufb9 NADH:ubiquinone oxidoreductase subunit B9 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NDUFB9 mRNA CTD PMID:18313992 NCBI chr15:58,805,650...58,811,365
Ensembl chr15:58,805,605...58,811,337
JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of NDUFC1 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFC1 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 3:51,312,876...51,323,167
Ensembl chr 3:51,312,098...51,316,409
JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 increases expression
multiple interactions
ISO
EXP
Zidovudine results in increased expression of NDUFS1 mRNA
[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFS1 mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992
JBrowse link
G Ndufs2 NADH:ubiquinone oxidoreductase core subunit S2 decreases expression ISO Zidovudine results in decreased expression of NDUFS2 mRNA CTD PMID:16894629 NCBI chr 1:171,062,426...171,078,956
Ensembl chr 1:171,062,422...171,078,957
JBrowse link
G Ndufs5 NADH:ubiquinone oxidoreductase core subunit S5 increases expression ISO Zidovudine results in increased expression of NDUFS5 mRNA CTD PMID:16894629 NCBI chr 4:123,606,503...123,611,979
Ensembl chr 4:123,606,503...123,611,995
JBrowse link
G Ndufs6 NADH:ubiquinone oxidoreductase core subunit S6 increases expression ISO Zidovudine results in increased expression of NDUFS6 mRNA CTD PMID:16894629 NCBI chr13:73,467,995...73,476,574
Ensembl chr13:73,467,957...73,476,661
JBrowse link
G Ndufv1 NADH:ubiquinone oxidoreductase core subunit V1 decreases expression ISO Zidovudine results in decreased expression of NDUFV1 mRNA CTD PMID:16894629 NCBI chr19:4,057,499...4,062,755
Ensembl chr19:4,057,384...4,062,806
JBrowse link
G Nexn nexilin multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of NEXN mRNA CTD PMID:20370541 NCBI chr 3:151,942,619...151,972,000
Ensembl chr 3:151,942,619...151,971,987
JBrowse link
G Nfe2 nuclear factor, erythroid derived 2 decreases activity
decreases expression
ISO Zidovudine results in decreased activity of NFE2 protein
Zidovudine results in decreased expression of NFE2 mRNA
CTD PMID:8599995 NCBI chr15:103,156,640...103,166,809
Ensembl chr15:103,156,639...103,166,830
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 increases expression ISO Zidovudine results in increased expression of NFE2L2 protein CTD PMID:29594326 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Niban1 niban apoptosis regulator 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of NIBAN1 mRNA CTD PMID:15784690 NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
JBrowse link
G Noct nocturnin multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of NOCT mRNA CTD PMID:16931933 NCBI chr 3:51,131,868...51,159,075
Ensembl chr 3:51,131,868...51,159,065
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions
decreases phosphorylation
ISO coenzyme Q10 inhibits the reaction [Zidovudine results in decreased phosphorylation of NOS3 protein] CTD PMID:23640862 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Nppa natriuretic peptide type A multiple interactions
increases expression
EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA
Zidovudine results in increased expression of NPPA mRNA
CTD PMID:10701688 PMID:11706060 NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 increases expression ISO Zidovudine results in increased expression of NQO1 mRNA CTD PMID:29594326 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects expression ISO Zidovudine affects the expression of NR3C1 mRNA CTD PMID:20032539 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
JBrowse link
G Nrf1 nuclear respiratory factor 1 increases expression EXP Zidovudine results in increased expression of NRF1 mRNA CTD PMID:17926646 NCBI chr 6:30,047,984...30,153,462
Ensembl chr 6:30,047,987...30,153,457
JBrowse link
G Nt5c3 5'-nucleotidase, cytosolic III multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of NT5C3A mRNA CTD PMID:20370541 NCBI chr 6:56,859,385...56,900,993
Ensembl chr 6:56,859,385...56,900,917
JBrowse link
G Nub1 negative regulator of ubiquitin-like proteins 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of NUB1 mRNA CTD PMID:20370541 NCBI chr 5:24,890,813...24,915,376
Ensembl chr 5:24,890,530...24,915,376
JBrowse link
G Nuf2 NUF2, NDC80 kinetochore complex component multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of NUF2 mRNA CTD PMID:20370541 NCBI chr 1:169,325,503...169,359,033
Ensembl chr 1:169,325,503...169,359,033
JBrowse link
G Nup210 nucleoporin 210 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of NUP210 mRNA CTD PMID:16931933 NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811
JBrowse link
G Nxnl2 nucleoredoxin-like 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of NXNL2 mRNA CTD PMID:16931933 NCBI chr13:51,324,256...51,329,227
Ensembl chr13:51,325,058...51,329,224
JBrowse link
G Oas1g 2'-5' oligoadenylate synthetase 1G multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS1 mRNA CTD PMID:20370541 NCBI chr 5:121,014,205...121,025,676
Ensembl chr 5:121,014,205...121,025,676
JBrowse link
G Oas2 2'-5' oligoadenylate synthetase 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS2 mRNA CTD PMID:20370541 NCBI chr 5:120,868,398...120,887,949
Ensembl chr 5:120,868,398...120,887,918
JBrowse link
G Oas3 2'-5' oligoadenylate synthetase 3 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS3 mRNA CTD PMID:20370541 NCBI chr 5:120,891,163...120,915,755
Ensembl chr 5:120,891,163...120,915,726
JBrowse link
G Oaz3 ornithine decarboxylase antizyme 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OAZ3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OAZ3 mRNA CTD PMID:16931933 NCBI chr 3:94,340,694...94,343,958
Ensembl chr 3:94,339,721...94,351,222
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of OGT mRNA CTD PMID:15784690 NCBI chr  X:100,683,617...100,727,957
Ensembl chr  X:100,683,666...100,727,957
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of OPA1 mRNA
[DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 mRNA; [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 protein
CTD PMID:18313992 PMID:28683400 NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
JBrowse link
G Oprl1 opioid receptor-like 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of OPRL1 mRNA CTD PMID:16931933 NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
JBrowse link
G Or5an1 olfactory receptor family 5 subfamily AN member 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT5 mRNA CTD PMID:20370541 NCBI chr19:12,257,218...12,261,352
Ensembl chr19:12,257,218...12,262,990
JBrowse link
G Or8g37 olfactory receptor family 8 subfamily G member 37 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of OR8G37 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OR8G37 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of OR8G37 mRNA CTD PMID:16931933 NCBI chr 9:39,730,937...39,731,872
Ensembl chr 9:39,720,156...39,732,293
JBrowse link
G Parp9 poly (ADP-ribose) polymerase family, member 9 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of PARP9 mRNA CTD PMID:20370541 NCBI chr16:35,759,360...35,792,975
Ensembl chr16:35,758,840...35,792,975
JBrowse link
G Pcbp4 poly(rC) binding protein 4 increases expression ISO Zidovudine results in increased expression of PCBP4 mRNA CTD PMID:23675285 NCBI chr 9:106,330,181...106,341,211
Ensembl chr 9:106,330,490...106,341,211
JBrowse link
G Pcdh15 protocadherin 15 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PCDH15 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PCDH15 mRNA CTD PMID:16931933 NCBI chr10:72,932,003...74,485,663
Ensembl chr10:72,935,174...74,485,569
JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of PCK2 mRNA CTD PMID:15784690 NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of PCNA mRNA CTD PMID:20370541 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 decreases expression ISO Zidovudine results in decreased expression of PEBP1 mRNA CTD PMID:16894629 NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
JBrowse link
G Pf4 platelet factor 4 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of PF4 mRNA CTD PMID:20370541 NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PFKFB3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PFKFB3 mRNA CTD PMID:16931933 NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888
JBrowse link
G Pgap6 post-glycosylphosphatidylinositol attachment to proteins 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of PGAP6 mRNA CTD PMID:16931933 NCBI chr17:26,332,290...26,342,228
Ensembl chr17:26,332,273...26,342,228
JBrowse link
G Pgr progesterone receptor multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PGR mRNA CTD PMID:20370541 NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
JBrowse link
G Phf6 PHD finger protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PHF6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of PHF6 mRNA CTD PMID:16931933 NCBI chr  X:52,001,091...52,045,838
Ensembl chr  X:52,001,143...52,045,820
JBrowse link
G Pidd1 p53 induced death domain protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIDD1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIDD1 mRNA CTD PMID:16931933 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
JBrowse link
G Pierce1 piercer of microtubule wall 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PIERCE1 mRNA CTD PMID:20370541 NCBI chr 2:28,352,013...28,356,336
Ensembl chr 2:28,352,013...28,356,344
JBrowse link
G Pik3ap1 phosphoinositide-3-kinase adaptor protein 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of PIK3AP1 mRNA CTD PMID:20370541 NCBI chr19:41,260,980...41,373,541
Ensembl chr19:41,260,816...41,373,541
JBrowse link
G Pirb paired Ig-like receptor B multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRB3 mRNA CTD PMID:20370541 NCBI chr 7:3,715,504...3,723,381
Ensembl chr 7:3,714,408...3,723,390
JBrowse link
G Piwil2 piwi-like RNA-mediated gene silencing 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIWIL2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of PIWIL2 mRNA CTD PMID:16931933 NCBI chr14:70,609,926...70,674,338
Ensembl chr14:70,609,926...70,666,832
JBrowse link
G Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of PKMYT1 mRNA CTD PMID:20370541 NCBI chr17:23,945,385...23,955,709
Ensembl chr17:23,945,310...23,955,709
JBrowse link
G Plscr1 phospholipid scramblase 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of PLSCR1 mRNA CTD PMID:20370541 NCBI chr 9:92,132,265...92,154,034
Ensembl chr 9:92,131,803...92,154,331
JBrowse link
G Pnkp polynucleotide kinase 3'- phosphatase increases expression ISO Zidovudine results in increased expression of PNKP mRNA CTD PMID:23675285 NCBI chr 7:44,505,903...44,514,761
Ensembl chr 7:44,506,563...44,512,416
JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions
decreases expression
ISO [Zidovudine co-treated with Isoniazid] results in decreased expression of POR mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of POR mRNA]
Zidovudine results in decreased expression of POR mRNA
CTD PMID:28619387 NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
JBrowse link
G Porcn porcupine O-acyltransferase multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PPN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PPN mRNA CTD PMID:16931933 NCBI chr  X:8,060,085...8,072,794
Ensembl chr  X:8,060,087...8,072,764
JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of POU5F1 mRNA CTD PMID:16931933 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma decreases expression EXP Zidovudine results in decreased expression of PPARG mRNA; Zidovudine results in decreased expression of PPARG protein CTD PMID:15722030 PMID:17926646 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRDM1 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRDM1 mRNA CTD PMID:16931933 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
JBrowse link
G Prl2c2 prolactin family 2, subfamily c, member 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C2 mRNA CTD PMID:16931933 NCBI chr13:13,170,705...13,179,978
Ensembl chr13:13,170,710...13,179,968
JBrowse link
G Prl2c3 prolactin family 2, subfamily c, member 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C3 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C3 mRNA CTD PMID:16931933 NCBI chr13:12,805,705...12,814,982
Ensembl chr13:12,805,705...12,814,968
JBrowse link
G Prl2c4 prolactin family 2, subfamily c, member 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of PRL2C4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRL2C4 mRNA CTD PMID:16931933 Ensembl chr13:12,805,705...12,814,968 JBrowse link
G Psat1 phosphoserine aminotransferase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA CTD PMID:15784690 NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression EXP Zidovudine results in decreased expression of PTGS2 protein CTD PMID:18389896 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Rab17 RAB17, member RAS oncogene family multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RAB17 mRNA CTD PMID:20370541 NCBI chr 1:90,885,855...90,897,395
Ensembl chr 1:90,885,855...90,897,383
JBrowse link
G Rab3b RAB3B, member RAS oncogene family multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RAB3B mRNA CTD PMID:20370541 NCBI chr 4:108,736,267...108,800,521
Ensembl chr 4:108,736,260...108,800,521
JBrowse link
G Rabepk Rab9 effector protein with kelch motifs multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of RABEPK mRNA CTD PMID:15784690 NCBI chr 2:34,662,946...34,690,200
Ensembl chr 2:34,667,568...34,689,924
JBrowse link
G Rassf7 Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RASSF7 mRNA CTD PMID:20370541 NCBI chr 7:140,795,338...140,798,571
Ensembl chr 7:140,795,773...140,798,571
JBrowse link
G Rbl1 RB transcriptional corepressor like 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA CTD PMID:15784690 NCBI chr 2:156,987,813...157,046,454
Ensembl chr 2:156,987,813...157,046,454
JBrowse link
G Rbl2 RB transcriptional corepressor like 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL2 mRNA CTD PMID:15784690 NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
JBrowse link
G Reep6 receptor accessory protein 6 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of REEP6 mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of REEP6 mRNA CTD PMID:16931933 NCBI chr10:80,165,831...80,172,275
Ensembl chr10:80,165,787...80,172,275
JBrowse link
G Rel reticuloendotheliosis oncogene multiple interactions ISO REL protein results in decreased susceptibility to [Zidovudine co-treated with IFNA1 protein] CTD PMID:17138822 NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases expression
EXP
ISO
2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine inhibits the reaction [Zidovudine results in increased expression of RELA protein]; glutapyrone inhibits the reaction [Zidovudine results in increased expression of RELA protein]; tauropyrone inhibits the reaction [Zidovudine results in increased expression of RELA protein]
Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]
CTD PMID:18801031 PMID:27238871 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Rgs6 regulator of G-protein signaling 6 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of RGS6 mRNA CTD PMID:20370541 NCBI chr12:82,663,325...83,208,835
Ensembl chr12:82,635,066...83,208,830
JBrowse link
G Ripk2 receptor (TNFRSF)-interacting serine-threonine kinase 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA CTD PMID:15784690 NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647
JBrowse link
G Rnf151 ring finger protein 151 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of RNF151 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of RNF151 mRNA CTD PMID:16931933 NCBI chr17:24,934,813...24,937,031
Ensembl chr17:24,934,813...24,937,037
JBrowse link
G Rnf213 ring finger protein 213 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of RNF213 mRNA CTD PMID:20370541 NCBI chr11:119,280,778...119,378,245
Ensembl chr11:119,283,926...119,378,244
JBrowse link
G Rpa1 replication protein A1 increases expression ISO Zidovudine results in increased expression of RPA1 mRNA CTD PMID:21192964 NCBI chr11:75,191,085...75,239,478
Ensembl chr11:75,188,992...75,239,150
JBrowse link
G Rpain RPA interacting protein multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of RPAIN mRNA; [Zidovudine co-treated with Lamivudine] results in decreased expression of RPAIN mRNA CTD PMID:16931933 NCBI chr11:70,860,403...70,868,759
Ensembl chr11:70,861,039...70,868,659
JBrowse link
G Rrm2b ribonucleotide reductase M2 B (TP53 inducible) increases expression ISO Zidovudine results in increased expression of RRM2B mRNA CTD PMID:21704725 NCBI chr15:37,924,196...37,961,562
Ensembl chr15:37,924,196...37,961,562
JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of RSAD2 mRNA CTD PMID:20370541 NCBI chr12:26,492,742...26,506,451
Ensembl chr12:26,492,745...26,506,451
JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of S100A8 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of S100A8 mRNA CTD PMID:16931933 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
JBrowse link
G Samd9l sterile alpha motif domain containing 9-like multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SAMD9L mRNA CTD PMID:20370541 NCBI chr 6:3,372,257...3,399,458
Ensembl chr 6:3,372,257...3,399,572
JBrowse link
G Sapcd2 suppressor APC domain containing 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of SAPCD2 mRNA CTD PMID:20370541 NCBI chr 2:25,261,974...25,268,225
Ensembl chr 2:25,262,333...25,268,225
JBrowse link
G Scimp SLP adaptor and CSK interacting membrane protein multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SCIMP mRNA CTD PMID:20370541 NCBI chr11:70,681,758...70,703,387
Ensembl chr11:70,681,758...70,703,412
JBrowse link
G Sdhb succinate dehydrogenase complex, subunit B, iron sulfur (Ip) decreases expression
multiple interactions
ISO
EXP
Zidovudine results in decreased expression of SDHB mRNA
[Zidovudine co-treated with Lamivudine] results in decreased expression of SDHB mRNA
CTD PMID:16894629 PMID:18313992 NCBI chr 4:140,688,582...140,706,509
Ensembl chr 4:140,688,514...140,706,504
JBrowse link
G Sdhd succinate dehydrogenase complex, subunit D, integral membrane protein increases expression ISO Zidovudine results in increased expression of SDHD mRNA CTD PMID:16894629 NCBI chr 9:50,507,640...50,515,149
Ensembl chr 9:50,507,657...50,515,112
JBrowse link
G Serinc1 serine incorporator 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SERINC1 mRNA CTD PMID:16931933 NCBI chr10:57,391,870...57,408,573
Ensembl chr10:57,391,870...57,408,626
JBrowse link
G Serpina1a serine (or cysteine) peptidase inhibitor, clade A, member 1A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SERPINA1A mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SERPINA1A mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SERPINA1A mRNA CTD PMID:16931933 NCBI chr12:103,819,554...103,829,878
Ensembl chr12:103,819,848...103,829,821
JBrowse link
G Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SERPING1 mRNA CTD PMID:20370541 NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
JBrowse link
G Sfxn1 sideroflexin 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN1 mRNA CTD PMID:18313992 NCBI chr13:54,225,675...54,262,365
Ensembl chr13:54,225,888...54,262,361
JBrowse link
G Sfxn2 sideroflexin 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA CTD PMID:18313992 NCBI chr19:46,561,798...46,585,340
Ensembl chr19:46,561,804...46,586,505
JBrowse link
G Sfxn4 sideroflexin 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN4 mRNA CTD PMID:18313992 NCBI chr19:60,824,747...60,850,222
Ensembl chr19:60,825,715...60,849,917
JBrowse link
G Sgpp1 sphingosine-1-phosphate phosphatase 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SGPP1 mRNA CTD PMID:18313992 NCBI chr12:75,761,022...75,782,503
Ensembl chr12:75,761,023...75,782,503
JBrowse link
G Shfl shiftless antiviral inhibitor of ribosomal frameshifting multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SHFL mRNA CTD PMID:20370541 NCBI chr 9:20,779,914...20,785,603
Ensembl chr 9:20,779,938...20,785,603
JBrowse link
G Siglec1 sialic acid binding Ig-like lectin 1, sialoadhesin multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SIGLEC1 mRNA CTD PMID:20370541 NCBI chr 2:130,911,140...130,928,697
Ensembl chr 2:130,911,140...130,928,685
JBrowse link
G Sirt3 sirtuin 3 increases expression ISO Zidovudine results in increased expression of SIRT3 protein CTD PMID:27041070 NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
JBrowse link
G Slc10a3 solute carrier family 10 (sodium/bile acid cotransporter family), member 3 increases expression ISO Zidovudine results in increased expression of SLC10A3 mRNA CTD PMID:24292225 NCBI chr  X:73,412,823...73,416,955
Ensembl chr  X:73,412,823...73,416,955
JBrowse link
G Slc12a3 solute carrier family 12, member 3 decreases expression ISO Zidovudine results in decreased expression of SLC12A3 mRNA CTD PMID:24292225 NCBI chr 8:95,055,737...95,092,850
Ensembl chr 8:95,055,829...95,092,842
JBrowse link
G Slc12a4 solute carrier family 12, member 4 increases expression ISO Zidovudine results in increased expression of SLC12A4 mRNA CTD PMID:24292225 NCBI chr 8:106,670,222...106,692,781
Ensembl chr 8:106,670,222...106,692,729
JBrowse link
G Slc12a9 solute carrier family 12 (potassium/chloride transporters), member 9 increases expression ISO Zidovudine results in increased expression of SLC12A9 mRNA CTD PMID:24292225 NCBI chr 5:137,312,820...137,338,331
Ensembl chr 5:137,312,820...137,331,859
JBrowse link
G Slc13a3 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 increases expression
decreases expression
ISO Zidovudine results in increased expression of SLC13A3 mRNA
Zidovudine results in decreased expression of SLC13A3 mRNA
CTD PMID:24292225 NCBI chr 2:165,247,215...165,315,117
Ensembl chr 2:165,246,948...165,315,150
JBrowse link
G Slc13a5 solute carrier family 13 (sodium-dependent citrate transporter), member 5 decreases expression
increases expression
ISO Zidovudine results in decreased expression of SLC13A5 mRNA
Zidovudine results in increased expression of SLC13A5 mRNA
CTD PMID:24292225 NCBI chr11:72,132,816...72,158,092
Ensembl chr11:72,132,815...72,158,048
JBrowse link
G Slc16a1 solute carrier family 16 (monocarboxylic acid transporters), member 1 decreases expression ISO Zidovudine results in decreased expression of SLC16A1 mRNA CTD PMID:24292225 NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
JBrowse link
G Slc16a2 solute carrier family 16 (monocarboxylic acid transporters), member 2 increases expression ISO Zidovudine results in increased expression of SLC16A2 mRNA CTD PMID:24292225 NCBI chr  X:102,741,020...102,865,594
Ensembl chr  X:102,741,020...102,865,589
JBrowse link
G Slc16a3 solute carrier family 16 (monocarboxylic acid transporters), member 3 decreases expression ISO Zidovudine results in decreased expression of SLC16A3 mRNA CTD PMID:24292225 NCBI chr11:120,839,310...120,849,826
Ensembl chr11:120,839,306...120,851,694
JBrowse link
G Slc16a4 solute carrier family 16 (monocarboxylic acid transporters), member 4 increases expression ISO Zidovudine results in increased expression of SLC16A4 mRNA CTD PMID:24292225 NCBI chr 3:107,198,543...107,219,437
Ensembl chr 3:107,198,546...107,219,431
JBrowse link
G Slc16a6 solute carrier family 16 (monocarboxylic acid transporters), member 6 decreases expression
increases expression
ISO Zidovudine results in decreased expression of SLC16A6 mRNA
Zidovudine results in increased expression of SLC16A6 mRNA
CTD PMID:24292225 NCBI chr11:109,341,681...109,366,428
Ensembl chr11:109,341,681...109,364,424
JBrowse link
G Slc17a2 solute carrier family 17 (sodium phosphate), member 2 decreases expression ISO Zidovudine results in decreased expression of SLC17A2 mRNA CTD PMID:24292225 NCBI chr13:23,990,924...24,009,174
Ensembl chr13:23,990,976...24,009,163
JBrowse link
G Slc17a8 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 increases expression ISO Zidovudine results in increased expression of SLC17A8 mRNA CTD PMID:24292225 NCBI chr10:89,409,882...89,457,111
Ensembl chr10:89,409,882...89,457,115
JBrowse link
G Slc19a2 solute carrier family 19 (thiamine transporter), member 2 decreases expression ISO Zidovudine results in decreased expression of SLC19A2 mRNA CTD PMID:24292225 NCBI chr 1:164,076,615...164,092,954
Ensembl chr 1:164,076,615...164,092,954
JBrowse link
G Slc19a3 solute carrier family 19, member 3 decreases expression ISO Zidovudine results in decreased expression of SLC19A3 mRNA CTD PMID:24292225 NCBI chr 1:82,990,242...83,016,541
Ensembl chr 1:82,990,244...83,016,169
JBrowse link
G Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 increases expression ISO Zidovudine results in increased expression of SLC1A1 mRNA CTD PMID:24292225 NCBI chr19:28,812,535...28,891,360
Ensembl chr19:28,812,449...28,891,360
JBrowse link
G Slc1a4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 multiple interactions
increases expression
ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A4 mRNA
Zidovudine results in increased expression of SLC1A4 mRNA
CTD PMID:15784690 PMID:24292225 NCBI chr11:20,252,180...20,282,713
Ensembl chr11:20,252,180...20,282,713
JBrowse link
G Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 5 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC1A5 mRNA CTD PMID:15784690 NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
JBrowse link
G Slc20a1 solute carrier family 20, member 1 decreases expression ISO Zidovudine results in decreased expression of SLC20A1 mRNA CTD PMID:24292225 NCBI chr 2:129,038,662...129,053,535
Ensembl chr 2:129,040,684...129,053,536
JBrowse link
G Slc20a2 solute carrier family 20, member 2 increases expression ISO Zidovudine results in increased expression of SLC20A2 mRNA CTD PMID:24292225 NCBI chr 8:22,966,771...23,059,632
Ensembl chr 8:22,966,804...23,059,628
JBrowse link
G Slc22a15 solute carrier family 22 (organic anion/cation transporter), member 15 decreases expression ISO Zidovudine results in decreased expression of SLC22A15 mRNA CTD PMID:24292225 NCBI chr 3:101,763,084...101,831,769
Ensembl chr 3:101,763,092...101,831,769
JBrowse link
G Slc22a17 solute carrier family 22 (organic cation transporter), member 17 increases expression ISO Zidovudine results in increased expression of SLC22A17 mRNA CTD PMID:24292225 NCBI chr14:55,144,184...55,154,527
Ensembl chr14:55,143,761...55,150,589
JBrowse link
G Slc22a18 solute carrier family 22 (organic cation transporter), member 18 increases expression ISO Zidovudine results in increased expression of SLC22A18 mRNA CTD PMID:24292225 NCBI chr 7:143,027,502...143,053,071
Ensembl chr 7:143,027,473...143,053,071
JBrowse link
G Slc22a19 solute carrier family 22 (organic anion transporter), member 19 decreases expression ISO Zidovudine results in decreased expression of SLC22A9 mRNA CTD PMID:24292225 NCBI chr19:7,650,440...7,688,675
Ensembl chr19:7,650,426...7,688,675
JBrowse link
G Slc22a23 solute carrier family 22, member 23 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC22A23 mRNA CTD PMID:20370541 NCBI chr13:34,363,141...34,530,666
Ensembl chr13:34,363,141...34,529,165
JBrowse link
G Slc22a4 solute carrier family 22 (organic cation transporter), member 4 increases expression ISO Zidovudine results in increased expression of SLC22A4 mRNA CTD PMID:24292225 NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
JBrowse link
G Slc22a5 solute carrier family 22 (organic cation transporter), member 5 increases expression ISO Zidovudine results in increased expression of SLC22A5 mRNA CTD PMID:24292225 NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
JBrowse link
G Slc22a7 solute carrier family 22 (organic anion transporter), member 7 increases uptake
increases expression
ISO SLC22A7 protein results in increased uptake of Zidovudine
Zidovudine results in increased expression of SLC22A7 mRNA
CTD PMID:15901346 PMID:24292225 NCBI chr17:46,743,111...46,749,403
Ensembl chr17:46,743,109...46,749,383
JBrowse link
G Slc23a2 solute carrier family 23 (nucleobase transporters), member 2 increases expression ISO Zidovudine results in increased expression of SLC23A2 mRNA CTD PMID:24292225 NCBI chr 2:131,894,416...131,987,287
Ensembl chr 2:131,894,416...131,987,028
JBrowse link
G Slc24a4 solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC24A4 mRNA CTD PMID:20370541 NCBI chr12:102,094,986...102,239,562
Ensembl chr12:102,094,992...102,233,350
JBrowse link
G Slc25a1 solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 increases expression ISO Zidovudine results in increased expression of SLC25A1 mRNA CTD PMID:24292225 NCBI chr16:17,743,075...17,746,083
Ensembl chr16:17,743,087...17,746,083
JBrowse link
G Slc25a10 solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 increases expression ISO Zidovudine results in increased expression of SLC25A10 mRNA CTD PMID:24292225 NCBI chr11:120,382,663...120,391,987
Ensembl chr11:120,382,666...120,390,013
JBrowse link
G Slc25a11 solute carrier family 25 (mitochondrial carrier oxoglutarate carrier), member 11 increases expression ISO Zidovudine results in increased expression of SLC25A11 mRNA CTD PMID:24292225 NCBI chr11:70,534,845...70,538,356
Ensembl chr11:70,535,022...70,538,305
JBrowse link
G Slc25a12 solute carrier family 25 (mitochondrial carrier, Aralar), member 12 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA CTD PMID:18313992 NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
JBrowse link
G Slc25a15 solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A15 mRNA CTD PMID:18313992 NCBI chr 8:22,865,566...22,888,637
Ensembl chr 8:22,865,567...22,888,613
JBrowse link
G Slc25a16 solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 increases expression ISO Zidovudine results in increased expression of SLC25A16 mRNA CTD PMID:24292225 NCBI chr10:62,756,454...62,782,278
Ensembl chr10:62,756,412...62,782,277
JBrowse link
G Slc25a19 solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 multiple interactions ISO
EXP
SLC25A19 protein affects the susceptibility to [Zidovudine co-treated with Lamivudine co-treated with Indinavir]
[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A19 mRNA
CTD PMID:15951836 PMID:18313992 NCBI chr11:115,504,991...115,519,122
Ensembl chr11:115,505,004...115,519,121
JBrowse link
G Slc25a2 solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A2 mRNA CTD PMID:18313992 NCBI chr18:37,770,431...37,771,776
Ensembl chr18:37,770,431...37,771,776
JBrowse link
G Slc25a20 solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 multiple interactions
increases expression
EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A20 mRNA
Zidovudine results in increased expression of SLC25A20 mRNA
CTD PMID:18313992 PMID:24292225 NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
JBrowse link
G Slc25a21 solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 increases expression ISO Zidovudine results in increased expression of SLC25A21 mRNA CTD PMID:24292225 NCBI chr12:56,759,419...57,244,257
Ensembl chr12:56,759,419...57,244,257
JBrowse link
G Slc25a29 solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A29 mRNA CTD PMID:18313992 NCBI chr12:108,791,804...108,801,802
Ensembl chr12:108,791,799...108,801,809
JBrowse link
G Slc25a3 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A3 mRNA CTD PMID:18313992 NCBI chr10:90,952,436...90,959,902
Ensembl chr10:90,952,436...90,959,921
JBrowse link
G Slc25a4 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SLC25A4 mRNA CTD PMID:18313992 NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
JBrowse link
G Slc26a1 solute carrier family 26 (sulfate transporter), member 1 increases expression ISO Zidovudine results in increased expression of SLC26A1 mRNA CTD PMID:24292225 NCBI chr 5:108,817,744...108,826,246
Ensembl chr 5:108,817,744...108,823,435
JBrowse link
G Slc26a11 solute carrier family 26, member 11 increases expression ISO Zidovudine results in increased expression of SLC26A11 mRNA CTD PMID:24292225 NCBI chr11:119,246,328...119,271,902
Ensembl chr11:119,246,383...119,271,905
JBrowse link
G Slc26a2 solute carrier family 26 (sulfate transporter), member 2 increases expression ISO Zidovudine results in increased expression of SLC26A2 mRNA CTD PMID:24292225 NCBI chr18:61,329,926...61,344,668
Ensembl chr18:61,325,991...61,344,684
JBrowse link
G Slc26a3 solute carrier family 26, member 3 decreases expression ISO Zidovudine results in decreased expression of SLC26A3 mRNA CTD PMID:24292225 NCBI chr12:31,483,141...31,523,921
Ensembl chr12:31,440,870...31,523,916
JBrowse link
G Slc26a9 solute carrier family 26, member 9 increases expression ISO Zidovudine results in increased expression of SLC26A9 mRNA CTD PMID:24292225 NCBI chr 1:131,671,760...131,699,242
Ensembl chr 1:131,671,760...131,699,242
JBrowse link
G Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 increases expression ISO Zidovudine results in increased expression of SLC27A2 mRNA CTD PMID:24292225 NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
JBrowse link
G Slc28a1 solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 affects transport
multiple interactions
increases uptake
ISO SLC28A1 protein affects the transport of Zidovudine
Zidovudine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]; Zidovudine promotes the reaction [SLC28A1 protein results in increased export of Uridine]
SLC28A1 protein results in increased uptake of Zidovudine
CTD PMID:8027026 PMID:8700147 PMID:8713072 PMID:9124315 NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
JBrowse link
G Slc28a3 solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 increases expression ISO Zidovudine results in increased expression of SLC28A3 mRNA CTD PMID:24292225 NCBI chr13:58,701,121...58,758,691
Ensembl chr13:58,693,213...58,758,691
JBrowse link
G Slc29a1 solute carrier family 29 (nucleoside transporters), member 1 increases expression ISO Zidovudine results in increased expression of SLC29A1 mRNA CTD PMID:24292225 NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
JBrowse link
G Slc29a3 solute carrier family 29 (nucleoside transporters), member 3 affects transport
increases expression
ISO SLC29A3 protein affects the transport of Zidovudine
Zidovudine results in increased expression of SLC29A3 mRNA
CTD PMID:19164483 PMID:24292225 NCBI chr10:60,547,851...60,588,624
Ensembl chr10:60,547,851...60,588,573
JBrowse link
G Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 decreases expression ISO Zidovudine results in decreased expression of SLC2A1 mRNA CTD PMID:24292225 NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
JBrowse link
G Slc2a10 solute carrier family 2 (facilitated glucose transporter), member 10 decreases expression ISO Zidovudine results in decreased expression of SLC2A10 mRNA CTD PMID:24292225 NCBI chr 2:165,345,817...165,361,837
Ensembl chr 2:165,345,707...165,361,837
JBrowse link
G Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 decreases expression ISO Zidovudine results in decreased expression of SLC2A3 mRNA CTD PMID:24292225 NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
JBrowse link
G Slc2a4 solute carrier family 2 (facilitated glucose transporter), member 4 affects expression ISO Zidovudine affects the expression of SLC2A4 mRNA CTD PMID:20032539 NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
JBrowse link
G Slc2a6 solute carrier family 2 (facilitated glucose transporter), member 6 increases expression ISO Zidovudine results in increased expression of SLC2A6 mRNA CTD PMID:24292225 NCBI chr 2:26,911,375...26,918,011
Ensembl chr 2:26,911,375...26,918,010
JBrowse link
G Slc2a8 solute carrier family 2, (facilitated glucose transporter), member 8 increases expression ISO Zidovudine results in increased expression of SLC2A8 mRNA CTD PMID:24292225 NCBI chr 2:32,862,993...32,872,088
Ensembl chr 2:32,863,002...32,872,095
JBrowse link
G Slc30a1 solute carrier family 30 (zinc transporter), member 1 increases expression ISO Zidovudine results in increased expression of SLC30A1 mRNA CTD PMID:24292225 NCBI chr 1:191,638,810...191,645,359
Ensembl chr 1:191,638,879...191,645,359
JBrowse link
G Slc30a3 solute carrier family 30 (zinc transporter), member 3 increases expression ISO Zidovudine results in increased expression of SLC30A3 mRNA CTD PMID:24292225 NCBI chr 5:31,243,450...31,265,576
Ensembl chr 5:31,243,450...31,265,581
JBrowse link
G Slc30a7 solute carrier family 30 (zinc transporter), member 7 increases expression ISO Zidovudine results in increased expression of SLC30A7 mRNA CTD PMID:24292225 NCBI chr 3:115,732,622...115,801,079
Ensembl chr 3:115,732,622...115,801,055
JBrowse link
G Slc30a9 solute carrier family 30 (zinc transporter), member 9 increases expression ISO Zidovudine results in increased expression of SLC30A9 mRNA CTD PMID:24292225 NCBI chr 5:67,464,298...67,513,485
Ensembl chr 5:67,464,298...67,515,786
JBrowse link
G Slc31a1 solute carrier family 31, member 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006
JBrowse link
G Slc31a2 solute carrier family 31, member 2 increases expression ISO Zidovudine results in increased expression of SLC31A2 mRNA CTD PMID:24292225 NCBI chr 4:62,198,630...62,216,649
Ensembl chr 4:62,180,799...62,216,648
JBrowse link
G Slc35a4 solute carrier family 35, member A4 increases expression ISO Zidovudine results in increased expression of SLC35A4 mRNA CTD PMID:24292225 NCBI chr18:36,812,268...36,816,915
Ensembl chr18:36,812,268...36,816,914
JBrowse link
G Slc35b3 solute carrier family 35, member B3 increases expression ISO Zidovudine results in increased expression of SLC35B3 mRNA CTD PMID:24292225 NCBI chr13:39,116,112...39,144,855
Ensembl chr13:39,116,112...39,144,851
JBrowse link
G Slc35b4 solute carrier family 35, member B4 increases expression ISO Zidovudine results in increased expression of SLC35B4 mRNA CTD PMID:24292225 NCBI chr 6:34,132,810...34,153,921
Ensembl chr 6:34,130,315...34,154,046
JBrowse link
G Slc35d1 solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 increases expression ISO Zidovudine results in increased expression of SLC35D1 mRNA CTD PMID:24292225 NCBI chr 4:103,027,846...103,078,208
Ensembl chr 4:103,027,846...103,072,361
JBrowse link
G Slc35f2 solute carrier family 35, member F2 increases expression ISO Zidovudine results in increased expression of SLC35F2 mRNA CTD PMID:24292225 NCBI chr 9:53,678,733...53,725,445
Ensembl chr 9:53,678,822...53,725,438
JBrowse link
G Slc37a1 solute carrier family 37 (glycerol-3-phosphate transporter), member 1 increases expression ISO Zidovudine results in increased expression of SLC37A1 mRNA CTD PMID:24292225 NCBI chr17:31,495,722...31,569,683
Ensembl chr17:31,505,766...31,569,713
JBrowse link
G Slc37a2 solute carrier family 37 (glycerol-3-phosphate transporter), member 2 increases expression ISO Zidovudine results in increased expression of SLC37A2 mRNA CTD PMID:24292225 NCBI chr 9:37,140,445...37,166,709
Ensembl chr 9:37,138,881...37,167,034
JBrowse link
G Slc38a2 solute carrier family 38, member 2 decreases expression ISO Zidovudine results in decreased expression of SLC38A2 mRNA CTD PMID:24292225 NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
JBrowse link
G Slc38a3 solute carrier family 38, member 3 increases expression ISO Zidovudine results in increased expression of SLC38A3 mRNA CTD PMID:24292225 NCBI chr 9:107,528,353...107,546,167
Ensembl chr 9:107,527,833...107,546,729
JBrowse link
G Slc38a4 solute carrier family 38, member 4 decreases expression ISO Zidovudine results in decreased expression of SLC38A4 mRNA CTD PMID:24292225 NCBI chr15:96,892,701...96,953,837
Ensembl chr15:96,892,701...96,953,837
JBrowse link
G Slc38a5 solute carrier family 38, member 5 decreases expression ISO Zidovudine results in decreased expression of SLC38A5 mRNA CTD PMID:24292225 NCBI chr  X:8,137,620...8,146,418
Ensembl chr  X:8,137,372...8,146,418
JBrowse link
G Slc38a6 solute carrier family 38, member 6 increases expression ISO Zidovudine results in increased expression of SLC38A6 mRNA CTD PMID:24292225 NCBI chr12:73,333,622...73,408,772
Ensembl chr12:73,333,553...73,400,823
JBrowse link
G Slc39a10 solute carrier family 39 (zinc transporter), member 10 decreases expression ISO Zidovudine results in decreased expression of SLC39A10 mRNA CTD PMID:24292225 NCBI chr 1:46,846,704...46,964,952
Ensembl chr 1:46,846,704...46,932,012
JBrowse link
G Slc39a14 solute carrier family 39 (zinc transporter), member 14 decreases expression ISO Zidovudine results in decreased expression of SLC39A14 mRNA CTD PMID:24292225 NCBI chr14:70,540,916...70,588,873
Ensembl chr14:70,540,918...70,588,874
JBrowse link
G Slc39a9 solute carrier family 39 (zinc transporter), member 9 increases expression ISO Zidovudine results in increased expression of SLC39A9 mRNA CTD PMID:24292225 NCBI chr12:80,690,657...80,730,116
Ensembl chr12:80,690,657...80,730,116
JBrowse link
G Slc3a2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 multiple interactions
increases expression
ISO [Zidovudine co-treated with Lamivudine] results in increased expression of SLC3A2 mRNA
Zidovudine results in increased expression of SLC3A2 mRNA
CTD PMID:15784690 PMID:24292225 NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 multiple interactions
increases expression
EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of SLC40A1 mRNA
Zidovudine results in increased expression of SLC40A1 mRNA
CTD PMID:18313992 PMID:24292225 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
JBrowse link
G Slc4a2 solute carrier family 4 (anion exchanger), member 2 increases expression ISO Zidovudine results in increased expression of SLC4A2 mRNA CTD PMID:24292225 NCBI chr 5:24,628,834...24,645,945
Ensembl chr 5:24,628,835...24,645,948
JBrowse link
G Slc5a3 solute carrier family 5 (inositol transporters), member 3 decreases expression ISO Zidovudine results in decreased expression of SLC5A3 mRNA CTD PMID:24292225 NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
JBrowse link
G Slc6a11 solute carrier family 6 (neurotransmitter transporter, GABA), member 11 increases expression ISO Zidovudine results in increased expression of SLC6A11 mRNA CTD PMID:24292225 NCBI chr 6:114,108,202...114,226,847
Ensembl chr 6:114,108,202...114,226,913
JBrowse link
G Slc6a12 solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 increases expression ISO Zidovudine results in increased expression of SLC6A12 mRNA CTD PMID:24292225 NCBI chr 6:121,319,533...121,342,732
Ensembl chr 6:121,320,035...121,342,734
JBrowse link
G Slc6a2 solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 increases expression ISO Zidovudine results in increased expression of SLC6A2 mRNA CTD PMID:24292225 NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
JBrowse link
G Slc6a8 solute carrier family 6 (neurotransmitter transporter, creatine), member 8 decreases expression ISO Zidovudine results in decreased expression of SLC6A8 mRNA CTD PMID:24292225 NCBI chr  X:72,716,739...72,726,108
Ensembl chr  X:72,716,756...72,726,108
JBrowse link
G Slc7a10 solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 decreases expression
increases expression
ISO Zidovudine results in decreased expression of SLC7A10 mRNA
Zidovudine results in increased expression of SLC7A10 mRNA
CTD PMID:24292225 NCBI chr 7:34,885,520...34,900,539
Ensembl chr 7:34,885,810...34,900,539
JBrowse link
G Slc7a2 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 decreases expression ISO Zidovudine results in decreased expression of SLC7A2 mRNA CTD PMID:24292225 NCBI chr 8:41,315,404...41,375,107
Ensembl chr 8:41,315,433...41,375,345
JBrowse link
G Slc7a5 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 increases expression ISO Zidovudine results in increased expression of SLC7A5 mRNA CTD PMID:24292225 NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
JBrowse link
G Slc7a7 solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 multiple interactions
increases expression
ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC7A7 mRNA
Zidovudine results in increased expression of SLC7A7 mRNA
CTD PMID:20370541 PMID:24292225 NCBI chr14:54,606,899...54,657,525
Ensembl chr14:54,606,899...54,655,237
JBrowse link
G Slc7a8 solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 increases expression ISO Zidovudine results in increased expression of SLC7A8 mRNA CTD PMID:24292225 NCBI chr14:54,959,672...55,019,343
Ensembl chr14:54,959,666...55,019,403
JBrowse link
G Slc7a9 solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 increases expression ISO Zidovudine results in increased expression of SLC7A9 mRNA CTD PMID:24292225 NCBI chr 7:35,148,152...35,165,459
Ensembl chr 7:35,148,221...35,165,461
JBrowse link
G Slc9a1 solute carrier family 9 (sodium/hydrogen exchanger), member 1 increases expression ISO Zidovudine results in increased expression of SLC9A1 mRNA CTD PMID:24292225 NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013
JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 decreases expression ISO Zidovudine results in decreased expression of SLCO2A1 mRNA CTD PMID:24292225 NCBI chr 9:102,885,686...102,973,201
Ensembl chr 9:102,865,911...102,973,201
JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 decreases expression
increases expression
ISO Zidovudine results in decreased expression of SLCO2B1 mRNA
Zidovudine results in increased expression of SLCO2B1 mRNA
CTD PMID:24292225 NCBI chr 7:99,307,011...99,360,547
Ensembl chr 7:99,307,011...99,360,547
JBrowse link
G Slco4a1 solute carrier organic anion transporter family, member 4a1 decreases expression ISO Zidovudine results in decreased expression of SLCO4A1 mRNA CTD PMID:24292225 NCBI chr 2:180,098,019...180,116,646
Ensembl chr 2:180,098,038...180,116,660
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial decreases response to substance
multiple interactions
EXP
ISO
SOD2 protein results in decreased susceptibility to Zidovudine
[SOD2 co-treated with CYP3A4] affects the susceptibility to Zidovudine
CTD PMID:19398959 PMID:19501153 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Spink5 serine peptidase inhibitor, Kazal type 5 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SPINK5 mRNA CTD PMID:16931933 NCBI chr18:44,092,612...44,155,554
Ensembl chr18:44,096,302...44,155,568
JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO Zidovudine results in increased expression of SQSTM1 protein CTD PMID:29594326 NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of STAR mRNA CTD PMID:18313992 NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of STAT1 mRNA CTD PMID:20370541 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
JBrowse link
G Stat2 signal transducer and activator of transcription 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of STAT2 mRNA CTD PMID:20370541 NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718
JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of STC2 mRNA CTD PMID:15784690 NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
JBrowse link
G Sub1 SUB1 homolog, transcriptional regulator multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of SUB1 mRNA CTD PMID:16931933 NCBI chr15:11,981,422...11,996,091
Ensembl chr15:11,981,425...11,997,069
JBrowse link
G Sval2 seminal vesicle antigen-like 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SVAL2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SVAL2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SVAL2 mRNA CTD PMID:16931933 NCBI chr 6:41,837,241...41,841,347
Ensembl chr 6:41,829,923...41,841,347
JBrowse link
G Tcea1 transcription elongation factor A (SII) 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of TCEA1 mRNA CTD PMID:15784690 NCBI chr 1:4,927,917...4,968,132
Ensembl chr 1:4,928,037...4,968,132
JBrowse link
G Tcn2 transcobalamin 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TCN2 mRNA CTD PMID:20370541 NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159
JBrowse link
G Tert telomerase reverse transcriptase decreases activity ISO Zidovudine results in decreased activity of TERT protein CTD PMID:16601281 PMID:18097608 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
G Tfam transcription factor A, mitochondrial increases expression ISO Zidovudine results in increased expression of TFAM mRNA CTD PMID:10535663 NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
JBrowse link
G Tfap2a transcription factor AP-2, alpha decreases expression EXP Zidovudine results in decreased expression of TFAP2A mRNA CTD PMID:17926646 NCBI chr13:40,867,278...40,891,715
Ensembl chr13:40,868,778...40,891,852
JBrowse link
G Tfeb transcription factor EB decreases expression ISO Zidovudine results in decreased expression of TFEB protein CTD PMID:29594326 NCBI chr17:48,047,962...48,103,341
Ensembl chr17:48,047,955...48,103,344
JBrowse link
G Timm17b translocase of inner mitochondrial membrane 17b multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of TIMM17B mRNA CTD PMID:18313992 NCBI chr  X:7,765,575...7,773,891
Ensembl chr  X:7,765,596...7,776,168
JBrowse link
G Timm23 translocase of inner mitochondrial membrane 23 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of TIMM23 mRNA CTD PMID:18313992 NCBI chr14:31,902,123...31,923,848
Ensembl chr14:31,902,119...31,923,855
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TIMP2 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TIMP2 mRNA CTD PMID:16931933 NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
JBrowse link
G Tk1 thymidine kinase 1 decreases response to substance
increases expression
decreases expression
increases mutagenesis
increases response to substance
increases metabolic processing
increases activity
increases methylation
decreases activity
affects transport
multiple interactions
ISO
EXP
TK1 gene modified form results in decreased susceptibility to Zidovudine
Zidovudine results in increased expression of TK1 mRNA; Zidovudine results in increased expression of TK1 protein
Zidovudine results in decreased expression of TK1 mRNA; Zidovudine results in decreased expression of TK1 protein
Zidovudine results in increased mutagenesis of TK1 gene
TK1 protein results in increased susceptibility to Zidovudine
TK1 protein results in increased metabolism of Zidovudine
Zidovudine results in increased activity of TK1 protein
Zidovudine results in increased methylation of TK1 exon
Zidovudine results in decreased activity of TK1 protein
TK1 protein affects the transport of Zidovudine
Ethanol inhibits the reaction [Zidovudine results in increased activity of TK1 protein]; Zidovudine inhibits the reaction [Ethanol results in decreased activity of TK1 protein]
CTD PMID:8915012 PMID:8941356 PMID:11923581 PMID:15013700 PMID:15708581 More... NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
JBrowse link
G Tk2 thymidine kinase 2, mitochondrial multiple interactions
increases expression
EXP
ISO
[Zidovudine co-treated with Lamivudine] results in increased expression of TK2 mRNA
Zidovudine results in increased expression of TK2 mRNA
CTD PMID:18313992 PMID:24292225 NCBI chr 8:104,953,323...104,975,224
Ensembl chr 8:104,953,317...104,975,190
JBrowse link
G Tlr7 toll-like receptor 7 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TLR7 mRNA CTD PMID:20370541 NCBI chr  X:166,086,376...166,113,570
Ensembl chr  X:166,087,925...166,113,554
JBrowse link
G Tmem97 transmembrane protein 97 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TMEM97 mRNA CTD PMID:20370541 NCBI chr11:78,432,643...78,441,561
Ensembl chr11:78,432,643...78,441,603
JBrowse link
G Tnc tenascin C multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TNC mRNA CTD PMID:20370541 NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions
increases expression
ISO Zidovudine analog results in decreased expression of TNF protein
[Isoniazid co-treated with Zidovudine] results in increased expression of TNF protein; silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased expression of TNF protein]
Zidovudine results in increased expression of TNF protein
CTD PMID:12729831 PMID:17668557 PMID:28619387 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF10 mRNA CTD PMID:20370541 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
JBrowse link
G Tnfsf13b tumor necrosis factor (ligand) superfamily, member 13b multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF13B mRNA CTD PMID:20370541 NCBI chr 8:10,056,637...10,086,000
Ensembl chr 8:10,056,467...10,089,072
JBrowse link
G Tnni2 troponin I, skeletal, fast 2 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNNI2 mRNA CTD PMID:20370541 NCBI chr 7:141,995,553...141,998,147
Ensembl chr 7:141,995,545...141,998,147
JBrowse link
G Tnni3 troponin I, cardiac 3 affects localization EXP Zidovudine affects the localization of TNNI3 protein CTD PMID:17943461 NCBI chr 7:4,521,304...4,526,228
Ensembl chr 7:4,521,304...4,527,228
JBrowse link
G Trdmt1 tRNA aspartic acid methyltransferase 1 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TRDMT1 mRNA CTD PMID:20370541 NCBI chr 2:13,509,690...13,549,475
Ensembl chr 2:13,513,825...13,549,479
JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of TRIB3 mRNA CTD PMID:15784690 NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
JBrowse link
G Trim30a tripartite motif-containing 30A multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TRIM22 mRNA CTD PMID:20370541 NCBI chr 7:104,058,232...104,114,400
Ensembl chr 7:104,058,232...104,114,400
JBrowse link
G Trim42 tripartite motif-containing 42 multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TRIM42 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of TRIM42 mRNA CTD PMID:16931933 NCBI chr 9:97,231,615...97,252,011
Ensembl chr 9:97,231,615...97,252,011
JBrowse link
G Triqk triple QxxK/R motif containing multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of TRIQK mRNA CTD PMID:20370541 NCBI chr 4:12,906,837...12,981,485
Ensembl chr 4:12,906,838...12,983,553
JBrowse link
G Trmt44 tRNA methyltransferase 44 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TRMT44 mRNA CTD PMID:20370541 NCBI chr 5:35,713,552...35,732,424
Ensembl chr 5:35,713,547...35,732,414
JBrowse link
G Trp53 transformation related protein 53 increases expression ISO Zidovudine results in increased expression of TP53 protein CTD PMID:16797627 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Ttc21a tetratricopeptide repeat domain 21A multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of TTC21A mRNA CTD PMID:20370541 NCBI chr 9:119,766,656...119,798,496
Ensembl chr 9:119,766,672...119,796,859
JBrowse link
G Twnk twinkle mtDNA helicase multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of TWNK mRNA CTD PMID:18313992 NCBI chr19:44,994,102...45,001,203
Ensembl chr19:44,994,102...45,001,201
JBrowse link
G Tymp thymidine phosphorylase multiple interactions
increases expression
increases activity
ISO [5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine
Zidovudine results in increased expression of TYMP mRNA; Zidovudine results in increased expression of TYMP protein
CTD PMID:16457948 NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
JBrowse link
G Tyms thymidylate synthase multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of TYMS mRNA CTD PMID:15784690 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Tyrp1 tyrosinase-related protein 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in decreased expression of TYRP1 mRNA CTD PMID:15784690 NCBI chr 4:80,752,360...80,769,973
Ensembl chr 4:80,752,360...80,769,956
JBrowse link
G Ucp1 uncoupling protein 1 (mitochondrial, proton carrier) increases expression
decreases expression
ISO
EXP
Zidovudine results in increased expression of UCP1 mRNA
Zidovudine results in decreased expression of UCP1 mRNA
CTD PMID:14518702 PMID:17926646 NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
JBrowse link
G Ugt2b1 UDP glucuronosyltransferase 2 family, polypeptide B1 increases glucuronidation ISO UGT2B1 protein results in increased glucuronidation of Zidovudine CTD PMID:8302279 NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
JBrowse link
G Ugt2b34 UDP glucuronosyltransferase 2 family, polypeptide B34 decreases expression
increases expression
multiple interactions
increases glucuronidation
ISO Zidovudine results in decreased expression of UGT2B7 mRNA; Zidovudine results in decreased expression of UGT2B7 protein
Zidovudine results in increased expression of UGT2B7 mRNA; Zidovudine results in increased expression of UGT2B7 protein
10-hydroxywarfarin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine]; 4'-hydroxywarfarin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine]; 7-hydroxywarfarin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine]; [10-hydroxywarfarin binds to and results in decreased activity of UGT2B7 protein] which results in decreased glucuronidation of Zidovudine; [4'-hydroxywarfarin binds to and results in decreased activity of UGT2B7 protein] which results in decreased glucuronidation of Zidovudine; [7-hydroxywarfarin binds to and results in decreased activity of UGT2B7 protein] which results in decreased glucuronidation of Zidovudine; [Warfarin binds to and results in decreased activity of UGT2B7 protein] which results in decreased glucuronidation of Zidovudine; shikonin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine]; Warfarin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine]
CTD PMID:10772627 PMID:17898154 PMID:24292225 PMID:25393417 PMID:31128210 NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
JBrowse link
G Ulk1 unc-51 like kinase 1 decreases phosphorylation ISO Zidovudine results in decreased phosphorylation of ULK1 protein CTD PMID:29594326 NCBI chr 5:110,932,355...110,957,991
Ensembl chr 5:110,932,354...110,957,963
JBrowse link
G Uqcrb ubiquinol-cytochrome c reductase binding protein multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA CTD PMID:18313992 NCBI chr13:67,048,640...67,053,414
Ensembl chr13:67,048,681...67,053,442
JBrowse link
G Uqcrc1 ubiquinol-cytochrome c reductase core protein 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRC1 mRNA CTD PMID:17526437 PMID:18313992 NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691
JBrowse link
G Uqcrc2 ubiquinol cytochrome c reductase core protein 2 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of UQCRC2 mRNA CTD PMID:18313992 NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
JBrowse link
G Usp18 ubiquitin specific peptidase 18 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of USP18 mRNA CTD PMID:20370541 NCBI chr 6:121,222,865...121,247,876
Ensembl chr 6:121,222,865...121,247,876
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VDAC1 mRNA CTD PMID:18313992 NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
JBrowse link
G Vdr vitamin D (1,25-dihydroxyvitamin D3) receptor multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
JBrowse link
G Vps4b vacuolar protein sorting 4B multiple interactions EXP [Zidovudine co-treated with Lamivudine] results in decreased expression of VPS4B mRNA CTD PMID:16931933 NCBI chr 1:106,698,518...106,724,455
Ensembl chr 1:106,691,801...106,724,458
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of WARS1 mRNA CTD PMID:15784690 NCBI chr12:108,825,956...108,860,095
Ensembl chr12:108,825,956...108,860,100
JBrowse link
G Wdr62 WD repeat domain 62 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in decreased expression of WDR62 mRNA CTD PMID:20370541 NCBI chr 7:29,939,563...29,980,243
Ensembl chr 7:29,939,563...29,979,844
JBrowse link
G Wnt10a wingless-type MMTV integration site family, member 10A multiple interactions EXP [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of WNT10A mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of WNT10A mRNA CTD PMID:16931933 NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
JBrowse link
G Xpa xeroderma pigmentosum, complementation group A increases expression ISO Zidovudine results in increased expression of XPA mRNA; Zidovudine results in increased expression of XPA protein CTD PMID:21192964 PMID:23675285 NCBI chr 4:46,175,222...46,196,317
Ensembl chr 4:46,155,347...46,196,311
JBrowse link
G Xpc xeroderma pigmentosum, complementation group C decreases response to substance
increases expression
ISO XPC protein results in decreased susceptibility to Zidovudine
Zidovudine results in increased expression of XPC mRNA; Zidovudine results in increased expression of XPC protein
CTD PMID:21192964 PMID:23675285 NCBI chr 6:91,466,287...91,492,870
Ensembl chr 6:91,466,287...91,492,870
JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 multiple interactions ISO [Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA CTD PMID:15784690 NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400
JBrowse link
G Zfp629 zinc finger protein 629 multiple interactions ISO [Zidovudine co-treated with IFNA1 protein] results in increased expression of ZNF629 mRNA CTD PMID:20370541 NCBI chr 7:127,206,203...127,215,053
Ensembl chr 7:127,206,203...127,214,969
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 22194
    role 22179
      biological role 22178
        antimicrobial agent 19567
          antiviral agent 11407
            antiviral drug 1951
              1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine 0
              5-iodo-2'-deoxyuridine 4
              Descovy 0
              EC 3.2.1.18 (exo-alpha-sialidase) inhibitor + 19
              Epclusa 0
              GS-441524 monophosphate 0
              GS-443902 0
              Genvoya 0
              HIV fusion inhibitor + 12
              Harvoni 0
              Kaletra 0
              N-acetyl-L-cysteinate + 0
              N-acetyl-L-cysteine + 951
              Odefsey 0
              Prezcobix 0
              Technivie 0
              Viekira Pak 0
              Zepatier 0
              abacavir + 32
              acyclovir 19
              adefovir + 116
              adefovir pivoxil 102
              amantadine 11
              amantadine sulfate 0
              amprenavir 5
              aphidicolin 21
              atazanavir + 120
              boceprevir 0
              cidofovir anhydrous + 267
              cidofovir dihydrate 0
              costunolide + 7
              daclatasvir 0
              daclatasvir hydrochloride 0
              darunavir + 0
              dasabuvir 0
              dasabuvir sodium + 0
              dasabuvir sodium hydrate + 0
              delavirdine + 2
              delavirdine mesylate 0
              didanosine 6
              docosan-1-ol + 0
              efavirenz 43
              elbasvir + 0
              emivirine 0
              emtricitabine + 5
              entecavir (anhydrous) + 0
              entecavir hydrate 0
              famciclovir 0
              favipiravir + 1
              favipiravir-RTP 0
              floxuridine 16
              ganciclovir + 4
              gemcitabine + 284
              gemcitabine hydrochloride 0
              grazoprevir + 0
              lamivudine 225
              ledipasvir + 3
              lopinavir + 15
              maraviroc 9
              molnupiravir 0
              narlaprevir 0
              nevirapine + 129
              ombitasvir + 0
              oseltamivir + 5
              oseltamivir acid 0
              paritaprevir + 0
              penciclovir 0
              peramivir 0
              peramivir hydrate + 0
              phosphonoformic acid + 9
              raltegravir 0
              remdesivir 27
              ritonavir + 113
              saquinavir 85
              seliciclib 4
              sofosbuvir + 2
              telaprevir 0
              telbivudine 9
              tenofovir (anhydrous) + 44
              tenofovir alafenamide 0
              tenofovir alafenamide fumarate + 0
              tenofovir disoproxil + 44
              tenofovir disoproxil fumarate 44
              tenofovir hydrate 0
              tenofovir(1-) 0
              tilorone dihydrochloride 0
              tipranavir 2
              trifluridine + 11
              trisodium phosphonoformate + 0
              trisodium phosphonoformate hexahydrate 0
              valacyclovir 0
              valganciclovir 0
              vaniprevir 0
              velpatasvir + 0
              zalcitabine 53
              zidovudine 532
Path 2
Term Annotations click to browse term
  CHEBI ontology 22194
    role 22179
      application 21760
        pharmaceutical 21174
          drug 21174
            antiinfective agent 16301
              antimicrobial drug 9894
                antiviral drug 1951
                  1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine 0
                  5-iodo-2'-deoxyuridine 4
                  Descovy 0
                  EC 3.2.1.18 (exo-alpha-sialidase) inhibitor + 19
                  Epclusa 0
                  GS-441524 monophosphate 0
                  GS-443902 0
                  Genvoya 0
                  HIV fusion inhibitor + 12
                  Harvoni 0
                  Kaletra 0
                  N-acetyl-L-cysteinate + 0
                  N-acetyl-L-cysteine + 951
                  Odefsey 0
                  Prezcobix 0
                  Technivie 0
                  Viekira Pak 0
                  Zepatier 0
                  abacavir + 32
                  acyclovir 19
                  adefovir + 116
                  adefovir pivoxil 102
                  amantadine 11
                  amantadine sulfate 0
                  amprenavir 5
                  aphidicolin 21
                  atazanavir + 120
                  boceprevir 0
                  cidofovir anhydrous + 267
                  cidofovir dihydrate 0
                  costunolide + 7
                  daclatasvir 0
                  daclatasvir hydrochloride 0
                  darunavir + 0
                  dasabuvir 0
                  dasabuvir sodium + 0
                  dasabuvir sodium hydrate + 0
                  delavirdine + 2
                  delavirdine mesylate 0
                  didanosine 6
                  docosan-1-ol + 0
                  efavirenz 43
                  elbasvir + 0
                  emivirine 0
                  emtricitabine + 5
                  entecavir (anhydrous) + 0
                  entecavir hydrate 0
                  famciclovir 0
                  favipiravir + 1
                  favipiravir-RTP 0
                  floxuridine 16
                  ganciclovir + 4
                  gemcitabine + 284
                  gemcitabine hydrochloride 0
                  grazoprevir + 0
                  lamivudine 225
                  ledipasvir + 3
                  lopinavir + 15
                  maraviroc 9
                  molnupiravir 0
                  narlaprevir 0
                  nevirapine + 129
                  ombitasvir + 0
                  oseltamivir + 5
                  oseltamivir acid 0
                  paritaprevir + 0
                  penciclovir 0
                  peramivir 0
                  peramivir hydrate + 0
                  phosphonoformic acid + 9
                  raltegravir 0
                  remdesivir 27
                  ritonavir + 113
                  saquinavir 85
                  seliciclib 4
                  sofosbuvir + 2
                  telaprevir 0
                  telbivudine 9
                  tenofovir (anhydrous) + 44
                  tenofovir alafenamide 0
                  tenofovir alafenamide fumarate + 0
                  tenofovir disoproxil + 44
                  tenofovir disoproxil fumarate 44
                  tenofovir hydrate 0
                  tenofovir(1-) 0
                  tilorone dihydrochloride 0
                  tipranavir 2
                  trifluridine + 11
                  trisodium phosphonoformate + 0
                  trisodium phosphonoformate hexahydrate 0
                  valacyclovir 0
                  valganciclovir 0
                  vaniprevir 0
                  velpatasvir + 0
                  zalcitabine 53
                  zidovudine 532
paths to the root